{ "meta": { "tracker_site_url": "https://psilocybin-research.com", "publication_tracker_url": "https://psilocybin-research.com/", "generated_at_utc": "2026-08-23 23:06:29", "record_count": 1741, "schema_variant": "rights-safe-core-v1", "text_redistribution": "Source-derived abstracts, descriptions, keywords, and unrestricted payload text are not redistributed." }, "papers": [ { "id": 64, "title": "Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression", "authors": "Kelly Carlton M., Fradet Mathieu, Bostian Catherine M., Donnelly Anna, Ellis Sara, Ostacher Michael, Aaronson Scott, Suppes Trisha", "journal": "Journal of Affective Disorders", "publication_date": "2026-11-01", "publication_year": 2026, "doi": "10.1016/j.jad.2026.122063", "pubmed_id": "42248535", "openalex_id": "https://openalex.org/W7163510976", "source_url": "https://doi.org/10.1016/j.jad.2026.122063", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Treatment-Resistant Depression,Veterans", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:45", "bibtex": null, "source_record_id": "PMID:42248535", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.122063", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42248535", "source_url": "https://doi.org/10.1016/j.jad.2026.122063", "doi": "10.1016/j.jad.2026.122063", "pmid": "42248535", "publication_date": "2026-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1990, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.", "authors": "Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2026-09-01", "publication_year": 2026, "doi": "10.1177/28314425251404460", "pubmed_id": "42539893", "openalex_id": "https://openalex.org/W7116873484", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42539893/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:27:44", "bibtex": null, "source_record_id": "PMID:42539893", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42539893/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42539893", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42539893/", "doi": "10.1177/28314425251404460", "pmid": "42539893", "publication_date": "2026-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 301, "title": "Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress", "authors": "Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki", "journal": "Neuropsychopharmacology Reports", "publication_date": "2026-09-01", "publication_year": 2026, "doi": "10.1002/npr2.70152", "pubmed_id": "42379141", "openalex_id": "https://openalex.org/W7166665532", "source_url": "https://doi.org/10.1002/npr2.70152", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Resilience,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:03", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:42379141", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/npr2.70152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42379141", "source_url": "https://doi.org/10.1002/npr2.70152", "doi": "10.1002/npr2.70152", "pmid": "42379141", "publication_date": "2026-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 46, "title": "Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.", "authors": "Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC", "journal": "Journal of clinical psychology", "publication_date": "2026-09-01", "publication_year": 2026, "doi": "10.1002/jclp.70167", "pubmed_id": "42296474", "openalex_id": "https://openalex.org/W7164838909", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42296474/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:44", "bibtex": null, "source_record_id": "PMID:42296474", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42296474/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42296474", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42296474/", "doi": "10.1002/jclp.70167", "pmid": "42296474", "publication_date": "2026-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4169, "title": "Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies", "authors": "Belle Buzzi", "journal": "VCU Scholars Compass (Virginia Commonwealth University)", "publication_date": "2026-08-21", "publication_year": 2026, "doi": "10.25772/0t5k-3r51", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127870091", "source_url": "https://scholarscompass.vcu.edu/etd/8246", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "DOI:10.25772/0t5k-3r51", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholarscompass.vcu.edu/etd/8246", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25772/0t5k-3r51", "source_url": "https://scholarscompass.vcu.edu/etd/8246", "doi": "10.25772/0t5k-3r51", "pmid": "", "publication_date": "2026-08-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3540, "title": "Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07211438", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-23 01:23:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07211438", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07211438", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07211438", "source_url": "https://clinicaltrials.gov/study/NCT07211438", "doi": "", "pmid": "", "publication_date": "2026-08-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5878, "title": "Psilocybin lengthens hippocampal sharp wave ripples", "authors": "Bozkir, I. K.; Lashin, R.; Liu, T.; Pal, D.; Diba, K.; Kinsky, N. R.", "journal": "bioRxiv", "publication_date": "2026-08-20", "publication_year": 2026, "doi": "10.64898/2026.08.17.745042", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.08.17.745042", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-08-23 01:20:15", "last_checked": "2026-08-23 01:21:56", "bibtex": null, "source_record_id": "DOI:10.64898/2026.08.17.745042", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.08.17.745042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.08.17.745042", "source_url": "https://doi.org/10.64898/2026.08.17.745042", "doi": "10.64898/2026.08.17.745042", "pmid": "", "publication_date": "2026-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5877, "title": "The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review", "authors": "Clark Rachel N", "journal": "Lynchburg Journal of Medical Science", "publication_date": "2026-08-20", "publication_year": 2026, "doi": "10.63932/3067-7106.1087", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.63932/3067-7106.1087", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-22 01:20:15", "last_checked": "2026-08-23 01:20:15", "bibtex": null, "source_record_id": "DOI:10.63932/3067-7106.1087", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.63932/3067-7106.1087", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.63932/3067-7106.1087", "source_url": "https://doi.org/10.63932/3067-7106.1087", "doi": "10.63932/3067-7106.1087", "pmid": "", "publication_date": "2026-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3607, "title": "Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-20", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07607938", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Emotional Processing", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-23 01:23:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07607938", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07607938", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07607938", "source_url": "https://clinicaltrials.gov/study/NCT07607938", "doi": "", "pmid": "", "publication_date": "2026-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5867, "title": "Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services", "authors": "Korthuis P. Todd, Cook Ryan R., Gregoire Devin, Stauffer Christopher S., Luoma Jason B., Pertl Kellie, Des Jarlais Don, McCarty Dennis, Levander Ximena A., Hoffman Kim A., Wilson-Poe Adrianne R.", "journal": "JAMA Network Open", "publication_date": "2026-08-19", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.30608", "pubmed_id": "42616497", "openalex_id": "https://openalex.org/W7203781486", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.30608", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Wellbeing,Observational Study,Veterans,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-20 01:20:15", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "PMID:42616497", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.30608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42616497", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.30608", "doi": "10.1001/jamanetworkopen.2026.30608", "pmid": "42616497", "publication_date": "2026-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5710, "title": "Prospective real-world evidence of mental health outcomes following supervised psilocybin services within Oregons state-regulated model", "authors": "Gow, A.; Shih, E.; Reid, R.; Qian, J. J.; Mellor, C.; McInnes, L. A.; Carhart-Harris, R.; Davis, J. N.", "journal": "medRxiv", "publication_date": "2026-08-19", "publication_year": 2026, "doi": "10.64898/2026.02.18.26346580", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.02.18.26346580", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Observational Study", "study_type": "Observational Study", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-23 01:20:34", "bibtex": null, "source_record_id": "DOI:10.64898/2026.02.18.26346580", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.02.18.26346580", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.02.18.26346580", "source_url": "https://doi.org/10.64898/2026.02.18.26346580", "doi": "10.64898/2026.02.18.26346580", "pmid": "", "publication_date": "2026-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5866, "title": "Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care", "authors": "Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements", "journal": null, "publication_date": "2026-08-17", "publication_year": 2026, "doi": "10.5281/zenodo.21983116", "pubmed_id": null, "openalex_id": "https://openalex.org/W7203633773", "source_url": "https://doi.org/10.5281/zenodo.21983116", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-19 01:20:25", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.21983116", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.21983116", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.21983116", "source_url": "https://doi.org/10.5281/zenodo.21983116", "doi": "10.5281/zenodo.21983116", "pmid": "", "publication_date": "2026-08-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3472, "title": "A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans", "authors": "VA Office of Research and Development", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07226232", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-21 01:27:46", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07226232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07226232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07226232", "source_url": "https://clinicaltrials.gov/study/NCT07226232", "doi": "", "pmid": "", "publication_date": "2026-08-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5862, "title": "Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.", "authors": "Meshkat S, Leung M, Meshkat S, Lin Q, Wijendran D, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Monson CM, Vermetten E, Jetly R, Lou W, Zeifman RJ, Bhat V.", "journal": "CNS drugs", "publication_date": "2026-08-13", "publication_year": 2026, "doi": "10.1007/s40263-026-01325-5", "pubmed_id": "42593636", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40263-026-01325-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Microdosing,Personality Change,Creativity,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-15 01:20:04", "last_checked": "2026-08-20 01:20:16", "bibtex": null, "source_record_id": "PMID:42593636", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-026-01325-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42593636", "source_url": "https://doi.org/10.1007/s40263-026-01325-5", "doi": "10.1007/s40263-026-01325-5", "pmid": "42593636", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3562, "title": "Processing Intergenerational Trauma With Psilocybin-Assisted Therapy", "authors": "Rachel Yehuda", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06899165", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Biomarkers,Wellbeing,Resilience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-20 01:29:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06899165", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06899165", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06899165", "source_url": "https://clinicaltrials.gov/study/NCT06899165", "doi": "", "pmid": "", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3539, "title": "The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder", "authors": "Sharmin Ghaznavi", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06247839", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-20 01:29:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06247839", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06247839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06247839", "source_url": "https://clinicaltrials.gov/study/NCT06247839", "doi": "", "pmid": "", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5856, "title": "Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)", "authors": "Anghel Teodora, Cojocaru Adriana, Hogea Lavinia, Costea Iuliana, Marinca Amalia, Dumache Raluca, Nussbaum Laura, Trăilă Iuliana-Anamaria", "journal": "Journal of Clinical Medicine", "publication_date": "2026-08-12", "publication_year": 2026, "doi": "10.3390/jcm15166228", "pubmed_id": null, "openalex_id": "https://openalex.org/W7202254245", "source_url": "https://doi.org/10.3390/jcm15166228", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-13 01:20:21", "last_checked": "2026-08-19 01:20:25", "bibtex": null, "source_record_id": "DOI:10.3390/jcm15166228", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/jcm15166228", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3390/jcm15166228", "source_url": "https://doi.org/10.3390/jcm15166228", "doi": "10.3390/jcm15166228", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3684, "title": "TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy", "authors": "M.D. Anderson Cancer Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06200155", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06200155", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06200155", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06200155", "source_url": "https://clinicaltrials.gov/study/NCT06200155", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3674, "title": "TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors", "authors": "M.D. Anderson Cancer Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06801041", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06801041", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06801041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06801041", "source_url": "https://clinicaltrials.gov/study/NCT06801041", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3581, "title": "Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality", "authors": "The University of Texas Health Science Center, Houston", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06706232", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06706232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "source_url": "https://clinicaltrials.gov/study/NCT06706232", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5858, "title": "Psychedelic Therapy for Depression", "authors": "Saanvi Gutta", "journal": null, "publication_date": "2026-08-11", "publication_year": 2026, "doi": "10.5281/zenodo.21893916", "pubmed_id": null, "openalex_id": "https://openalex.org/W7202215062", "source_url": "https://doi.org/10.5281/zenodo.21893916", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-13 01:20:27", "last_checked": "2026-08-18 01:20:14", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.21893916", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.21893916", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.21893916", "source_url": "https://doi.org/10.5281/zenodo.21893916", "doi": "10.5281/zenodo.21893916", "pmid": "", "publication_date": "2026-08-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5855, "title": "Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.", "authors": "Kaadt E, Søkilde RF, Garling HD, Raval NR, Lundgaard L, Just J, Knudsen GM, Elfving B.", "journal": "European journal of pharmacology", "publication_date": "2026-08-11", "publication_year": 2026, "doi": "10.1016/j.ejphar.2026.179222", "pubmed_id": "42580506", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.ejphar.2026.179222", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Adolescents", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-13 01:20:05", "last_checked": "2026-08-18 01:20:10", "bibtex": null, "source_record_id": "PMID:42580506", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ejphar.2026.179222", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42580506", "source_url": "https://doi.org/10.1016/j.ejphar.2026.179222", "doi": "10.1016/j.ejphar.2026.179222", "pmid": "42580506", "publication_date": "2026-08-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3523, "title": "Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06656702", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-18 01:24:17", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06656702", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06656702", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06656702", "source_url": "https://clinicaltrials.gov/study/NCT06656702", "doi": "", "pmid": "", "publication_date": "2026-08-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3642, "title": "An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)", "authors": "Charles Raison", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06512194", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Wellbeing,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06512194", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06512194", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06512194", "source_url": "https://clinicaltrials.gov/study/NCT06512194", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3532, "title": "A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05711940", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05711940", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "source_url": "https://clinicaltrials.gov/study/NCT05711940", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3531, "title": "Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury", "authors": "James J. Peters Veterans Affairs Medical Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07251491", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Wellbeing,Veterans,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07251491", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07251491", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07251491", "source_url": "https://clinicaltrials.gov/study/NCT07251491", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3521, "title": "A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05624268", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05624268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "source_url": "https://clinicaltrials.gov/study/NCT05624268", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3453, "title": "Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06506019", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06506019", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06506019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06506019", "source_url": "https://clinicaltrials.gov/study/NCT06506019", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5746, "title": "Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease", "authors": "National Institute on Aging (NIA)", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07721467", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Mitochondrial Function,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Older Adults,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-24 01:25:24", "last_checked": "2026-08-14 01:24:53", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07721467", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07721467", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07721467", "source_url": "https://clinicaltrials.gov/study/NCT07721467", "doi": "", "pmid": "", "publication_date": "2026-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3561, "title": "The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease", "authors": "Joshua Woolley, MD, PhD", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06455293", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Microdosing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-14 01:24:53", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06455293", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06455293", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06455293", "source_url": "https://clinicaltrials.gov/study/NCT06455293", "doi": "", "pmid": "", "publication_date": "2026-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5779, "title": "Correspondence: \"Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy\".", "authors": "Hörnqvist N.", "journal": "Journal of affective disorders", "publication_date": "2026-08-06", "publication_year": 2026, "doi": "10.1016/j.jad.2026.122315", "pubmed_id": "42562064", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2026.122315", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-07 01:20:13", "last_checked": "2026-08-13 01:20:23", "bibtex": null, "source_record_id": "PMID:42562064", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42562064", "source_url": "https://doi.org/10.1016/j.jad.2026.122315", "doi": "10.1016/j.jad.2026.122315", "pmid": "42562064", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5778, "title": "Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.", "authors": "Rucker JJ, Mantingh T, Kerr-Gaffney J, Bird C, Chu P, Modlin NL, Campbell-Coker K, Hambleton S, Seath P, Hignett R, Fennema D, Hampsey E, Tsapekos D, Thomas RJ, Cattell J, Jafari H, Day C, Borissova A, Lloyd M, Boardman-Pretty T, Seynaeve M, Askari F, Creed M, Baxter L, Rifkin-Zybutz R, Butler M, Jelen LA, Carter B, Young AH.", "journal": "Nature medicine", "publication_date": "2026-08-06", "publication_year": 2026, "doi": "10.1038/s41591-026-04541-0", "pubmed_id": "42562964", "openalex_id": "https://openalex.org/W7196979420", "source_url": "https://doi.org/10.1038/s41591-026-04541-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-07 01:20:12", "last_checked": "2026-08-13 01:20:27", "bibtex": null, "source_record_id": "PMID:42562964", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41591-026-04541-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42562964", "source_url": "https://doi.org/10.1038/s41591-026-04541-0", "doi": "10.1038/s41591-026-04541-0", "pmid": "42562964", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3704, "title": "Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder", "authors": "Trent Emerick", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07406828", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-13 01:25:57", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07406828", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "source_url": "https://clinicaltrials.gov/study/NCT07406828", "doi": "", "pmid": "", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3582, "title": "Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731621", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-13 01:25:57", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731621", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "source_url": "https://clinicaltrials.gov/study/NCT06731621", "doi": "", "pmid": "", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1369, "title": "A suite of engineered mice for interrogating psychedelic drug actions.", "authors": "Chiu YT, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD, Llorach P, Bowyer KR, Liu B, Sciaky N, Hua K, Chen C, Mott SE, Niehaus J, DiBerto JF, English J, Walsh JJ, Scherrer G, Herman MA, Wu Z, Wetsel WC, Roth BL.", "journal": "Nature neuroscience", "publication_date": "2026-08-06", "publication_year": 2026, "doi": "10.1038/s41593-026-02375-0", "pubmed_id": "42563032", "openalex_id": "https://openalex.org/W4387039546", "source_url": "https://doi.org/10.1038/s41593-026-02375-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-13 01:20:27", "bibtex": null, "source_record_id": "PMID:42563032", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41593-026-02375-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42563032", "source_url": "https://doi.org/10.1038/s41593-026-02375-0", "doi": "10.1038/s41593-026-02375-0", "pmid": "42563032", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5846, "title": "Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07745569", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Brain Imaging,Aging,Emotional Processing,Observational Study,Safety,Transcriptomics", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-08-09 10:12:43", "last_checked": "2026-08-11 01:26:59", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07745569", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07745569", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07745569", "source_url": "https://clinicaltrials.gov/study/NCT07745569", "doi": "", "pmid": "", "publication_date": "2026-08-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5776, "title": "Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.", "authors": "Kuypers KPC, Mason NL, Carlier A, Totomanova I, Haijen-Bongers ECHM.", "journal": "Molecular psychiatry", "publication_date": "2026-08-04", "publication_year": 2026, "doi": "10.1038/s41380-026-03801-2", "pubmed_id": "42552418", "openalex_id": "https://openalex.org/W7172382485", "source_url": "https://doi.org/10.1038/s41380-026-03801-2", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Longevity,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-06 01:20:05", "last_checked": "2026-08-11 01:20:23", "bibtex": null, "source_record_id": "PMID:42552418", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-026-03801-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42552418", "source_url": "https://doi.org/10.1038/s41380-026-03801-2", "doi": "10.1038/s41380-026-03801-2", "pmid": "42552418", "publication_date": "2026-08-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5773, "title": "Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.", "authors": "Schaefer DA, Agrawal M, Mazzola E, Leff MK, Leeks C, Kematick BS, Beaussant Y.", "journal": "Journal of pain and symptom management", "publication_date": "2026-08-03", "publication_year": 2026, "doi": "10.1016/j.jpainsymman.2026.07.030", "pubmed_id": "42546985", "openalex_id": "https://openalex.org/W7172261546", "source_url": "https://doi.org/10.1016/j.jpainsymman.2026.07.030", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-04 01:20:19", "last_checked": "2026-08-10 01:20:17", "bibtex": null, "source_record_id": "PMID:42546985", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpainsymman.2026.07.030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42546985", "source_url": "https://doi.org/10.1016/j.jpainsymman.2026.07.030", "doi": "10.1016/j.jpainsymman.2026.07.030", "pmid": "42546985", "publication_date": "2026-08-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5752, "title": "Evaluating psilocybin for the management of depression: a literature review", "authors": "Sinclair Rachel", "journal": "British Journal of Mental Health Nursing", "publication_date": "2026-08-02", "publication_year": 2026, "doi": "10.12968/bjmh.2025.0020", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171361377", "source_url": "https://doi.org/10.12968/bjmh.2025.0020", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Microdosing,Wellbeing,Review Article,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-29 01:20:18", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.12968/bjmh.2025.0020", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.12968/bjmh.2025.0020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.12968/bjmh.2025.0020", "source_url": "https://doi.org/10.12968/bjmh.2025.0020", "doi": "10.12968/bjmh.2025.0020", "pmid": "", "publication_date": "2026-08-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5729, "title": "From trial to clinic: psilocybin's efficacy in routine treatment-resistant depression.", "authors": "Martiadis V", "journal": "The Lancet regional health. Europe", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1016/j.lanepe.2026.101780", "pubmed_id": "42519708", "openalex_id": "https://openalex.org/W7168392508", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42519708/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-18 01:20:14", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42519708", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42519708/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42519708", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42519708/", "doi": "10.1016/j.lanepe.2026.101780", "pmid": "42519708", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 63, "title": "Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.", "authors": "Lu S, Zhang Z, Xue X, Jiang Y, Zhang C, Liu P, He D, Shen W, Yang S, Wang F", "journal": "Hearing research", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1016/j.heares.2026.109701", "pubmed_id": "42289149", "openalex_id": "https://openalex.org/W7163574586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42289149/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42289149", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42289149/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42289149", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42289149/", "doi": "10.1016/j.heares.2026.109701", "pmid": "42289149", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 54, "title": "Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression", "authors": "Mingardi J., Molteni R., Bifari F.", "journal": "Pharmacological Research", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1016/j.phrs.2026.108290", "pubmed_id": "42276399", "openalex_id": "https://openalex.org/W7164387819", "source_url": "https://doi.org/10.1016/j.phrs.2026.108290", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42276399", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42276399", "source_url": "https://doi.org/10.1016/j.phrs.2026.108290", "doi": "10.1016/j.phrs.2026.108290", "pmid": "42276399", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5, "title": "Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis", "authors": "Kishi Taro, Sakuma Kenji, Hatano Masakazu, Uchida Hiroyuki, Iwata Nakao", "journal": "Journal of Affective Disorders", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121675", "pubmed_id": "41876058", "openalex_id": "https://openalex.org/W7140041737", "source_url": "https://doi.org/10.1016/j.jad.2026.121675", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:41876058", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.121675", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41876058", "source_url": "https://doi.org/10.1016/j.jad.2026.121675", "doi": "10.1016/j.jad.2026.121675", "pmid": "41876058", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4, "title": "The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis", "authors": "Goodwin Guy M., Aaronson Scott T., Alvarez Oscar, Carhart-Harris Robin, Croal Megan, Feifel David, Hellerstein David J., Husain Muhammad I., Kelly John R., Kirlic Namik, Licht Rasmus W., Marwood Lindsey, Nowakowska Ania, Páleníček Tomáš, Repantis Dimitris, Schoevers Robert A., Simmons Hollie, Soares Jair C., Somers Metten, Tsai Joyce, Wahba Mourad, Williams Ella, Young Allan H., Young Matthew B., Zisook Sidney, Malievskaia Ekaterina", "journal": "Journal of Affective Disorders", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121662", "pubmed_id": "41881122", "openalex_id": "https://openalex.org/W7140125435", "source_url": "https://doi.org/10.1016/j.jad.2026.121662", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:41881122", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.121662", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41881122", "source_url": "https://doi.org/10.1016/j.jad.2026.121662", "doi": "10.1016/j.jad.2026.121662", "pmid": "41881122", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3576, "title": "A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-31", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07336238", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07336238", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "source_url": "https://clinicaltrials.gov/study/NCT07336238", "doi": "", "pmid": "", "publication_date": "2026-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5770, "title": "Retreat from racism: A psychedelic group experience for racial stress and trauma", "authors": "Sergio R Pérez Rosal, Sonya Faber, M. Myriah MacIntyre, Monnica Williams", "journal": "Psychedelics", "publication_date": "2026-07-30", "publication_year": 2026, "doi": "10.1016/j.psyche.2026.100031", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171783611", "source_url": "https://doi.org/10.1016/j.psyche.2026.100031", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Mechanism of Action,Wellbeing,Spirituality,Psychological Flexibility,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-03 01:20:22", "last_checked": "2026-08-09 08:24:59", "bibtex": null, "source_record_id": "DOI:10.1016/j.psyche.2026.100031", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psyche.2026.100031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psyche.2026.100031", "source_url": "https://doi.org/10.1016/j.psyche.2026.100031", "doi": "10.1016/j.psyche.2026.100031", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5761, "title": "Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression", "authors": "Joshua Rosenblat", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07737990", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-31 01:27:07", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07737990", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07737990", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07737990", "source_url": "https://clinicaltrials.gov/study/NCT07737990", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5760, "title": "Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for Post-Traumatic Stress Disorder", "authors": "Tel-Aviv Sourasky Medical Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07737054", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Psychological Flexibility,Clinical Trial,Randomized Controlled Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-31 01:27:07", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07737054", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07737054", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07737054", "source_url": "https://clinicaltrials.gov/study/NCT07737054", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3647, "title": "Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06512220", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06512220", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06512220", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06512220", "source_url": "https://clinicaltrials.gov/study/NCT06512220", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3591, "title": "Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06518720", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06518720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "source_url": "https://clinicaltrials.gov/study/NCT06518720", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5757, "title": "Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica", "authors": "Sams Caitlyn Hanna, Davis Jasmine, Ramdas Anuradha, Delgoda Rupika, Vidot Denise, Reid Marvin, De La Haye Winston", "journal": "Frontiers in Psychiatry", "publication_date": "2026-07-29", "publication_year": 2026, "doi": "10.3389/fpsyt.2026.1876189", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171627278", "source_url": "https://doi.org/10.3389/fpsyt.2026.1876189", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Chronic Pain,Resilience,Mystical Experience", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-30 01:20:09", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.3389/fpsyt.2026.1876189", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2026.1876189", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3389/fpsyt.2026.1876189", "source_url": "https://doi.org/10.3389/fpsyt.2026.1876189", "doi": "10.3389/fpsyt.2026.1876189", "pmid": "", "publication_date": "2026-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5756, "title": "Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.", "authors": "Jones GH, Gilbert JR, Johnston JN, Akula N, Schulmann A, Arakelian M, Peng S, Yuan P, Winful EA, Yavi M, Quintanilla B, Elkahloun A, Moaddel R, Henter ID, Greenstein D, Machado-Vieira R, Bartley CM, Kadriu B, Amit M, Rezvani K, Kvarta MD, McMahon FJ, Zarate CA", "journal": "Molecular psychiatry", "publication_date": "2026-07-28", "publication_year": 2026, "doi": "10.1038/s41380-026-03777-z", "pubmed_id": "42521762", "openalex_id": "https://openalex.org/W7171585406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42521762/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Healthy Volunteers,Treatment-Resistant Depression,Transcriptomics,Proteomics,Immune Function", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-30 01:20:03", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42521762", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42521762/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42521762", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42521762/", "doi": "10.1038/s41380-026-03777-z", "pmid": "42521762", "publication_date": "2026-07-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5755, "title": "Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.", "authors": "Pontifícia Universidade Católica do Rio de Janeiro", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07732166", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Healthy Volunteers", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-29 01:27:13", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07732166", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07732166", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07732166", "source_url": "https://clinicaltrials.gov/study/NCT07732166", "doi": "", "pmid": "", "publication_date": "2026-07-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5748, "title": "Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.", "authors": "Wilkowska A, Nizgorska-Ohler J, Cubała WJ", "journal": "Molecular neurobiology", "publication_date": "2026-07-28", "publication_year": 2026, "doi": "10.1007/s12035-026-06086-2", "pubmed_id": "42517990", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42517990/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Epigenetics,Systematic Review,Review Article,Animal Study,Treatment-Resistant Depression,Inflammation", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-29 01:20:04", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42517990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42517990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42517990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42517990/", "doi": "10.1007/s12035-026-06086-2", "pmid": "42517990", "publication_date": "2026-07-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5758, "title": "A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in Depression", "authors": "Danial Beniameen, Armya Beniameen", "journal": "Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal", "publication_date": "2026-07-27", "publication_year": 2026, "doi": "10.26685/urncst.1027", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171560399", "source_url": "https://doi.org/10.26685/urncst.1027", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Consciousness,Biomarkers,Aging,Clinical Trial,Systematic Review,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-30 01:20:13", "last_checked": "2026-07-30 01:20:13", "bibtex": null, "source_record_id": "DOI:10.26685/urncst.1027", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26685/urncst.1027", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26685/urncst.1027", "source_url": "https://doi.org/10.26685/urncst.1027", "doi": "10.26685/urncst.1027", "pmid": "", "publication_date": "2026-07-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5751, "title": "Participants' Music Experiences Associated With Psychedelic-Assisted Psychotherapy for Life-Threatening Illness: Interpretivist Research.", "authors": "O'Callaghan C, Kallianis V, Ross M", "journal": "Journal of music therapy", "publication_date": "2026-07-24", "publication_year": 2026, "doi": "10.1093/jmt/thag015", "pubmed_id": "42517555", "openalex_id": "https://openalex.org/W7171508041", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42517555/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Aging,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-29 01:20:05", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42517555", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42517555/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42517555", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42517555/", "doi": "10.1093/jmt/thag015", "pmid": "42517555", "publication_date": "2026-07-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3590, "title": "Psilocybin and Affective Function in Chronic Lower Back Pain Depression", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-24", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06355414", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Observational Study,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06355414", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06355414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06355414", "source_url": "https://clinicaltrials.gov/study/NCT06355414", "doi": "", "pmid": "", "publication_date": "2026-07-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3615, "title": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06308653", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06308653", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06308653", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06308653", "source_url": "https://clinicaltrials.gov/study/NCT06308653", "doi": "", "pmid": "", "publication_date": "2026-07-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3566, "title": "A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety", "authors": "Ohio State University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06820723", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06820723", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06820723", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06820723", "source_url": "https://clinicaltrials.gov/study/NCT06820723", "doi": "", "pmid": "", "publication_date": "2026-07-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3522, "title": "Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06814522", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Biomarkers,Wellbeing,Emotional Processing,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06814522", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06814522", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06814522", "source_url": "https://clinicaltrials.gov/study/NCT06814522", "doi": "", "pmid": "", "publication_date": "2026-07-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5845, "title": "The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-20", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07610369", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-08-09 10:12:43", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07610369", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07610369", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07610369", "source_url": "https://clinicaltrials.gov/study/NCT07610369", "doi": "", "pmid": "", "publication_date": "2026-07-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5734, "title": "Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression", "authors": "Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra Blicharz, Wojciech Kozdraś, Lidia Kozaczko, Gabriela Szewczyk, Elżbieta Bukowczan, Alicja Zając, Damian Broda, Alicja Benecka", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-07-17", "publication_year": 2026, "doi": "10.5281/zenodo.21406174", "pubmed_id": null, "openalex_id": "https://openalex.org/W7169604178", "source_url": "https://doi.org/10.5281/zenodo.21406174", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-19 01:20:13", "last_checked": "2026-08-09 08:25:00", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.21406174", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.21406174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.21406174", "source_url": "https://doi.org/10.5281/zenodo.21406174", "doi": "10.5281/zenodo.21406174", "pmid": "", "publication_date": "2026-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5731, "title": "A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin", "authors": "Diamond Therapeutics Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07710027", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Biomarkers,Review Article,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-18 01:24:24", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07710027", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07710027", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07710027", "source_url": "https://clinicaltrials.gov/study/NCT07710027", "doi": "", "pmid": "", "publication_date": "2026-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5730, "title": "Publication bias in randomized trials of psilocybin for depression: a Robust Bayesian Meta-Analysis", "authors": "Çağrı Özkurt", "journal": "PsyArXiv", "publication_date": "2026-07-17", "publication_year": 2026, "doi": "10.31234/osf.io/6gy8v_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6gy8v_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-18 01:24:20", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/6gy8v_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6gy8v_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/6gy8v_v1", "source_url": "https://osf.io/preprints/psyarxiv/6gy8v_v1", "doi": "10.31234/osf.io/6gy8v_v1", "pmid": "", "publication_date": "2026-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5735, "title": "Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder", "authors": "Jakub Bajer, Aleksandra Włodarczyk, Hubert Kulawinek, Julia Obersztyn, Krzysztof Kasparek, Marta Czech, Grzegorz Kasparek, Adrianna Szczecińska, Wiktoria Glanert, Aleksandra Mliczek, Piotr Mrozek", "journal": "Journal of Education Health and Sport", "publication_date": "2026-07-16", "publication_year": 2026, "doi": "10.12775/jehs.2026.94.73071", "pubmed_id": null, "openalex_id": "https://openalex.org/W7169523177", "source_url": "https://doi.org/10.12775/jehs.2026.94.73071", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-19 01:20:13", "last_checked": "2026-08-09 08:25:00", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2026.94.73071", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2026.94.73071", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2026.94.73071", "source_url": "https://doi.org/10.12775/jehs.2026.94.73071", "doi": "10.12775/jehs.2026.94.73071", "pmid": "", "publication_date": "2026-07-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5722, "title": "Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled Trial", "authors": "Khyber Medical University Peshawar", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07703722", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Emotional Processing,Randomized Controlled Trial,Microbiome,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-15 01:27:00", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07703722", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07703722", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07703722", "source_url": "https://clinicaltrials.gov/study/NCT07703722", "doi": "", "pmid": "", "publication_date": "2026-07-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5717, "title": "Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview", "authors": "Hörnqvist Nils", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-07-13", "publication_year": 2026, "doi": "10.1556/2054.2026.00505", "pubmed_id": null, "openalex_id": "https://openalex.org/W7168134125", "source_url": "https://doi.org/10.1556/2054.2026.00505", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Observational Study,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-14 01:20:09", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00505", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00505", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1556/2054.2026.00505", "source_url": "https://doi.org/10.1556/2054.2026.00505", "doi": "10.1556/2054.2026.00505", "pmid": "", "publication_date": "2026-07-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5787, "title": "MDMA and Psilocybin-Assisted Therapy in Australia: Early Real-World Prescribing, Safety Monitoring and Regulatory Developments", "authors": "Brinzei OV.", "journal": "ScienceOpen Preprints", "publication_date": "2026-07-12", "publication_year": 2026, "doi": "10.14293/pr2199.004090.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.14293/pr2199.004090.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-08-09 08:14:50", "last_checked": "2026-08-09 08:14:50", "bibtex": null, "source_record_id": "DOI:10.14293/pr2199.004090.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.14293/pr2199.004090.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.14293/pr2199.004090.v1", "source_url": "https://doi.org/10.14293/pr2199.004090.v1", "doi": "10.14293/pr2199.004090.v1", "pmid": "", "publication_date": "2026-07-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5789, "title": "Psilocybin bei Depression: Systematisches Review und Meta-Analyse zur antidepressiven Wirksamkeit", "authors": "Nele Böhm, Frank Euteneuer", "journal": "OSF", "publication_date": "2026-07-10", "publication_year": 2026, "doi": "10.17605/osf.io/axgjw", "pubmed_id": null, "openalex_id": "https://openalex.org/W7169560877", "source_url": "https://osf.io/axgjw", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Review Article,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "preprint", "date_added": "2026-08-09 08:25:00", "last_checked": "2026-08-09 09:00:16", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/axgjw", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/axgjw", "source_url": "https://osf.io/axgjw", "doi": "10.17605/osf.io/axgjw", "pmid": "", "publication_date": "2026-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3502, "title": "PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial", "authors": "Bruyère Health Research Institute.", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07063862", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Receptor Pharmacology,Default Mode Network,Aging,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07063862", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "source_url": "https://clinicaltrials.gov/study/NCT07063862", "doi": "", "pmid": "", "publication_date": "2026-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3467, "title": "PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial", "authors": "Ottawa Hospital Research Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04754061", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Aging,Microdosing,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04754061", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "source_url": "https://clinicaltrials.gov/study/NCT04754061", "doi": "", "pmid": "", "publication_date": "2026-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3610, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06341426", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06341426", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "source_url": "https://clinicaltrials.gov/study/NCT06341426", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3537, "title": "Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06624137", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Headache / Migraine,Brain Imaging,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06624137", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06624137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06624137", "source_url": "https://clinicaltrials.gov/study/NCT06624137", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5677, "title": "CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder", "authors": "Paslawski Wojciech, Doyon Daniel, Ekman Carl Johan, Yngwe Hampus, Mamula Dejan, Zareba-Paslawska Justyna, Beckman Maria, Xu Zhi-Qing David, Hökfelt Tomas, Tiger Mikael, Lundberg Johan, Svenningsson Per", "journal": "Neuropsychopharmacology", "publication_date": "2026-07-07", "publication_year": 2026, "doi": "10.1038/s41386-026-02490-3", "pubmed_id": "42414566", "openalex_id": "https://openalex.org/W7167637338", "source_url": "https://doi.org/10.1038/s41386-026-02490-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Biomarkers", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-08 01:20:22", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42414566", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s41386-026-02490-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42414566", "source_url": "https://doi.org/10.1038/s41386-026-02490-3", "doi": "10.1038/s41386-026-02490-3", "pmid": "42414566", "publication_date": "2026-07-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5674, "title": "Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review", "authors": "Omar Azuara-Antonio, Erika Rubí De La Cruz-Elizaldeb, José Eduardo Carmona-Rodriguez, Lesly Idaliht Hernandez-Martinez", "journal": "Mexican Journal of Medical Research ICSA", "publication_date": "2026-07-05", "publication_year": 2026, "doi": "10.29057/mjmr.v14i28.16493", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167422156", "source_url": "https://doi.org/10.29057/mjmr.v14i28.16493", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Consciousness,Review Article,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-07 01:20:41", "last_checked": "2026-08-09 08:25:02", "bibtex": null, "source_record_id": "DOI:10.29057/mjmr.v14i28.16493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29057/mjmr.v14i28.16493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29057/mjmr.v14i28.16493", "source_url": "https://doi.org/10.29057/mjmr.v14i28.16493", "doi": "10.29057/mjmr.v14i28.16493", "pmid": "", "publication_date": "2026-07-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3978, "title": "Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions", "authors": "Whitfield Henry J., Schepers Jan, Mason Natasha L., Luca Maria, Kuypers Kim P. C.", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-07-03", "publication_year": 2026, "doi": "10.1556/2054.2026.00530", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167262029", "source_url": "https://doi.org/10.1556/2054.2026.00530", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Psychological Flexibility,Observational Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 01:20:27", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00530", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1556/2054.2026.00530", "source_url": "https://doi.org/10.1556/2054.2026.00530", "doi": "10.1556/2054.2026.00530", "pmid": "", "publication_date": "2026-07-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3982, "title": "Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?", "authors": "Matthew A. Boehm, Oriana Mayorga", "journal": "Journal of Science Policy & Governance", "publication_date": "2026-07-02", "publication_year": 2026, "doi": "10.38126/jspg280103", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167073096", "source_url": "https://doi.org/10.38126/jspg280103", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:30", "last_checked": "2026-08-09 08:25:03", "bibtex": null, "source_record_id": "DOI:10.38126/jspg280103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.38126/jspg280103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.38126/jspg280103", "source_url": "https://doi.org/10.38126/jspg280103", "doi": "10.38126/jspg280103", "pmid": "", "publication_date": "2026-07-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3975, "title": "Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019", "authors": "Seale M.", "journal": "Research Square", "publication_date": "2026-07-02", "publication_year": 2026, "doi": "10.21203/rs.3.rs-10208910/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-10208910/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Drug Interactions", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-03 01:20:31", "last_checked": "2026-08-09 08:14:51", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-10208910/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-10208910/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-10208910/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-10208910/v1", "doi": "10.21203/rs.3.rs-10208910/v1", "pmid": "", "publication_date": "2026-07-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5720, "title": "Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study", "authors": "Meyer Thomas D, Vale Lauren N, Ibrahim Maya, Olmos Carolina, Quevedo João, Soares Jair C", "journal": "BMJ Open", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1136/bmjopen-2026-118471", "pubmed_id": "42442821", "openalex_id": "https://openalex.org/W7168165083", "source_url": "https://doi.org/10.1136/bmjopen-2026-118471", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-15 01:20:04", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42442821", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2026-118471", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42442821", "source_url": "https://doi.org/10.1136/bmjopen-2026-118471", "doi": "10.1136/bmjopen-2026-118471", "pmid": "42442821", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3812, "title": "Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms", "authors": "Hummel Haley M., Obrochta Alexia N., Kerr David C. R., Cservenka Anita", "journal": "Journal of Drug Issues", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1177/00220426261466154", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166830239", "source_url": "https://doi.org/10.1177/00220426261466154", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study", "study_type": "Observational Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-02 06:54:51", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.1177/00220426261466154", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1177/00220426261466154", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1177/00220426261466154", "source_url": "https://doi.org/10.1177/00220426261466154", "doi": "10.1177/00220426261466154", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3811, "title": "Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.", "authors": "Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y", "journal": "Psychopharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1007/s00213-026-07110-y", "pubmed_id": "42380668", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42380668/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 13:00:05", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42380668", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42380668/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42380668", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42380668/", "doi": "10.1007/s00213-026-07110-y", "pmid": "42380668", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3662, "title": "Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07638553", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07638553", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07638553", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07638553", "source_url": "https://clinicaltrials.gov/study/NCT07638553", "doi": "", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3002, "title": "Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits", "authors": "Pasquini Lorenzo, Vohryzek Jakub, Escrichs Anira, Perl Yonatan Sanz, Ponce-Alvarez Adrian, Idesis Sebastian, Girn Manesh, Roseman Leor, Mitchell Jennifer M., Gazzaley Adam, Kringelbach Morten, Nutt David J., Lyons Taylor, Carhart-Harris Robin L., Deco Gustavo", "journal": "Human Brain Mapping", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1002/hbm.70596", "pubmed_id": "42381187", "openalex_id": "https://openalex.org/W7166854327", "source_url": "https://doi.org/10.1002/hbm.70596", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Healthy Volunteers", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 11:03:06", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42381187", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/hbm.70596", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42381187", "source_url": "https://doi.org/10.1002/hbm.70596", "doi": "10.1002/hbm.70596", "pmid": "42381187", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1923, "title": "Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence", "authors": "Sabani Astrit, Khatak Adnan", "journal": "Annals of Medicine & Surgery", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1097/ms9.0000000000005244", "pubmed_id": "42433813", "openalex_id": "https://openalex.org/W7165127045", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42433813", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1097/ms9.0000000000005244", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42433813", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "doi": "10.1097/ms9.0000000000005244", "pmid": "42433813", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 185, "title": "An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder", "authors": "Grant Jon E., Boutouis Sophia, O’Brien Margaret, Avila Laurie, Neelapu Megha, Ehsan Dustin", "journal": "Clinical Neuropharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1097/wnf.0000000000000683", "pubmed_id": "41973961", "openalex_id": "https://openalex.org/W7154114794", "source_url": "https://doi.org/10.1097/wnf.0000000000000683", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41973961", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1097/wnf.0000000000000683", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41973961", "source_url": "https://doi.org/10.1097/wnf.0000000000000683", "doi": "10.1097/wnf.0000000000000683", "pmid": "41973961", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 58, "title": "MFCC-DFT mapping of ligand recognition at the 5-HT receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.", "authors": "Junior WSC, Bezerra KS, Matias EGC, Oliveira JIN, Fulco UL", "journal": "Physical chemistry chemical physics: PCCP", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1039/d6cp00943c", "pubmed_id": "42300394", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42300394/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42300394", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42300394/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42300394", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42300394/", "doi": "10.1039/d6cp00943c", "pmid": "42300394", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 30, "title": "The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.", "authors": "Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1177/02698811261456191", "pubmed_id": "42345450", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42345450", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42345450", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "doi": "10.1177/02698811261456191", "pmid": "42345450", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 20, "title": "Psilocybin as a novel treatment for chronic pain.", "authors": "Askey T, Lasrado R, Maiarú M, Stephens GJ", "journal": "British journal of pharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1111/bph.17420", "pubmed_id": "39614355", "openalex_id": "https://openalex.org/W4404843727", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39614355/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Animal Study,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:39614355", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39614355/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39614355", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39614355/", "doi": "10.1111/bph.17420", "pmid": "39614355", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 19, "title": "The Australia story: Current status and future challenges for the clinical applications of psychedelics.", "authors": "Nutt DJ, Hunt P, Schlag AK, Fitzgerald P", "journal": "British journal of pharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1111/bph.17398", "pubmed_id": "39701143", "openalex_id": "https://openalex.org/W4405565174", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39701143/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:39701143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39701143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39701143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39701143/", "doi": "10.1111/bph.17398", "pmid": "39701143", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 18, "title": "Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.", "authors": "Sharp T, Ippolito A", "journal": "British journal of pharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1111/bph.70050", "pubmed_id": "40405723", "openalex_id": "https://openalex.org/W4410698430", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40405723/", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:40405723", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40405723/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40405723", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40405723/", "doi": "10.1111/bph.70050", "pmid": "40405723", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 17, "title": "Psychedelics, entactogens and psychoplastogens for depression and related disorders.", "authors": "Hoyer D", "journal": "British journal of pharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1111/bph.70088", "pubmed_id": "40518133", "openalex_id": "https://openalex.org/W4411319821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:40518133", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40518133", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518133/", "doi": "10.1111/bph.70088", "pmid": "40518133", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 16, "title": "Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.", "authors": "Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T", "journal": "British journal of pharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1111/bph.70109", "pubmed_id": "40545270", "openalex_id": "https://openalex.org/W4411528016", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40545270/", "substance_tags": "psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:40545270", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40545270/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40545270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40545270/", "doi": "10.1111/bph.70109", "pmid": "40545270", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 14, "title": "Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.", "authors": "Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D", "journal": "British journal of pharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1111/bph.70181", "pubmed_id": "40891276", "openalex_id": "https://openalex.org/W4413906381", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:40891276", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40891276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40891276/", "doi": "10.1111/bph.70181", "pmid": "40891276", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 8, "title": "Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants", "authors": "Arikci Denis, Borgulya Joran, Straumann Isabelle, Vizeli Patrick, Luethi Dino, Thomann Jan, Rudin Deborah, Vukalovic Ina, Eckert Anne, Liechti Matthias E., Holze Friederike", "journal": "Neuropsychopharmacology", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1038/s41386-026-02428-9", "pubmed_id": "42049943", "openalex_id": "https://openalex.org/W7157683682", "source_url": "https://doi.org/10.1038/s41386-026-02428-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Consciousness,Emotional Processing,In Vitro Study,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:42049943", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s41386-026-02428-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42049943", "source_url": "https://doi.org/10.1038/s41386-026-02428-9", "doi": "10.1038/s41386-026-02428-9", "pmid": "42049943", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 7, "title": "Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.", "authors": "Giri Y, Furst P, Loo CK, Clark SR, Tibrewal P", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1177/00048674261450390", "pubmed_id": "42198984", "openalex_id": "https://openalex.org/W7162546150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42198984/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42198984", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42198984/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42198984", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42198984/", "doi": "10.1177/00048674261450390", "pmid": "42198984", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 22, "title": "Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.", "authors": "Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT", "journal": "Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1007/s40211-026-00584-4", "pubmed_id": "42377806", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42377806/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Aging,Epigenetics,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42377806", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42377806/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42377806", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42377806/", "doi": "10.1007/s40211-026-00584-4", "pmid": "42377806", "publication_date": "2026-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 24, "title": "Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex", "authors": "Du Yingjie, Zhao Xiangting, Yao Yishan, Li Yunfeng, Wang Guyan, Zhang Liming", "journal": "Journal of Psychopharmacology", "publication_date": "2026-06-28", "publication_year": 2026, "doi": "10.1177/02698811261453819", "pubmed_id": "42365496", "openalex_id": "https://openalex.org/W7166436963", "source_url": "https://doi.org/10.1177/02698811261453819", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Neurogenesis,Mechanism of Action,Biomarkers,Animal Study", "study_type": "Animal Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42365496", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1177/02698811261453819", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42365496", "source_url": "https://doi.org/10.1177/02698811261453819", "doi": "10.1177/02698811261453819", "pmid": "42365496", "publication_date": "2026-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3026, "title": "Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitalopram", "authors": "Dagnino PC, Acero-Pousa I, Carhart-Harris RL, Erritzoe D, Nutt DJ, Kringelbach ML, Perl YS, Deco G.", "journal": "bioRxiv", "publication_date": "2026-06-26", "publication_year": 2026, "doi": "10.64898/2026.06.22.733731", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.06.22.733731", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:51", "bibtex": null, "source_record_id": "DOI:10.64898/2026.06.22.733731", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.06.22.733731", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.06.22.733731", "source_url": "https://doi.org/10.64898/2026.06.22.733731", "doi": "10.64898/2026.06.22.733731", "pmid": "", "publication_date": "2026-06-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3595, "title": "Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06884514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Consciousness,Wellbeing,Personality Change,Emotional Processing,Safety", "study_type": "Qualitative Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06884514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06884514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06884514", "source_url": "https://clinicaltrials.gov/study/NCT06884514", "doi": "", "pmid": "", "publication_date": "2026-06-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3560, "title": "A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)", "authors": "Anthony P King", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07104916", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Randomized Controlled Trial,Healthcare Workers,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07104916", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07104916", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07104916", "source_url": "https://clinicaltrials.gov/study/NCT07104916", "doi": "", "pmid": "", "publication_date": "2026-06-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 29, "title": "Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.", "authors": "Guidetti C, Fava M, Papakostas GI", "journal": "Molecular psychiatry", "publication_date": "2026-06-25", "publication_year": 2026, "doi": "10.1038/s41380-026-03722-0", "pubmed_id": "42350785", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42350785/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42350785", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42350785/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42350785", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42350785/", "doi": "10.1038/s41380-026-03722-0", "pmid": "42350785", "publication_date": "2026-06-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5790, "title": "PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW", "authors": "Łoś Aleksandra, Szkodziński Kacper, Jakubczyk Inga, Maternia Jagoda, Majowicz-Czaszyńska Karolina, Pempuś Wiktoria, Król Nikola, Tomaszek Barbara, Blok Aleksandra, Wiater Dominik, Płodzień Gabriela", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-06-24", "publication_year": 2026, "doi": "10.31435/ijitss.2(50).2026.5755", "pubmed_id": null, "openalex_id": "https://openalex.org/W7168266726", "source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5755", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-09 08:25:05", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.2(50).2026.5755", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5755", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.31435/ijitss.2(50).2026.5755", "source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5755", "doi": "10.31435/ijitss.2(50).2026.5755", "pmid": "", "publication_date": "2026-06-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3986, "title": "Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care", "authors": "Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti", "journal": "Translational Psychiatry", "publication_date": "2026-06-23", "publication_year": 2026, "doi": "10.1038/s41398-026-04203-2", "pubmed_id": "42342649", "openalex_id": "https://openalex.org/W7165728379", "source_url": "https://doi.org/10.1038/s41398-026-04203-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Personality Change,Mystical Experience,Clinical Trial,Animal Study,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-07-04 06:34:34", "bibtex": null, "source_record_id": "PMID:42342649", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-026-04203-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42342649", "source_url": "https://doi.org/10.1038/s41398-026-04203-2", "doi": "10.1038/s41398-026-04203-2", "pmid": "42342649", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3705, "title": "Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07449351", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Longevity,Microdosing,Wellbeing,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07449351", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07449351", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07449351", "source_url": "https://clinicaltrials.gov/study/NCT07449351", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3650, "title": "Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07048743", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07048743", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "source_url": "https://clinicaltrials.gov/study/NCT07048743", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 34, "title": "Blocking 5-HT2B receptors abolishes psilocybin's efficacy in the rat forced swim test.", "authors": "Seillier L, Seillier A, Zvolska MA, Šlamberová R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-06-23", "publication_year": 2026, "doi": "10.1177/02698811261458349", "pubmed_id": "42334341", "openalex_id": "https://openalex.org/W7165643590", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42334341/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42334341", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42334341/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42334341", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42334341/", "doi": "10.1177/02698811261458349", "pmid": "42334341", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3024, "title": "Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes", "authors": "Frick A, Blest-Hopley G, Grin M, Erritzoe D, Nutt D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2026-06-19", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9880403/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:51", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9880403/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9880403/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9880403/v1", "doi": "10.21203/rs.3.rs-9880403/v1", "pmid": "", "publication_date": "2026-06-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 38, "title": "Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.", "authors": "Berg CJ, McCready DM, LoParco CR, Schubel LC, Romm KF, Thakkar S, Williams J, Cavazos-Rehg PA, Yang YT", "journal": "Journal of psychoactive drugs", "publication_date": "2026-06-19", "publication_year": 2026, "doi": "10.1080/02791072.2026.2685527", "pubmed_id": "42318842", "openalex_id": "https://openalex.org/W7165130491", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42318842/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42318842", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42318842/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42318842", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42318842/", "doi": "10.1080/02791072.2026.2685527", "pmid": "42318842", "publication_date": "2026-06-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 43, "title": "Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.", "authors": "Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S", "journal": "ACS chemical neuroscience", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.1021/acschemneuro.6c00202", "pubmed_id": "42257400", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42257400/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42257400", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42257400/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42257400", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42257400/", "doi": "10.1021/acschemneuro.6c00202", "pmid": "42257400", "publication_date": "2026-06-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3023, "title": "Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem", "authors": "Dagnino PC, Acero-Pousa I, Zamora-López G, Escrichs A, Erritzoe D, Nutt DJ, Carhart-Harris RL, Sanz Perl Y, Kringelbach ML, Deco G.", "journal": "bioRxiv", "publication_date": "2026-06-16", "publication_year": 2026, "doi": "10.64898/2026.06.12.731811", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.06.12.731811", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:51", "bibtex": null, "source_record_id": "DOI:10.64898/2026.06.12.731811", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.06.12.731811", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.06.12.731811", "source_url": "https://doi.org/10.64898/2026.06.12.731811", "doi": "10.64898/2026.06.12.731811", "pmid": "", "publication_date": "2026-06-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1927, "title": "Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA", "authors": "SAIMSARA", "journal": "SAIMSARA Journal", "publication_date": "2026-06-15", "publication_year": 2026, "doi": "10.62487/saimsara7a54f680", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164845889", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Mechanism of Action,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.62487/saimsara7a54f680", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.62487/saimsara7a54f680", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.62487/saimsara7a54f680", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "doi": "10.62487/saimsara7a54f680", "pmid": "", "publication_date": "2026-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1926, "title": "Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis", "authors": "Labra-Lorenzana Angel, Lima-Sánchez Dania Nimbe, Delaflor-Wagner Christian Alejandro, Martínez-Hernández Diana, Ramos-Jiménez Christian, Toledo-Lozano Christian Gabriel", "journal": "Psychiatry International", "publication_date": "2026-06-15", "publication_year": 2026, "doi": "10.3390/psychiatryint7030137", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164820747", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.3390/psychiatryint7030137", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/psychiatryint7030137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3390/psychiatryint7030137", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "doi": "10.3390/psychiatryint7030137", "pmid": "", "publication_date": "2026-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3210, "title": "Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression", "authors": "Theo Tobel, Aidan Cone, Emily M Choquette, McKenna Garland, Micah Johnson, Keller Mink, Caitlin Lynch, Joel Frohlich, Justin Feinstein, Nicco Reggente", "journal": "PsyArXiv", "publication_date": "2026-06-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Consciousness,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v2", "doi": "", "pmid": "", "publication_date": "2026-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 56, "title": "The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review.", "authors": "Raikkerus H, Bujour A, Kennedy M, Tiihonen J", "journal": "Acta neuropsychiatrica", "publication_date": "2026-06-10", "publication_year": 2026, "doi": "10.1017/neu.2026.10088", "pubmed_id": "42265057", "openalex_id": "https://openalex.org/W7164031094", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42265057/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42265057", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42265057/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42265057", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42265057/", "doi": "10.1017/neu.2026.10088", "pmid": "42265057", "publication_date": "2026-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3367, "title": "Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults", "authors": "Carter D, Reardon I, Swain J, Vando L.", "journal": "Research Square", "publication_date": "2026-06-02", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9839240/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Emotional Processing,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9839240/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9839240/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "doi": "10.21203/rs.3.rs-9839240/v1", "pmid": "", "publication_date": "2026-06-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 70, "title": "Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.", "authors": "Kelly JR, Sheridan C, Iusan P, Coakley L, Burke L, Brennan C, MacDonald A, Ivers JH, Trepel D, Tormey G, Finnegan M, Young GW, Harkin A", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2026-06-02", "publication_year": 2026, "doi": "10.1093/ijnp/pyag028", "pubmed_id": "42113605", "openalex_id": "https://openalex.org/W7160867854", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42113605/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42113605", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42113605/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42113605", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42113605/", "doi": "10.1093/ijnp/pyag028", "pmid": "42113605", "publication_date": "2026-06-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5792, "title": "One dose of Psilocybin modulates Brain Activity among Depressive patients: Preliminary Neuroimaging Results from the PSILODAC Study", "authors": "Pastre M., Pereira F., Gibert T., Giron A., Goemare B., Olié E., Courtet P., Lopez-Castroman J., Conejero I.", "journal": "European Psychiatry", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1192/j.eurpsy.2026.10729", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171996200", "source_url": "https://doi.org/10.1192/j.eurpsy.2026.10729", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-09 08:25:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2026.10729", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2026.10729", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1192/j.eurpsy.2026.10729", "source_url": "https://doi.org/10.1192/j.eurpsy.2026.10729", "doi": "10.1192/j.eurpsy.2026.10729", "pmid": "", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1940, "title": "Psilocybin shows rapid relief for depression symptoms", "authors": "Canady Valerie A.", "journal": "Mental Health Weekly", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1002/mhw.34890", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162755829", "source_url": "https://doi.org/10.1002/mhw.34890", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34890", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/mhw.34890", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1002/mhw.34890", "source_url": "https://doi.org/10.1002/mhw.34890", "doi": "10.1002/mhw.34890", "pmid": "", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1930, "title": "EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION", "authors": "Ziadi Yosr, Park Taehwan", "journal": "Value in Health", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1016/j.jval.2026.03.635", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166194446", "source_url": "https://doi.org/10.1016/j.jval.2026.03.635", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1016/j.jval.2026.03.635", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1016/j.jval.2026.03.635", "source_url": "https://doi.org/10.1016/j.jval.2026.03.635", "doi": "10.1016/j.jval.2026.03.635", "pmid": "", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 217, "title": "Psilocybin: Chemical Foundations and Emerging Therapeutic Potential", "authors": "Patil Shivaputra A., Hunsberger Holly C.", "journal": "Mini-Reviews in Medicinal Chemistry", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.2174/0113895575429775260119043318", "pubmed_id": "41879500", "openalex_id": "https://openalex.org/W7140303704", "source_url": "https://doi.org/10.2174/0113895575429775260119043318", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Longevity,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:41879500", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.2174/0113895575429775260119043318", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41879500", "source_url": "https://doi.org/10.2174/0113895575429775260119043318", "doi": "10.2174/0113895575429775260119043318", "pmid": "41879500", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 86, "title": "Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.", "authors": "He Z, Wang Y, Chen J, Cheng J, Feng Y, Niu S, Yan J", "journal": "European archives of psychiatry and clinical neuroscience", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1007/s00406-025-02165-y", "pubmed_id": "41677823", "openalex_id": "https://openalex.org/W7128718542", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41677823/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:41677823", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41677823/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41677823", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41677823/", "doi": "10.1007/s00406-025-02165-y", "pmid": "41677823", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 83, "title": "Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations", "authors": "Yonezawa Kengo, Hirata Mayuko, Takano Hiroaki, Kusudo Keisuke, Tomiyama Sota, Harada Lisa, Suzuki Kouta, Nutt David J., Uchida Hiroyuki, Tani Hideaki", "journal": "Psychiatry and Clinical Neurosciences", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1111/pcn.70042", "pubmed_id": "41749057", "openalex_id": "https://openalex.org/W7131868995", "source_url": "https://doi.org/10.1111/pcn.70042", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Brain Imaging,Aging,Spirituality,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41749057", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1111/pcn.70042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41749057", "source_url": "https://doi.org/10.1111/pcn.70042", "doi": "10.1111/pcn.70042", "pmid": "41749057", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 82, "title": "Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.", "authors": "Sabé M, Grof P, Sackett NB, Tai S, Kryskow P, Bershad A, Turkington D, Buonarroti M, De Pieri M, Baniotopoulos P, Eskinazi M, Böge K, Leucht S, Seragnoli F, Furtado L, Brakha TA, Curtis L, Kirschner M, Kaiser S, Penzenstadler L, Zullino D, Højlund M, Gallo J, Solmi M, Sapienza J, Bosia M, La Torre J", "journal": "Schizophrenia research", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1016/j.schres.2026.03.003", "pubmed_id": "41830808", "openalex_id": "https://openalex.org/W7135185290", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41830808/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Default Mode Network,Review Article,Case Report,Animal Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:41830808", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41830808/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41830808", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41830808/", "doi": "10.1016/j.schres.2026.03.003", "pmid": "41830808", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 79, "title": "Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy.", "authors": "Lappan SN, Davis SD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1177/28314425251404021", "pubmed_id": "42131862", "openalex_id": "https://openalex.org/W7117297881", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42131862/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42131862", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42131862/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42131862", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42131862/", "doi": "10.1177/28314425251404021", "pmid": "42131862", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 75, "title": "Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens.", "authors": "Miller CWT, Kozak Z", "journal": "Psychodynamic psychiatry", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1521/pdps.2026.54.2.308", "pubmed_id": "42301163", "openalex_id": "https://openalex.org/W7164890397", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42301163/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Spirituality", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42301163", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42301163/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42301163", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42301163/", "doi": "10.1521/pdps.2026.54.2.308", "pmid": "42301163", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 74, "title": "Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study.", "authors": "Poppe C, Lyck L, Bechtold L, Repantis D", "journal": "Brain and behavior", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1002/brb3.71544", "pubmed_id": "42304595", "openalex_id": "https://openalex.org/W7164930745", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42304595/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42304595", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42304595/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42304595", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42304595/", "doi": "10.1002/brb3.71544", "pmid": "42304595", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 73, "title": "Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.", "authors": "Rosa WE, Napolitano S, McAndrew N, Jenkins B, Lichtenthal WG, Applebaum AJ, Breitbart W, Agrawal M", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1177/28314425251363983", "pubmed_id": "42311441", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42311441/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42311441", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42311441/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42311441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42311441/", "doi": "10.1177/28314425251363983", "pmid": "42311441", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 48, "title": "Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression", "authors": "Kaczmarek Erica S., Rodrigues Nelson B., Chisamore Noah, Doyle Zoe, Meshkat Shakila, Blainey Marc G., Brudner Ryan, Ali Shaun, Teopiz Kayla M., McIntyre Roger S., Rosenblat Joshua D.", "journal": "Journal of Affective Disorders", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121385", "pubmed_id": "41690631", "openalex_id": "https://openalex.org/W7128743161", "source_url": "https://doi.org/10.1016/j.jad.2026.121385", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:41690631", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.121385", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41690631", "source_url": "https://doi.org/10.1016/j.jad.2026.121385", "doi": "10.1016/j.jad.2026.121385", "pmid": "41690631", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 47, "title": "Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial", "authors": "Weintraub Marc J., Jeffrey Jessica K., Ichinose Megan C., Bergman R. Lindsey, Shapiro Benjamin, Barnett Gregory, Artin Hewa, Lynn Marc, Salimian Anabel, Grody Shelby, Ramesh Rahul, Eales Lauren, Grob Charles S., Miklowitz David J.", "journal": "Journal of Affective Disorders", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121423", "pubmed_id": "41707717", "openalex_id": "https://openalex.org/W7129028447", "source_url": "https://doi.org/10.1016/j.jad.2026.121423", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:41707717", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.121423", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41707717", "source_url": "https://doi.org/10.1016/j.jad.2026.121423", "doi": "10.1016/j.jad.2026.121423", "pmid": "41707717", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1937, "title": "Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis", "authors": "Hood Alex, Elkins Gary", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-05-29", "publication_year": 2026, "doi": "10.1556/2054.2026.00507", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162785692", "source_url": "https://doi.org/10.1556/2054.2026.00507", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Receptor Pharmacology,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00507", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00507", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1556/2054.2026.00507", "source_url": "https://doi.org/10.1556/2054.2026.00507", "doi": "10.1556/2054.2026.00507", "pmid": "", "publication_date": "2026-05-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 90, "title": "Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.", "authors": "Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M", "journal": "Molecular psychiatry", "publication_date": "2026-05-29", "publication_year": 2026, "doi": "10.1038/s41380-026-03657-6", "pubmed_id": "42215638", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42215638/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:42215638", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42215638/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42215638", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42215638/", "doi": "10.1038/s41380-026-03657-6", "pmid": "42215638", "publication_date": "2026-05-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 99, "title": "Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial", "authors": "Mertens Lea J., Betzler Felix, Brand Manuela, Evens Ricarda, Jungaberle Andrea, Jungaberle Henrik, Kärtner Laura, Majić Tomislav, Schmitz Christian N., Ströhle Andreas, Scharf Dennis, Spangemacher Moritz, Wolff Max, Assadi Zahra, Bahri Scharif, Becher Lilith, Färber Luca V., Harder Henry, Kirchen Niklas, Kulakova Eugenia, Kunz Linda C., Meijer Andy, Rohrmoser Barbara, Wellek Stefan, Berger Moritz M., Koslowski Michael, Gründer Gerhard", "journal": "Psychotherapy and Psychosomatics", "publication_date": "2026-05-27", "publication_year": 2026, "doi": "10.1159/000552272", "pubmed_id": "42201843", "openalex_id": "https://openalex.org/W7162570449", "source_url": "https://doi.org/10.1159/000552272", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42201843", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1159/000552272", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42201843", "source_url": "https://doi.org/10.1159/000552272", "doi": "10.1159/000552272", "pmid": "42201843", "publication_date": "2026-05-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3660, "title": "The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-26", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07332143", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07332143", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07332143", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07332143", "source_url": "https://clinicaltrials.gov/study/NCT07332143", "doi": "", "pmid": "", "publication_date": "2026-05-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 100, "title": "Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder", "authors": "Urban Marvin M., Zillich Lea, Rieser Nathalie M., Herdener Marcus, Spanagel Rainer, Vollenweider Franz X., Preller Katrin H., Meinhardt Marcus W.", "journal": "Translational Psychiatry", "publication_date": "2026-05-26", "publication_year": 2026, "doi": "10.1038/s41398-026-03961-3", "pubmed_id": "42192100", "openalex_id": "https://openalex.org/W4412872234", "source_url": "https://doi.org/10.1038/s41398-026-03961-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Epigenetics,Observational Study,Genomics,Immune Function", "study_type": "Observational Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42192100", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s41398-026-03961-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42192100", "source_url": "https://doi.org/10.1038/s41398-026-03961-3", "doi": "10.1038/s41398-026-03961-3", "pmid": "42192100", "publication_date": "2026-05-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5697, "title": "Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.", "authors": "Laursen DRT, Salazar J, Jürgens G, Hróbjartsson A", "journal": "Journal of clinical epidemiology", "publication_date": "2026-05-25", "publication_year": 2026, "doi": "10.1016/j.jclinepi.2026.112345", "pubmed_id": "42190765", "openalex_id": "https://openalex.org/W7162326878", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42190765/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:42190765", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42190765/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42190765", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42190765/", "doi": "10.1016/j.jclinepi.2026.112345", "pmid": "42190765", "publication_date": "2026-05-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4012, "title": "Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential", "authors": "Dallas T Mason", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162235135", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4011, "title": "The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach", "authors": "Rachel N Clark", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162225828", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4010, "title": "Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients", "authors": "Caleb Lemus", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162222410", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Aging,Wellbeing,Emotional Processing,Randomized Controlled Trial,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3661, "title": "Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06230757", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06230757", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06230757", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06230757", "source_url": "https://clinicaltrials.gov/study/NCT06230757", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3636, "title": "A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-20", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07582120", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Psychological Flexibility,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07582120", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07582120", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07582120", "source_url": "https://clinicaltrials.gov/study/NCT07582120", "doi": "", "pmid": "", "publication_date": "2026-05-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5844, "title": "Psilocybin-assisted Cognitive Behavioral Therapy for Depression", "authors": "University of California, Los Angeles", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05227612", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-08-09 10:12:42", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05227612", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05227612", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05227612", "source_url": "https://clinicaltrials.gov/study/NCT05227612", "doi": "", "pmid": "", "publication_date": "2026-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 123, "title": "Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression", "authors": "Yngwe Hampus, Plavén-Sigray Pontus, Ekman Carl Johan, Henje Eva, Berglund Anders, Tiger Mikael, Beckman Maria, Lundberg Johan", "journal": "JAMA Network Open", "publication_date": "2026-05-15", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.12589", "pubmed_id": "42138922", "openalex_id": "https://openalex.org/W7161294763", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42138922", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42138922", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.12589", "doi": "10.1001/jamanetworkopen.2026.12589", "pmid": "42138922", "publication_date": "2026-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3606, "title": "Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)", "authors": "Alan Davis", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07216404", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07216404", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "source_url": "https://clinicaltrials.gov/study/NCT07216404", "doi": "", "pmid": "", "publication_date": "2026-05-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3511, "title": "Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence", "authors": "University of Calgary", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06885996", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Biomarkers,Oxidative Stress,Emotional Processing,Randomized Controlled Trial,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06885996", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06885996", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06885996", "source_url": "https://clinicaltrials.gov/study/NCT06885996", "doi": "", "pmid": "", "publication_date": "2026-05-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1945, "title": "Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin", "authors": "Kosiarski Bartłomiej, Skrzypek Anna, Markowicz Patrycja, Zbrożek Mikołaj, Biłyk Krzysztof, Hutkowski Maciej, Chwostek Zuzanna, Maruchniak Hanna, Marzec Wiktoria, Biedroń Paulina", "journal": "Journal of Pre-Clinical and Clinical Research", "publication_date": "2026-05-12", "publication_year": 2026, "doi": "10.26444/jpccr/221219", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160910785", "source_url": "https://doi.org/10.26444/jpccr/221219", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.26444/jpccr/221219", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.26444/jpccr/221219", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.26444/jpccr/221219", "source_url": "https://doi.org/10.26444/jpccr/221219", "doi": "10.26444/jpccr/221219", "pmid": "", "publication_date": "2026-05-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4018, "title": "Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care", "authors": "Khadija Kamene", "journal": "Premier Journal of Neuroscience", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.70389/pjn.100014", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162007156", "source_url": "https://doi.org/10.70389/pjn.100014", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Systematic Review,Review Article,Treatment-Resistant Depression,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:08", "bibtex": null, "source_record_id": "DOI:10.70389/pjn.100014", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.70389/pjn.100014", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.70389/pjn.100014", "source_url": "https://doi.org/10.70389/pjn.100014", "doi": "10.70389/pjn.100014", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4017, "title": "Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for Care", "authors": "Sean M. Viña", "journal": "Psychoactives", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.3390/psychoactives5020014", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160952638", "source_url": "https://doi.org/10.3390/psychoactives5020014", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 06:34:35", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives5020014", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives5020014", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives5020014", "source_url": "https://doi.org/10.3390/psychoactives5020014", "doi": "10.3390/psychoactives5020014", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3022, "title": "Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review", "authors": "Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ.", "journal": "Research Square", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9283280/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:50", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "doi": "10.21203/rs.3.rs-9283280/v1", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4019, "title": "From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice", "authors": "Jessie Kim, Liam Lochhead, Cory R. Weissman", "journal": "Pharmacology Research & Perspectives", "publication_date": "2026-05-10", "publication_year": 2026, "doi": "10.1002/prp2.70262", "pubmed_id": "42108552", "openalex_id": "https://openalex.org/W7160830727", "source_url": "https://doi.org/10.1002/prp2.70262", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:08", "bibtex": null, "source_record_id": "PMID:42108552", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/prp2.70262", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42108552", "source_url": "https://doi.org/10.1002/prp2.70262", "doi": "10.1002/prp2.70262", "pmid": "42108552", "publication_date": "2026-05-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3570, "title": "The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.", "authors": "University Medical Center Groningen", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06782724", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Brain Imaging,Biomarkers,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06782724", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "source_url": "https://clinicaltrials.gov/study/NCT06782724", "doi": "", "pmid": "", "publication_date": "2026-05-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1955, "title": "1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power", "authors": "Reid Matthew, Weisman Eli, Martinez Luis Luna, Coon William, Barrett Frederick", "journal": "SLEEPJ", "publication_date": "2026-05-08", "publication_year": 2026, "doi": "10.1093/sleep/zsag091.1079", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160609961", "source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Consciousness,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1093/sleep/zsag091.1079", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1093/sleep/zsag091.1079", "source_url": "https://doi.org/10.1093/sleep/zsag091.1079", "doi": "10.1093/sleep/zsag091.1079", "pmid": "", "publication_date": "2026-05-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 116, "title": "Exploring new avenues: Psychedelic-assisted therapy for young people.", "authors": "Vamvakopoulou IA, Nicholls D, Nutt DJ, Di Simplicio M", "journal": "British journal of clinical pharmacology", "publication_date": "2026-05-08", "publication_year": 2026, "doi": "10.1002/bcp.70579", "pubmed_id": "42101062", "openalex_id": "https://openalex.org/W7160597817", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42101062/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Review Article,Observational Study,Adolescents,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:42101062", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42101062/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42101062", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42101062/", "doi": "10.1002/bcp.70579", "pmid": "42101062", "publication_date": "2026-05-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3496, "title": "Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05710237", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05710237", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "source_url": "https://clinicaltrials.gov/study/NCT05710237", "doi": "", "pmid": "", "publication_date": "2026-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1947, "title": "Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review", "authors": "Zachar Kinga, Sito Maksymilian, Jurkowski Filip, Wójcik Łukasz, Gawron Natalia, Bojanowski Hubert Tomasz, Dobracka Aleksandra, Marczak Zuzanna, Jarowicz Monika, Czmyr Jędrzej", "journal": "Journal of Education, Health and Sport", "publication_date": "2026-05-07", "publication_year": 2026, "doi": "10.12775/jehs.2026.91.70672", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160694792", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "doi": "10.12775/jehs.2026.91.70672", "pmid": "", "publication_date": "2026-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4020, "title": "Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’", "authors": "Bart A. Ellenbroek, Gernot Riedel", "journal": "Behavioural Pharmacology", "publication_date": "2026-05-06", "publication_year": 2026, "doi": "10.1097/fbp.0000000000000878", "pubmed_id": "42100839", "openalex_id": "https://openalex.org/W7160630756", "source_url": "https://doi.org/10.1097/fbp.0000000000000878", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:08", "bibtex": null, "source_record_id": "PMID:42100839", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000878", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42100839", "source_url": "https://doi.org/10.1097/fbp.0000000000000878", "doi": "10.1097/fbp.0000000000000878", "pmid": "42100839", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3620, "title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05947383", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05947383", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "source_url": "https://clinicaltrials.gov/study/NCT05947383", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3613, "title": "Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study", "authors": "University of North Carolina, Chapel Hill", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06303739", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06303739", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06303739", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06303739", "source_url": "https://clinicaltrials.gov/study/NCT06303739", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3536, "title": "A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder", "authors": "Stanford University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07479550", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07479550", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "source_url": "https://clinicaltrials.gov/study/NCT07479550", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 119, "title": "Human brain changes after first psilocybin use", "authors": "Lyons T., Spriggs M., Kerkelä L., Rosas F. E., Roseman L., Mediano P. A. M., Timmermann C., Oestreich L., Pagni B. A., Zeifman R. J., Hampshire A., Trender W., Douglass H. M., Girn M., Godfrey K., Kettner H., Sharif F., Espasiano L., Gazzaley A., Wall M. B., Erritzoe D., Nutt D. J., Carhart-Harris R. L.", "journal": "Nature Communications", "publication_date": "2026-05-05", "publication_year": 2026, "doi": "10.1038/s41467-026-71962-3", "pubmed_id": "42086570", "openalex_id": "https://openalex.org/W4403392138", "source_url": "https://doi.org/10.1038/s41467-026-71962-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Wellbeing", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42086570", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s41467-026-71962-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42086570", "source_url": "https://doi.org/10.1038/s41467-026-71962-3", "doi": "10.1038/s41467-026-71962-3", "pmid": "42086570", "publication_date": "2026-05-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3577, "title": "A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04353921", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04353921", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04353921", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04353921", "source_url": "https://clinicaltrials.gov/study/NCT04353921", "doi": "", "pmid": "", "publication_date": "2026-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3559, "title": "A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07565909", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07565909", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "source_url": "https://clinicaltrials.gov/study/NCT07565909", "doi": "", "pmid": "", "publication_date": "2026-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3516, "title": "Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder", "authors": "University of California, Los Angeles", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07566104", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07566104", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07566104", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07566104", "source_url": "https://clinicaltrials.gov/study/NCT07566104", "doi": "", "pmid": "", "publication_date": "2026-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1948, "title": "Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use Disorder", "authors": "Sayali Ceyda, Weisman Eli, Barrett Frederick", "journal": "JoCN Forum", "publication_date": "2026-05-02", "publication_year": 2026, "doi": "10.21428/8e6ba8ef.31e358f9", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160707086", "source_url": "https://doi.org/10.21428/8e6ba8ef.31e358f9", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.21428/8e6ba8ef.31e358f9", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.21428/8e6ba8ef.31e358f9", "source_url": "https://doi.org/10.21428/8e6ba8ef.31e358f9", "doi": "10.21428/8e6ba8ef.31e358f9", "pmid": "", "publication_date": "2026-05-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3600, "title": "Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial", "authors": "Lakshmi N Yatham", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06943573", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06943573", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06943573", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06943573", "source_url": "https://clinicaltrials.gov/study/NCT06943573", "doi": "", "pmid": "", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1961, "title": "483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis", "authors": "Poulin Joshua, Viulet Nic, Liu Ashley, MacIntosh Bradley J., Nestor Sean M.", "journal": "Biological Psychiatry", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1016/j.biopsych.2026.03.717", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155645923", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.717", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2026.03.717", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1016/j.biopsych.2026.03.717", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.717", "doi": "10.1016/j.biopsych.2026.03.717", "pmid": "", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 150, "title": "The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.", "authors": "Greenway KT, Garel N, Dinh-Williams LL, Thibault Lévesque J, Kaelen M, Dagenais-Beaulé V, de la Salle S, Erritzoe D, Looper K, Turecki G, Rej S, Richard-Devantoy S", "journal": "The British journal of psychiatry: the journal of mental science", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1192/bjp.2025.102", "pubmed_id": "40528492", "openalex_id": "https://openalex.org/W4411430663", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40528492/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:40528492", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40528492/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40528492", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40528492/", "doi": "10.1192/bjp.2025.102", "pmid": "40528492", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 147, "title": "Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.", "authors": "Viljoen G, Walter H, Bendau A, Koslowski M, Betzler F", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811251389581", "pubmed_id": "41388888", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41388888/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Mystical Experience,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41388888", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41388888/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41388888", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41388888/", "doi": "10.1177/02698811251389581", "pmid": "41388888", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 142, "title": "Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.", "authors": "Garcia Garcia M, Belahda D, Graux C, Serrand C, Igounenc N, Sergent F, Mura T, Luquiens A", "journal": "Journal of affective disorders", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121215", "pubmed_id": "41558304", "openalex_id": "https://openalex.org/W7124752751", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41558304/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Mechanism of Action,Biomarkers,Emotional Processing,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41558304", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41558304/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41558304", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41558304/", "doi": "10.1016/j.jad.2026.121215", "pmid": "41558304", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 140, "title": "Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms", "authors": "Domi Ana, Lucente Erika, Cadeddu Davide, Bengtsson Niklas, Smedler Erik, Adermark Louise", "journal": "Neuropharmacology", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1016/j.neuropharm.2026.110854", "pubmed_id": "41577180", "openalex_id": "https://openalex.org/W7125257065", "source_url": "https://doi.org/10.1016/j.neuropharm.2026.110854", "substance_tags": "psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:41577180", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2026.110854", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41577180", "source_url": "https://doi.org/10.1016/j.neuropharm.2026.110854", "doi": "10.1016/j.neuropharm.2026.110854", "pmid": "41577180", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 138, "title": "Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.", "authors": "Lewis BR, Reid MJ, Novick AM, Byrne K, Niciu MJ, Fonzo GA, Meyer TD, Feifel D, El-Mallakh RS, Soares J, Suppes T, Barrett FS", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811251413490", "pubmed_id": "41645048", "openalex_id": "https://openalex.org/W7128008256", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41645048/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41645048", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41645048/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41645048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41645048/", "doi": "10.1177/02698811251413490", "pmid": "41645048", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 137, "title": "Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.", "authors": "Goldy SP, Sepeda ND, Hilbert SN, Bari BA, Garcia-Romeu A, Gukasyan N, Barrett FS, Yaden DB, Nayak SM", "journal": "Psychiatry research", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1016/j.psychres.2026.117010", "pubmed_id": "41747432", "openalex_id": "https://openalex.org/W7128814597", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41747432/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41747432", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41747432/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41747432", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41747432/", "doi": "10.1016/j.psychres.2026.117010", "pmid": "41747432", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 133, "title": "Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression", "authors": "Mertens Lea J., Koslowski Michael, Betzler Felix, Brand Manuela, Evens Ricarda, Kärtner Laura, Jungaberle Andrea, Jungaberle Henrik, Majić Tomislav, Schmitz Christian N., Ströhle Andreas, Scharf Dennis, Spangemacher Moritz, Wolff Max, Assadi Zahra, Bahri Scharif, Becher Lilith, Färber Luca V., Kirchen Niklas, Kulakova Eugenia, Kunz Linda, Meijer Andy, Rohrmoser Barbara, Wellek Stefan, Berger Moritz M., Gründer Gerhard", "journal": "JAMA Psychiatry", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2026.0132", "pubmed_id": "41848690", "openalex_id": "https://openalex.org/W7138853109", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41848690", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41848690", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "doi": "10.1001/jamapsychiatry.2026.0132", "pmid": "41848690", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 130, "title": "Trip killers: Addressing a critical knowledge gap in psychedelic research.", "authors": "O'Mahony B, Harrington C, Harkin A, Lally N", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811261431056", "pubmed_id": "41869862", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41869862", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41869862", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "doi": "10.1177/02698811261431056", "pmid": "41869862", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 128, "title": "Effects of psychedelic use on authoritarian attitudes revisited.", "authors": "Simonsson O, Lyons T, Marks J, Kettner H, Roseman L, Haijen E, Kaelen M, Carhart-Harris R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811261443677", "pubmed_id": "42068187", "openalex_id": "https://openalex.org/W7159826531", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42068187/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:42068187", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42068187/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42068187", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42068187/", "doi": "10.1177/02698811261443677", "pmid": "42068187", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 121, "title": "Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.", "authors": "Hajivalizadeh S, Farahmand K, Kazemzadeh K, Hajivalizadeh G, Shamabadi A", "journal": "Cancer reports (Hoboken, N.J.)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1002/cnr2.70587", "pubmed_id": "42178235", "openalex_id": "https://openalex.org/W7162254813", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42178235/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Animal Study,Cancer Patients,Toxicity,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:42178235", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42178235/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42178235", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42178235/", "doi": "10.1002/cnr2.70587", "pmid": "42178235", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 114, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM", "authors": "Beidas Zeina, Ragnhildstveit Anya, Blackman Adam, Anderson Thomas, Fewster Emily, Syed Omer A., Sobolenko Valentyne, Kanca Ismail Kaan, Son Tatiana, Farb Norman, Petranker Rotem", "journal": "BJPsych Open", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1192/bjo.2026.12000", "pubmed_id": "42125778", "openalex_id": "https://openalex.org/W7161014612", "source_url": "https://doi.org/10.1192/bjo.2026.12000", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:42125778", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42125778", "source_url": "https://doi.org/10.1192/bjo.2026.12000", "doi": "10.1192/bjo.2026.12000", "pmid": "42125778", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3509, "title": "Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05883540", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05883540", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05883540", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05883540", "source_url": "https://clinicaltrials.gov/study/NCT05883540", "doi": "", "pmid": "", "publication_date": "2026-04-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3474, "title": "A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain", "authors": "Joshua Woolley, MD, PhD", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05351541", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Emotional Processing", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05351541", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05351541", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05351541", "source_url": "https://clinicaltrials.gov/study/NCT05351541", "doi": "", "pmid": "", "publication_date": "2026-04-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 154, "title": "Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review.", "authors": "Magnani L, Ghirotto L, Fesce F, Re T, Tanzi S, Amerio A, Costanza A", "journal": "BMJ supportive & palliative care", "publication_date": "2026-04-28", "publication_year": 2026, "doi": "10.1136/spcare-2025-005689", "pubmed_id": "41708300", "openalex_id": "https://openalex.org/W7130337407", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41708300/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Pharmacology,Review Article,Cancer Patients,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41708300", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41708300/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41708300", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41708300/", "doi": "10.1136/spcare-2025-005689", "pmid": "41708300", "publication_date": "2026-04-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 152, "title": "The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.", "authors": "Wang H, Li X, Yu F, Wang X", "journal": "Current neuropharmacology", "publication_date": "2026-04-28", "publication_year": 2026, "doi": "10.2174/011570159x442471260422110855", "pubmed_id": "42083530", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42083530/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Emotional Processing,Review Article,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:42083530", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42083530/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42083530", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42083530/", "doi": "10.2174/011570159x442471260422110855", "pmid": "42083530", "publication_date": "2026-04-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3596, "title": "A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03866174", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03866174", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03866174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03866174", "source_url": "https://clinicaltrials.gov/study/NCT03866174", "doi": "", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3567, "title": "Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy", "authors": "Kyle Greenway", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07373535", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07373535", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "source_url": "https://clinicaltrials.gov/study/NCT07373535", "doi": "", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1968, "title": "Psilocybin as an alternative to conventional treatments: A systematic review", "authors": "Cahuasqui-Mendoza Deivid Antonio", "journal": "Gaceta Médica de Caracas", "publication_date": "2026-04-22", "publication_year": 2026, "doi": "10.47307/gmc.2026.134.s2.32", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155199454", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "doi": "10.47307/gmc.2026.134.s2.32", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3436, "title": "Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06430541", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06430541", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06430541", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06430541", "source_url": "https://clinicaltrials.gov/study/NCT06430541", "doi": "", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2978, "title": "The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes", "authors": "Khosravi Mohsen, De Berardis Domenico, Tusconi Massimo", "journal": "Mental Wellness", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.4081/mw.2026.40", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155066504", "source_url": "https://doi.org/10.4081/mw.2026.40", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.4081/mw.2026.40", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.4081/mw.2026.40", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.4081/mw.2026.40", "source_url": "https://doi.org/10.4081/mw.2026.40", "doi": "10.4081/mw.2026.40", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2977, "title": "Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials", "authors": "Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari", "journal": "Open Access Indonesian Journal of Medical Reviews", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.37275/oaijmr.v6i2.883", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155091271", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "doi": "10.37275/oaijmr.v6i2.883", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4033, "title": "Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers", "authors": "Vipul Janardan, Amit Khanna, Om Prakash, Anadrika Debbarma, SK Mathur", "journal": "Journal of Mental Health Disorders", "publication_date": "2026-04-18", "publication_year": 2026, "doi": "10.33696/mentalhealth.6.068", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166815336", "source_url": "https://doi.org/10.33696/mentalhealth.6.068", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Consciousness,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:09", "bibtex": null, "source_record_id": "DOI:10.33696/mentalhealth.6.068", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.33696/mentalhealth.6.068", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.33696/mentalhealth.6.068", "source_url": "https://doi.org/10.33696/mentalhealth.6.068", "doi": "10.33696/mentalhealth.6.068", "pmid": "", "publication_date": "2026-04-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 168, "title": "Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.", "authors": "Gondi CS, Gnanamony M, Gondi TP, Nersesyan L, Demirkhanyan L", "journal": "Current issues in molecular biology", "publication_date": "2026-04-18", "publication_year": 2026, "doi": "10.3390/cimb48040417", "pubmed_id": "42042077", "openalex_id": "https://openalex.org/W7154992046", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42042077/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:42042077", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42042077/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42042077", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42042077/", "doi": "10.3390/cimb48040417", "pmid": "42042077", "publication_date": "2026-04-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 169, "title": "Psilocybin reshapes cortical inhibition through selective interneuron recruitment.", "authors": "Davoudian PA, Jiang Q, Knox CA, Savalia NK, Shao LX, Wilson J, Weiner AM, Chong CW, Liao C, Nothnagel JD, Sakurai T, Kwan AC", "journal": "bioRxiv: the preprint server for biology", "publication_date": "2026-04-17", "publication_year": 2026, "doi": "10.64898/2026.04.16.718963", "pubmed_id": "42039555", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42039555/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:42039555", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42039555/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42039555", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42039555/", "doi": "10.64898/2026.04.16.718963", "pmid": "42039555", "publication_date": "2026-04-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3019, "title": "Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration", "authors": "Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E.", "journal": "Preprints.org", "publication_date": "2026-04-15", "publication_year": 2026, "doi": "10.20944/preprints202604.1125.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Inflammaging,Review Article,Older Adults,Treatment-Resistant Depression,Safety,Drug Interactions,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:50", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202604.1125.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202604.1125.v1", "source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "doi": "10.20944/preprints202604.1125.v1", "pmid": "", "publication_date": "2026-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 172, "title": "A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience", "authors": "Back Anthony L., McGregor Bonnie A., Thorn Leslie L., Harvey Kalin, Blom Dianna, Callan George, Guy John, Kumar Sameet, Hershberg Rob, Layer Melissa, Levin Jackie, Myers Susanna, Perez Juliana, Salmonson Kathy, Thompson Peter, Whinney Joseph", "journal": "Frontiers in Public Health", "publication_date": "2026-04-14", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1810904", "pubmed_id": "42058096", "openalex_id": "https://openalex.org/W7154396122", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:42058096", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42058096", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "doi": "10.3389/fpubh.2026.1810904", "pmid": "42058096", "publication_date": "2026-04-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3578, "title": "CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06319378", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06319378", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06319378", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06319378", "source_url": "https://clinicaltrials.gov/study/NCT06319378", "doi": "", "pmid": "", "publication_date": "2026-04-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 176, "title": "Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat.", "authors": "Veysi A, Atanasovski D, Ardalan M, Motamed N, Eriksson E", "journal": "Acta neuropsychiatrica", "publication_date": "2026-04-10", "publication_year": 2026, "doi": "10.1017/neu.2026.10075", "pubmed_id": "41958297", "openalex_id": "https://openalex.org/W7153263780", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41958297/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41958297", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41958297/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41958297", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41958297/", "doi": "10.1017/neu.2026.10075", "pmid": "41958297", "publication_date": "2026-04-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4044, "title": "Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression", "authors": "Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman", "journal": "Figshare", "publication_date": "2026-04-09", "publication_year": 2026, "doi": "10.6084/m9.figshare.32048850", "pubmed_id": null, "openalex_id": "https://openalex.org/W7154853940", "source_url": "https://doi.org/10.6084/m9.figshare.32048850", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:09", "bibtex": null, "source_record_id": "DOI:10.6084/m9.figshare.32048850", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.6084/m9.figshare.32048850", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.6084/m9.figshare.32048850", "source_url": "https://doi.org/10.6084/m9.figshare.32048850", "doi": "10.6084/m9.figshare.32048850", "pmid": "", "publication_date": "2026-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 178, "title": "Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression", "authors": "Morel Nikita Sanati, Stenbaek Dea Siggaard, Lundberg Johan, Beckman Maria", "journal": "BMC Medical Education", "publication_date": "2026-04-09", "publication_year": 2026, "doi": "10.1186/s12909-026-09124-8", "pubmed_id": "41952163", "openalex_id": "https://openalex.org/W7151958593", "source_url": "https://doi.org/10.1186/s12909-026-09124-8", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41952163", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1186/s12909-026-09124-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41952163", "source_url": "https://doi.org/10.1186/s12909-026-09124-8", "doi": "10.1186/s12909-026-09124-8", "pmid": "41952163", "publication_date": "2026-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3249, "title": "Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy", "authors": "Gallardo LM.", "journal": "Preprints.org", "publication_date": "2026-04-07", "publication_year": 2026, "doi": "10.20944/preprints202604.0415.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202604.0415.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:15", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202604.0415.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202604.0415.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202604.0415.v1", "source_url": "https://doi.org/10.20944/preprints202604.0415.v1", "doi": "10.20944/preprints202604.0415.v1", "pmid": "", "publication_date": "2026-04-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1971, "title": "A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression", "authors": "Singleton S. Parker, Sevchik Brooke L., Lahey Analiese, Cuijpers Pim, Harrer Mathias, Jones Megan T., Nayak Sandeep M., Strain Eric C., Vandekar Simon N., Dworkin Robert H., Scott J. Cobb, Satterthwaite Theodore D.", "journal": "Nature Mental Health", "publication_date": "2026-04-06", "publication_year": 2026, "doi": "10.1038/s44220-026-00630-8", "pubmed_id": null, "openalex_id": "https://openalex.org/W7151101131", "source_url": "https://doi.org/10.1038/s44220-026-00630-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.1038/s44220-026-00630-8", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1038/s44220-026-00630-8", "source_url": "https://doi.org/10.1038/s44220-026-00630-8", "doi": "10.1038/s44220-026-00630-8", "pmid": "", "publication_date": "2026-04-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3651, "title": "Effects of Psilocybin in Obsessive Compulsive Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05546658", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05546658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05546658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05546658", "source_url": "https://clinicaltrials.gov/study/NCT05546658", "doi": "", "pmid": "", "publication_date": "2026-04-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2981, "title": "MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!", "authors": "Richmond Linda M.", "journal": "Psychiatric News", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1176/appi.pn.2026.04.4.3", "pubmed_id": null, "openalex_id": "https://openalex.org/W7143348770", "source_url": "https://doi.org/10.1176/appi.pn.2026.04.4.3", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2026.04.4.3", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1176/appi.pn.2026.04.4.3", "source_url": "https://doi.org/10.1176/appi.pn.2026.04.4.3", "doi": "10.1176/appi.pn.2026.04.4.3", "pmid": "", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 201, "title": "The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence.", "authors": "Teopiz KM, Le GH, Wong S, McIntyre RS", "journal": "Journal of affective disorders", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120836", "pubmed_id": "41360373", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41360373/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,Healthy Volunteers", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41360373", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41360373/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41360373", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41360373/", "doi": "10.1016/j.jad.2025.120836", "pmid": "41360373", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 195, "title": "Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis", "authors": "Syed Omer A., Tsang Benjamin, Nestor Sean M., Lipsman Nir, Husain Muhammad Ishrat, Alam Fahad, Giacobbe Peter", "journal": "Neuroscience & Biobehavioral Reviews", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1016/j.neubiorev.2026.106573", "pubmed_id": "41587629", "openalex_id": "https://openalex.org/W7125613611", "source_url": "https://doi.org/10.1016/j.neubiorev.2026.106573", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41587629", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2026.106573", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41587629", "source_url": "https://doi.org/10.1016/j.neubiorev.2026.106573", "doi": "10.1016/j.neubiorev.2026.106573", "pmid": "41587629", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 194, "title": "PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial.", "authors": "Downar J, Lapenskie J, Anderson K, Parsons G, Polskaia N, Lalumiere G, Lawlor P", "journal": "Palliative medicine", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1177/02692163261416269", "pubmed_id": "41617652", "openalex_id": "https://openalex.org/W7126258550", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41617652/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41617652", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41617652/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41617652", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41617652/", "doi": "10.1177/02692163261416269", "pmid": "41617652", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 188, "title": "Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.", "authors": "Kazdan J, Ladha KS, Husain MI", "journal": "Pharmacology research & perspectives", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1002/prp2.70238", "pubmed_id": "41940853", "openalex_id": "https://openalex.org/W7150989008", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41940853/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41940853", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41940853/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41940853", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41940853/", "doi": "10.1002/prp2.70238", "pmid": "41940853", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 186, "title": "Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.", "authors": "Marazziti D, Gambini M, Gurrieri R, Russomanno G, Sità G, Pescini E, Digiuseppe FR, Mucci F", "journal": "Expert opinion on pharmacotherapy", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1080/14656566.2026.2654682", "pubmed_id": "41944071", "openalex_id": "https://openalex.org/W7151630586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41944071/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41944071", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41944071/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41944071", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41944071/", "doi": "10.1080/14656566.2026.2654682", "pmid": "41944071", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4054, "title": "Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders", "authors": "Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin", "journal": "Psychiatry and Clinical Psychopharmacology", "publication_date": "2026-03-30", "publication_year": 2026, "doi": "10.65801/pcp.3512", "pubmed_id": null, "openalex_id": "https://openalex.org/W7143411647", "source_url": "https://doi.org/10.65801/pcp.3512", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.65801/pcp.3512", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.65801/pcp.3512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.65801/pcp.3512", "source_url": "https://doi.org/10.65801/pcp.3512", "doi": "10.65801/pcp.3512", "pmid": "", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3663, "title": "Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression", "authors": "Sunnybrook Health Sciences Centre", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06072898", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06072898", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06072898", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06072898", "source_url": "https://clinicaltrials.gov/study/NCT06072898", "doi": "", "pmid": "", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3478, "title": "Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder", "authors": "Indiana University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07499583", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Default Mode Network,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07499583", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "source_url": "https://clinicaltrials.gov/study/NCT07499583", "doi": "", "pmid": "", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1942, "title": "Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”", "authors": "Max Wolff, Samuli Kangaslampi, Richard J. Zeifman, Moritz Spangemacher", "journal": "PsyArXiv", "publication_date": "2026-03-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "source_url": "https://osf.io/preprints/psyarxiv/8s7xk_v1", "doi": "", "pmid": "", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 210, "title": "Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin", "authors": "Smith Katharine A., Harcourt Edward, Cipriani Andrea", "journal": "The British Journal of Psychiatry", "publication_date": "2026-03-30", "publication_year": 2026, "doi": "10.1192/bjp.2026.10612", "pubmed_id": "41906234", "openalex_id": "https://openalex.org/W7143417129", "source_url": "https://doi.org/10.1192/bjp.2026.10612", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41906234", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1192/bjp.2026.10612", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41906234", "source_url": "https://doi.org/10.1192/bjp.2026.10612", "doi": "10.1192/bjp.2026.10612", "pmid": "41906234", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 209, "title": "Unlocking 'stuckness' and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic-assisted therapy for substance use and mental health problems.", "authors": "Catchlove SJ, Oliver K, Savic M, Arunogiri S", "journal": "Addiction (Abingdon, England)", "publication_date": "2026-03-30", "publication_year": 2026, "doi": "10.1111/add.70403", "pubmed_id": "41906885", "openalex_id": "https://openalex.org/W7143442364", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41906885/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Healthcare Workers", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41906885", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41906885/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41906885", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41906885/", "doi": "10.1111/add.70403", "pmid": "41906885", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3696, "title": "Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression", "authors": "Federal University of Latin American Integration", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-27", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06898606", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06898606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "source_url": "https://clinicaltrials.gov/study/NCT06898606", "doi": "", "pmid": "", "publication_date": "2026-03-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 213, "title": "Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons", "authors": "Schmidt Malin, Hoffrichter Anne, Davoudi Mahnaz, Horschitz Sandra, Lau Thorsten, Meinhardt Marcus W, Spanagel Rainer, Ladewig Julia, Köhr Georg, Koch Philipp", "journal": "eLife", "publication_date": "2026-03-27", "publication_year": 2026, "doi": "10.7554/elife.104006", "pubmed_id": "41891829", "openalex_id": null, "source_url": "https://doi.org/10.7554/elife.104006", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Biomarkers,Treatment-Resistant Depression,Transcriptomics", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:41891829", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.7554/elife.104006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41891829", "source_url": "https://doi.org/10.7554/elife.104006", "doi": "10.7554/elife.104006", "pmid": "41891829", "publication_date": "2026-03-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4057, "title": "Classic psychedelic medicines for adolescent refractory mental health disease", "authors": "Aly Shah Aziz", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-03-26", "publication_year": 2026, "doi": "10.1556/2054.2026.00452", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140928407", "source_url": "https://doi.org/10.1556/2054.2026.00452", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00452", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00452", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00452", "source_url": "https://doi.org/10.1556/2054.2026.00452", "doi": "10.1556/2054.2026.00452", "pmid": "", "publication_date": "2026-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 214, "title": "Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)", "authors": "Skalski Piotr, Pękacka-Falkowska Katarzyna, Pluto-Prądzyńska Agnieszka, Owecki Michał K.", "journal": "Brain Sciences", "publication_date": "2026-03-26", "publication_year": 2026, "doi": "10.3390/brainsci16040358", "pubmed_id": "42041769", "openalex_id": "https://openalex.org/W7140611633", "source_url": "https://doi.org/10.3390/brainsci16040358", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:42041769", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/brainsci16040358", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42041769", "source_url": "https://doi.org/10.3390/brainsci16040358", "doi": "10.3390/brainsci16040358", "pmid": "42041769", "publication_date": "2026-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3447, "title": "Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial", "authors": "Medical University of Vienna", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-24", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07490353", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Wellbeing,Clinical Trial,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07490353", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07490353", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07490353", "source_url": "https://clinicaltrials.gov/study/NCT07490353", "doi": "", "pmid": "", "publication_date": "2026-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2983, "title": "Psilocybin, Lp(a), CAC, Niere und Darmkrebs - Evidenz-Quickies KW12", "authors": "Nößler Denis", "journal": "EvidenzUpdate", "publication_date": "2026-03-22", "publication_year": 2026, "doi": "10.69156/quick/2026.03.00011", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140105589", "source_url": "https://doi.org/10.69156/quick/2026.03.00011", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.69156/quick/2026.03.00011", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.69156/quick/2026.03.00011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.69156/quick/2026.03.00011", "source_url": "https://doi.org/10.69156/quick/2026.03.00011", "doi": "10.69156/quick/2026.03.00011", "pmid": "", "publication_date": "2026-03-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3657, "title": "Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-20", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07484906", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Observational Study,Veterans,Safety,Transcriptomics", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07484906", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07484906", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07484906", "source_url": "https://clinicaltrials.gov/study/NCT07484906", "doi": "", "pmid": "", "publication_date": "2026-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 221, "title": "Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.", "authors": "Portes MAM, Bertoglio LJ", "journal": "Journal of psychoactive drugs", "publication_date": "2026-03-20", "publication_year": 2026, "doi": "10.1080/02791072.2026.2644865", "pubmed_id": "41860795", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41860795/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Neuroplasticity,Receptor Pharmacology,Resilience,Observational Study,Inflammation", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41860795", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41860795/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41860795", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41860795/", "doi": "10.1080/02791072.2026.2644865", "pmid": "41860795", "publication_date": "2026-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1974, "title": "PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS", "authors": "Komarczewska Anna, Kociński Michał, Iglewski Patryk, Pietrasz Michał, Idziński Jakub, Lubomska Anna", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-03-19", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.5034", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164003040", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Receptor Pharmacology,Wellbeing,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "doi": "10.31435/ijitss.1(49).2026.5034", "pmid": "", "publication_date": "2026-03-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 225, "title": "Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies", "authors": "Farré-Colomés Àlvar, Rublinetska Olga, Soto-Angona Óscar", "journal": "Discover Mental Health", "publication_date": "2026-03-19", "publication_year": 2026, "doi": "10.1007/s44192-026-00384-w", "pubmed_id": "41854988", "openalex_id": "https://openalex.org/W7139105479", "source_url": "https://doi.org/10.1007/s44192-026-00384-w", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41854988", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1007/s44192-026-00384-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41854988", "source_url": "https://doi.org/10.1007/s44192-026-00384-w", "doi": "10.1007/s44192-026-00384-w", "pmid": "41854988", "publication_date": "2026-03-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3641, "title": "Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study", "authors": "Gustavo Vazquez", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-18", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06818994", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Aging,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06818994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "source_url": "https://clinicaltrials.gov/study/NCT06818994", "doi": "", "pmid": "", "publication_date": "2026-03-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4065, "title": "Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted Therapies", "authors": "Georgia Chlebek", "journal": "ThinkIR: The University of Louisville's Institutional Repository (University of Louisville)", "publication_date": "2026-03-16", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7138827229", "source_url": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Review Article,Adolescents,Treatment-Resistant Depression,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "source_url": "https://ir.library.louisville.edu/tce/vol3/iss1/11", "doi": "", "pmid": "", "publication_date": "2026-03-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3604, "title": "Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-16", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04123314", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04123314", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04123314", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04123314", "source_url": "https://clinicaltrials.gov/study/NCT04123314", "doi": "", "pmid": "", "publication_date": "2026-03-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1976, "title": "Explainable AI framework for psilocybin depression treatment optimization", "authors": "Sungheetha Akey, Rajesh Sharma R., Aroba Oluwasegun Julius, Mahapatra Sheila, Mahendhiran P. D.", "journal": "Frontiers in Computer Science", "publication_date": "2026-03-16", "publication_year": 2026, "doi": "10.3389/fcomp.2025.1652190", "pubmed_id": null, "openalex_id": "https://openalex.org/W7136253679", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "doi": "10.3389/fcomp.2025.1652190", "pmid": "", "publication_date": "2026-03-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4064, "title": "Editorial: Psychedelic substances and neurological diseases: from basics to clinical application", "authors": "Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino", "journal": "Frontiers in Pharmacology", "publication_date": "2026-03-15", "publication_year": 2026, "doi": "10.3389/fphar.2026.1816812", "pubmed_id": "41919223", "openalex_id": "https://openalex.org/W7136503554", "source_url": "https://doi.org/10.3389/fphar.2026.1816812", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Wellbeing,Spirituality,Clinical Trial,Review Article,Animal Study,Toxicity,Proteomics,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41919223", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fphar.2026.1816812", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41919223", "source_url": "https://doi.org/10.3389/fphar.2026.1816812", "doi": "10.3389/fphar.2026.1816812", "pmid": "41919223", "publication_date": "2026-03-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3493, "title": "Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04620759", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04620759", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04620759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04620759", "source_url": "https://clinicaltrials.gov/study/NCT04620759", "doi": "", "pmid": "", "publication_date": "2026-03-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 231, "title": "The renaissance of research on psychedelics in child and adolescent psychopharmacology.", "authors": "Crocq MA, Auby P", "journal": "Child and adolescent psychiatry and mental health", "publication_date": "2026-03-13", "publication_year": 2026, "doi": "10.1186/s13034-026-01069-6", "pubmed_id": "41826990", "openalex_id": "https://openalex.org/W7135184973", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41826990/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,OCD,Eating Disorders,Neuroplasticity,Pharmacology,Clinical Trial,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41826990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41826990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41826990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41826990/", "doi": "10.1186/s13034-026-01069-6", "pmid": "41826990", "publication_date": "2026-03-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3473, "title": "Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06442423", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06442423", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "source_url": "https://clinicaltrials.gov/study/NCT06442423", "doi": "", "pmid": "", "publication_date": "2026-03-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 233, "title": "Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.", "authors": "Chauhan SB, Akhtar N, Jain C, Singh I", "journal": "CNS & neurological disorders drug targets", "publication_date": "2026-03-11", "publication_year": 2026, "doi": "10.2174/0118715273434237251212095005", "pubmed_id": "41833044", "openalex_id": "https://openalex.org/W7135100807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41833044/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41833044", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41833044/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41833044", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41833044/", "doi": "10.2174/0118715273434237251212095005", "pmid": "41833044", "publication_date": "2026-03-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3228, "title": "Age moderates the relationship between psychedelics use and mental health in naturalistic settings", "authors": "Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M.", "journal": "Research Square", "publication_date": "2026-03-10", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9022170/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Longevity,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:13", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "doi": "10.21203/rs.3.rs-9022170/v1", "pmid": "", "publication_date": "2026-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 237, "title": "The combination of exercise and psychedelics for the treatment of major depressive disorder.", "authors": "Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R", "journal": "Discover mental health", "publication_date": "2026-03-07", "publication_year": 2026, "doi": "10.1007/s44192-026-00408-5", "pubmed_id": "41793582", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Resilience,Emotional Processing,Psychological Flexibility,Safety,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41793582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41793582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "doi": "10.1007/s44192-026-00408-5", "pmid": "41793582", "publication_date": "2026-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3016, "title": "Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin", "authors": "Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ.", "journal": "bioRxiv", "publication_date": "2026-03-04", "publication_year": 2026, "doi": "10.64898/2026.03.02.709133", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.03.02.709133", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:49", "bibtex": null, "source_record_id": "DOI:10.64898/2026.03.02.709133", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.03.02.709133", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.03.02.709133", "source_url": "https://doi.org/10.64898/2026.03.02.709133", "doi": "10.64898/2026.03.02.709133", "pmid": "", "publication_date": "2026-03-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3616, "title": "A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.", "authors": "Psyence Australia Pty Ltd", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07072728", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07072728", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "source_url": "https://clinicaltrials.gov/study/NCT07072728", "doi": "", "pmid": "", "publication_date": "2026-03-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4074, "title": "THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICE", "authors": "Zeinab Asghari, Gregory Robinson, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Timur Zanikov, Yasaman Rastamian, Olga Kovalchuk, Igor Kovalchuk*", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.5281/zenodo.18796594", "pubmed_id": null, "openalex_id": "https://openalex.org/W7131870859", "source_url": "https://doi.org/10.5281/zenodo.18796594", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Animal Study,Microbiome,Inflammation,Immune Function", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18796594", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18796594", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18796594", "source_url": "https://doi.org/10.5281/zenodo.18796594", "doi": "10.5281/zenodo.18796594", "pmid": "", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 254, "title": "Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023-2024.", "authors": "Jorgenson DM, Santos Leon E, Vakkalanka JP, Krispin S, Radke JB", "journal": "Clinical toxicology (Philadelphia, Pa.)", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1080/15563650.2025.2599402", "pubmed_id": "41493095", "openalex_id": "https://openalex.org/W7119143402", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41493095/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41493095", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41493095/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41493095", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41493095/", "doi": "10.1080/15563650.2025.2599402", "pmid": "41493095", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 252, "title": "Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.", "authors": "Rached G, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, Barnett BS", "journal": "CNS drugs", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1007/s40263-025-01256-7", "pubmed_id": "41546846", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41546846/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Review Article,Safety,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41546846", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41546846/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41546846", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41546846/", "doi": "10.1007/s40263-025-01256-7", "pmid": "41546846", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 251, "title": "Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy", "authors": "Doyle Zoe, Chisamore Noah, Kaczmarek Erica S., Johnson Danica E., Brudner Ryan M., Weiglein Geneva, Blainey Marc G., Bawks Jordan, Riva-Cambrin Jeremy, Sethi Rickinder, McIntyre Roger S., Rosenblat Joshua D.", "journal": "General Hospital Psychiatry", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1016/j.genhosppsych.2026.01.001", "pubmed_id": "41581334", "openalex_id": "https://openalex.org/W7124833468", "source_url": "https://doi.org/10.1016/j.genhosppsych.2026.01.001", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41581334", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41581334", "source_url": "https://doi.org/10.1016/j.genhosppsych.2026.01.001", "doi": "10.1016/j.genhosppsych.2026.01.001", "pmid": "41581334", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 245, "title": "[Perspectives opened up by the physiopathological understanding of psychiatric disorders].", "authors": "Girault N, Quiroga L, Jedrecy S, Bertin S, Djonouma N, Fossati P", "journal": "La Revue du praticien", "publication_date": "2026-03-01", "publication_year": 2026, "doi": null, "pubmed_id": "41878960", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41878960/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Genomics", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:41878960", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41878960/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41878960", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41878960/", "doi": "", "pmid": "41878960", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 229, "title": "Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy", "authors": "Khan Faheem Ahmed, Pandupuspitasari Nuruliarizki Shinta, Tencomnao Tewin, Chuchawankul Siriporn", "journal": "Journal of Affective Disorders", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120882", "pubmed_id": "41419063", "openalex_id": "https://openalex.org/W4417535188", "source_url": "https://doi.org/10.1016/j.jad.2025.120882", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41419063", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.jad.2025.120882", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41419063", "source_url": "https://doi.org/10.1016/j.jad.2025.120882", "doi": "10.1016/j.jad.2025.120882", "pmid": "41419063", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 227, "title": "Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression", "authors": "Ziadi Yosr, Park Taehwan", "journal": "Value in Health Regional Issues", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1016/j.vhri.2026.101605", "pubmed_id": "41842876", "openalex_id": "https://openalex.org/W7138831903", "source_url": "https://doi.org/10.1016/j.vhri.2026.101605", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41842876", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.vhri.2026.101605", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41842876", "source_url": "https://doi.org/10.1016/j.vhri.2026.101605", "doi": "10.1016/j.vhri.2026.101605", "pmid": "41842876", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4075, "title": "A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations", "authors": "Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1177/20451253261433836", "pubmed_id": "41918771", "openalex_id": "https://openalex.org/W7141801946", "source_url": "https://doi.org/10.1177/20451253261433836", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "PMID:41918771", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253261433836", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41918771", "source_url": "https://doi.org/10.1177/20451253261433836", "doi": "10.1177/20451253261433836", "pmid": "41918771", "publication_date": "2026-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 259, "title": "Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.", "authors": "Zhang J, Lin C, Lv X, Zhao H, Wang X", "journal": "Biological psychiatry", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1016/j.biopsych.2026.02.011", "pubmed_id": "41765343", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41765343/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41765343", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41765343/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41765343", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41765343/", "doi": "10.1016/j.biopsych.2026.02.011", "pmid": "41765343", "publication_date": "2026-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4076, "title": "Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making", "authors": "C Faria, Diana Dias da Silva, João José Sousa", "journal": "Instituto Politécnico do Porto", "publication_date": "2026-02-27", "publication_year": 2026, "doi": "10.26537/prpaeh.v4i3.7173", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166641777", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "doi": "10.26537/prpaeh.v4i3.7173", "pmid": "", "publication_date": "2026-02-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 261, "title": "Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.", "authors": "Beaussant Y, Sager Z, Brennan C, Kristan I, Ljuslin M, Mazzola E, Macdonald D, Murphy ME, Nigam K, Rinaldi AD, Sanders J, Schaefer KG, Sholevar R, Summer L, Waliji-Banglawala A, Yudilevich-Espinoza S, Tulsky JA", "journal": "BMJ supportive & palliative care", "publication_date": "2026-02-27", "publication_year": 2026, "doi": "10.1136/spcare-2025-005773", "pubmed_id": "41184102", "openalex_id": "https://openalex.org/W4415820910", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41184102/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Emotional Processing,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41184102", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41184102/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41184102", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41184102/", "doi": "10.1136/spcare-2025-005773", "pmid": "41184102", "publication_date": "2026-02-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 260, "title": "Psychedelic therapy and cultural humility.", "authors": "Gearin A, Docherty J, Sun X, Cheung EH, Tanuseputro P", "journal": "Translational psychiatry", "publication_date": "2026-02-27", "publication_year": 2026, "doi": "10.1038/s41398-026-03913-x", "pubmed_id": "41748534", "openalex_id": "https://openalex.org/W7131675232", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41748534/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Spirituality,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41748534", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41748534/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41748534", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41748534/", "doi": "10.1038/s41398-026-03913-x", "pmid": "41748534", "publication_date": "2026-02-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3032, "title": "Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial", "authors": "Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A.", "journal": "Research Square", "publication_date": "2026-02-23", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8319478/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:52", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "doi": "10.21203/rs.3.rs-8319478/v1", "pmid": "", "publication_date": "2026-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 264, "title": "Psychedelic medicine: mechanisms, evidence, and translation to practice.", "authors": "Jacobs E, Zahid Z, Hinkle J, Nayak S, Yaden DB", "journal": "BMJ (Clinical research ed.)", "publication_date": "2026-02-23", "publication_year": 2026, "doi": "10.1136/bmj-2024-081723", "pubmed_id": "41730563", "openalex_id": "https://openalex.org/W7131088236", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41730563/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Emotional Processing,Psychological Flexibility,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41730563", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41730563/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41730563", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41730563/", "doi": "10.1136/bmj-2024-081723", "pmid": "41730563", "publication_date": "2026-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1982, "title": "Effects of Psilocybin and Select Pharmaceutical Interactions", "authors": "Jordan McDowell, Jada Middleton, Alanna Bluett, Alisa Kozachenko, Bayan Attar, Yuvraj Singh Saini, Jennifer Burke, Cayden McPhee, Mutahera Mutahera, Talya Ahmed, Nabila Ibrahim, Gilbert Atukwatsibwe, Sulabha Adhikari, Mohammad Esmaili, Jean-Vital Yambayamba", "journal": "MacEwan University Student eJournal", "publication_date": "2026-02-18", "publication_year": 2026, "doi": "10.31542/bcek6t76", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130340064", "source_url": "https://doi.org/10.31542/bcek6t76", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Older Adults,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.31542/bcek6t76", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31542/bcek6t76", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31542/bcek6t76", "source_url": "https://doi.org/10.31542/bcek6t76", "doi": "10.31542/bcek6t76", "pmid": "", "publication_date": "2026-02-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4900, "title": "Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis.", "authors": "Khan Z, Weaver S, Dando RV, Schlag AK, Neill JC, Wainwright V", "journal": "Qualitative health research", "publication_date": "2026-02-17", "publication_year": 2026, "doi": "10.1177/10497323261419338", "pubmed_id": "41700878", "openalex_id": "https://openalex.org/W7129539813", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41700878/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 06:51:51", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41700878", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41700878/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41700878", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41700878/", "doi": "10.1177/10497323261419338", "pmid": "41700878", "publication_date": "2026-02-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3520, "title": "Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study", "authors": "Yvan Beaussant, MD, MSci", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04950608", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Cancer Patients,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04950608", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04950608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04950608", "source_url": "https://clinicaltrials.gov/study/NCT04950608", "doi": "", "pmid": "", "publication_date": "2026-02-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 269, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.", "authors": "Beidas Z, Ragnhildstveit A, Blackman A, Anderson T, Fewster E, Syed OA, Sobolenko V, Kanca IK, Jaglinska M, Son T, Farb N, Petranker R", "journal": "BJPsych open", "publication_date": "2026-02-16", "publication_year": 2026, "doi": "10.1192/bjo.2025.10968", "pubmed_id": "41693474", "openalex_id": "https://openalex.org/W7129015437", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41693474/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity,Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41693474", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41693474/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41693474", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41693474/", "doi": "10.1192/bjo.2025.10968", "pmid": "41693474", "publication_date": "2026-02-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3541, "title": "A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07050368", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07050368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "source_url": "https://clinicaltrials.gov/study/NCT07050368", "doi": "", "pmid": "", "publication_date": "2026-02-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3624, "title": "Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07405606", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07405606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "source_url": "https://clinicaltrials.gov/study/NCT07405606", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3514, "title": "Psilocybin-Assisted Cognitive Behavioral Therapy for Depression", "authors": "University of California, Los Angeles", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07281352", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07281352", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07281352", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07281352", "source_url": "https://clinicaltrials.gov/study/NCT07281352", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1983, "title": "Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study", "authors": "Matthew Hicks, Olivia Hicks, Ryan Bradley, Heather Zwickey", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-02-12", "publication_year": 2026, "doi": "10.1556/2054.2026.00485", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128687864", "source_url": "https://doi.org/10.1556/2054.2026.00485", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00485", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00485", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00485", "source_url": "https://doi.org/10.1556/2054.2026.00485", "doi": "10.1556/2054.2026.00485", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 275, "title": "Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.", "authors": "Johnston J, Jones G, Peng S, Yuan P, Yavi M, Kadriu B, Henter I, Quintanilla B, Elkahloun AG, Moaddel R, Schulmann A, Akula N, Kvarta M, McMahon F, Zarate C", "journal": "Research square", "publication_date": "2026-02-12", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8733841/v1", "pubmed_id": "41743330", "openalex_id": "https://openalex.org/W7170779894", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41743330/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Healthy Volunteers,Treatment-Resistant Depression,Transcriptomics,Proteomics,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41743330", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41743330/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41743330", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41743330/", "doi": "10.21203/rs.3.rs-8733841/v1", "pmid": "41743330", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3031, "title": "Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD", "authors": "Sarah Shnayder, Gabrielle Agin-Liebes, Troy Hubert, Terence Ching, Jamila Hokanson, Christopher Pittenger, Benjamin Kelmendi, Thomas Adams", "journal": "PsyArXiv", "publication_date": "2026-02-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/d94hb_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mystical Experience", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/d94hb_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/d94hb_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/d94hb_v1", "source_url": "https://osf.io/preprints/psyarxiv/d94hb_v1", "doi": "", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4086, "title": "Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature", "authors": "Blake Beaton", "journal": "Deviant Behavior", "publication_date": "2026-02-09", "publication_year": 2026, "doi": "10.1080/01639625.2026.2624690", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128430445", "source_url": "https://doi.org/10.1080/01639625.2026.2624690", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.1080/01639625.2026.2624690", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/01639625.2026.2624690", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/01639625.2026.2624690", "source_url": "https://doi.org/10.1080/01639625.2026.2624690", "doi": "10.1080/01639625.2026.2624690", "pmid": "", "publication_date": "2026-02-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4089, "title": "Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study", "authors": "Zen Revista", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-02-06", "publication_year": 2026, "doi": "10.5281/zenodo.18501514", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127925138", "source_url": "https://doi.org/10.5281/zenodo.18501514", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Aging,Review Article,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18501514", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18501514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18501514", "source_url": "https://doi.org/10.5281/zenodo.18501514", "doi": "10.5281/zenodo.18501514", "pmid": "", "publication_date": "2026-02-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3690, "title": "Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers", "authors": "Hadassah Medical Organization", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07079930", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Clinical Trial,Observational Study,Animal Study,Healthy Volunteers,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07079930", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "source_url": "https://clinicaltrials.gov/study/NCT07079930", "doi": "", "pmid": "", "publication_date": "2026-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3550, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06206265", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Aging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06206265", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "source_url": "https://clinicaltrials.gov/study/NCT06206265", "doi": "", "pmid": "", "publication_date": "2026-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 280, "title": "Acute psilocin increased cortical activity in rat", "authors": "Liu Junhong, Wang Yuanyuan, Xia Ke, Wu Jinfeng, Zheng Danhao, Cai Aoling, Yan Haitao, Su Ruibin", "journal": "Frontiers in Neuroscience", "publication_date": "2026-02-04", "publication_year": 2026, "doi": "10.3389/fnins.2026.1593703", "pubmed_id": "41716660", "openalex_id": "https://openalex.org/W7127681443", "source_url": "https://doi.org/10.3389/fnins.2026.1593703", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:41716660", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fnins.2026.1593703", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41716660", "source_url": "https://doi.org/10.3389/fnins.2026.1593703", "doi": "10.3389/fnins.2026.1593703", "pmid": "41716660", "publication_date": "2026-02-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1985, "title": "Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia", "authors": "Sheida Shadani, Erika Greaves, Zane B. Andrews, Claire J. Foldi", "journal": "Psychedelics.", "publication_date": "2026-02-03", "publication_year": 2026, "doi": "10.61373/pp026a.0003", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127440111", "source_url": "https://doi.org/10.61373/pp026a.0003", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Animal Study,Toxicity,Inflammation,Immune Function", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.61373/pp026a.0003", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp026a.0003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp026a.0003", "source_url": "https://doi.org/10.61373/pp026a.0003", "doi": "10.61373/pp026a.0003", "pmid": "", "publication_date": "2026-02-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2984, "title": "Psilocybin wirkt bei therapieresistenter Depression", "authors": "Thomas Müller", "journal": "DNP - Die Neurologie & Psychiatrie", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1007/s15202-025-6636-1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127040761", "source_url": "https://doi.org/10.1007/s15202-025-6636-1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.1007/s15202-025-6636-1", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15202-025-6636-1", "source_url": "https://doi.org/10.1007/s15202-025-6636-1", "doi": "10.1007/s15202-025-6636-1", "pmid": "", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1986, "title": "Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).", "authors": "Jorge Encantado, Laura C. Carvalho, Pedro Mota, Catarina Cunha, Albert Garcia-Romeu, Matthew W. Johnson, Pedro J. Teixeira", "journal": "Professional Psychology Research and Practice", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1037/pro0000664", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128674161", "source_url": "https://doi.org/10.1037/pro0000664", "substance_tags": "psilocybin", "topic_tags": "Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.1037/pro0000664", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1037/pro0000664", "source_url": "https://doi.org/10.1037/pro0000664", "doi": "10.1037/pro0000664", "pmid": "", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 311, "title": "Compassionate use of psilocybin for treatment-resistant depression in Germany.", "authors": "Gründer G, Mertens LJ, Jungaberle A, Jungaberle H, Spangemacher M", "journal": "The lancet. Psychiatry", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/s2215-0366(25)00277-9", "pubmed_id": "40976246", "openalex_id": "https://openalex.org/W4414422524", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40976246/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:40976246", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40976246", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40976246/", "doi": "10.1016/s2215-0366(25)00277-9", "pmid": "40976246", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 307, "title": "Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.", "authors": "Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1177/07067437251389090", "pubmed_id": "41148143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41148143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41148143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41148143/", "doi": "10.1177/07067437251389090", "pmid": "41148143", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 306, "title": "Psilocybin use in bipolar disorder: A comprehensive review.", "authors": "Do A, Cloutier L, Hébert-Tremblay L, Thauvin C", "journal": "Journal of affective disorders", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120485", "pubmed_id": "41177271", "openalex_id": "https://openalex.org/W4415742444", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41177271/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41177271", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41177271/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41177271", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41177271/", "doi": "10.1016/j.jad.2025.120485", "pmid": "41177271", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 305, "title": "Pharmacodynamic biomarker - or psychotherapeutic process? Comment on \"The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression\".", "authors": "Wolff M, Kangaslampi S", "journal": "Journal of affective disorders", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120637", "pubmed_id": "41224017", "openalex_id": "https://openalex.org/W4416412154", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41224017/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Biomarkers,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41224017", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41224017", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41224017/", "doi": "10.1016/j.jad.2025.120637", "pmid": "41224017", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 300, "title": "Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.", "authors": "Ansari M, Elliott SI, Holmes SE, Sanacora G", "journal": "Neurologic clinics", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.ncl.2025.08.009", "pubmed_id": "41232997", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41232997/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41232997", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41232997/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41232997", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41232997/", "doi": "10.1016/j.ncl.2025.08.009", "pmid": "41232997", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 294, "title": "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.", "authors": "Dutton M, Schwenn P, Mitchell J, Hoffmann P, Bailey NW, Fitzgerald PB, Lagopoulos J, Can AT", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1177/00048674251398677", "pubmed_id": "41405025", "openalex_id": "https://openalex.org/W4417431364", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41405025/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41405025", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41405025/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41405025", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41405025/", "doi": "10.1177/00048674251398677", "pmid": "41405025", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 293, "title": "Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.", "authors": "Vollebregt R, Storm AEM, Lucassen PJ, Somers M", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.neubiorev.2025.106529", "pubmed_id": "41412413", "openalex_id": "https://openalex.org/W4417399627", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41412413/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Emotional Processing,Systematic Review,Review Article,Treatment-Resistant Depression,Drug Interactions", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41412413", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41412413/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41412413", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41412413/", "doi": "10.1016/j.neubiorev.2025.106529", "pmid": "41412413", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 291, "title": "Psilocybin and Bipolar Depression: Promise and Prudence.", "authors": "Marques MG, Patarroyo-Rodriguez L, Singh B", "journal": "CNS drugs", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1007/s40263-025-01255-8", "pubmed_id": "41485178", "openalex_id": "https://openalex.org/W7118127068", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485178/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41485178", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41485178/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41485178", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485178/", "doi": "10.1007/s40263-025-01255-8", "pmid": "41485178", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 289, "title": "Patient perspectives on research gaps in cluster headache.", "authors": "Haghdoost F, Bahceci D, Delcourt C, Wijeratne T, Jensen RH, Cincinnato C, Tomlinson S, Wold B, Polito V, Carcel C, Ashraf U, Jenkins B, Petersen AS, Ray JC, Schindler EAD, Tsang B, Gianacas C, Rodgers A", "journal": "Headache", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1111/head.70031", "pubmed_id": "41562498", "openalex_id": "https://openalex.org/W7125283737", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41562498/", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Clinical Trial,Observational Study,Healthcare Workers,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41562498", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41562498/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41562498", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41562498/", "doi": "10.1111/head.70031", "pmid": "41562498", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 287, "title": "Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access.", "authors": "Halm S", "journal": "Brain and behavior", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1002/brb3.71265", "pubmed_id": "41699879", "openalex_id": "https://openalex.org/W7129286008", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41699879/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41699879", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41699879/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41699879", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41699879/", "doi": "10.1002/brb3.71265", "pmid": "41699879", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 284, "title": "Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.", "authors": "Kala K, Bederska-Lojewska D, Lazur J, Gasior K, Maslanka A, Szewczyk A, Sulkowska-Ziaja K, Turek J, Szewczyk B, Pilc A, Muszynska B", "journal": "Journal of physiology and pharmacology: an official journal of the Polish Physiological Society", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.26402/jpp.2026.1.07", "pubmed_id": "41931735", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41931735/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41931735", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41931735/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41931735", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41931735/", "doi": "10.26402/jpp.2026.1.07", "pmid": "41931735", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 270, "title": "Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments.", "authors": "McNaughton N, Shadli SM, Beaglehole B, Glue P", "journal": "Journal of the Royal Society of New Zealand", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1002/snz2.70002", "pubmed_id": "41798779", "openalex_id": "https://openalex.org/W7128951017", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41798779/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Brain Imaging,Mechanism of Action,Biomarkers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41798779", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41798779/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41798779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41798779/", "doi": "10.1002/snz2.70002", "pmid": "41798779", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1988, "title": "Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects", "authors": "Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz", "journal": "Quality in Sport", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.12775/qs.2026.51.68216", "pubmed_id": null, "openalex_id": "https://openalex.org/W7126403964", "source_url": "https://doi.org/10.12775/qs.2026.51.68216", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Meta-Analysis,Review Article,Animal Study,Cancer Patients,Treatment-Resistant Depression,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.51.68216", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.51.68216", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.51.68216", "source_url": "https://doi.org/10.12775/qs.2026.51.68216", "doi": "10.12775/qs.2026.51.68216", "pmid": "", "publication_date": "2026-01-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4097, "title": "Protecting patient autonomy in psychedelic-assisted psychotherapy: a nursing ethics perspective", "authors": "Aditi Kanwar, Nitin Jeengar, Pramod Kumar Ashaiya", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-30", "publication_year": 2026, "doi": "10.5281/zenodo.18425838", "pubmed_id": null, "openalex_id": "https://openalex.org/W7126227261", "source_url": "https://doi.org/10.5281/zenodo.18425838", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Consciousness,Emotional Processing,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18425838", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18425838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18425838", "source_url": "https://doi.org/10.5281/zenodo.18425838", "doi": "10.5281/zenodo.18425838", "pmid": "", "publication_date": "2026-01-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4098, "title": "Psychedelic research and sexuality: opportunities and pitfalls", "authors": "H. Knegtering, Thalia Herder, Nynke Boonstra, S. K. Spoelstra", "journal": "The Journal of Sexual Medicine", "publication_date": "2026-01-28", "publication_year": 2026, "doi": "10.1093/jsxmed/qdag025", "pubmed_id": "41722098", "openalex_id": "https://openalex.org/W7130838555", "source_url": "https://doi.org/10.1093/jsxmed/qdag025", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Emotional Processing,Review Article,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "PMID:41722098", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/jsxmed/qdag025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41722098", "source_url": "https://doi.org/10.1093/jsxmed/qdag025", "doi": "10.1093/jsxmed/qdag025", "pmid": "41722098", "publication_date": "2026-01-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1989, "title": "PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION", "authors": "Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-28", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4711", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125929049", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "doi": "10.31435/ijitss.1(49).2026.4711", "pmid": "", "publication_date": "2026-01-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4101, "title": "Psychedelics in psychiatric treatment: a literature review", "authors": "Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska", "journal": "Quality in Sport", "publication_date": "2026-01-26", "publication_year": 2026, "doi": "10.12775/qs.2026.50.68013", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125801196", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.50.68013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.50.68013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.50.68013", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "doi": "10.12775/qs.2026.50.68013", "pmid": "", "publication_date": "2026-01-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4100, "title": "The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence", "authors": "Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-26", "publication_year": 2026, "doi": "10.5281/zenodo.18375715", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125699554", "source_url": "https://doi.org/10.5281/zenodo.18375715", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18375715", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18375715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18375715", "source_url": "https://doi.org/10.5281/zenodo.18375715", "doi": "10.5281/zenodo.18375715", "pmid": "", "publication_date": "2026-01-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1991, "title": "The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression", "authors": "Rishika Scott, James Smith", "journal": "Emerging Minds Journal for Student Research", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.59973/emjsr.317", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125652025", "source_url": "https://doi.org/10.59973/emjsr.317", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.59973/emjsr.317", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59973/emjsr.317", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59973/emjsr.317", "source_url": "https://doi.org/10.59973/emjsr.317", "doi": "10.59973/emjsr.317", "pmid": "", "publication_date": "2026-01-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4106, "title": "Does psilocybin help with mental health conditions?", "authors": "Tripdatabase", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.5281/zenodo.18339283", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125428177", "source_url": "https://doi.org/10.5281/zenodo.18339283", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18339283", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18339283", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18339283", "source_url": "https://doi.org/10.5281/zenodo.18339283", "doi": "10.5281/zenodo.18339283", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1992, "title": "THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS", "authors": "Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4582", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127606273", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "doi": "10.31435/ijitss.1(49).2026.4582", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4108, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.", "authors": "Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria", "journal": "Open Access CRIS of the University of Bern", "publication_date": "2026-01-21", "publication_year": 2026, "doi": "10.48620/94398", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128014083", "source_url": "https://doi.org/10.48620/94398", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.48620/94398", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48620/94398", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48620/94398", "source_url": "https://doi.org/10.48620/94398", "doi": "10.48620/94398", "pmid": "", "publication_date": "2026-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 323, "title": "[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].", "authors": "Xia K, Gao T", "journal": "Nan fang yi ke da xue xue bao = Journal of Southern Medical University", "publication_date": "2026-01-20", "publication_year": 2026, "doi": "10.12122/j.issn.1673-4254.2026.01.01", "pubmed_id": "41540686", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41540686/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41540686", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41540686/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41540686", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41540686/", "doi": "10.12122/j.issn.1673-4254.2026.01.01", "pmid": "41540686", "publication_date": "2026-01-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1993, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study", "authors": "Anthony L. Back, Bonnie A. McGregor, Leslie Lazar Thorn, Kelsey K. Baker, T. Gooley, Mendel Kaelen, Kalin Harvey, John M. Guy, Susanna Myers, Juliana Pérez, Peter Thompson, Lindsay Billingsley, Cheryl Sesnon", "journal": "Psychedelic Medicine", "publication_date": "2026-01-18", "publication_year": 2026, "doi": "10.1177/28314425251413856", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124682544", "source_url": "https://doi.org/10.1177/28314425251413856", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251413856", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251413856", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251413856", "source_url": "https://doi.org/10.1177/28314425251413856", "doi": "10.1177/28314425251413856", "pmid": "", "publication_date": "2026-01-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3261, "title": "Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST", "authors": "Theo Tobel, Aidan Cone, Emily M Choquette, McKenna Garland, Micah Johnson, Keller Mink, Caitlin Lynch, Joel Frohlich, Justin Feinstein, Nicco Reggente", "journal": "PsyArXiv", "publication_date": "2026-01-15", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Consciousness,Spirituality,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "source_url": "https://osf.io/preprints/psyarxiv/6mj8n_v1", "doi": "", "pmid": "", "publication_date": "2026-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3038, "title": "Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms", "authors": "Hinchcliffe JK, Thomas CW, Gilmour G, Robinson ES.", "journal": "bioRxiv", "publication_date": "2026-01-15", "publication_year": 2026, "doi": "10.64898/2026.01.14.699553", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.01.14.699553", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Animal Study,Inflammation", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:52", "bibtex": null, "source_record_id": "DOI:10.64898/2026.01.14.699553", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.01.14.699553", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.01.14.699553", "source_url": "https://doi.org/10.64898/2026.01.14.699553", "doi": "10.64898/2026.01.14.699553", "pmid": "", "publication_date": "2026-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3029, "title": "Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial", "authors": "Benjamin Kelmendi, Thomas Adams, Terence Ching, Rachael Grazioplene, Stephen Kichuk, Geena Fram, Prerana Patel, Jeff Eilbott, Elizabeth D’Amico, Sarah Shnayder", "journal": "PsyArXiv", "publication_date": "2026-01-15", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "doi": "", "pmid": "", "publication_date": "2026-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 326, "title": "Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.", "authors": "Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS", "journal": "Journal of affective disorders", "publication_date": "2026-01-15", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120335", "pubmed_id": "40962065", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40962065/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:40962065", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40962065/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40962065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40962065/", "doi": "10.1016/j.jad.2025.120335", "pmid": "40962065", "publication_date": "2026-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 325, "title": "Corrigendum to \"The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression\" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E", "journal": "Journal of affective disorders", "publication_date": "2026-01-15", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120352", "pubmed_id": "41075579", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41075579/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41075579", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41075579", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41075579/", "doi": "10.1016/j.jad.2025.120352", "pmid": "41075579", "publication_date": "2026-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 266, "title": "Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological Analysis", "authors": "Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna; id_orcid 0000-0002-2717-9739 Neill, Verity; id_orcid 0000-0002-9876-250X Wainwright", "journal": "Research Explorer (The University of Manchester)", "publication_date": "2026-01-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7128133091", "source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "source_url": "https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3", "doi": "", "pmid": "", "publication_date": "2026-01-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3014, "title": "Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons", "authors": "Koch P, Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt M, Spanagel R, Ladewig J, Köhr G.", "journal": "Research Square", "publication_date": "2026-01-07", "publication_year": 2026, "doi": "10.21203/rs.3.rs-4242829/v3", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4242829/v3", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Biomarkers,Treatment-Resistant Depression,Transcriptomics", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:49", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4242829/v3", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4242829/v3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4242829/v3", "source_url": "https://doi.org/10.21203/rs.3.rs-4242829/v3", "doi": "10.21203/rs.3.rs-4242829/v3", "pmid": "", "publication_date": "2026-01-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 329, "title": "From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.", "authors": "Mitchell J, Neitzke-Spruill L, Mathai DS, Robinson JO, Kavan Z, Averil LA, McGuire AL", "journal": "Translational behavioral medicine", "publication_date": "2026-01-07", "publication_year": 2026, "doi": "10.1093/tbm/ibag027", "pubmed_id": "42152689", "openalex_id": "https://openalex.org/W7161692886", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42152689/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:42152689", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42152689/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42152689", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42152689/", "doi": "10.1093/tbm/ibag027", "pmid": "42152689", "publication_date": "2026-01-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 333, "title": "An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.", "authors": "Dallery J, Miller JL, Boissoneault J, Harvey L, Ives L, Knerr A, Blaes S, Ransom MN, Munson M, Gilligan JP, Silverman MH, Guzzo PR, Loeser B", "journal": "Journal of eating disorders", "publication_date": "2026-01-03", "publication_year": 2026, "doi": "10.1186/s40337-025-01508-3", "pubmed_id": "41485073", "openalex_id": "https://openalex.org/W7118124310", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485073/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Brain Imaging,Biomarkers,Aging,Emotional Processing,Psychological Flexibility,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41485073", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41485073/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41485073", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485073/", "doi": "10.1186/s40337-025-01508-3", "pmid": "41485073", "publication_date": "2026-01-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 336, "title": "The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis.", "authors": "Moshfeghinia R, Mostafavi S, Jazi K, Ghasemi AR, Khosravaninezhad Y, Narayanan S, Ahmadi J, Pasalar M", "journal": "BMC psychology", "publication_date": "2026-01-02", "publication_year": 2026, "doi": "10.1186/s40359-025-03935-y", "pubmed_id": "41484687", "openalex_id": "https://openalex.org/W7118088637", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41484687/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41484687", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41484687/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41484687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41484687/", "doi": "10.1186/s40359-025-03935-y", "pmid": "41484687", "publication_date": "2026-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 334, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.", "authors": "Florineth GA, Klima I, Boeker AL, Catzeflis P, Wopfner A, Denier N, Bracht T, Adorjan K, Pfammatter M, Müller F, Soravia LM", "journal": "JAMA network open", "publication_date": "2026-01-02", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2025.54843", "pubmed_id": "41563753", "openalex_id": "https://openalex.org/W7125277592", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41563753/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Drug Interactions", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41563753", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41563753/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41563753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41563753/", "doi": "10.1001/jamanetworkopen.2025.54843", "pmid": "41563753", "publication_date": "2026-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5794, "title": "Psychedelic Drugs", "authors": "Federico Durbano, Marco Otto Toscano", "journal": "IntechOpen", "publication_date": "2026-01-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7170998516", "source_url": "https://www.intechopen.com/books/1004886", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Consciousness,Emotional Processing,Spirituality,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:13", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://www.intechopen.com/books/1004886", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://www.intechopen.com/books/1004886", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.intechopen.com/books/1004886", "source_url": "https://www.intechopen.com/books/1004886", "doi": "", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4203, "title": "COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSIS", "authors": "Rodrigues Paulo Henrique Rodrigues e, Júnior Weliton Rodrigues dos Santos, Araújo Ivan de Sousa, Leony Leonardo Maia, Gomes Fernanda Adélia Almeida Custódio Pires, Junior Tairone Matos de Lima, Moreira Luís Felipe Freitas, Santana Rafael Telles, Santos Manoel Carlos Matos, Silva Roberto de Barros", "journal": "The Study of Phenomena Related to Health", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.55905/edicon.978-65-83115-47-8_8", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417258517", "source_url": "https://doi.org/10.55905/edicon.978-65-83115-47-8_8", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:34:58", "bibtex": null, "source_record_id": "DOI:10.55905/edicon.978-65-83115-47-8_8", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.55905/edicon.978-65-83115-47-8_8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.55905/edicon.978-65-83115-47-8_8", "source_url": "https://doi.org/10.55905/edicon.978-65-83115-47-8_8", "doi": "10.55905/edicon.978-65-83115-47-8_8", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4182, "title": "Motivation-based subtypes of psilocybin microdosers", "authors": "Ethan Klukas", "journal": "Open Collections", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.14288/1.0452623", "pubmed_id": null, "openalex_id": "https://openalex.org/W7163695947", "source_url": "https://doi.org/10.14288/1.0452623", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Creativity,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.14288/1.0452623", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.14288/1.0452623", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.14288/1.0452623", "source_url": "https://doi.org/10.14288/1.0452623", "doi": "10.14288/1.0452623", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4181, "title": "COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER", "authors": "Mahvash Khan, Muhammad Omar Malik, Sara Sajjad, Muhammad Uzair, Inayat Shah, Muhammad Ismail Bhatti", "journal": "Genetics and Molecular Research", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.4238/e91xh631", "pubmed_id": null, "openalex_id": "https://openalex.org/W7163017615", "source_url": "https://doi.org/10.4238/e91xh631", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Pharmacology,Receptor Pharmacology,Emotional Processing,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.4238/e91xh631", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4238/e91xh631", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4238/e91xh631", "source_url": "https://doi.org/10.4238/e91xh631", "doi": "10.4238/e91xh631", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4179, "title": "Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review", "authors": "Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate", "journal": "Open Science Framework", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.17605/osf.io/yu3n9", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162447643", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/yu3n9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/yu3n9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/yu3n9", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "doi": "10.17605/osf.io/yu3n9", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4175, "title": "Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression", "authors": "Yosr Ziadi, Taehwan Park", "journal": "Open MIND", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.17605/osf.io/nrt59", "pubmed_id": null, "openalex_id": "https://openalex.org/W7161800164", "source_url": "https://osf.io/nrt59", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/nrt59", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/nrt59", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/nrt59", "source_url": "https://osf.io/nrt59", "doi": "10.17605/osf.io/nrt59", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4172, "title": "Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal Extract", "authors": "Mateus Araújo da Luz, Taynah Pereira Galdino, Lucas Matheus da S. Oliveira, H. Guedes, Anauara Silva, Victor I. Afonso, Suédina M. L. Silva, Antônio G. B. Lima, Marcus V. L. Fook, Maria C. M. Torres", "journal": "Journal of the Brazilian Chemical Society", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.21577/0103-5053.20260049", "pubmed_id": null, "openalex_id": "https://openalex.org/W7138979953", "source_url": "https://doi.org/10.21577/0103-5053.20260049", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.21577/0103-5053.20260049", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21577/0103-5053.20260049", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21577/0103-5053.20260049", "source_url": "https://doi.org/10.21577/0103-5053.20260049", "doi": "10.21577/0103-5053.20260049", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4171, "title": "Psychedelic-assisted psychotherapy: Clarifying the role of the \"psychotherapy\"", "authors": "Stefan Jerotić, Olga Čolović, Nađa Marić", "journal": "Medicinska istrazivanja", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.5937/medi0-62051", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130417929", "source_url": "https://doi.org/10.5937/medi0-62051", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.5937/medi0-62051", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5937/medi0-62051", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5937/medi0-62051", "source_url": "https://doi.org/10.5937/medi0-62051", "doi": "10.5937/medi0-62051", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4161, "title": "‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury", "authors": "Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah", "journal": "Internal Medicine Journal", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1111/imj.70313", "pubmed_id": "41518153", "openalex_id": "https://openalex.org/W7119893738", "source_url": "https://doi.org/10.1111/imj.70313", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "PMID:41518153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/imj.70313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41518153", "source_url": "https://doi.org/10.1111/imj.70313", "doi": "10.1111/imj.70313", "pmid": "41518153", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4158, "title": "Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial", "authors": "L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer", "journal": "Neuroscience Applied", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.nsa.2025.105779", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118005769", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "doi": "10.1016/j.nsa.2025.105779", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4155, "title": "An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes", "authors": "N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.nsa.2025.106821", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117964120", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "doi": "10.1016/j.nsa.2025.106821", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4153, "title": "Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression", "authors": "L. Puhl, L. Kunz, M. Berger, G. Gründer, L. Mertens, M. Spangemacher", "journal": "Neuroscience Applied", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.nsa.2025.106390", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117961846", "source_url": "https://doi.org/10.1016/j.nsa.2025.106390", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106390", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106390", "source_url": "https://doi.org/10.1016/j.nsa.2025.106390", "doi": "10.1016/j.nsa.2025.106390", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4152, "title": "Psilocybin Treatment for Refractory Depression: A Clinical Review", "authors": "Jensen, Hailey A", "journal": "Digital Commons - Gardner-Webb University (Gardner-Webb University)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110564344", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "doi": "", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 372, "title": "Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.", "authors": "Viljoen G, Betzler F", "journal": "Current topics in behavioral neurosciences", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/7854_2024_534", "pubmed_id": "39436632", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:39436632", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39436632", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "doi": "10.1007/7854_2024_534", "pmid": "39436632", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 371, "title": "Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.", "authors": "Aghajanian S, Shafiee A, Parvizi Omran S, Rezaei Nejad A, Jafarabady K, Kohandel Gargari O, Rajai S, Mohammadi I, Bahrami Babaheidari T, Bakhtiyari M", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811241287542", "pubmed_id": "39480198", "openalex_id": "https://openalex.org/W4403943147", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39480198/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:39480198", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39480198/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39480198", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39480198/", "doi": "10.1177/02698811241287542", "pmid": "39480198", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 370, "title": "Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.", "authors": "Barstowe A, Kajonius PJ", "journal": "Journal of psychoactive drugs", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1080/02791072.2024.2424272", "pubmed_id": "39503404", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39503404/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:39503404", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39503404/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39503404", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39503404/", "doi": "10.1080/02791072.2024.2424272", "pmid": "39503404", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 368, "title": "Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.", "authors": "Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811241303594", "pubmed_id": "39655749", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39655749/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:39655749", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39655749/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39655749", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39655749/", "doi": "10.1177/02698811241303594", "pmid": "39655749", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 361, "title": "Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.", "authors": "McGowan NM, Rucker JJ, Yehuda R, Agrawal M, Modlin NL, Simmons H, Tofil-Kaluza A, Das S, Goodwin GM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811251362390", "pubmed_id": "40883964", "openalex_id": "https://openalex.org/W4413839750", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883964/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Headache / Migraine,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:40883964", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40883964/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40883964", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883964/", "doi": "10.1177/02698811251362390", "pmid": "40883964", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 358, "title": "A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.", "authors": "Marek GJ, Makai-Bölöni S, Umbricht D, Christian EP, Winters J, Dvorak D, Raines S, Hughes ZA, Austin EW, Klein AK, Leong W, Krol FJ, Graaf AJV, Juachon MJ, Otto ME, Borghans LGJM, Jacobs G, Kruegel AC, Sporn J", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811251378512", "pubmed_id": "41099491", "openalex_id": "https://openalex.org/W4415246252", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41099491/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41099491", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41099491/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41099491", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41099491/", "doi": "10.1177/02698811251378512", "pmid": "41099491", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 354, "title": "Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.", "authors": "Konstantinou GN, Rosenblat J, Hales S, Husain MI, Blumberger DM", "journal": "General hospital psychiatry", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.genhosppsych.2025.12.005", "pubmed_id": "41401486", "openalex_id": "https://openalex.org/W4417166023", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41401486/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Mechanism of Action,Default Mode Network,Aging,Clinical Trial,Review Article,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41401486", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41401486/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41401486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41401486/", "doi": "10.1016/j.genhosppsych.2025.12.005", "pmid": "41401486", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 353, "title": "Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.", "authors": "Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S", "journal": "Palliative medicine", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02692163251383335", "pubmed_id": "41410211", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410211/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41410211", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41410211/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41410211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410211/", "doi": "10.1177/02692163251383335", "pmid": "41410211", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 350, "title": "An exploration of the relationships between the effects of psilocybin on behavior, 5-HT receptor occupancy, and neuroplastic effects in mice.", "authors": "Maltby CJ, Klein AK, Paschen E, Pinto J, Dvorak D, Hedde JR, Hanks AN, Bianchi M, Hughes ZA", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811251395386", "pubmed_id": "41493065", "openalex_id": "https://openalex.org/W7118979083", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41493065/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41493065", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41493065/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41493065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41493065/", "doi": "10.1177/02698811251395386", "pmid": "41493065", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 349, "title": "The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors.", "authors": "Moghadam H, Akbari P, Beirami E, Nabavifard S, Ameli A, Valian N", "journal": "Journal of neuroscience research", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1002/jnr.70107", "pubmed_id": "41493855", "openalex_id": "https://openalex.org/W7119167790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41493855/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Oxidative Stress,Drug Interactions,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41493855", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41493855/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41493855", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41493855/", "doi": "10.1002/jnr.70107", "pmid": "41493855", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 348, "title": "Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.", "authors": "Rasheed S, Arif R, Raza AA, Samadi A", "journal": "Annals of medicine and surgery (2012)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1097/ms9.0000000000004349", "pubmed_id": "41497122", "openalex_id": "https://openalex.org/W4416592848", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497122/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41497122", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41497122/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41497122", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497122/", "doi": "10.1097/ms9.0000000000004349", "pmid": "41497122", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 345, "title": "Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex.", "authors": "Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W", "journal": "Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.neurot.2026.e00841", "pubmed_id": "41620327", "openalex_id": "https://openalex.org/W7126381155", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41620327/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,OCD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41620327", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41620327/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41620327", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41620327/", "doi": "10.1016/j.neurot.2026.e00841", "pmid": "41620327", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 344, "title": "Magic mushrooms and mood: Exploring psilocybin as a depression treatment.", "authors": "Rasool M, Hannan TM, Imam M", "journal": "JPMA. The Journal of the Pakistan Medical Association", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.47391/jpma.30858", "pubmed_id": "41736353", "openalex_id": "https://openalex.org/W7117257845", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41736353/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41736353", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41736353/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41736353", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41736353/", "doi": "10.47391/jpma.30858", "pmid": "41736353", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 340, "title": "New Antidepressant Development in the Treatment of Depression.", "authors": "Spiti A, Caldirola D, Perna G", "journal": "Advances in experimental medicine and biology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/978-981-95-6872-7_23", "pubmed_id": "42036580", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036580/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:42036580", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42036580/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42036580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036580/", "doi": "10.1007/978-981-95-6872-7_23", "pmid": "42036580", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 339, "title": "Psychedelics: Future Therapeutics in Major Depression?", "authors": "Olivier B, Olivier JDA", "journal": "Advances in experimental medicine and biology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/978-981-95-6872-7_25", "pubmed_id": "42036582", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036582/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:42036582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42036582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42036582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036582/", "doi": "10.1007/978-981-95-6872-7_25", "pmid": "42036582", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 338, "title": "Rural-Urban Disparities in Access to Interventional Psychiatry Treatments among VA Patients.", "authors": "Shiner B, DuFort V, Peltzman T, Watts BV", "journal": "Rural mental health", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1037/rmh0000333", "pubmed_id": "42267190", "openalex_id": "https://openalex.org/W7128431906", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42267190/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Veterans", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:42267190", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42267190/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42267190", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42267190/", "doi": "10.1037/rmh0000333", "pmid": "42267190", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 316, "title": "A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry.", "authors": "Raza M, Kaur J", "journal": "Cureus", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.7759/cureus.102421", "pubmed_id": "41769492", "openalex_id": "https://openalex.org/W7125808618", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41769492/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Emotional Processing,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41769492", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41769492/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41769492", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41769492/", "doi": "10.7759/cureus.102421", "pmid": "41769492", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 312, "title": "The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review.", "authors": "Siwek L, Nowocien M, Balajewicz B, Samborska A, Szukalska S, Karczewska M, Lichwala K, Wróblewski K, Wróblewska P", "journal": "Cureus", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.7759/cureus.102694", "pubmed_id": "41777966", "openalex_id": "https://openalex.org/W7126444817", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41777966/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Review Article,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41777966", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41777966/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41777966", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41777966/", "doi": "10.7759/cureus.102694", "pmid": "41777966", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 256, "title": "The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.", "authors": "Kirlić N, Atli M, Mistry S, Gold M, Goodwin GM", "journal": "Journal of clinical psychopharmacology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1097/jcp.0000000000002119", "pubmed_id": "41362124", "openalex_id": "https://openalex.org/W4417148678", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41362124/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Consciousness,Personality Change,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41362124", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41362124/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41362124", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41362124/", "doi": "10.1097/jcp.0000000000002119", "pmid": "41362124", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 235, "title": "Psychedelic therapy and postpartum depression: priorities and prospects.", "authors": "Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/20451253251408280", "pubmed_id": "41816502", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Aging,Review Article,Safety,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41816502", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41816502", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "doi": "10.1177/20451253251408280", "pmid": "41816502", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 167, "title": "Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.", "authors": "Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L", "journal": "Frontiers in psychiatry", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.3389/fpsyt.2026.1834094", "pubmed_id": "42088004", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42088004/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:42088004", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42088004/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42088004", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42088004/", "doi": "10.3389/fpsyt.2026.1834094", "pmid": "42088004", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 106, "title": "Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.", "authors": "Beichmann K, Catzeflis P, Aicher HD, Seragnoli F, Calder A, Amrani A, Hasler G", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/20451253261448745", "pubmed_id": "42179908", "openalex_id": "https://openalex.org/W7161849392", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42179908/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:42179908", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42179908/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42179908", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42179908/", "doi": "10.1177/20451253261448745", "pmid": "42179908", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4183, "title": "Psychedelics and neuroanesthesia: A narrative review of converging mechanisms", "authors": "Kunal Kumar Sharma", "journal": "Journal of Scientific Innovations in Anesthesiology", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.65929/jsia.2026.1.2.002", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164804665", "source_url": "https://doi.org/10.65929/jsia.2026.1.2.002", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Review Article,Treatment-Resistant Depression,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.65929/jsia.2026.1.2.002", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.65929/jsia.2026.1.2.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.65929/jsia.2026.1.2.002", "source_url": "https://doi.org/10.65929/jsia.2026.1.2.002", "doi": "10.65929/jsia.2026.1.2.002", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4162, "title": "Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity", "authors": "Aneta Petrušková", "journal": "OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.25593/open-fau-2619", "pubmed_id": null, "openalex_id": "https://openalex.org/W7121233275", "source_url": "https://open.fau.de/handle/openfau/38445", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.25593/open-fau-2619", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://open.fau.de/handle/openfau/38445", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25593/open-fau-2619", "source_url": "https://open.fau.de/handle/openfau/38445", "doi": "10.25593/open-fau-2619", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3464, "title": "Microdosing Psychedelics to Improve Mood", "authors": "Rotem Petranker", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-30", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05259943", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05259943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "source_url": "https://clinicaltrials.gov/study/NCT05259943", "doi": "", "pmid": "", "publication_date": "2025-12-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 377, "title": "Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.", "authors": "Dominiak M, Gędek A, Modrzejewski S, Permoda-Pachuta A, Antosik AZ", "journal": "Journal of clinical medicine", "publication_date": "2025-12-29", "publication_year": 2025, "doi": "10.3390/jcm15010253", "pubmed_id": "41517502", "openalex_id": "https://openalex.org/W7117705718", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41517502/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Randomized Controlled Trial,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41517502", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41517502/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41517502", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41517502/", "doi": "10.3390/jcm15010253", "pmid": "41517502", "publication_date": "2025-12-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3701, "title": "The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05220410", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05220410", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05220410", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05220410", "source_url": "https://clinicaltrials.gov/study/NCT05220410", "doi": "", "pmid": "", "publication_date": "2025-12-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3506, "title": "An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder", "authors": "University of Chicago", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05399498", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05399498", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05399498", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05399498", "source_url": "https://clinicaltrials.gov/study/NCT05399498", "doi": "", "pmid": "", "publication_date": "2025-12-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3052, "title": "Psilocybin modulates social behaviour in male and female mice in a time-dependent manner", "authors": "Shadani S, McCoy K, Ong L, Greaves E, Conn K, Andrews ZB, Foldi CJ.", "journal": "bioRxiv", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.64898/2025.12.18.695064", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2025.12.18.695064", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:54", "bibtex": null, "source_record_id": "DOI:10.64898/2025.12.18.695064", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2025.12.18.695064", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2025.12.18.695064", "source_url": "https://doi.org/10.64898/2025.12.18.695064", "doi": "10.64898/2025.12.18.695064", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 391, "title": "Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.", "authors": "Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-12-20", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111541", "pubmed_id": "41138900", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41138900/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41138900", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41138900/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41138900", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41138900/", "doi": "10.1016/j.pnpbp.2025.111541", "pmid": "41138900", "publication_date": "2025-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 390, "title": "Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.", "authors": "Johnson DE, Meshkat S, Kaczmarek ES, Rabin JS, Brudner RM, Chisamore N, Doyle Z, Bawks J, Riva-Cambrin J, Mansur RB, Lipsitz O, McIntyre RS, Lanctôt KL, Rosenblat JD", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-12-20", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111565", "pubmed_id": "41285295", "openalex_id": "https://openalex.org/W4416549169", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41285295/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41285295", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41285295/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41285295", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41285295/", "doi": "10.1016/j.pnpbp.2025.111565", "pmid": "41285295", "publication_date": "2025-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4195, "title": "Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study", "authors": "Mylène Cheng, Tatiana Aboulafia Brakha, Albert Buchard, Raya Anastasova, Léa Girani, Anna Breitenmoser, Sylvie Alaux, Cédric Mabilais, Caroline Amberger, Federico Seragnoli, Leonice Furtado, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler", "journal": "Psychology International", "publication_date": "2025-12-19", "publication_year": 2025, "doi": "10.3390/psycholint8010001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417497243", "source_url": "https://doi.org/10.3390/psycholint8010001", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Observational Study,Treatment-Resistant Depression,Adverse Events,Toxicity,Drug Interactions", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.3390/psycholint8010001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psycholint8010001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psycholint8010001", "source_url": "https://doi.org/10.3390/psycholint8010001", "doi": "10.3390/psycholint8010001", "pmid": "", "publication_date": "2025-12-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 392, "title": "Psilocybin reporting in media (PRiMe) for the treatment of depression.", "authors": "Brar G, Burke T, Gribben AD, Harrington C, Thuery G, Kelly JR", "journal": "Irish journal of psychological medicine", "publication_date": "2025-12-18", "publication_year": 2025, "doi": "10.1017/ipm.2025.10142", "pubmed_id": "41410115", "openalex_id": "https://openalex.org/W4417453981", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410115/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41410115", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41410115/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41410115", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410115/", "doi": "10.1017/ipm.2025.10142", "pmid": "41410115", "publication_date": "2025-12-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 393, "title": "Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?", "authors": "Koning E, Bacchi P, Chaves C, Gomes FA, Brietzke E", "journal": "Trends in psychiatry and psychotherapy", "publication_date": "2025-12-17", "publication_year": 2025, "doi": "10.47626/2237-6089-2025-1197", "pubmed_id": "41405984", "openalex_id": "https://openalex.org/W4417437388", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41405984/", "substance_tags": "psilocybin", "topic_tags": "Depression,Psychological Flexibility,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41405984", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41405984/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41405984", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41405984/", "doi": "10.47626/2237-6089-2025-1197", "pmid": "41405984", "publication_date": "2025-12-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4201, "title": "Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats", "authors": "Sophie Woodruff, Meghan Hibicke, Charles D. Nichols", "journal": "Psychedelic Medicine", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.1177/28314425251393186", "pubmed_id": null, "openalex_id": "https://openalex.org/W7116737777", "source_url": "https://doi.org/10.1177/28314425251393186", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Pharmacology,Receptor Pharmacology,Longevity,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251393186", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251393186", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251393186", "source_url": "https://doi.org/10.1177/28314425251393186", "doi": "10.1177/28314425251393186", "pmid": "", "publication_date": "2025-12-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4200, "title": "Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment", "authors": "M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya", "journal": "˜The œjournal of desk research review and analysis.", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.4038/jdrra.v3i2.87", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115587785", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Older Adults,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "doi": "10.4038/jdrra.v3i2.87", "pmid": "", "publication_date": "2025-12-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4199, "title": "Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot Study", "authors": "Shannon Antoine-Hardy, D’Elia Bonilla", "journal": "Journal of Complementary and Alternative Medical Research", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.9734/jocamr/2025/v26i11723", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417387420", "source_url": "https://doi.org/10.9734/jocamr/2025/v26i11723", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.9734/jocamr/2025/v26i11723", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.9734/jocamr/2025/v26i11723", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.9734/jocamr/2025/v26i11723", "source_url": "https://doi.org/10.9734/jocamr/2025/v26i11723", "doi": "10.9734/jocamr/2025/v26i11723", "pmid": "", "publication_date": "2025-12-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 395, "title": "Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.", "authors": "Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI", "journal": "Journal of affective disorders", "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.1016/j.jad.2025.119952", "pubmed_id": "40684956", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40684956/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Eating Disorders,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40684956", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40684956/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40684956", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40684956/", "doi": "10.1016/j.jad.2025.119952", "pmid": "40684956", "publication_date": "2025-12-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3059, "title": "Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study", "authors": "Jake Hooper, Sarah Williams, Raeghan Mueller, Kent Hutchison", "journal": "PsyArXiv", "publication_date": "2025-12-10", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dczw2_v2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Mystical Experience,Older Adults", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dczw2_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dczw2_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dczw2_v2", "source_url": "https://osf.io/preprints/psyarxiv/dczw2_v2", "doi": "", "pmid": "", "publication_date": "2025-12-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3048, "title": "Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study", "authors": "Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S.", "journal": "Research Square", "publication_date": "2025-12-10", "publication_year": 2025, "doi": "10.21203/rs.3.rs-8079137/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:53", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "doi": "10.21203/rs.3.rs-8079137/v1", "pmid": "", "publication_date": "2025-12-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4205, "title": "Are Magic Mushrooms the Magic to Healing?", "authors": "Wohlfarth, Gale, Hardy, Susan, Ray, Herman", "journal": "DigitalCommons - Kennesaw State University (Kennesaw State University)", "publication_date": "2025-12-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7113308122", "source_url": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Observational Study,Veterans,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "source_url": "https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134", "doi": "", "pmid": "", "publication_date": "2025-12-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3625, "title": "Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06798636", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06798636", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06798636", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06798636", "source_url": "https://clinicaltrials.gov/study/NCT06798636", "doi": "", "pmid": "", "publication_date": "2025-12-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4210, "title": "Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges", "authors": "Taslim Uddin, Suma Akter, Kanak Yadab Ghosh", "journal": "Advanced Neurology", "publication_date": "2025-12-04", "publication_year": 2025, "doi": "10.36922/an025410095", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417099564", "source_url": "https://doi.org/10.36922/an025410095", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.36922/an025410095", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36922/an025410095", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36922/an025410095", "source_url": "https://doi.org/10.36922/an025410095", "doi": "10.36922/an025410095", "pmid": "", "publication_date": "2025-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3513, "title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05398484", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05398484", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "source_url": "https://clinicaltrials.gov/study/NCT05398484", "doi": "", "pmid": "", "publication_date": "2025-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4212, "title": "Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears", "authors": "Spohn, Kyle", "journal": "eYLS (Yale Law School)", "publication_date": "2025-12-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112471464", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "doi": "", "pmid": "", "publication_date": "2025-12-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4225, "title": "Psychedelic Assisted Psychotherapy (PAP): the Geneva University Hospital model", "authors": "F. Seragnoli", "journal": "Emerging Trends in Drugs Addictions and Health", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.etdah.2025.100256", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115197406", "source_url": "https://doi.org/10.1016/j.etdah.2025.100256", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:15", "bibtex": null, "source_record_id": "DOI:10.1016/j.etdah.2025.100256", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.etdah.2025.100256", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.etdah.2025.100256", "source_url": "https://doi.org/10.1016/j.etdah.2025.100256", "doi": "10.1016/j.etdah.2025.100256", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4221, "title": "Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions", "authors": "S. Fereydouni", "journal": "Emerging Trends in Drugs Addictions and Health", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.etdah.2025.100215", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115166480", "source_url": "https://doi.org/10.1016/j.etdah.2025.100215", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Review Article,Animal Study,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.1016/j.etdah.2025.100215", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.etdah.2025.100215", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.etdah.2025.100215", "source_url": "https://doi.org/10.1016/j.etdah.2025.100215", "doi": "10.1016/j.etdah.2025.100215", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3166, "title": "Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement", "authors": "Buchard A, Seragnoli F, Sabe M, Eskinazi M, Aboulafia T, Furtado L, Briefer J, Roediger E, Penzenstadler L, Zullino D, Thorens G.", "journal": "Research Square", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.21203/rs.3.rs-8214817/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8214817/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8214817/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8214817/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8214817/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8214817/v1", "doi": "10.21203/rs.3.rs-8214817/v1", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3154, "title": "Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland", "authors": "Aboulafia-Brakha T, Buchard A, Mabilais C, Alaux S, Amberger C, Furtado L, Seragnoli F, Briefer J, Thorens G, Sabé M, Szczesniak L, Iuga R, Zullino D, Penzenstadler L.", "journal": "medRxiv", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1101/2025.12.01.25341335", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.12.01.25341335", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:06", "bibtex": null, "source_record_id": "DOI:10.1101/2025.12.01.25341335", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.12.01.25341335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.12.01.25341335", "source_url": "https://doi.org/10.1101/2025.12.01.25341335", "doi": "10.1101/2025.12.01.25341335", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 420, "title": "[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].", "authors": "Dumenil M, Cordova G, El-Hage W", "journal": "L'Encephale", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.encep.2025.02.007", "pubmed_id": "40413068", "openalex_id": "https://openalex.org/W4410695397", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40413068/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Emotional Processing,Treatment-Resistant Depression,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40413068", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40413068/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40413068", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40413068/", "doi": "10.1016/j.encep.2025.02.007", "pmid": "40413068", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 419, "title": "Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older Patients.", "authors": "Gillespie CM, Bering JM", "journal": "The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.jagp.2025.07.003", "pubmed_id": "40829966", "openalex_id": "https://openalex.org/W4412611593", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40829966/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Older Adults,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40829966", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40829966/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40829966", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40829966/", "doi": "10.1016/j.jagp.2025.07.003", "pmid": "40829966", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 416, "title": "Above the threshold, beyond the trip: the role of the 5-HT receptor in psychedelic-induced neuroplasticity and antidepressant effects.", "authors": "Drewko AJ, Habets RLP, Brunt TM", "journal": "Molecular psychiatry", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1038/s41380-025-03169-9", "pubmed_id": "40849544", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849544/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40849544", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40849544/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40849544", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849544/", "doi": "10.1038/s41380-025-03169-9", "pmid": "40849544", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 409, "title": "Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity.", "authors": "García-Cabrerizo R, Beruete-Fresnillo I, Bergas-Cladera P, García-Fuster MJ", "journal": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.biopha.2025.118720", "pubmed_id": "41172953", "openalex_id": "https://openalex.org/W4415713367", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41172953/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Biomarkers,Observational Study,Adolescents", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41172953", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41172953/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41172953", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41172953/", "doi": "10.1016/j.biopha.2025.118720", "pmid": "41172953", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 408, "title": "Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.", "authors": "Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.euroneuro.2025.09.011", "pubmed_id": "41205366", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41205366/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41205366", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41205366/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41205366", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41205366/", "doi": "10.1016/j.euroneuro.2025.09.011", "pmid": "41205366", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 407, "title": "Psilocybin reduces comorbid chronic pain and depression in mice.", "authors": "Ferreira J", "journal": "Lab animal", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1038/s41684-025-01663-9", "pubmed_id": "41298885", "openalex_id": "https://openalex.org/W4416717006", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41298885/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41298885", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41298885", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41298885/", "doi": "10.1038/s41684-025-01663-9", "pmid": "41298885", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 405, "title": "Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin.", "authors": "Kleditzsch N, Gattuso JJ, Hannan AJ, Renoir T", "journal": "The European journal of neuroscience", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1111/ejn.70351", "pubmed_id": "41365493", "openalex_id": "https://openalex.org/W4417176534", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41365493/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41365493", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41365493/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41365493", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41365493/", "doi": "10.1111/ejn.70351", "pmid": "41365493", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 401, "title": "Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.", "authors": "Modlin NL, Williamson V, Goodwin GM, Malievskaia E, Atli M, Elek Z, Gaillard A, Koelpin D, Cleare A, Agrawal M, Yehuda R, Kirlic N, Rucker J", "journal": "EClinicalMedicine", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103692", "pubmed_id": "41497513", "openalex_id": "https://openalex.org/W4417031290", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497513/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41497513", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41497513/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41497513", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497513/", "doi": "10.1016/j.eclinm.2025.103692", "pmid": "41497513", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 380, "title": "Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review.", "authors": "Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J", "journal": "Cureus", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.7759/cureus.99942", "pubmed_id": "41583322", "openalex_id": "https://openalex.org/W7116864166", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41583322/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41583322", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41583322/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41583322", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41583322/", "doi": "10.7759/cureus.99942", "pmid": "41583322", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4230, "title": "Efficacy of psilocybin on death anxiety in terminal patients: a narrative review", "authors": "Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana", "journal": "Progress in Palliative Care", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1080/09699260.2026.2657096", "pubmed_id": null, "openalex_id": "https://openalex.org/W7152631097", "source_url": "https://doi.org/10.1080/09699260.2026.2657096", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1080/09699260.2026.2657096", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/09699260.2026.2657096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/09699260.2026.2657096", "source_url": "https://doi.org/10.1080/09699260.2026.2657096", "doi": "10.1080/09699260.2026.2657096", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3681, "title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder", "authors": "University of Texas at Austin", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-26", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06132178", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06132178", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "source_url": "https://clinicaltrials.gov/study/NCT06132178", "doi": "", "pmid": "", "publication_date": "2025-11-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 421, "title": "A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model.", "authors": "Domżalska M, Kwiatkowska J, Cichoń I, Sokołowska E", "journal": "Scientific reports", "publication_date": "2025-11-26", "publication_year": 2025, "doi": "10.1038/s41598-025-29642-7", "pubmed_id": "41290975", "openalex_id": "https://openalex.org/W4416669801", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41290975/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41290975", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41290975/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41290975", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41290975/", "doi": "10.1038/s41598-025-29642-7", "pmid": "41290975", "publication_date": "2025-11-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3700, "title": "Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life", "authors": "Charles S. Grob, M.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05403086", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05403086", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "source_url": "https://clinicaltrials.gov/study/NCT05403086", "doi": "", "pmid": "", "publication_date": "2025-11-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4232, "title": "Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review", "authors": "J Pincombe, M.L. Williams, Sean Carruthers, Susan L. Rossell", "journal": "Psychedelic Medicine", "publication_date": "2025-11-24", "publication_year": 2025, "doi": "10.1177/28314425251394012", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416994935", "source_url": "https://doi.org/10.1177/28314425251394012", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Eating Disorders,Chronic Pain,Systematic Review,Review Article,Healthcare Workers", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:15", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251394012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251394012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251394012", "source_url": "https://doi.org/10.1177/28314425251394012", "doi": "10.1177/28314425251394012", "pmid": "", "publication_date": "2025-11-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4235, "title": "Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience", "authors": "Stacey B. Armstrong, Meghan DellaCrosse, Jaime Fuentes-Balderrama, Rafaelle Lancelotta, Alan K. Davis", "journal": "Psychedelics", "publication_date": "2025-11-20", "publication_year": 2025, "doi": "10.1016/j.psyche.2025.100006", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106133965", "source_url": "https://doi.org/10.1016/j.psyche.2025.100006", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Mystical Experience,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:15", "bibtex": null, "source_record_id": "DOI:10.1016/j.psyche.2025.100006", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psyche.2025.100006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psyche.2025.100006", "source_url": "https://doi.org/10.1016/j.psyche.2025.100006", "doi": "10.1016/j.psyche.2025.100006", "pmid": "", "publication_date": "2025-11-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 425, "title": "Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?", "authors": "Natoli S, Cuomo A, Marchesini M, Luongo L, Lo Bianco G, Guardamagna VA, Yamaguchi S", "journal": "Medical sciences (Basel, Switzerland)", "publication_date": "2025-11-20", "publication_year": 2025, "doi": "10.3390/medsci13040277", "pubmed_id": "41283278", "openalex_id": "https://openalex.org/W4416407616", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41283278/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Randomized Controlled Trial,Review Article,Animal Study,Safety,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41283278", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41283278/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41283278", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41283278/", "doi": "10.3390/medsci13040277", "pmid": "41283278", "publication_date": "2025-11-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3548, "title": "A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07183748", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07183748", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "source_url": "https://clinicaltrials.gov/study/NCT07183748", "doi": "", "pmid": "", "publication_date": "2025-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3454, "title": "Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04882839", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Spirituality,Clinical Trial,Case Report,Animal Study,Cancer Patients,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04882839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "source_url": "https://clinicaltrials.gov/study/NCT04882839", "doi": "", "pmid": "", "publication_date": "2025-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 429, "title": "Synaptic priming: A framework for pharmacotherapy in depression.", "authors": "Brown KA, Ajibola MI, Medeiros GC, Gould TD", "journal": "Neuron", "publication_date": "2025-11-19", "publication_year": 2025, "doi": "10.1016/j.neuron.2025.09.010", "pubmed_id": "41067229", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41067229/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41067229", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41067229/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41067229", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41067229/", "doi": "10.1016/j.neuron.2025.09.010", "pmid": "41067229", "publication_date": "2025-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 428, "title": "Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics.", "authors": "Agrawal R, Gillie D, Mungenast A, Chytil M, Engel S, Wu MC, Rasmussen K, Salinas E, Olson DE", "journal": "ACS chemical neuroscience", "publication_date": "2025-11-19", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00667", "pubmed_id": "41078264", "openalex_id": "https://openalex.org/W4415115279", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41078264/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41078264", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41078264/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41078264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41078264/", "doi": "10.1021/acschemneuro.5c00667", "pmid": "41078264", "publication_date": "2025-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3058, "title": "Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial", "authors": "Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily Fewster, Omer Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son", "journal": "PsyArXiv", "publication_date": "2025-11-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "doi": "", "pmid": "", "publication_date": "2025-11-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4241, "title": "Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents", "authors": "Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis", "journal": "Psychedelics", "publication_date": "2025-11-15", "publication_year": 2025, "doi": "10.1016/j.psyche.2025.100004", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416229038", "source_url": "https://doi.org/10.1016/j.psyche.2025.100004", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Emotional Processing,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:15", "bibtex": null, "source_record_id": "DOI:10.1016/j.psyche.2025.100004", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psyche.2025.100004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psyche.2025.100004", "source_url": "https://doi.org/10.1016/j.psyche.2025.100004", "doi": "10.1016/j.psyche.2025.100004", "pmid": "", "publication_date": "2025-11-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 433, "title": "Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.", "authors": "Ellis S, Bostian C, Donnelly A, Feng W, Eisen K, Lean M, Conlan E, Ostacher M, Aaronson S, Suppes T", "journal": "Journal of affective disorders", "publication_date": "2025-11-15", "publication_year": 2025, "doi": "10.1016/j.jad.2025.119655", "pubmed_id": "40499827", "openalex_id": "https://openalex.org/W4411137642", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40499827/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Veterans", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40499827", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40499827/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40499827", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40499827/", "doi": "10.1016/j.jad.2025.119655", "pmid": "40499827", "publication_date": "2025-11-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 430, "title": "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.", "authors": "Gattuso JJ, Kong G, Bezcioglu B, Lu D, Ekwudo MN, Wilson C, Gubert C, Hannan AJ, Renoir T", "journal": "Neuropharmacology", "publication_date": "2025-11-15", "publication_year": 2025, "doi": "10.1016/j.neuropharm.2025.110648", "pubmed_id": "40849086", "openalex_id": "https://openalex.org/W4413389430", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849086/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Mechanism of Action,Receptor Pharmacology,Animal Study,Microbiome", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40849086", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40849086/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40849086", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849086/", "doi": "10.1016/j.neuropharm.2025.110648", "pmid": "40849086", "publication_date": "2025-11-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 436, "title": "Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.", "authors": "Martens MAG, Cunha BG, Erritzoe D, Nutt D, Carhart-Harris R, Harmer CJ", "journal": "Translational psychiatry", "publication_date": "2025-11-13", "publication_year": 2025, "doi": "10.1038/s41398-025-03693-w", "pubmed_id": "41257994", "openalex_id": "https://openalex.org/W4416593366", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41257994/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41257994", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41257994/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41257994", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41257994/", "doi": "10.1038/s41398-025-03693-w", "pmid": "41257994", "publication_date": "2025-11-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4245, "title": "Novel qNMR Methodto Quantify Psilocybin and Psilocinin Psychedelic Mushrooms", "authors": "Luisina Rodríguez (12333694), Guillermo Morera (22593717), Sandra Lupo (22593720), Danilo Davyt (2738347), Ignacio Carrera (1677175), Gonzalo Hernández Dossi (22593723)", "journal": "Figshare", "publication_date": "2025-11-10", "publication_year": 2025, "doi": "10.1021/acsomega.5c07092.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111180330", "source_url": "https://figshare.com/articles/journal_contribution/Novel_qNMR_Method_to_Quantify_Psilocybin_and_Psilocin_in_Psychedelic_Mushrooms/30584544", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:15", "bibtex": null, "source_record_id": "DOI:10.1021/acsomega.5c07092.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/Novel_qNMR_Method_to_Quantify_Psilocybin_and_Psilocin_in_Psychedelic_Mushrooms/30584544", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acsomega.5c07092.s001", "source_url": "https://figshare.com/articles/journal_contribution/Novel_qNMR_Method_to_Quantify_Psilocybin_and_Psilocin_in_Psychedelic_Mushrooms/30584544", "doi": "10.1021/acsomega.5c07092.s001", "pmid": "", "publication_date": "2025-11-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3033, "title": "Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity", "authors": "Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P, Vollenweider FX, Diaconescu AO.", "journal": "bioRxiv", "publication_date": "2025-11-07", "publication_year": 2025, "doi": "10.1101/2025.11.06.687023", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.11.06.687023", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:52", "bibtex": null, "source_record_id": "DOI:10.1101/2025.11.06.687023", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.11.06.687023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.11.06.687023", "source_url": "https://doi.org/10.1101/2025.11.06.687023", "doi": "10.1101/2025.11.06.687023", "pmid": "", "publication_date": "2025-11-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4248, "title": "Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm", "authors": "Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider, Andreea O. Diaconescu", "journal": "Universität Zürich, ZORA", "publication_date": "2025-11-05", "publication_year": 2025, "doi": "10.5167/uzh-292276", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130720501", "source_url": "https://doi.org/10.5167/uzh-292276", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Healthy Volunteers", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:15", "bibtex": null, "source_record_id": "DOI:10.5167/uzh-292276", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5167/uzh-292276", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5167/uzh-292276", "source_url": "https://doi.org/10.5167/uzh-292276", "doi": "10.5167/uzh-292276", "pmid": "", "publication_date": "2025-11-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3510, "title": "Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03554174", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03554174", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03554174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03554174", "source_url": "https://clinicaltrials.gov/study/NCT03554174", "doi": "", "pmid": "", "publication_date": "2025-11-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3489, "title": "A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05847686", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05847686", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "source_url": "https://clinicaltrials.gov/study/NCT05847686", "doi": "", "pmid": "", "publication_date": "2025-11-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3067, "title": "Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes", "authors": "Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J, Harker S, Ford A, Lewis C.", "journal": "Research Square", "publication_date": "2025-11-05", "publication_year": 2025, "doi": "10.21203/rs.3.rs-7890051/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-7890051/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Aging,Epigenetics,Wellbeing,Resilience,Emotional Processing,Animal Study,Genomics,Inflammation,Immune Function", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-7890051/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-7890051/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-7890051/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-7890051/v1", "doi": "10.21203/rs.3.rs-7890051/v1", "pmid": "", "publication_date": "2025-11-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4247, "title": "Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required", "authors": "Aisling McGuigan", "journal": "Drugs & Therapy Perspectives", "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.1007/s40267-025-01199-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415932492", "source_url": "https://doi.org/10.1007/s40267-025-01199-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 06:34:38", "bibtex": null, "source_record_id": "DOI:10.1007/s40267-025-01199-5", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40267-025-01199-5", "source_url": "https://doi.org/10.1007/s40267-025-01199-5", "doi": "10.1007/s40267-025-01199-5", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 449, "title": "Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review.", "authors": "Marinis J, Clarke ST, Guerin AA, Guastella AJ, Bedi G", "journal": "BJPsych open", "publication_date": "2025-11-03", "publication_year": 2025, "doi": "10.1192/bjo.2025.10847", "pubmed_id": "41178084", "openalex_id": "https://openalex.org/W4415782096", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41178084/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41178084", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41178084/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41178084", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41178084/", "doi": "10.1192/bjo.2025.10847", "pmid": "41178084", "publication_date": "2025-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4249, "title": "Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy", "authors": "Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli", "journal": "Psychoactives", "publication_date": "2025-11-02", "publication_year": 2025, "doi": "10.3390/psychoactives4040039", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415817857", "source_url": "https://doi.org/10.3390/psychoactives4040039", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Longevity,Review Article,Animal Study,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4040039", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4040039", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4040039", "source_url": "https://doi.org/10.3390/psychoactives4040039", "doi": "10.3390/psychoactives4040039", "pmid": "", "publication_date": "2025-11-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1987, "title": "Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?", "authors": "Thomas Zandonai, Sofia Venturini, Ornella Corazza", "journal": "Performance Enhancement & Health", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.peh.2025.100386", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415757045", "source_url": "https://doi.org/10.1016/j.peh.2025.100386", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Receptor Pharmacology,Resilience,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.1016/j.peh.2025.100386", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.peh.2025.100386", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.peh.2025.100386", "source_url": "https://doi.org/10.1016/j.peh.2025.100386", "doi": "10.1016/j.peh.2025.100386", "pmid": "", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 463, "title": "Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "International journal of psychiatry in medicine", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1177/00912174251337572", "pubmed_id": "40279353", "openalex_id": "https://openalex.org/W4409797469", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40279353/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40279353", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40279353/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40279353", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40279353/", "doi": "10.1177/00912174251337572", "pmid": "40279353", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 462, "title": "Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.", "authors": "Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H", "journal": "Molecular neurobiology", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1007/s12035-025-05097-9", "pubmed_id": "40461729", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40461729/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Review Article,Animal Study,In Vitro Study,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40461729", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40461729/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40461729", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40461729/", "doi": "10.1007/s12035-025-05097-9", "pmid": "40461729", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 461, "title": "Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.", "authors": "Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S", "journal": "Health policy (Amsterdam, Netherlands)", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.healthpol.2025.105392", "pubmed_id": "40694950", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40694950/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40694950", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40694950/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40694950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40694950/", "doi": "10.1016/j.healthpol.2025.105392", "pmid": "40694950", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 460, "title": "The emotional architecture of the psychedelic brain.", "authors": "Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH", "journal": "Trends in cognitive sciences", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.tics.2025.07.006", "pubmed_id": "40830011", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40830011/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Emotional Processing,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40830011", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40830011/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40830011", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40830011/", "doi": "10.1016/j.tics.2025.07.006", "pmid": "40830011", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 459, "title": "Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians.", "authors": "Koenig HG", "journal": "International journal of psychiatry in medicine", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1177/00912174251369880", "pubmed_id": "40833259", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40833259/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40833259", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40833259", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40833259/", "doi": "10.1177/00912174251369880", "pmid": "40833259", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 458, "title": "The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.", "authors": "Rahmani S, Crupi R, Riley AL, Davidson T", "journal": "Pharmacology, biochemistry, and behavior", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.pbb.2025.174087", "pubmed_id": "40849009", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40849009", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40849009", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "doi": "10.1016/j.pbb.2025.174087", "pmid": "40849009", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 456, "title": "Emerging mechanisms of psilocybin-induced neuroplasticity.", "authors": "Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A", "journal": "Trends in pharmacological sciences", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.tips.2025.08.012", "pubmed_id": "40957728", "openalex_id": "https://openalex.org/W4414267802", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40957728/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40957728", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40957728/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40957728", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40957728/", "doi": "10.1016/j.tips.2025.08.012", "pmid": "40957728", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 454, "title": "Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain.", "authors": "Hammo A, Wisser S, Cichon J", "journal": "Nature neuroscience", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1038/s41593-025-02068-0", "pubmed_id": "41039182", "openalex_id": "https://openalex.org/W4414747399", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41039182/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41039182", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41039182/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41039182", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41039182/", "doi": "10.1038/s41593-025-02068-0", "pmid": "41039182", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 453, "title": "Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.", "authors": "Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS", "journal": "EClinicalMedicine", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103517", "pubmed_id": "41048658", "openalex_id": "https://openalex.org/W4414476150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41048658/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41048658", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41048658/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41048658", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41048658/", "doi": "10.1016/j.eclinm.2025.103517", "pmid": "41048658", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4254, "title": "“It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics", "authors": "Blake Beaton", "journal": "Journal of Drug Issues", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1177/00220426251395178", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415749444", "source_url": "https://doi.org/10.1177/00220426251395178", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Wellbeing,Spirituality,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.1177/00220426251395178", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00220426251395178", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00220426251395178", "source_url": "https://doi.org/10.1177/00220426251395178", "doi": "10.1177/00220426251395178", "pmid": "", "publication_date": "2025-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 466, "title": "Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.", "authors": "d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G", "journal": "Translational psychiatry", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1038/s41398-025-03654-3", "pubmed_id": "41173871", "openalex_id": "https://openalex.org/W4415725218", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173871/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41173871", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41173871/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41173871", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173871/", "doi": "10.1038/s41398-025-03654-3", "pmid": "41173871", "publication_date": "2025-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3597, "title": "A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?", "authors": "Anna Rose Childress, Ph.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06786325", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Consciousness,Biomarkers,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06786325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "source_url": "https://clinicaltrials.gov/study/NCT06786325", "doi": "", "pmid": "", "publication_date": "2025-10-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 467, "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.", "authors": "Richardson C, Chan C, Macgregor E, Hare C, Hannon B, Black S, Schneider E, Buchman D, Wang S, Rac V, Abrahamyan L, Huszti E, Nissim R, Li M, Zimmermann C, Hapke E, Rosenbaum D, Hales S", "journal": "Pilot and feasibility studies", "publication_date": "2025-10-28", "publication_year": 2025, "doi": "10.1186/s40814-025-01706-5", "pubmed_id": "41152967", "openalex_id": "https://openalex.org/W4415616586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41152967/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41152967", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41152967/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41152967", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41152967/", "doi": "10.1186/s40814-025-01706-5", "pmid": "41152967", "publication_date": "2025-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4259, "title": "Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence", "authors": "James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir", "journal": "Psychedelics.", "publication_date": "2025-10-27", "publication_year": 2025, "doi": "10.61373/pp025i.0044", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415615338", "source_url": "https://doi.org/10.61373/pp025i.0044", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,OCD,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Animal Study,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025i.0044", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025i.0044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025i.0044", "source_url": "https://doi.org/10.61373/pp025i.0044", "doi": "10.61373/pp025i.0044", "pmid": "", "publication_date": "2025-10-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 472, "title": "Structure-Guided Design of Novel 5-HT Partial Agonists as Psychedelic Analogues with Antidepressant Effects.", "authors": "Li R, Yan H, Chen Y, Liu Y, Tang L, Yu J, Liu J, Wang H, Wang S, Cheng J", "journal": "Journal of medicinal chemistry", "publication_date": "2025-10-23", "publication_year": 2025, "doi": "10.1021/acs.jmedchem.5c02045", "pubmed_id": "41087124", "openalex_id": "https://openalex.org/W4415182565", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41087124/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41087124", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41087124/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41087124", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41087124/", "doi": "10.1021/acs.jmedchem.5c02045", "pmid": "41087124", "publication_date": "2025-10-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 471, "title": "Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report.", "authors": "Farzin H, Koren B, Ferrier H, Sanders JJ, Garel N", "journal": "Palliative & supportive care", "publication_date": "2025-10-23", "publication_year": 2025, "doi": "10.1017/s1478951525100941", "pubmed_id": "41127918", "openalex_id": "https://openalex.org/W4415464487", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41127918/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Case Report", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41127918", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41127918/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41127918", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41127918/", "doi": "10.1017/s1478951525100941", "pmid": "41127918", "publication_date": "2025-10-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4260, "title": "Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy", "authors": "Pu Jiang, Cong Lin, Xiaohui Wang", "journal": "Psychedelics.", "publication_date": "2025-10-21", "publication_year": 2025, "doi": "10.61373/pp025p.0041", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415381295", "source_url": "https://doi.org/10.61373/pp025p.0041", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Consciousness", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.61373/pp025p.0041", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025p.0041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025p.0041", "source_url": "https://doi.org/10.61373/pp025p.0041", "doi": "10.61373/pp025p.0041", "pmid": "", "publication_date": "2025-10-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4262, "title": "Is there more to magic mushrooms than psilocybin?", "authors": "special to C EN Mara Johnson-Groh", "journal": "C&EN Global Enterprise", "publication_date": "2025-10-19", "publication_year": 2025, "doi": "10.1021/cen-10322-feature2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416285937", "source_url": "https://doi.org/10.1021/cen-10322-feature2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10322-feature2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10322-feature2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10322-feature2", "source_url": "https://doi.org/10.1021/cen-10322-feature2", "doi": "10.1021/cen-10322-feature2", "pmid": "", "publication_date": "2025-10-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4267, "title": "Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant Effects", "authors": "Rongyan Li (11403789), Haohan Yan (22432650), Yujin Chen (1412254), Yangyang Liu (807797), Lingjie Tang (9276407), Jing Yu (81085), Junjun Liu (674159), Huan Wang (109286), Sheng Wang (339979), Jianjun Cheng (646595)", "journal": "Figshare", "publication_date": "2025-10-15", "publication_year": 2025, "doi": "10.1021/acs.jmedchem.5c02045.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111070235", "source_url": "https://figshare.com/articles/journal_contribution/Structure-Guided_Design_of_Novel_5_HT_sub_2A_sub_Partial_Agonists_as_Psychedelic_Analogues_with_Antidepressant_Effects/30360072", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.1021/acs.jmedchem.5c02045.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/Structure-Guided_Design_of_Novel_5_HT_sub_2A_sub_Partial_Agonists_as_Psychedelic_Analogues_with_Antidepressant_Effects/30360072", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acs.jmedchem.5c02045.s001", "source_url": "https://figshare.com/articles/journal_contribution/Structure-Guided_Design_of_Novel_5_HT_sub_2A_sub_Partial_Agonists_as_Psychedelic_Analogues_with_Antidepressant_Effects/30360072", "doi": "10.1021/acs.jmedchem.5c02045.s001", "pmid": "", "publication_date": "2025-10-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3057, "title": "Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA)", "authors": "Shadani S, Greaves E, Andrews ZB, Foldi CJ.", "journal": "bioRxiv", "publication_date": "2025-10-15", "publication_year": 2025, "doi": "10.1101/2025.10.14.682467", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.10.14.682467", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Eating Disorders,Mechanism of Action,Emotional Processing,Animal Study,Inflammation,Immune Function", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:54", "bibtex": null, "source_record_id": "DOI:10.1101/2025.10.14.682467", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.10.14.682467", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.10.14.682467", "source_url": "https://doi.org/10.1101/2025.10.14.682467", "doi": "10.1101/2025.10.14.682467", "pmid": "", "publication_date": "2025-10-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4268, "title": "Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment", "authors": "Sha Jin, H.Y. Wang, Xiaohui Wang", "journal": "Psychedelics.", "publication_date": "2025-10-14", "publication_year": 2025, "doi": "10.61373/pp025v.0038", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415151524", "source_url": "https://doi.org/10.61373/pp025v.0038", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Wellbeing,Emotional Processing", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.61373/pp025v.0038", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025v.0038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025v.0038", "source_url": "https://doi.org/10.61373/pp025v.0038", "doi": "10.61373/pp025v.0038", "pmid": "", "publication_date": "2025-10-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 476, "title": "Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice.", "authors": "Razidlo J, Cataldo N, Wenthur CJ", "journal": "ACS pharmacology & translational science", "publication_date": "2025-10-10", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00462", "pubmed_id": "41244305", "openalex_id": "https://openalex.org/W4414130775", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41244305/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41244305", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41244305/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41244305", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41244305/", "doi": "10.1021/acsptsci.5c00462", "pmid": "41244305", "publication_date": "2025-10-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4272, "title": "Psychedelics in Practice: Science, Safety, and the Future of Healing", "authors": "Renee Ireland", "journal": "˜The œproceedings of sliit international conference on advancements in science and humanities", "publication_date": "2025-10-09", "publication_year": 2025, "doi": "10.54389/epsd8792", "pubmed_id": null, "openalex_id": "https://openalex.org/W7119484008", "source_url": "https://doi.org/10.54389/epsd8792", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Treatment-Resistant Depression,Safety,Toxicity,Contraindications", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.54389/epsd8792", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54389/epsd8792", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54389/epsd8792", "source_url": "https://doi.org/10.54389/epsd8792", "doi": "10.54389/epsd8792", "pmid": "", "publication_date": "2025-10-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3575, "title": "Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)", "authors": "Centre Hospitalier St Anne", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07210112", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07210112", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "source_url": "https://clinicaltrials.gov/study/NCT07210112", "doi": "", "pmid": "", "publication_date": "2025-10-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3065, "title": "Towards Novel Antidepressant Strategies: A Comparative Study of Ketamine, Psilocybin, and Fluoxetine in a Chronic Stress Model", "authors": "Domzalska M, Kwiatkowska J, Cichon I, Sokolowska E.", "journal": "Research Square", "publication_date": "2025-10-07", "publication_year": 2025, "doi": "10.21203/rs.3.rs-7269356/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-7269356/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-7269356/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-7269356/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-7269356/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-7269356/v1", "doi": "10.21203/rs.3.rs-7269356/v1", "pmid": "", "publication_date": "2025-10-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4488, "title": "Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD", "authors": "Mackenzie Hancock, Nicole Getz, Shambhu Prasad Adhikari", "journal": "Open Science Framework", "publication_date": "2025-10-06", "publication_year": 2025, "doi": "10.17605/osf.io/ar2s4", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106330185", "source_url": "https://osf.io/ar2s4", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/ar2s4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/ar2s4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/ar2s4", "source_url": "https://osf.io/ar2s4", "doi": "10.17605/osf.io/ar2s4", "pmid": "", "publication_date": "2025-10-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4275, "title": "Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders", "authors": "M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali", "journal": "Journal of Pharma Insights and Research.", "publication_date": "2025-10-05", "publication_year": 2025, "doi": "10.69613/thv1dn30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416779935", "source_url": "https://doi.org/10.69613/thv1dn30", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.69613/thv1dn30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.69613/thv1dn30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.69613/thv1dn30", "source_url": "https://doi.org/10.69613/thv1dn30", "doi": "10.69613/thv1dn30", "pmid": "", "publication_date": "2025-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5795, "title": "Psilocybin as a Treatment for Depression", "authors": "Arif Ersegün Kahraman", "journal": "University of Debrecen Electronic Archive", "publication_date": "2025-10-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7198794859", "source_url": "https://hdl.handle.net/2437/398317", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:16", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://hdl.handle.net/2437/398317", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/2437/398317", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://hdl.handle.net/2437/398317", "source_url": "https://hdl.handle.net/2437/398317", "doi": "", "pmid": "", "publication_date": "2025-10-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3677, "title": "Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment", "authors": "University Hospital, Geneva", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164287", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164287", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164287", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164287", "source_url": "https://clinicaltrials.gov/study/NCT07164287", "doi": "", "pmid": "", "publication_date": "2025-10-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 484, "title": "Psilocybin-assisted psychotherapy in adults with depression - A literature review.", "authors": "Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-10-02", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111508", "pubmed_id": "40998282", "openalex_id": "https://openalex.org/W4414482106", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40998282/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40998282", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40998282/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40998282", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40998282/", "doi": "10.1016/j.pnpbp.2025.111508", "pmid": "40998282", "publication_date": "2025-10-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 502, "title": "Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.", "authors": "Chisamore N, Kaczmarek ES, Doyle Z, Johnson DE, Weiglein G, Meshkat S, Brudner RM, Blainey MG, Riva-Cambrin J, McIntyre RS, Rosenblat JD", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1177/07067437251328316", "pubmed_id": "40129307", "openalex_id": "https://openalex.org/W4408813813", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40129307/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40129307", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40129307/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40129307", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40129307/", "doi": "10.1177/07067437251328316", "pmid": "40129307", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 500, "title": "Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.", "authors": "Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD", "journal": "Psychopharmacology", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1007/s00213-025-06788-w", "pubmed_id": "40266291", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40266291/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40266291", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40266291/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40266291", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40266291/", "doi": "10.1007/s00213-025-06788-w", "pmid": "40266291", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 498, "title": "Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.", "authors": "Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD", "journal": "Psychopharmacology", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1007/s00213-025-06818-7", "pubmed_id": "40381005", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40381005/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40381005", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40381005", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40381005/", "doi": "10.1007/s00213-025-06818-7", "pmid": "40381005", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 497, "title": "Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.", "authors": "Pellegrini L, Fineberg NA, O'Connor S, De Souza AMFLP, Godfrey K, Reed S, Peill J, Healy M, Rohani-Shukla C, Lee H, Carhart-Harris R, Robbins TW, Nutt D, Erritzoe D", "journal": "Comprehensive psychiatry", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1016/j.comppsych.2025.152619", "pubmed_id": "40618640", "openalex_id": "https://openalex.org/W4411969620", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40618640/", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Healthcare Workers,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40618640", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40618640/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40618640", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40618640/", "doi": "10.1016/j.comppsych.2025.152619", "pmid": "40618640", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 496, "title": "The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.", "authors": "Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW", "journal": "Molecular psychiatry", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1038/s41380-025-03100-2", "pubmed_id": "40624295", "openalex_id": "https://openalex.org/W4412073006", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40624295/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40624295", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40624295/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40624295", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40624295/", "doi": "10.1038/s41380-025-03100-2", "pmid": "40624295", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 493, "title": "The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.", "authors": "Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, Suomivuori CM, Huang XP, Shub L, DiBerto JF, Kim K, DeLeon C, Krumm BE, Fay JF, Keiser M, Hauser AS, Dror RO, Shoichet B, Gloriam DE, Nichols DE, Roth BL", "journal": "Neuron", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1016/j.neuron.2025.06.012", "pubmed_id": "40683247", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40683247/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Headache / Migraine,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40683247", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40683247/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40683247", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40683247/", "doi": "10.1016/j.neuron.2025.06.012", "pmid": "40683247", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 492, "title": "Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.", "authors": "Rosa I, Padula LP, Semeraro F, Marrangone C, Inserra A, De Risio L, Boffa M, Zoratto F, Borgi M, Guidotti R, Lorenzo GD, D'Addario C, Pettorruso M, Martinotti G", "journal": "Psychiatry research", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116697", "pubmed_id": "40840197", "openalex_id": "https://openalex.org/W4413296887", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40840197/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40840197", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40840197/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40840197", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40840197/", "doi": "10.1016/j.psychres.2025.116697", "pmid": "40840197", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 489, "title": "Concomitant use of antidepressants and classic psychedelics: A scoping review.", "authors": "Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1177/02698811251368360", "pubmed_id": "40937732", "openalex_id": "https://openalex.org/W4414152565", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40937732/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40937732", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40937732/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40937732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40937732/", "doi": "10.1177/02698811251368360", "pmid": "40937732", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 488, "title": "Serotonin 5-HT Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.", "authors": "Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD", "journal": "ACS chemical neuroscience", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00647", "pubmed_id": "40944639", "openalex_id": "https://openalex.org/W4414162276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40944639/", "substance_tags": "psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40944639", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40944639/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40944639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40944639/", "doi": "10.1021/acschemneuro.5c00647", "pmid": "40944639", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 485, "title": "[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?].", "authors": "Sabé M, Seragnoli F, Penzenstadler L, Thorens G", "journal": "La Revue du praticien", "publication_date": "2025-10-01", "publication_year": 2025, "doi": null, "pubmed_id": "41575100", "openalex_id": "https://openalex.org/W7125566383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:41575100", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41575100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100/", "doi": "", "pmid": "41575100", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4283, "title": "3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception", "authors": "Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman", "journal": "Poster Abstracts", "publication_date": "2025-09-30", "publication_year": 2025, "doi": "10.1136/bmjno-2025-anzan.170", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415496150", "source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Microdosing,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:37:47", "bibtex": null, "source_record_id": "DOI:10.1136/bmjno-2025-anzan.170", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/bmjno-2025-anzan.170", "source_url": "https://doi.org/10.1136/bmjno-2025-anzan.170", "doi": "10.1136/bmjno-2025-anzan.170", "pmid": "", "publication_date": "2025-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4289, "title": "Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review", "authors": "Stefania Chiappini, Clara Cavallotto, Andrea Miuli, Giacomo d’Andrea, Alessio Mosca, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Antonio d'Attilio, Giovanna Mammarella, Luca Persico, Alessia Santeusanio, Gianfranco Tamagnini, Mauro Pettorruso, Giovanni Martinotti", "journal": "Clinical Neuropsychopharmacology and Addiction", "publication_date": "2025-09-24", "publication_year": 2025, "doi": "10.53941/cna.2025.100006", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414523550", "source_url": "https://doi.org/10.53941/cna.2025.100006", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Biomarkers,Aging,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.53941/cna.2025.100006", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.53941/cna.2025.100006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53941/cna.2025.100006", "source_url": "https://doi.org/10.53941/cna.2025.100006", "doi": "10.53941/cna.2025.100006", "pmid": "", "publication_date": "2025-09-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3588, "title": "Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism", "authors": "Healing Advocacy Fund", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07189988", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Wellbeing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07189988", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "source_url": "https://clinicaltrials.gov/study/NCT07189988", "doi": "", "pmid": "", "publication_date": "2025-09-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4290, "title": "With great power comes great responsibility: Promise and caution in the new psychedelic renaissance", "authors": "Matthew Halma, R. Levy, Joseph Varón", "journal": "Brain Disorders", "publication_date": "2025-09-23", "publication_year": 2025, "doi": "10.1016/j.dscb.2025.100286", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414440106", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "doi": "10.1016/j.dscb.2025.100286", "pmid": "", "publication_date": "2025-09-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 509, "title": "Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.", "authors": "Knock E, Siefried KJ, Bedi G, Albert S, Day RO, Ezard N, Ross M, Liknaitzky P, Brett J", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-09-20", "publication_year": 2025, "doi": "10.1111/add.70187", "pubmed_id": "40974259", "openalex_id": "https://openalex.org/W4414374510", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40974259/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40974259", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40974259/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40974259", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40974259/", "doi": "10.1111/add.70187", "pmid": "40974259", "publication_date": "2025-09-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4292, "title": "S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial", "authors": "Benjamin R. Lewis (22279166), John Hendrick (22279169), Kevin Byrne (1610821), Madeleine Odette (22279172), Chaorong Wu (8444343), Eric L. Garland (4666660)", "journal": "Figshare", "publication_date": "2025-09-19", "publication_year": 2025, "doi": "10.1371/journal.pmed.1004519.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7110952270", "source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.1371/journal.pmed.1004519.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1371/journal.pmed.1004519.s001", "source_url": "https://figshare.com/articles/journal_contribution/S1_Appendix_-_Psilocybin-assisted_group_psychotherapy_and_mindfulness-based_stress_reduction_for_frontline_healthcare_provider_COVID-19-related_depression_and_burnout_A_randomized_controlled_trial/30170132", "doi": "10.1371/journal.pmed.1004519.s001", "pmid": "", "publication_date": "2025-09-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 513, "title": "Reappraisal of the hype and hope offered by psilocybin treatment of depression.", "authors": "Beaglehole B, Manuel J", "journal": "The New Zealand medical journal", "publication_date": "2025-09-19", "publication_year": 2025, "doi": "10.26635/6965.7138", "pubmed_id": "40966702", "openalex_id": "https://openalex.org/W4414175451", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40966702/", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40966702", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40966702/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40966702", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40966702/", "doi": "10.26635/6965.7138", "pmid": "40966702", "publication_date": "2025-09-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4293, "title": "Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-Analyses", "authors": "Lopez, Alissa A, Salloum, Ihsan, Lopez-Alvarenga, Juan C", "journal": "ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley)", "publication_date": "2025-09-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110568410", "source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "source_url": "https://scholarworks.utrgv.edu/colloquium/2025/talks/1", "doi": "", "pmid": "", "publication_date": "2025-09-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5626, "title": "Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism", "authors": "Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910)", "journal": "Figshare", "publication_date": "2025-09-13", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00647.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111383702", "source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "substance_tags": "psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:10", "last_checked": "2026-08-09 08:25:59", "bibtex": null, "source_record_id": "DOI:10.1021/acschemneuro.5c00647.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acschemneuro.5c00647.s001", "source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "doi": "10.1021/acschemneuro.5c00647.s001", "pmid": "", "publication_date": "2025-09-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 519, "title": "Therapeutic Divergence in 5-HTA Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2025-09-11", "publication_year": 2025, "doi": "10.1021/acsmedchemlett.5c00475", "pubmed_id": "40959252", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40959252/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40959252", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40959252/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40959252", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40959252/", "doi": "10.1021/acsmedchemlett.5c00475", "pmid": "40959252", "publication_date": "2025-09-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3699, "title": "Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-10", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164755", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Treatment-Resistant Depression,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164755", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "source_url": "https://clinicaltrials.gov/study/NCT07164755", "doi": "", "pmid": "", "publication_date": "2025-09-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4297, "title": "Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder", "authors": "Alan K. Davis, Meghan DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Washington Taylor, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan, Stacey B. Armstrong, Frederick S. Barrett", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-09-04", "publication_year": 2025, "doi": "10.1556/2054.2025.00461", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413975912", "source_url": "https://doi.org/10.1556/2054.2025.00461", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Emotional Processing,Randomized Controlled Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00461", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00461", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00461", "source_url": "https://doi.org/10.1556/2054.2025.00461", "doi": "10.1556/2054.2025.00461", "pmid": "", "publication_date": "2025-09-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 524, "title": "Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.", "authors": "Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM", "journal": "Acta neuropsychiatrica", "publication_date": "2025-09-03", "publication_year": 2025, "doi": "10.1017/neu.2025.10039", "pubmed_id": "40899152", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40899152/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40899152", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40899152/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40899152", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40899152/", "doi": "10.1017/neu.2025.10039", "pmid": "40899152", "publication_date": "2025-09-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4302, "title": "Therapeutic Effects of Psychedelics and their Non-Hallucinogenic Analogs on Depressive-Like Behaviour", "authors": "Kaylee Reid, Daniel Kot, Argel Aguilar-Valles", "journal": "Carleton undergraduate journal of science.", "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.22215/cujs.v5i1.5286", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413920645", "source_url": "https://doi.org/10.22215/cujs.v5i1.5286", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.22215/cujs.v5i1.5286", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22215/cujs.v5i1.5286", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22215/cujs.v5i1.5286", "source_url": "https://doi.org/10.22215/cujs.v5i1.5286", "doi": "10.22215/cujs.v5i1.5286", "pmid": "", "publication_date": "2025-09-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4300, "title": "Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?", "authors": "Gregor Hasler", "journal": "Psychedelics.", "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.61373/pp025k.0032", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413911705", "source_url": "https://doi.org/10.61373/pp025k.0032", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Biomarkers,Safety,Genomics", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0032", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0032", "source_url": "https://doi.org/10.61373/pp025k.0032", "doi": "10.61373/pp025k.0032", "pmid": "", "publication_date": "2025-09-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4298, "title": "Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care", "authors": "Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher", "journal": "Psychoactives", "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.3390/psychoactives4030031", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413908189", "source_url": "https://doi.org/10.3390/psychoactives4030031", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Wellbeing,Resilience,Emotional Processing,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030031", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030031", "source_url": "https://doi.org/10.3390/psychoactives4030031", "doi": "10.3390/psychoactives4030031", "pmid": "", "publication_date": "2025-09-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3571, "title": "Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial", "authors": "Khyber Medical University Peshawar", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06746441", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06746441", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06746441", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06746441", "source_url": "https://clinicaltrials.gov/study/NCT06746441", "doi": "", "pmid": "", "publication_date": "2025-09-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4308, "title": "We may know why psilocybin helps treat mental health conditions", "authors": "Chris Simms", "journal": "The New Scientist", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1016/s0262-4079(25)01446-0", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414149661", "source_url": "https://doi.org/10.1016/s0262-4079(25)01446-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.1016/s0262-4079(25)01446-0", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0262-4079(25)01446-0", "source_url": "https://doi.org/10.1016/s0262-4079(25)01446-0", "doi": "10.1016/s0262-4079(25)01446-0", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4305, "title": "Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report", "authors": "M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler", "journal": "Psychoactives", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.3390/psychoactives4030030", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413893315", "source_url": "https://doi.org/10.3390/psychoactives4030030", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Case Report,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030030", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030030", "source_url": "https://doi.org/10.3390/psychoactives4030030", "doi": "10.3390/psychoactives4030030", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4304, "title": "PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH", "authors": "Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.31435/ijitss.3(47).2025.3650", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413888032", "source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Neuroplasticity,Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.3(47).2025.3650", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.3(47).2025.3650", "source_url": "https://doi.org/10.31435/ijitss.3(47).2025.3650", "doi": "10.31435/ijitss.3(47).2025.3650", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 606, "title": "Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review", "authors": "Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J.", "journal": "Curr Microbiol", "publication_date": "2025-09-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/AGR/IND609227368", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:14:57", "bibtex": null, "source_record_id": "https://europepmc.org/article/AGR/IND609227368", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/AGR/IND609227368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/AGR/IND609227368", "source_url": "https://europepmc.org/article/AGR/IND609227368", "doi": "", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 547, "title": "Psilocybin biosynthesis enhancement through gene source optimization.", "authors": "Keller MR, McKinney MG, Sen AK, Guagliardo FG, Hellwarth EB, Islam KN, Kaplan NA, Gibbons WJ, Kemmerly GE, Meers C, Wang X, Jones JA", "journal": "Metabolic engineering", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1016/j.ymben.2025.04.003", "pubmed_id": "40250599", "openalex_id": "https://openalex.org/W4409500508", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40250599/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Clinical Trial,Proteomics", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40250599", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40250599/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40250599", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40250599/", "doi": "10.1016/j.ymben.2025.04.003", "pmid": "40250599", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 541, "title": "Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms.", "authors": "Blanton AM, Parikh P, Zhou S, Mohamed M, Ufret-Vincenty RL, Mancini R", "journal": "American journal of ophthalmology case reports", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1016/j.ajoc.2025.102359", "pubmed_id": "40535325", "openalex_id": "https://openalex.org/W4410946123", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40535325/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Case Report,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40535325", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40535325/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40535325", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40535325/", "doi": "10.1016/j.ajoc.2025.102359", "pmid": "40535325", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 540, "title": "Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.", "authors": "Brudner RM, Kaczmarek E, Blainey MG, Schulz-Quach C, Meshkat S, Doyle Z, Lipsitz O, Offman H, Sethi R, Weiglein G, McIntyre RS, Rosenblat JD", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1177/02698811251346697", "pubmed_id": "40590216", "openalex_id": "https://openalex.org/W4411880520", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40590216/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Mystical Experience,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40590216", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40590216/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40590216", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40590216/", "doi": "10.1177/02698811251346697", "pmid": "40590216", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 535, "title": "Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers.", "authors": "Nadeem Z, Parker S, McGovern H, Sebben B, Oestreich LK", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1177/00048674251346679", "pubmed_id": "40660894", "openalex_id": "https://openalex.org/W4412418522", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40660894/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Observational Study,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40660894", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40660894/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40660894", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40660894/", "doi": "10.1177/00048674251346679", "pmid": "40660894", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 533, "title": "Psilocybin as a psychophysical adaptogen in chronic pain rehabilitation.", "authors": "Cherup NP, Finan PH", "journal": "The journal of pain", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1016/j.jpain.2025.105507", "pubmed_id": "40701207", "openalex_id": "https://openalex.org/W4412529549", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40701207/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Consciousness,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40701207", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40701207/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40701207", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40701207/", "doi": "10.1016/j.jpain.2025.105507", "pmid": "40701207", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 512, "title": "Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.", "authors": "Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL", "journal": "PLoS medicine", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1371/journal.pmed.1004519", "pubmed_id": "40972137", "openalex_id": "https://openalex.org/W4414366251", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40972137/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40972137", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40972137/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40972137", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40972137/", "doi": "10.1371/journal.pmed.1004519", "pmid": "40972137", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4303, "title": "A lexicon for psychedelic research and treatment", "authors": "David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill", "journal": "Drug Science Policy and Law", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1177/20503245251380511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414407628", "source_url": "https://doi.org/10.1177/20503245251380511", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/20503245251380511", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245251380511", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245251380511", "source_url": "https://doi.org/10.1177/20503245251380511", "doi": "10.1177/20503245251380511", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 555, "title": "An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.", "authors": "Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-08-30", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111461", "pubmed_id": "40716639", "openalex_id": "https://openalex.org/W4412714464", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40716639/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Review Article,Observational Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40716639", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40716639/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40716639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40716639/", "doi": "10.1016/j.pnpbp.2025.111461", "pmid": "40716639", "publication_date": "2025-08-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 557, "title": "Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.", "authors": "Avanceña ALV, Vuong L, Kahn JG, Marseille E", "journal": "Translational psychiatry", "publication_date": "2025-08-29", "publication_year": 2025, "doi": "10.1038/s41398-025-03556-4", "pubmed_id": "40883271", "openalex_id": "https://openalex.org/W4413817374", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883271/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40883271", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40883271/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40883271", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883271/", "doi": "10.1038/s41398-025-03556-4", "pmid": "40883271", "publication_date": "2025-08-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3192, "title": "Psilocybin: Systematic review of its use in the treatment of depression", "authors": "Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C, Gonzalez-Bolaños R, Brito-Rey R, Marín-Lorenzo C, Arribas-Simon B.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2025-08-26", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12436869", "substance_tags": "psilocybin", "topic_tags": "Depression,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12436869", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12436869", "source_url": "https://europepmc.org/article/PMC/PMC12436869", "doi": "", "pmid": "", "publication_date": "2025-08-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4314, "title": "“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy", "authors": "Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Kimberly Roddy, James A. Tulsky, Manish Agrawal, Yvan Beaussant", "journal": "Psychedelic Medicine", "publication_date": "2025-08-25", "publication_year": 2025, "doi": "10.1177/28314425251370303", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414955208", "source_url": "https://doi.org/10.1177/28314425251370303", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251370303", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251370303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251370303", "source_url": "https://doi.org/10.1177/28314425251370303", "doi": "10.1177/28314425251370303", "pmid": "", "publication_date": "2025-08-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 560, "title": "Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion.", "authors": "Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V, Ross S, Erritzoe D, Carhart-Harris R", "journal": "Research square", "publication_date": "2025-08-22", "publication_year": 2025, "doi": "10.21203/rs.3.rs-7420529/v1", "pubmed_id": "40894046", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894046/", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40894046", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40894046/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40894046", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894046/", "doi": "10.21203/rs.3.rs-7420529/v1", "pmid": "40894046", "publication_date": "2025-08-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3557, "title": "Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-20", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06650800", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06650800", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06650800", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06650800", "source_url": "https://clinicaltrials.gov/study/NCT06650800", "doi": "", "pmid": "", "publication_date": "2025-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3466, "title": "A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05733546", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05733546", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "source_url": "https://clinicaltrials.gov/study/NCT05733546", "doi": "", "pmid": "", "publication_date": "2025-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3070, "title": "Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource", "authors": "Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD.", "journal": "medRxiv", "publication_date": "2025-08-16", "publication_year": 2025, "doi": "10.1101/2025.08.13.25333530", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.1101/2025.08.13.25333530", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.08.13.25333530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.08.13.25333530", "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "doi": "10.1101/2025.08.13.25333530", "pmid": "", "publication_date": "2025-08-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 565, "title": "Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.", "authors": "Repple J, Bayas M, Möser C, Kobayashi NF, Reif A", "journal": "Biological psychiatry", "publication_date": "2025-08-15", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.903", "pubmed_id": "40064389", "openalex_id": "https://openalex.org/W4408254485", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40064389/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40064389", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40064389/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40064389", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40064389/", "doi": "10.1016/j.biopsych.2025.02.903", "pmid": "40064389", "publication_date": "2025-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 567, "title": "Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.", "authors": "Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A", "journal": "Medical science monitor: international medical journal of experimental and clinical research", "publication_date": "2025-08-09", "publication_year": 2025, "doi": "10.12659/msm.948302", "pubmed_id": "40781763", "openalex_id": "https://openalex.org/W4411816478", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40781763/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40781763", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40781763/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40781763", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40781763/", "doi": "10.12659/msm.948302", "pmid": "40781763", "publication_date": "2025-08-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 568, "title": "The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal.", "authors": "Fernández-Borkel T, Borkel LF, Rojas-Hernández J, Hernández-Álvarez E, Quintana-Hernández DJ, Ponti LG, Henríquez-Hernández LA", "journal": "ACS pharmacology & translational science", "publication_date": "2025-08-08", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00445", "pubmed_id": "40894333", "openalex_id": "https://openalex.org/W4412475877", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894333/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Consciousness,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40894333", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40894333/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40894333", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894333/", "doi": "10.1021/acsptsci.5c00445", "pmid": "40894333", "publication_date": "2025-08-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4317, "title": "The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?", "authors": "Trevor R. Norman", "journal": "Exploration of neuroscience", "publication_date": "2025-08-07", "publication_year": 2025, "doi": "10.37349/en.2025.1006105", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413121359", "source_url": "https://doi.org/10.37349/en.2025.1006105", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Emotional Processing,Treatment-Resistant Depression,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "DOI:10.37349/en.2025.1006105", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.37349/en.2025.1006105", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.37349/en.2025.1006105", "source_url": "https://doi.org/10.37349/en.2025.1006105", "doi": "10.37349/en.2025.1006105", "pmid": "", "publication_date": "2025-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4333, "title": "544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES", "authors": "Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.363", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284752", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.363", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,In Vitro Study,Treatment-Resistant Depression,Transcriptomics", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.363", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.363", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.363", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.363", "doi": "10.1093/ijnp/pyaf052.363", "pmid": "", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4322, "title": "670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE?", "authors": "Guy M. Goodwin", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.159", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284175", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.159", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "doi": "10.1093/ijnp/pyaf052.159", "pmid": "", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3265, "title": "631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS", "authors": "G Martinotti, C Cavallotto, G D'Andrea, A D'Attilio, G Mammarella, F Zoratto, M Pettorruso", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359594", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:16", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359594", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359594", "source_url": "https://europepmc.org/article/PMC/PMC12359594", "doi": "", "pmid": "", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3235, "title": "229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL", "authors": "S Meikle, O Carter, P Liknaitzky, L Johansen, R Iyer, N Strauss, M Williams, D Castle, S Rossell", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359778", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359778", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359778", "source_url": "https://europepmc.org/article/PMC/PMC12359778", "doi": "", "pmid": "", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3213, "title": "597. ARE SIDE EFFECTS NECESSARY FOR ANTIDEPRESSIVE TREATMENT: THE PSILOCYBIN EXPERIENCE", "authors": "S Kasper", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359505", "substance_tags": "psilocybin", "topic_tags": "Depression,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359505", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359505", "source_url": "https://europepmc.org/article/PMC/PMC12359505", "doi": "", "pmid": "", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 594, "title": "Are \"mystical experiences\" essential for antidepressant actions of ketamine and the classic psychedelics?", "authors": "Hashimoto K", "journal": "European archives of psychiatry and clinical neuroscience", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1007/s00406-024-01770-7", "pubmed_id": "38411629", "openalex_id": "https://openalex.org/W4392193120", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38411629/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Mystical Experience,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:38411629", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38411629/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38411629", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38411629/", "doi": "10.1007/s00406-024-01770-7", "pmid": "38411629", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 588, "title": "Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.", "authors": "Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "Psychiatry research", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116559", "pubmed_id": "40440859", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440859/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40440859", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40440859/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40440859", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440859/", "doi": "10.1016/j.psychres.2025.116559", "pmid": "40440859", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 587, "title": "Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.", "authors": "Berkovitch L, Fauvel B, Preller KH, Gaillard R", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106239", "pubmed_id": "40456393", "openalex_id": "https://openalex.org/W4410910940", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40456393/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Healthy Volunteers", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40456393", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40456393/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40456393", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40456393/", "doi": "10.1016/j.neubiorev.2025.106239", "pmid": "40456393", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 585, "title": "Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.", "authors": "Vinarcsik L, Smoller C, Grossberg G", "journal": "Drugs & aging", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1007/s40266-025-01221-5", "pubmed_id": "40553322", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40553322/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Aging,Review Article,Older Adults,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40553322", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40553322/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40553322", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40553322/", "doi": "10.1007/s40266-025-01221-5", "pmid": "40553322", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 583, "title": "Australia's psychedelic experiment: reflections from a psychiatrist clinical researcher.", "authors": "Bayes A", "journal": "Australasian psychiatry: bulletin of Royal Australian and New Zealand College of Psychiatrists", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1177/10398562251347890", "pubmed_id": "40574457", "openalex_id": "https://openalex.org/W4411736916", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40574457/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40574457", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40574457/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40574457", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40574457/", "doi": "10.1177/10398562251347890", "pmid": "40574457", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 580, "title": "Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.", "authors": "Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM", "journal": "Fundamental & clinical pharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1111/fcp.70038", "pubmed_id": "40670864", "openalex_id": "https://openalex.org/W4412489091", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40670864/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40670864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40670864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40670864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40670864/", "doi": "10.1111/fcp.70038", "pmid": "40670864", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 563, "title": "Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.", "authors": "Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S", "journal": "Cureus", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.7759/cureus.90425", "pubmed_id": "40970030", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40970030/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Meta-Analysis,Systematic Review,Review Article,Adolescents,Treatment-Resistant Depression", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40970030", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40970030/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40970030", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40970030/", "doi": "10.7759/cureus.90425", "pmid": "40970030", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 558, "title": "Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders:.", "authors": "Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1089/psymed.2024.0031", "pubmed_id": "40933206", "openalex_id": "https://openalex.org/W4406667777", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40933206/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40933206", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40933206/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40933206", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40933206/", "doi": "10.1089/psymed.2024.0031", "pmid": "40933206", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4335, "title": "577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES", "authors": "Hiroe Tani", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284846", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "doi": "10.1093/ijnp/pyaf052.377", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 597, "title": "Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.", "authors": "Cheung K, Brodie M, Chang SL, Deschamps P, Fallu JS, Farzin H, Hébert J, Stephan JF, Dorval M, Joly Y, P3A Study Group", "journal": "The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1017/jme.2025.10109", "pubmed_id": "40739983", "openalex_id": "https://openalex.org/W4412810429", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40739983/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40739983", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40739983/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40739983", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40739983/", "doi": "10.1017/jme.2025.10109", "pmid": "40739983", "publication_date": "2025-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 595, "title": "Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.", "authors": "Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L", "journal": "Folia medica Cracoviensia", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.24425/fmc.2025.156119", "pubmed_id": "41329968", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41329968/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Toxicity,Inflammation", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:41329968", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41329968/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41329968", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41329968/", "doi": "10.24425/fmc.2025.156119", "pmid": "41329968", "publication_date": "2025-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4342, "title": "Preparing Social Work for Psychedelic-Assisted Therapy", "authors": "Heidi Allen, B. Stott", "journal": "Social Work", "publication_date": "2025-07-30", "publication_year": 2025, "doi": "10.1093/sw/swaf031", "pubmed_id": "40803340", "openalex_id": "https://openalex.org/W4413116433", "source_url": "https://doi.org/10.1093/sw/swaf031", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "PMID:40803340", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/sw/swaf031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40803340", "source_url": "https://doi.org/10.1093/sw/swaf031", "doi": "10.1093/sw/swaf031", "pmid": "40803340", "publication_date": "2025-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4341, "title": "Psilocybin-assisted treatment of depression", "authors": "Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus", "journal": "Medical Science", "publication_date": "2025-07-30", "publication_year": 2025, "doi": "10.54905/disssi.v29i161.e110ms3657", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412885037", "source_url": "https://doi.org/10.54905/disssi.v29i161.e110ms3657", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "DOI:10.54905/disssi.v29i161.e110ms3657", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54905/disssi.v29i161.e110ms3657", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54905/disssi.v29i161.e110ms3657", "source_url": "https://doi.org/10.54905/disssi.v29i161.e110ms3657", "doi": "10.54905/disssi.v29i161.e110ms3657", "pmid": "", "publication_date": "2025-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 602, "title": "Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.", "authors": "Luquiens A, Belahda D, Graux C, Igounenc N, Serrand C, Rochefort P, Mura T, Sergent F", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-07-24", "publication_year": 2025, "doi": "10.1111/add.70152", "pubmed_id": "40702912", "openalex_id": "https://openalex.org/W4412642858", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40702912/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40702912", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40702912/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40702912", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40702912/", "doi": "10.1111/add.70152", "pmid": "40702912", "publication_date": "2025-07-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3633, "title": "The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05506982", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05506982", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "source_url": "https://clinicaltrials.gov/study/NCT05506982", "doi": "", "pmid": "", "publication_date": "2025-07-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 604, "title": "\"I've learned that I'm open-minded to this possibility\": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke.", "authors": "Cioe PA, Stang GS, Azam D, Dugal S", "journal": "Addiction science & clinical practice", "publication_date": "2025-07-21", "publication_year": 2025, "doi": "10.1186/s13722-025-00563-0", "pubmed_id": "40691651", "openalex_id": "https://openalex.org/W4412510542", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40691651/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety,Adverse Events", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40691651", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40691651/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40691651", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40691651/", "doi": "10.1186/s13722-025-00563-0", "pmid": "40691651", "publication_date": "2025-07-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3071, "title": "Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder", "authors": "Urban MM, Zillich L, Rieser NM, Herdener M, Vollenweider FX, Spanagel R, Preller KH, Meinhardt MW.", "journal": "bioRxiv", "publication_date": "2025-07-18", "publication_year": 2025, "doi": "10.1101/2025.07.18.664368", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.07.18.664368", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Epigenetics,Observational Study,Genomics,Immune Function", "study_type": "Observational Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.1101/2025.07.18.664368", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.07.18.664368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.07.18.664368", "source_url": "https://doi.org/10.1101/2025.07.18.664368", "doi": "10.1101/2025.07.18.664368", "pmid": "", "publication_date": "2025-07-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4345, "title": "Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot study", "authors": "Michael-Paul Schallmo, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Link Swanson", "journal": "Journal of Vision", "publication_date": "2025-07-15", "publication_year": 2025, "doi": "10.1167/jov.25.9.2091", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412459077", "source_url": "https://doi.org/10.1167/jov.25.9.2091", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.1167/jov.25.9.2091", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1167/jov.25.9.2091", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1167/jov.25.9.2091", "source_url": "https://doi.org/10.1167/jov.25.9.2091", "doi": "10.1167/jov.25.9.2091", "pmid": "", "publication_date": "2025-07-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3097, "title": "Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.", "authors": "Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J", "journal": "Current microbiology", "publication_date": "2025-07-15", "publication_year": 2025, "doi": "10.1007/s00284-025-04379-8", "pubmed_id": "40663181", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40663181/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40663181", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40663181/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40663181", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40663181/", "doi": "10.1007/s00284-025-04379-8", "pmid": "40663181", "publication_date": "2025-07-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4347, "title": "The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin", "authors": "Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899)", "journal": "Figshare", "publication_date": "2025-07-08", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00324.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111003529", "source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.1021/acsptsci.5c00324.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acsptsci.5c00324.s001", "source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "doi": "10.1021/acsptsci.5c00324.s001", "pmid": "", "publication_date": "2025-07-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3072, "title": "An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression", "authors": "Balazs Szigeti", "journal": "PsyArXiv", "publication_date": "2025-07-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/97cqx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/97cqx_v1", "source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "doi": "", "pmid": "", "publication_date": "2025-07-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4348, "title": "Explore the effect of psilocybin on depression and anxiety", "authors": "Yutong Song", "journal": "Arts Culture and Language", "publication_date": "2025-07-06", "publication_year": 2025, "doi": "10.61173/rcg8me57", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412054280", "source_url": "https://doi.org/10.61173/rcg8me57", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Headache / Migraine,Wellbeing,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.61173/rcg8me57", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61173/rcg8me57", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61173/rcg8me57", "source_url": "https://doi.org/10.61173/rcg8me57", "doi": "10.61173/rcg8me57", "pmid": "", "publication_date": "2025-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3745, "title": "An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression", "authors": "Szigeti B.", "journal": "PsyArXiv", "publication_date": "2025-07-06", "publication_year": 2025, "doi": "10.31234/osf.io/97cqx_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/97cqx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/97cqx_v1", "source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "doi": "10.31234/osf.io/97cqx_v1", "pmid": "", "publication_date": "2025-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 615, "title": "Exploring Jordanian Physicians' and Medical Students' Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East.", "authors": "Ahmed KE, Abu Nasrieh D, Banihani HA, Obaidat MF, Mazzawi T, Al-Tarawneh AK, Bani Mustafa R, Al Kayed Z", "journal": "Journal of psychoactive drugs", "publication_date": "2025-07-06", "publication_year": 2025, "doi": "10.1080/02791072.2025.2526403", "pubmed_id": "40619866", "openalex_id": "https://openalex.org/W4412097474", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40619866/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40619866", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40619866/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40619866", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40619866/", "doi": "10.1080/02791072.2025.2526403", "pmid": "40619866", "publication_date": "2025-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4350, "title": "Beyond prohibition: A public health analysis of naturalistic psychedelic use", "authors": "Mark Haden, Sarah A. Paschall, Birgitta Woods", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-07-03", "publication_year": 2025, "doi": "10.1556/2054.2025.00450", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411976075", "source_url": "https://doi.org/10.1556/2054.2025.00450", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Aging,Wellbeing,Emotional Processing,Spirituality,Psychological Flexibility,Review Article,Older Adults,Adolescents,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00450", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00450", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00450", "source_url": "https://doi.org/10.1556/2054.2025.00450", "doi": "10.1556/2054.2025.00450", "pmid": "", "publication_date": "2025-07-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3216, "title": "Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging", "authors": "Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM.", "journal": "bioRxiv", "publication_date": "2025-07-03", "publication_year": 2025, "doi": "10.1101/2025.07.02.662710", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.07.02.662710", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:11", "bibtex": null, "source_record_id": "DOI:10.1101/2025.07.02.662710", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.07.02.662710", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.07.02.662710", "source_url": "https://doi.org/10.1101/2025.07.02.662710", "doi": "10.1101/2025.07.02.662710", "pmid": "", "publication_date": "2025-07-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 642, "title": "Effects of psilocybin, the 5-HT receptor agonist TCB-2, and the 5-HT receptor antagonist M100907 on visual attention in male mice in the continuous performance test.", "authors": "Rahbarnia A, Li Z, Fletcher PJ", "journal": "Psychopharmacology", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1007/s00213-023-06474-9", "pubmed_id": "37855864", "openalex_id": "https://openalex.org/W4387764874", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37855864/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:37855864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37855864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37855864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37855864/", "doi": "10.1007/s00213-023-06474-9", "pmid": "37855864", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 640, "title": "Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.", "authors": "Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS", "journal": "Psychopharmacology", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1007/s00213-024-06599-5", "pubmed_id": "38743110", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Mystical Experience,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:38743110", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38743110", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "doi": "10.1007/s00213-024-06599-5", "pmid": "38743110", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 638, "title": "Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.", "authors": "Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A", "journal": "Psychopharmacology", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1007/s00213-024-06644-3", "pubmed_id": "38963553", "openalex_id": "https://openalex.org/W4400335852", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38963553/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Animal Study,Treatment-Resistant Depression,Drug Interactions", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:38963553", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38963553/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38963553", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38963553/", "doi": "10.1007/s00213-024-06644-3", "pmid": "38963553", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 634, "title": "Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.", "authors": "Bradley ER, Sakai K, Fernandes-Osterhold G, Szigeti B, Ludwig C, Ostrem JL, Tanner CM, Bock MA, Llerena K, Finley PR, O'Donovan A, Zuzuarregui JRP, Busby Z, McKernan A, Penn AD, Wang ACC, Rosen RC, Woolley JD", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1038/s41386-025-02097-0", "pubmed_id": "40205013", "openalex_id": "https://openalex.org/W4409286565", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40205013/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40205013", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40205013/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40205013", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40205013/", "doi": "10.1038/s41386-025-02097-0", "pmid": "40205013", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 633, "title": "Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "Pharmacopsychiatry", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1055/a-2529-7029", "pubmed_id": "40245934", "openalex_id": "https://openalex.org/W4409534321", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245934/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40245934", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40245934/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40245934", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245934/", "doi": "10.1055/a-2529-7029", "pmid": "40245934", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 631, "title": "Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.", "authors": "Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L", "journal": "Molecular psychiatry", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1038/s41380-025-03035-8", "pubmed_id": "40281226", "openalex_id": "https://openalex.org/W4409788022", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40281226/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40281226", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40281226/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40281226", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40281226/", "doi": "10.1038/s41380-025-03035-8", "pmid": "40281226", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 630, "title": "The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.", "authors": "Syed OA, Petranker R, Tsang B", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106204", "pubmed_id": "40348309", "openalex_id": "https://openalex.org/W4410237490", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40348309/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Wellbeing,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40348309", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40348309/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40348309", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40348309/", "doi": "10.1016/j.neubiorev.2025.106204", "pmid": "40348309", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 629, "title": "Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.", "authors": "Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD", "journal": "Psychiatry research", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116532", "pubmed_id": "40354769", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40354769/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Clinical Trial,Systematic Review,Review Article,Case Report", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40354769", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40354769/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40354769", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40354769/", "doi": "10.1016/j.psychres.2025.116532", "pmid": "40354769", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 626, "title": "5-HT receptors: Pharmacology and functional selectivity.", "authors": "Cummins BR, Billac GB, Nichols DE, Nichols CD", "journal": "Pharmacological reviews", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.pharmr.2025.100059", "pubmed_id": "40418878", "openalex_id": "https://openalex.org/W4409723793", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40418878/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40418878", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40418878/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40418878", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40418878/", "doi": "10.1016/j.pharmr.2025.100059", "pmid": "40418878", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 625, "title": "Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.", "authors": "Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L", "journal": "Molecular psychiatry", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1038/s41380-025-03066-1", "pubmed_id": "40481249", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40481249/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40481249", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40481249", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40481249/", "doi": "10.1038/s41380-025-03066-1", "pmid": "40481249", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 623, "title": "Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.", "authors": "Calnan M, Blest-Hopley G, Busch C, Adams M, Ruffell SGD, Piper T, Roseman L, Kettner H, Carhart-Harris R", "journal": "Brain and behavior", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1002/brb3.70660", "pubmed_id": "40619953", "openalex_id": "https://openalex.org/W4412096805", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40619953/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Veterans,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40619953", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40619953/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40619953", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40619953/", "doi": "10.1002/brb3.70660", "pmid": "40619953", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 618, "title": "Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.", "authors": "Hieronymus F, López E, Werin Sjögren H, Lundberg J", "journal": "JAMA network open", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1001/jamanetworkopen.2025.24119", "pubmed_id": "40736734", "openalex_id": "https://openalex.org/W4412738512", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40736734/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40736734", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40736734/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40736734", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40736734/", "doi": "10.1001/jamanetworkopen.2025.24119", "pmid": "40736734", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 617, "title": "Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-Position", "authors": "Brown Rodney, Hamilton Niall M., Mallon Connor, Stevenson James, Faley Michael T., Kargbo Robert B., Sherwood Alexander M., Upeandran Balasubramaniam", "journal": "Journal of Labelled Compounds and Radiopharmaceuticals", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1002/jlcr.4155", "pubmed_id": "40743107", "openalex_id": "https://openalex.org/W4412793773", "source_url": "https://doi.org/10.1002/jlcr.4155", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:40743107", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/jlcr.4155", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:40743107", "source_url": "https://doi.org/10.1002/jlcr.4155", "doi": "10.1002/jlcr.4155", "pmid": "40743107", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 644, "title": "Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.", "authors": "Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE", "journal": "Current oncology (Toronto, Ont.)", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.3390/curroncol32070380", "pubmed_id": "40710191", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40710191/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40710191", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40710191/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40710191", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40710191/", "doi": "10.3390/curroncol32070380", "pmid": "40710191", "publication_date": "2025-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4356, "title": "Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics", "authors": "Mathieu Fradet", "journal": "Psychoactives", "publication_date": "2025-06-29", "publication_year": 2025, "doi": "10.3390/psychoactives4030021", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411824807", "source_url": "https://doi.org/10.3390/psychoactives4030021", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030021", "source_url": "https://doi.org/10.3390/psychoactives4030021", "doi": "10.3390/psychoactives4030021", "pmid": "", "publication_date": "2025-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4358, "title": "Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease", "authors": "Nayiri Barton", "journal": "Global Journal of Medical Research", "publication_date": "2025-06-28", "publication_year": 2025, "doi": "10.34257/gjmravol25is1pg1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412955867", "source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Receptor Pharmacology,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.34257/gjmravol25is1pg1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34257/gjmravol25is1pg1", "source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "doi": "10.34257/gjmravol25is1pg1", "pmid": "", "publication_date": "2025-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4357, "title": "Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autism", "authors": "Paul Okugo Imoh, Aderonke Ajiboye, Tahir Kolawole Balogun, Amina Catherine Ijiga, Toyosi Motilola Olola, Emmanuel Oluwasayomi Ahmadu", "journal": "Magna Scientia Advanced Research and Reviews", "publication_date": "2025-06-28", "publication_year": 2025, "doi": "10.30574/msarr.2025.14.1.0079", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411744352", "source_url": "https://doi.org/10.30574/msarr.2025.14.1.0079", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.30574/msarr.2025.14.1.0079", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.30574/msarr.2025.14.1.0079", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.30574/msarr.2025.14.1.0079", "source_url": "https://doi.org/10.30574/msarr.2025.14.1.0079", "doi": "10.30574/msarr.2025.14.1.0079", "pmid": "", "publication_date": "2025-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 650, "title": "Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study.", "authors": "Koolen M, Wirsching A, Krediet E, van Elk M", "journal": "Journal of psychoactive drugs", "publication_date": "2025-06-23", "publication_year": 2025, "doi": "10.1080/02791072.2025.2508156", "pubmed_id": "40551401", "openalex_id": "https://openalex.org/W4411571625", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40551401/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Observational Study,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40551401", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40551401/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40551401", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40551401/", "doi": "10.1080/02791072.2025.2508156", "pmid": "40551401", "publication_date": "2025-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 652, "title": "Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.", "authors": "Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A", "journal": "ACS chemical neuroscience", "publication_date": "2025-06-18", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00152", "pubmed_id": "40474592", "openalex_id": "https://openalex.org/W4411103150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40474592/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40474592", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40474592/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40474592", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40474592/", "doi": "10.1021/acschemneuro.5c00152", "pmid": "40474592", "publication_date": "2025-06-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 654, "title": "Long-term benefits of single-dose psilocybin in depressed patients with cancer.", "authors": "Agrawal M, Roddy K, Jenkins B, Leeks C, Emanuel E", "journal": "Cancer", "publication_date": "2025-06-15", "publication_year": 2025, "doi": "10.1002/cncr.35889", "pubmed_id": "40518804", "openalex_id": "https://openalex.org/W4411327114", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518804/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40518804", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40518804/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40518804", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518804/", "doi": "10.1002/cncr.35889", "pmid": "40518804", "publication_date": "2025-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 656, "title": "Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.", "authors": "Erkizia-Santamaría I, Horrillo I, Martínez-Álvarez N, Pérez-Martínez D, Rivero G, Erdozain AM, Meana JJ, Ortega JE", "journal": "Translational psychiatry", "publication_date": "2025-06-14", "publication_year": 2025, "doi": "10.1038/s41398-025-03421-4", "pubmed_id": "40517150", "openalex_id": "https://openalex.org/W4411302754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40517150/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40517150", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40517150/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40517150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40517150/", "doi": "10.1038/s41398-025-03421-4", "pmid": "40517150", "publication_date": "2025-06-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 659, "title": "The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.", "authors": "Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL", "journal": "ACS pharmacology & translational science", "publication_date": "2025-06-13", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00208", "pubmed_id": "40534669", "openalex_id": "https://openalex.org/W4410859687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40534669/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40534669", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40534669/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40534669", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40534669/", "doi": "10.1021/acsptsci.5c00208", "pmid": "40534669", "publication_date": "2025-06-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4363, "title": "Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disorders", "authors": "Stephen Ross", "journal": "Psychedelics.", "publication_date": "2025-06-10", "publication_year": 2025, "doi": "10.61373/pp025k.0017", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411182514", "source_url": "https://doi.org/10.61373/pp025k.0017", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Adolescents,Cancer Patients,Genomics,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:20", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0017", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0017", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0017", "source_url": "https://doi.org/10.61373/pp025k.0017", "doi": "10.61373/pp025k.0017", "pmid": "", "publication_date": "2025-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4362, "title": "Is there mush-room to improve the environmental sustainability of psilocybin production?", "authors": "Luke Lanham, Alistair R. McTaggart, James R. Falconer", "journal": "Journal of CO2 Utilization", "publication_date": "2025-06-10", "publication_year": 2025, "doi": "10.1016/j.jcou.2025.103137", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411163945", "source_url": "https://doi.org/10.1016/j.jcou.2025.103137", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:20", "bibtex": null, "source_record_id": "DOI:10.1016/j.jcou.2025.103137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jcou.2025.103137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jcou.2025.103137", "source_url": "https://doi.org/10.1016/j.jcou.2025.103137", "doi": "10.1016/j.jcou.2025.103137", "pmid": "", "publication_date": "2025-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 665, "title": "Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice.", "authors": "Erkizia-Santamaría I, Martínez-Álvarez N, Salinas-Novoa L, Meana JJ, Ortega JE", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2025-06-06", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf035", "pubmed_id": "40413648", "openalex_id": "https://openalex.org/W4410718370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40413648/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,Drug Interactions", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40413648", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40413648/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40413648", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40413648/", "doi": "10.1093/ijnp/pyaf035", "pmid": "40413648", "publication_date": "2025-06-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3672, "title": "Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study", "authors": "Matthew Hicks", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06372197", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06372197", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "source_url": "https://clinicaltrials.gov/study/NCT06372197", "doi": "", "pmid": "", "publication_date": "2025-06-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3480, "title": "Optimizing Microdosing and Meditation", "authors": "National University of Natural Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06560658", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Microdosing,Wellbeing,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06560658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "source_url": "https://clinicaltrials.gov/study/NCT06560658", "doi": "", "pmid": "", "publication_date": "2025-06-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 668, "title": "Effects of Psilocybin on Mouse Brain Microstructure.", "authors": "Frautschi PC, Singh AP, Stowe NA, Grady SM, Zahid Z, Banks MI, Yu JJ", "journal": "AJNR. American journal of neuroradiology", "publication_date": "2025-06-03", "publication_year": 2025, "doi": "10.3174/ajnr.a8634", "pubmed_id": "39880687", "openalex_id": "https://openalex.org/W4406946828", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39880687/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:39880687", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39880687/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39880687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39880687/", "doi": "10.3174/ajnr.a8634", "pmid": "39880687", "publication_date": "2025-06-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 685, "title": "Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.", "authors": "Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A", "journal": "Psychopharmacology", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1007/s00213-024-06654-1", "pubmed_id": "39030424", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39030424/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:39030424", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39030424", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39030424/", "doi": "10.1007/s00213-024-06654-1", "pmid": "39030424", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 684, "title": "Psilocybin increases emotional empathy in patients with major depression.", "authors": "Jungwirth J, von Rotz R, Dziobek I, Vollenweider FX, Preller KH", "journal": "Molecular psychiatry", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1038/s41380-024-02875-0", "pubmed_id": "39695323", "openalex_id": "https://openalex.org/W4405510726", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39695323/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Healthy Volunteers,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:39695323", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39695323/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39695323", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39695323/", "doi": "10.1038/s41380-024-02875-0", "pmid": "39695323", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 681, "title": "Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.", "authors": "Becker AM, Humbert-Droz M, Mueller L, Jelušić A, Tolev A, Straumann I, Avedisian I, Erne L, Thomann J, Luethi D, Grünblatt E, Meyer Zu Schwabedissen H, Liechti ME", "journal": "Clinical pharmacology and therapeutics", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1002/cpt.3618", "pubmed_id": "40022427", "openalex_id": "https://openalex.org/W4408089698", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40022427/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40022427", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40022427/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40022427", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40022427/", "doi": "10.1002/cpt.3618", "pmid": "40022427", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 678, "title": "Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.", "authors": "Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH", "journal": "Expert opinion on emerging drugs", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1080/14728214.2025.2488786", "pubmed_id": "40178229", "openalex_id": "https://openalex.org/W4409148237", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40178229/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40178229", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40178229/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40178229", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40178229/", "doi": "10.1080/14728214.2025.2488786", "pmid": "40178229", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 671, "title": "There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.", "authors": "Fonzo GA, Doss MK, Nemeroff CB", "journal": "The American journal of psychiatry", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20250247", "pubmed_id": "40450555", "openalex_id": "https://openalex.org/W4410925857", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40450555/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40450555", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40450555", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40450555/", "doi": "10.1176/appi.ajp.20250247", "pmid": "40450555", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 669, "title": "Characterization and Identification of an Antimicrobial Compound Psilocybin from Psychedelic Mushroom.", "authors": "Karthiyayini B, Kalyani NN, Gowdhami B, Muthuselvam M, Dharumadurai D", "journal": "Indian journal of microbiology", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1007/s12088-024-01396-2", "pubmed_id": "40655360", "openalex_id": "https://openalex.org/W4403366793", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40655360/", "substance_tags": "psilocybin", "topic_tags": "Depression,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40655360", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40655360/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40655360", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40655360/", "doi": "10.1007/s12088-024-01396-2", "pmid": "40655360", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 649, "title": "The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.", "authors": "Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S", "journal": "Cureus", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.7759/cureus.86659", "pubmed_id": "40718283", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40718283/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Clinical Trial,Review Article,In Vitro Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40718283", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40718283/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40718283", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40718283/", "doi": "10.7759/cureus.86659", "pmid": "40718283", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3081, "title": "Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin", "authors": "Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P.", "journal": "bioRxiv", "publication_date": "2025-05-30", "publication_year": 2025, "doi": "10.1101/2025.05.26.655791", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.05.26.655791", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Microdosing,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:56", "bibtex": null, "source_record_id": "DOI:10.1101/2025.05.26.655791", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.05.26.655791", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.05.26.655791", "source_url": "https://doi.org/10.1101/2025.05.26.655791", "doi": "10.1101/2025.05.26.655791", "pmid": "", "publication_date": "2025-05-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 688, "title": "Patients' Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment.", "authors": "Abboud A, Schiebrel C, Nahhas RW, Durkin S, Hua K, Redding H, Gainer D", "journal": "Journal of psychoactive drugs", "publication_date": "2025-05-29", "publication_year": 2025, "doi": "10.1080/02791072.2025.2511752", "pubmed_id": "40443112", "openalex_id": "https://openalex.org/W4410874041", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40443112/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Personality Change,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40443112", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40443112/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40443112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40443112/", "doi": "10.1080/02791072.2025.2511752", "pmid": "40443112", "publication_date": "2025-05-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3708, "title": "Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2025-05-28", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06796361", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Consciousness,Personality Change,Spirituality,Healthy Volunteers", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06796361", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06796361", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06796361", "source_url": "https://clinicaltrials.gov/study/NCT06796361", "doi": "", "pmid": "", "publication_date": "2025-05-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 689, "title": "The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.", "authors": "Palmer C, Ferber AT, Greenwald BD", "journal": "Brain sciences", "publication_date": "2025-05-26", "publication_year": 2025, "doi": "10.3390/brainsci15060572", "pubmed_id": "40563744", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40563744/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Clinical Trial,Review Article,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40563744", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40563744/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40563744", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40563744/", "doi": "10.3390/brainsci15060572", "pmid": "40563744", "publication_date": "2025-05-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3747, "title": "Age and cannabis co-use moderate experience and perceived benefits of psilocybin", "authors": "Hooper J, Williams S, Mueller R, Hutchison K.", "journal": "PsyArXiv", "publication_date": "2025-05-22", "publication_year": 2025, "doi": "10.31234/osf.io/dczw2_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/dczw2_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Mystical Experience,Older Adults", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-08-09 08:14:57", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/dczw2_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/dczw2_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/dczw2_v1", "source_url": "https://doi.org/10.31234/osf.io/dczw2_v1", "doi": "10.31234/osf.io/dczw2_v1", "pmid": "", "publication_date": "2025-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3090, "title": "Age and cannabis co-use moderate experience and perceived benefits of psilocybin", "authors": "Jake Hooper, Sarah Williams, Raeghan Mueller, Kent Hutchison", "journal": "PsyArXiv", "publication_date": "2025-05-22", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dczw2_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Aging,Mystical Experience,Older Adults", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dczw2_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dczw2_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dczw2_v1", "source_url": "https://osf.io/preprints/psyarxiv/dczw2_v1", "doi": "", "pmid": "", "publication_date": "2025-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 693, "title": "In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes.", "authors": "Schäfer T, Sherwood A, Kirkland T, Krüger T, Worbs J, Kniemeyer O, Gressler M, Hoffmeister D", "journal": "Chemistry (Weinheim an der Bergstrasse, Germany)", "publication_date": "2025-05-22", "publication_year": 2025, "doi": "10.1002/chem.202501037", "pubmed_id": "40202903", "openalex_id": "https://openalex.org/W4409288174", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40202903/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40202903", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40202903/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40202903", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40202903/", "doi": "10.1002/chem.202501037", "pmid": "40202903", "publication_date": "2025-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3762, "title": "Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments", "authors": "Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C.", "journal": "PsyArXiv", "publication_date": "2025-05-16", "publication_year": 2025, "doi": "10.31234/osf.io/6hjkm_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:08", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/6hjkm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/6hjkm_v1", "source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "doi": "10.31234/osf.io/6hjkm_v1", "pmid": "", "publication_date": "2025-05-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3183, "title": "Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments", "authors": "Lukas A. Basedow, Lynn Lottes, Irina Falkenberg, Christoph Vogelbacher, Cüneyt Yildiz", "journal": "PsyArXiv", "publication_date": "2025-05-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "doi": "", "pmid": "", "publication_date": "2025-05-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3694, "title": "Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder", "authors": "Icahn School of Medicine at Mount Sinai", "journal": "ClinicalTrials.gov", "publication_date": "2025-05-14", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06592833", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06592833", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06592833", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06592833", "source_url": "https://clinicaltrials.gov/study/NCT06592833", "doi": "", "pmid": "", "publication_date": "2025-05-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4374, "title": "Psychedelic-assisted psychotherapy and its potential to manage demoralization: A brief exploration of an alternative approach to end of life care", "authors": "Ong Jennifer A.", "journal": "Advances in Complementary and Integrative Medicine", "publication_date": "2025-05-07", "publication_year": 2025, "doi": "10.70462/acim.2025.1.001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4410178457", "source_url": "https://doi.org/10.70462/acim.2025.1.001", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,End-of-Life Distress,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:34:58", "bibtex": null, "source_record_id": "DOI:10.70462/acim.2025.1.001", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.70462/acim.2025.1.001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.70462/acim.2025.1.001", "source_url": "https://doi.org/10.70462/acim.2025.1.001", "doi": "10.70462/acim.2025.1.001", "pmid": "", "publication_date": "2025-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 702, "title": "Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.", "authors": "Wang H, Wang X", "journal": "ACS chemical neuroscience", "publication_date": "2025-05-07", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00247", "pubmed_id": "40254808", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40254808/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Default Mode Network,Aging,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40254808", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40254808/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40254808", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40254808/", "doi": "10.1021/acschemneuro.5c00247", "pmid": "40254808", "publication_date": "2025-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4375, "title": "Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeed", "authors": "Michael A. Wheeler", "journal": "Psychedelics.", "publication_date": "2025-05-06", "publication_year": 2025, "doi": "10.61373/pp025k.0011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4410121503", "source_url": "https://doi.org/10.61373/pp025k.0011", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Genomics,Inflammation,Immune Function", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:20", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0011", "source_url": "https://doi.org/10.61373/pp025k.0011", "doi": "10.61373/pp025k.0011", "pmid": "", "publication_date": "2025-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3088, "title": "Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats", "authors": "Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y.", "journal": "Research Square", "publication_date": "2025-05-06", "publication_year": 2025, "doi": "10.21203/rs.3.rs-5493661/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-5493661/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Animal Study,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:56", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-5493661/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-5493661/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-5493661/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-5493661/v1", "doi": "10.21203/rs.3.rs-5493661/v1", "pmid": "", "publication_date": "2025-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4376, "title": "Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contexts", "authors": "Hannes Kettner", "journal": "Open MIND", "publication_date": "2025-05-04", "publication_year": 2025, "doi": "10.25560/125300", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124428185", "source_url": "https://hdl.handle.net/10044/1/125300", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Aging,Wellbeing,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:20", "bibtex": null, "source_record_id": "DOI:10.25560/125300", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/10044/1/125300", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25560/125300", "source_url": "https://hdl.handle.net/10044/1/125300", "doi": "10.25560/125300", "pmid": "", "publication_date": "2025-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4378, "title": "Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung", "authors": "Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther", "journal": "Nervenheilkunde", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1055/a-2517-1621", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409999287", "source_url": "https://doi.org/10.1055/a-2517-1621", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.1055/a-2517-1621", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2517-1621", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2517-1621", "source_url": "https://doi.org/10.1055/a-2517-1621", "doi": "10.1055/a-2517-1621", "pmid": "", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 724, "title": "Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.", "authors": "Menon V, Ramamurthy P, Venu S, Andrade C", "journal": "Acta psychiatrica Scandinavica", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1111/acps.13778", "pubmed_id": "39627679", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39627679/", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39627679", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39627679/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39627679", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39627679/", "doi": "10.1111/acps.13778", "pmid": "39627679", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 722, "title": "Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.", "authors": "Liebnau J, Betzler F, Kerber A", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1177/02698811241312866", "pubmed_id": "39829391", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39829391/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39829391", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39829391/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39829391", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39829391/", "doi": "10.1177/02698811241312866", "pmid": "39829391", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 713, "title": "Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges.", "authors": "Ghaznavi S, Richter SG", "journal": "Drugs", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1007/s40265-025-02172-2", "pubmed_id": "40128500", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40128500/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40128500", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40128500/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40128500", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40128500/", "doi": "10.1007/s40265-025-02172-2", "pmid": "40128500", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 708, "title": "Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.", "authors": "Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1038/s41386-025-02091-6", "pubmed_id": "40258990", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40258990/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40258990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40258990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40258990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40258990/", "doi": "10.1038/s41386-025-02091-6", "pmid": "40258990", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 706, "title": "Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.", "authors": "Weintraub MJ, Miklowitz DJ, Jeffrey JK", "journal": "Journal of psychiatric practice", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1097/pra.0000000000000853", "pubmed_id": "40440674", "openalex_id": "https://openalex.org/W4410847086", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440674/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40440674", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40440674/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40440674", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440674/", "doi": "10.1097/pra.0000000000000853", "pmid": "40440674", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 705, "title": "From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.", "authors": "Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK", "journal": "Expert review of clinical pharmacology", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1080/17512433.2025.2515866", "pubmed_id": "40470809", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40470809/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Spirituality,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40470809", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40470809/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40470809", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40470809/", "doi": "10.1080/17512433.2025.2515866", "pmid": "40470809", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 696, "title": "Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?", "authors": "Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR", "journal": "Neurobiology of stress", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1016/j.ynstr.2025.100732", "pubmed_id": "40496249", "openalex_id": "https://openalex.org/W4410487155", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40496249/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Microbiome,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40496249", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40496249/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40496249", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40496249/", "doi": "10.1016/j.ynstr.2025.100732", "pmid": "40496249", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4382, "title": "The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review", "authors": "Sevander Saara Susan, Rissanen Marja-Liisa Susan", "journal": "Health, environment and sustainable development: interdisciplinary approach", "publication_date": "2025-04-30", "publication_year": 2025, "doi": "10.59476/hesdia.v0i1.700", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411419984", "source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:34:58", "bibtex": null, "source_record_id": "DOI:10.59476/hesdia.v0i1.700", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.59476/hesdia.v0i1.700", "source_url": "https://doi.org/10.59476/hesdia.v0i1.700", "doi": "10.59476/hesdia.v0i1.700", "pmid": "", "publication_date": "2025-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4380, "title": "0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart Study", "authors": "Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Ranya Marrakchi El Fellah, Kylee Krivijanski, Albert Garcia-Romeu, Winston De La Haye, Clarence Locklear, Girardin Jean-Louis", "journal": "SLEEP", "publication_date": "2025-04-30", "publication_year": 2025, "doi": "10.1093/sleep/zsaf090.0391", "pubmed_id": null, "openalex_id": "https://openalex.org/W4410502978", "source_url": "https://doi.org/10.1093/sleep/zsaf090.0391", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/sleep/zsaf090.0391", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/sleep/zsaf090.0391", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/sleep/zsaf090.0391", "source_url": "https://doi.org/10.1093/sleep/zsaf090.0391", "doi": "10.1093/sleep/zsaf090.0391", "pmid": "", "publication_date": "2025-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 732, "title": "[Treatment with psychedelics: potential benefits in Parkinson's disease].", "authors": "Penzenstadler L, Baudois S, Lingenberg A, Catalano Chiuvé S, Tomkova E, Fleury V", "journal": "Revue medicale suisse", "publication_date": "2025-04-23", "publication_year": 2025, "doi": "10.53738/revmed.2025.21.915.47180", "pubmed_id": "40275842", "openalex_id": "https://openalex.org/W4409833807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40275842", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40275842", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842/", "doi": "10.53738/revmed.2025.21.915.47180", "pmid": "40275842", "publication_date": "2025-04-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4391, "title": "Regulatory Challenges of Integrating Psychedelics into Mental Health Sector", "authors": "Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Lusher", "journal": "Psychoactives", "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.3390/psychoactives4020011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409667310", "source_url": "https://doi.org/10.3390/psychoactives4020011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4020011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4020011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4020011", "source_url": "https://doi.org/10.3390/psychoactives4020011", "doi": "10.3390/psychoactives4020011", "pmid": "", "publication_date": "2025-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 734, "title": "Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.", "authors": "Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD", "journal": "Palliative & supportive care", "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.1017/s147895152500032x", "pubmed_id": "40259688", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40259688/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40259688", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40259688/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40259688", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40259688/", "doi": "10.1017/s147895152500032x", "pmid": "40259688", "publication_date": "2025-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3465, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia", "authors": "Kevin Boehnke", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05128162", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05128162", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "source_url": "https://clinicaltrials.gov/study/NCT05128162", "doi": "", "pmid": "", "publication_date": "2025-04-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 739, "title": "Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.", "authors": "Beesley VL, Kennedy TJ, Maccallum F, Ross M, Harvey R, Rossell SL, Sarris J, Perkins D, Neale RE, Bennett-Levy J, Johnson S, Beebe H, Roset N, Strobel J, Parker S", "journal": "BMJ open", "publication_date": "2025-04-15", "publication_year": 2025, "doi": "10.1136/bmjopen-2024-095992", "pubmed_id": "40233965", "openalex_id": "https://openalex.org/W4409449177", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40233965/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Psychological Flexibility,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40233965", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40233965/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40233965", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40233965/", "doi": "10.1136/bmjopen-2024-095992", "pmid": "40233965", "publication_date": "2025-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4401, "title": "194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy", "authors": "Orly Lipsitz, Joshua D. Rosenblat", "journal": "Biological Psychiatry", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.431", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409281338", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.431", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.431", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.431", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.431", "doi": "10.1016/j.biopsych.2025.02.431", "pmid": "", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4400, "title": "187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant Depression", "authors": "Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat", "journal": "Biological Psychiatry", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.424", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409281325", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.424", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.424", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.424", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.424", "doi": "10.1016/j.biopsych.2025.02.424", "pmid": "", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4399, "title": "186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted Psychotherapy", "authors": "Danica E. Johnson, Erica Kaczmarek, Noah Chisamore, Orly Lipitz, Zoe Doyle, Rodrigo B. Mansur, Roger S. McIntyre, Joshua D. Rosenblat", "journal": "Biological Psychiatry", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.423", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409281322", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.423", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.423", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.423", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.423", "doi": "10.1016/j.biopsych.2025.02.423", "pmid": "", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4397, "title": "166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant Depression", "authors": "Xue Zhang, Emily Zhai, Claire Bertrand, Sara Ellis, Isabelle Wydler, Anna J. Donnelly, Trisha Suppes, Leanne M. Williams", "journal": "Biological Psychiatry", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.403", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409280673", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.403", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.403", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.403", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.403", "doi": "10.1016/j.biopsych.2025.02.403", "pmid": "", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3446, "title": "Psilocybin-assisted Interpersonal Therapy for Depression", "authors": "University of Otago", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-09", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05581797", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05581797", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05581797", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05581797", "source_url": "https://clinicaltrials.gov/study/NCT05581797", "doi": "", "pmid": "", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 745, "title": "The Emergence of Psilocybin in Psychiatry and Neuroscience.", "authors": "Omidian H, Omidian A", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.3390/ph18040555", "pubmed_id": "40283990", "openalex_id": "https://openalex.org/W4409313347", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40283990/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40283990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40283990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40283990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40283990/", "doi": "10.3390/ph18040555", "pmid": "40283990", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 744, "title": "A multi-institutional investigation of psilocybin's effects on mouse behavior.", "authors": "Lu OD, White K, Raymond K, Liu C, Klein AS, Green N, Vaillancourt S, Gallagher A, Shindy L, Li A, Wallquist K, Li R, Zou M, Casey AB, Cameron LP, Pomrenze MB, Sohal V, Kheirbek MA, Gomez AM, Lammel S, Heifets BD, Malenka R", "journal": "bioRxiv: the preprint server for biology", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1101/2025.04.08.647810", "pubmed_id": "40291657", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40291657/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40291657", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40291657/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40291657", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40291657/", "doi": "10.1101/2025.04.08.647810", "pmid": "40291657", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4404, "title": "Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization", "authors": "Jennifer Jones", "journal": "Frontiers in Psychiatry", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1565852", "pubmed_id": "40264517", "openalex_id": "https://openalex.org/W4409274889", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Animal Study,Veterans,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "PMID:40264517", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40264517", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "doi": "10.3389/fpsyt.2025.1565852", "pmid": "40264517", "publication_date": "2025-04-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 750, "title": "Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.", "authors": "Kurkova V, Winkler O, Greenshaw A, Jetly R, Swainson J, Lodewyk K, Saghafi P, Dennett E, Burback L", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-04-02", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111333", "pubmed_id": "40113127", "openalex_id": "https://openalex.org/W4408579473", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40113127/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Personality Change,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40113127", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40113127/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40113127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40113127/", "doi": "10.1016/j.pnpbp.2025.111333", "pmid": "40113127", "publication_date": "2025-04-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 749, "title": "The effect of low-dose psilocybin on brain neurotransmission and rat behavior.", "authors": "Bysiek A, Wojtas A, Szpręgiel I, Wawrzczak-Bargieła A, Maćkowiak M, Gołembiowska K", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-04-02", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111347", "pubmed_id": "40157708", "openalex_id": "https://openalex.org/W4408958491", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40157708/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40157708", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40157708/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40157708", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40157708/", "doi": "10.1016/j.pnpbp.2025.111347", "pmid": "40157708", "publication_date": "2025-04-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4408, "title": "Minorities’ diminished psychedelic returns: Depression, suicide, distress, and serious mental illness", "authors": "Sean M. Viña", "journal": "Drug Science Policy and Law", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1177/20503245251337357", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409677856", "source_url": "https://doi.org/10.1177/20503245251337357", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.1177/20503245251337357", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245251337357", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245251337357", "source_url": "https://doi.org/10.1177/20503245251337357", "doi": "10.1177/20503245251337357", "pmid": "", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 761, "title": "Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.", "authors": "Sutherland I, Ho MF, Croarkin PE", "journal": "Journal of child and adolescent psychopharmacology", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1089/cap.2024.0082", "pubmed_id": "39761065", "openalex_id": "https://openalex.org/W4406088503", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39761065/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39761065", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39761065/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39761065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39761065/", "doi": "10.1089/cap.2024.0082", "pmid": "39761065", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 760, "title": "Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation.", "authors": "Irrmischer M, Puxty D, Yıldırım BO, Deijen JB, Engelbregt H", "journal": "Psychopharmacology", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1007/s00213-024-06733-3", "pubmed_id": "39775022", "openalex_id": "https://openalex.org/W4406141686", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39775022/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Personality Change,Emotional Processing,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39775022", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39775022/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39775022", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39775022/", "doi": "10.1007/s00213-024-06733-3", "pmid": "39775022", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 756, "title": "Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.", "authors": "Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY", "journal": "Advanced science (Weinheim, Baden-Wurttemberg, Germany)", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1002/advs.202413786", "pubmed_id": "40112231", "openalex_id": "https://openalex.org/W4408724900", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40112231/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Epigenetics,Review Article,Transcriptomics,Microbiome", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40112231", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40112231/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40112231", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40112231/", "doi": "10.1002/advs.202413786", "pmid": "40112231", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 752, "title": "De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli.", "authors": "Huang Z, Yao Y, Di R, Zhang J, Pan Y, Liu G", "journal": "Microbial biotechnology", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1111/1751-7915.70135", "pubmed_id": "40177917", "openalex_id": "https://openalex.org/W4409148851", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40177917/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Mechanism of Action,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40177917", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40177917/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40177917", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40177917/", "doi": "10.1111/1751-7915.70135", "pmid": "40177917", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 751, "title": "From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence-Based Policy and Practice.", "authors": "Schenberg EE", "journal": "Pharmacology research & perspectives", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1002/prp2.70097", "pubmed_id": "40230191", "openalex_id": "https://openalex.org/W4409463726", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40230191/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40230191", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40230191/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40230191", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40230191/", "doi": "10.1002/prp2.70097", "pmid": "40230191", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 737, "title": "Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.", "authors": "Mimms C, Sotelo K, Khaliq AS", "journal": "Cureus", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.7759/cureus.82532", "pubmed_id": "40385821", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40385821/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40385821", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40385821/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40385821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40385821/", "doi": "10.7759/cureus.82532", "pmid": "40385821", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3783, "title": "Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2025-03-27", "publication_year": 2025, "doi": "10.31234/osf.io/mzkyv_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/mzkyv_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-08-09 08:15:22", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/mzkyv_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/mzkyv_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/mzkyv_v1", "source_url": "https://doi.org/10.31234/osf.io/mzkyv_v1", "doi": "10.31234/osf.io/mzkyv_v1", "pmid": "", "publication_date": "2025-03-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3308, "title": "Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community", "authors": "Mika Turkia", "journal": "PsyArXiv", "publication_date": "2025-03-27", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Personality Change,Emotional Processing,Spirituality", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "source_url": "https://osf.io/preprints/psyarxiv/mzkyv_v1", "doi": "", "pmid": "", "publication_date": "2025-03-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 772, "title": "Structural basis for psilocybin biosynthesis.", "authors": "Meng C, Guo W, Xiao C, Wen Y, Zhu X, Zhang Q, Liang Y, Li H, Xu S, Qiu Y, Chen H, Lin WJ, Wu B", "journal": "Nature communications", "publication_date": "2025-03-22", "publication_year": 2025, "doi": "10.1038/s41467-025-58239-x", "pubmed_id": "40121242", "openalex_id": "https://openalex.org/W4408739043", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40121242/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40121242", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40121242/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40121242", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40121242/", "doi": "10.1038/s41467-025-58239-x", "pmid": "40121242", "publication_date": "2025-03-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3104, "title": "The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial", "authors": "Henry J, Giribaldi B, Nutt DJ, Erritzoe D, Carhart-Harris R, Lyons T.", "journal": "medRxiv", "publication_date": "2025-03-21", "publication_year": 2025, "doi": "10.1101/2025.03.17.25324123", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.03.17.25324123", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:58", "bibtex": null, "source_record_id": "DOI:10.1101/2025.03.17.25324123", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.03.17.25324123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.03.17.25324123", "source_url": "https://doi.org/10.1101/2025.03.17.25324123", "doi": "10.1101/2025.03.17.25324123", "pmid": "", "publication_date": "2025-03-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 773, "title": "Is there a place for psychedelics in sports practice?", "authors": "Portes MAM, Werle I, Bertoglio LJ", "journal": "Acta neuropsychiatrica", "publication_date": "2025-03-21", "publication_year": 2025, "doi": "10.1017/neu.2025.13", "pubmed_id": "40116762", "openalex_id": "https://openalex.org/W4408692899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40116762/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Neuroplasticity,Pharmacology,Receptor Pharmacology,Resilience,Animal Study,Inflammation", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40116762", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40116762/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40116762", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40116762/", "doi": "10.1017/neu.2025.13", "pmid": "40116762", "publication_date": "2025-03-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 775, "title": "Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.", "authors": "de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-03-20", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111278", "pubmed_id": "39892847", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39892847/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Drug Interactions,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:39892847", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39892847/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39892847", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39892847/", "doi": "10.1016/j.pnpbp.2025.111278", "pmid": "39892847", "publication_date": "2025-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3457, "title": "Psilocybin in Alcohol Use Disorder With Comorbid Depression", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06235411", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Observational Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06235411", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "source_url": "https://clinicaltrials.gov/study/NCT06235411", "doi": "", "pmid": "", "publication_date": "2025-03-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3530, "title": "A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05163496", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05163496", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05163496", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05163496", "source_url": "https://clinicaltrials.gov/study/NCT05163496", "doi": "", "pmid": "", "publication_date": "2025-03-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 781, "title": "Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.", "authors": "Meyer TD, Ibrahim M, Vale LN, Soares JC", "journal": "Journal of affective disorders", "publication_date": "2025-03-15", "publication_year": 2025, "doi": "10.1016/j.jad.2024.12.044", "pubmed_id": "39675677", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39675677/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:39675677", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39675677/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39675677", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39675677/", "doi": "10.1016/j.jad.2024.12.044", "pmid": "39675677", "publication_date": "2025-03-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 780, "title": "Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner.", "authors": "Farinha-Ferreira M, Miranda-Lourenço C, Galipeau C, Lenkei Z, Sebastião AM", "journal": "Neuropharmacology", "publication_date": "2025-03-15", "publication_year": 2025, "doi": "10.1016/j.neuropharm.2024.110280", "pubmed_id": "39725123", "openalex_id": "https://openalex.org/W4405738640", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39725123/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study,Animal Study,Drug Interactions", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:39725123", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39725123/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39725123", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39725123/", "doi": "10.1016/j.neuropharm.2024.110280", "pmid": "39725123", "publication_date": "2025-03-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 779, "title": "Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin.", "authors": "Gattuso JJ, Wilson C, Li S, Hannan AJ, Renoir T", "journal": "European journal of pharmacology", "publication_date": "2025-03-15", "publication_year": 2025, "doi": "10.1016/j.ejphar.2025.177304", "pubmed_id": "39864573", "openalex_id": "https://openalex.org/W4406874124", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39864573/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:39864573", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39864573/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39864573", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39864573/", "doi": "10.1016/j.ejphar.2025.177304", "pmid": "39864573", "publication_date": "2025-03-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4426, "title": "The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?", "authors": "Valentin Yurievich Skryabin", "journal": "Neurology Bulletin", "publication_date": "2025-03-14", "publication_year": 2025, "doi": "10.17816/nb639991", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408435134", "source_url": "https://doi.org/10.17816/nb639991", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.17816/nb639991", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17816/nb639991", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17816/nb639991", "source_url": "https://doi.org/10.17816/nb639991", "doi": "10.17816/nb639991", "pmid": "", "publication_date": "2025-03-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 783, "title": "Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation.", "authors": "Bobak L, Dorney I, Kovacevich A, Barnett BS", "journal": "Journal of psychoactive drugs", "publication_date": "2025-03-14", "publication_year": 2025, "doi": "10.1080/02791072.2025.2478097", "pubmed_id": "40084630", "openalex_id": "https://openalex.org/W4408456788", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40084630/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40084630", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40084630/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40084630", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40084630/", "doi": "10.1080/02791072.2025.2478097", "pmid": "40084630", "publication_date": "2025-03-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3649, "title": "Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety", "authors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-13", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00302744", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Consciousness,Spirituality,Cancer Patients", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00302744", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00302744", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00302744", "source_url": "https://clinicaltrials.gov/study/NCT00302744", "doi": "", "pmid": "", "publication_date": "2025-03-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4430, "title": "PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS", "authors": "Dr Hafiz Shafique Ahmad, Muhammad Waqar Ali, Usman Ul Haq", "journal": "Journal of medical & health sciences review.", "publication_date": "2025-03-11", "publication_year": 2025, "doi": "10.62019/r713mw08", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408376371", "source_url": "https://doi.org/10.62019/r713mw08", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.62019/r713mw08", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.62019/r713mw08", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.62019/r713mw08", "source_url": "https://doi.org/10.62019/r713mw08", "doi": "10.62019/r713mw08", "pmid": "", "publication_date": "2025-03-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3116, "title": "Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression", "authors": "Quah S, Glick C, Roseman L, Pasquini L, Carhart-Harris R, Saggar M.", "journal": "bioRxiv", "publication_date": "2025-03-10", "publication_year": 2025, "doi": "10.1101/2025.03.05.641592", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.03.05.641592", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Drug Interactions", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:15:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.03.05.641592", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.03.05.641592", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.03.05.641592", "source_url": "https://doi.org/10.1101/2025.03.05.641592", "doi": "10.1101/2025.03.05.641592", "pmid": "", "publication_date": "2025-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4431, "title": "Risks of using psilocybin in treatment of treatment-resistant depression", "authors": "Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Katarzyna Kalinowska", "journal": "Journal of Education Health and Sport", "publication_date": "2025-03-06", "publication_year": 2025, "doi": "10.12775/jehs.2025.79.58319", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408197223", "source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2025.79.58319", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2025.79.58319", "source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "doi": "10.12775/jehs.2025.79.58319", "pmid": "", "publication_date": "2025-03-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3666, "title": "Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05523401", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05523401", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "source_url": "https://clinicaltrials.gov/study/NCT05523401", "doi": "", "pmid": "", "publication_date": "2025-03-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 788, "title": "Further education in psychedelic-assisted therapy - experiences from Switzerland.", "authors": "Aicher HD, Müller F, Gasser P", "journal": "BMC medical education", "publication_date": "2025-03-05", "publication_year": 2025, "doi": "10.1186/s12909-025-06871-y", "pubmed_id": "40045361", "openalex_id": "https://openalex.org/W4408219591", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40045361/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Consciousness,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40045361", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40045361/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40045361", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40045361/", "doi": "10.1186/s12909-025-06871-y", "pmid": "40045361", "publication_date": "2025-03-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4433, "title": "Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?", "authors": "Craig, Danny R, Blalock, Eric M.", "journal": "UKnowledge (University of Kentucky)", "publication_date": "2025-03-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110662772", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Cellular Senescence,Resilience,Clinical Trial,Randomized Controlled Trial,Animal Study,Older Adults,Adolescents,Treatment-Resistant Depression,Safety,Drug Interactions,Transcriptomics,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "doi": "", "pmid": "", "publication_date": "2025-03-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 792, "title": "Psychedelic-assisted therapy: An overview for the internist.", "authors": "Barnett BS, Mauney EE, King F", "journal": "Cleveland Clinic journal of medicine", "publication_date": "2025-03-03", "publication_year": 2025, "doi": "10.3949/ccjm.92a.24032", "pubmed_id": "40032306", "openalex_id": "https://openalex.org/W4408107853", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40032306/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40032306", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40032306/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40032306", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40032306/", "doi": "10.3949/ccjm.92a.24032", "pmid": "40032306", "publication_date": "2025-03-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 790, "title": "Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.", "authors": "Goodwin GM, Nowakowska A, Atli M, Dunlop BW, Feifel D, Hellerstein DJ, Marwood L, Shabir Z, Mistry S, Stansfield SC, Teoh E, Tsai J, Young MB, Malievskaia E", "journal": "The Journal of clinical psychiatry", "publication_date": "2025-03-03", "publication_year": 2025, "doi": "10.4088/jcp.24m15449", "pubmed_id": "40047545", "openalex_id": "https://openalex.org/W4408151066", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047545/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Observational Study,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40047545", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40047545/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40047545", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047545/", "doi": "10.4088/jcp.24m15449", "pmid": "40047545", "publication_date": "2025-03-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 811, "title": "Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.", "authors": "Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M", "journal": "Molecular psychiatry", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1038/s41380-024-02800-5", "pubmed_id": "39592825", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39592825/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39592825", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39592825/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39592825", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39592825/", "doi": "10.1038/s41380-024-02800-5", "pmid": "39592825", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 810, "title": "Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.", "authors": "Høgsted ES, Beliveau V, Ozenne B, Madsen MK, Svarer C, Dam VH, Johansen A, Fisher P, Knudsen GM, Frokjaer VG, Sankar A", "journal": "The British journal of psychiatry: the journal of mental science", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1192/bjp.2024.143", "pubmed_id": "39632615", "openalex_id": "https://openalex.org/W4405084592", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39632615/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Personality Change,Observational Study,Healthy Volunteers,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:39632615", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39632615/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39632615", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39632615/", "doi": "10.1192/bjp.2024.143", "pmid": "39632615", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 809, "title": "Treatment Expectancies and Psilocybin vs Escitalopram for Depression.", "authors": "Dutcher EG, Krystal AD", "journal": "JAMA psychiatry", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1001/jamapsychiatry.2024.4387", "pubmed_id": "39653344", "openalex_id": "https://openalex.org/W4405172984", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39653344/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:39653344", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39653344/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39653344", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39653344/", "doi": "10.1001/jamapsychiatry.2024.4387", "pmid": "39653344", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 808, "title": "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E", "journal": "Journal of affective disorders", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1016/j.jad.2024.12.061", "pubmed_id": "39706482", "openalex_id": "https://openalex.org/W4405528804", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39706482/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Consciousness,Emotional Processing,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:39706482", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39706482/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39706482", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39706482/", "doi": "10.1016/j.jad.2024.12.061", "pmid": "39706482", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 802, "title": "Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report.", "authors": "Fleury V, Tomkova E, Catalano Chiuvé S, Penzenstadler L", "journal": "Journal of Parkinson's disease", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1177/1877718x241312604", "pubmed_id": "39973494", "openalex_id": "https://openalex.org/W4407078896", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39973494/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Resilience,Emotional Processing,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:39973494", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39973494/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39973494", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39973494/", "doi": "10.1177/1877718x241312604", "pmid": "39973494", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 800, "title": "Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons.", "authors": "Petrušková A, Guhathakurta D, Akdaş EY, Perelló-Amorós B, Frischknecht R, Weiss EM, Páleníček T, Fejtová A", "journal": "Journal of neurochemistry", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1111/jnc.70020", "pubmed_id": "40022486", "openalex_id": "https://openalex.org/W4408089796", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40022486/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Neuroplasticity,Brain Imaging,Mechanism of Action,Aging,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40022486", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40022486/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40022486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40022486/", "doi": "10.1111/jnc.70020", "pmid": "40022486", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 798, "title": "Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment.", "authors": "Somers M, Scheepers FE", "journal": "The American journal of psychiatry", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20240121", "pubmed_id": "40022534", "openalex_id": "https://openalex.org/W4408073069", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40022534/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40022534", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40022534", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40022534/", "doi": "10.1176/appi.ajp.20240121", "pmid": "40022534", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 797, "title": "Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.", "authors": "Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB", "journal": "Cancer medicine", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1002/cam4.70586", "pubmed_id": "40052631", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40052631/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40052631", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40052631/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40052631", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40052631/", "doi": "10.1002/cam4.70586", "pmid": "40052631", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 794, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.", "authors": "Meshkat S, Kaczmarek E, Doyle Z, Brudner RM, Gomes FA, Blainey MG, Weiglein G, McIntyre RS, Mansur RB, Rosenblat JD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1089/psymed.2024.0032", "pubmed_id": "40337756", "openalex_id": "https://openalex.org/W4404460385", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337756/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40337756", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40337756/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40337756", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337756/", "doi": "10.1089/psymed.2024.0032", "pmid": "40337756", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 778, "title": "A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.", "authors": "Dino F", "journal": "Cureus", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.7759/cureus.80707", "pubmed_id": "40242672", "openalex_id": "https://openalex.org/W4408529433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40242672/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions,Contraindications", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40242672", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40242672/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40242672", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40242672/", "doi": "10.7759/cureus.80707", "pmid": "40242672", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 771, "title": "Anhedonia: Current and future treatments.", "authors": "Serretti A", "journal": "PCN reports: psychiatry and clinical neurosciences", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1002/pcn5.70088", "pubmed_id": "40129874", "openalex_id": "https://openalex.org/W4408766037", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40129874/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40129874", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40129874/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40129874", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40129874/", "doi": "10.1002/pcn5.70088", "pmid": "40129874", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3764, "title": "Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample", "authors": "Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H.", "journal": "PsyArXiv", "publication_date": "2025-02-28", "publication_year": 2025, "doi": "10.31234/osf.io/26tz7_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/26tz7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/26tz7_v1", "source_url": "https://doi.org/10.31234/osf.io/26tz7_v1", "doi": "10.31234/osf.io/26tz7_v1", "pmid": "", "publication_date": "2025-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3196, "title": "Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample", "authors": "Dan Petrovitch, Samuel Hosford, Andrew K. Littlefield, Heather Austin-Robillard", "journal": "PsyArXiv", "publication_date": "2025-02-28", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/26tz7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/26tz7_v1", "source_url": "https://osf.io/preprints/psyarxiv/26tz7_v1", "doi": "", "pmid": "", "publication_date": "2025-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 817, "title": "Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2025-02-13", "publication_year": 2025, "doi": "10.1021/acsmedchemlett.5c00031", "pubmed_id": "39967620", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39967620/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39967620", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39967620/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39967620", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39967620/", "doi": "10.1021/acsmedchemlett.5c00031", "pmid": "39967620", "publication_date": "2025-02-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 826, "title": "Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.", "authors": "Lucido MJ, Dunlop BW", "journal": "Brain sciences", "publication_date": "2025-02-06", "publication_year": 2025, "doi": "10.3390/brainsci15020161", "pubmed_id": "40002494", "openalex_id": "https://openalex.org/W4407195838", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40002494/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:40002494", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40002494/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40002494", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40002494/", "doi": "10.3390/brainsci15020161", "pmid": "40002494", "publication_date": "2025-02-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4443, "title": "Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners", "authors": "Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-02-05", "publication_year": 2025, "doi": "10.1556/2054.2025.00375", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407157019", "source_url": "https://doi.org/10.1556/2054.2025.00375", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Receptor Pharmacology,Personality Change,Mystical Experience,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00375", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00375", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00375", "source_url": "https://doi.org/10.1556/2054.2025.00375", "doi": "10.1556/2054.2025.00375", "pmid": "", "publication_date": "2025-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 830, "title": "Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.", "authors": "de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL", "journal": "Expert opinion on drug discovery", "publication_date": "2025-02-03", "publication_year": 2025, "doi": "10.1080/17460441.2025.2460674", "pubmed_id": "39885729", "openalex_id": "https://openalex.org/W4407044130", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39885729/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39885729", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39885729/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39885729", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39885729/", "doi": "10.1080/17460441.2025.2460674", "pmid": "39885729", "publication_date": "2025-02-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 829, "title": "Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.", "authors": "Mori-Kreiner A, Aggarwal A, Bordoloi M", "journal": "Psychopharmacology bulletin", "publication_date": "2025-02-03", "publication_year": 2025, "doi": "10.64719/pb.4525", "pubmed_id": "39935673", "openalex_id": "https://openalex.org/W4407426725", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39935673/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Review Article,Case Report,Adolescents", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39935673", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39935673/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39935673", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39935673/", "doi": "10.64719/pb.4525", "pmid": "39935673", "publication_date": "2025-02-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4455, "title": "BEHAVIORAL ANALYSES OF ANTIDEPRESSANT-LIKE EFFECT OF SEROTONERGIC PSYCHEDELICS IN MICE", "authors": "Daisuke Ibi, Rika Takaba, Keisuke Yoshida, Takayoshi Mamiya, Shinji Kitagaki, Masayuki Hiramatsu", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1093/ijnp/pyae059.584", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407387174", "source_url": "https://doi.org/10.1093/ijnp/pyae059.584", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyae059.584", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyae059.584", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyae059.584", "source_url": "https://doi.org/10.1093/ijnp/pyae059.584", "doi": "10.1093/ijnp/pyae059.584", "pmid": "", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4450, "title": "Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey", "authors": "Jérémie Richard, Sandeep M. Nayak, Nathan D. Sepeda, Albert Garcia-Romeu", "journal": "Drug and Alcohol Dependence", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1016/j.drugalcdep.2024.112184", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407076188", "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112184", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2024.112184", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2024.112184", "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112184", "doi": "10.1016/j.drugalcdep.2024.112184", "pmid": "", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3292, "title": "BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL", "authors": "*Leonard Lerer, Katherine Spear, Jeet Varia, Cecily Keim, Alex Buko, Karin Blakolmer, Bernard Lerer", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2025-02-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC11815225", "substance_tags": "psilocybin", "topic_tags": "Depression,Metabolomics", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:15:19", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC11815225", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC11815225", "source_url": "https://europepmc.org/article/PMC/PMC11815225", "doi": "", "pmid": "", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3291, "title": "ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER", "authors": "Rebecca Harding, Natalie Ertl, Rayyan Zafar", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2025-02-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC11814992", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC11814992", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC11814992", "source_url": "https://europepmc.org/article/PMC/PMC11814992", "doi": "", "pmid": "", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 840, "title": "Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.", "authors": "Jones G, Lowe MX, Nayak S, Sepeda N, Kettner H, Carhart-Harris R, Jackson H, Garcia-Romeu A", "journal": "Journal of affective disorders", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1016/j.jad.2024.10.058", "pubmed_id": "39447981", "openalex_id": "https://openalex.org/W4403628871", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39447981/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Biomarkers,Wellbeing,Emotional Processing,Spirituality,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39447981", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39447981/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39447981", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39447981/", "doi": "10.1016/j.jad.2024.10.058", "pmid": "39447981", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 839, "title": "Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis.", "authors": "Rogge K, Wagner TJ, Hoffmeister D, Rupp B, Werten S", "journal": "FEBS letters", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1002/1873-3468.15042", "pubmed_id": "39449146", "openalex_id": "https://openalex.org/W4403779143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39449146/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39449146", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39449146/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39449146", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39449146/", "doi": "10.1002/1873-3468.15042", "pmid": "39449146", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 837, "title": "The safety of psilocybin-assisted psychotherapy: A systematic review.", "authors": "Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1177/00048674241289024", "pubmed_id": "39670342", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39670342/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39670342", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39670342/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39670342", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39670342/", "doi": "10.1177/00048674241289024", "pmid": "39670342", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 835, "title": "Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.", "authors": "Geller J, Whitney E", "journal": "Current psychiatry reports", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1007/s11920-024-01577-2", "pubmed_id": "39699759", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699759/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Aging,Clinical Trial,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39699759", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39699759/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39699759", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699759/", "doi": "10.1007/s11920-024-01577-2", "pmid": "39699759", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 833, "title": "Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "Psychiatry research", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2024.116337", "pubmed_id": "39754904", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39754904/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39754904", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39754904/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39754904", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39754904/", "doi": "10.1016/j.psychres.2024.116337", "pmid": "39754904", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 832, "title": "The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour.", "authors": "Louie E, Towers E, Morse AR, Watt J, Bryant Z, Haber P, Morley K", "journal": "International journal of mental health nursing", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1111/inm.70010", "pubmed_id": "39952893", "openalex_id": "https://openalex.org/W4407570589", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39952893/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39952893", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39952893/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39952893", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39952893/", "doi": "10.1111/inm.70010", "pmid": "39952893", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 831, "title": "Among Psychedelics, Only Psilocybin Has Demonstrated Benefit to Treat Depression.", "authors": "Shaughnessy AF", "journal": "American family physician", "publication_date": "2025-02-01", "publication_year": 2025, "doi": null, "pubmed_id": "39964936", "openalex_id": "https://openalex.org/W4407760123", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39964936/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:39964936", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39964936", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39964936/", "doi": "", "pmid": "39964936", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3679, "title": "A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression", "authors": "Central Institute of Mental Health, Mannheim", "journal": "ClinicalTrials.gov", "publication_date": "2025-01-20", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04670081", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04670081", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "source_url": "https://clinicaltrials.gov/study/NCT04670081", "doi": "", "pmid": "", "publication_date": "2025-01-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 854, "title": "Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.", "authors": "Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2025-01-19", "publication_year": 2025, "doi": "10.3390/ph18010130", "pubmed_id": "39861191", "openalex_id": "https://openalex.org/W4406629036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39861191/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Emotional Processing,Spirituality,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39861191", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39861191/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39861191", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39861191/", "doi": "10.3390/ph18010130", "pmid": "39861191", "publication_date": "2025-01-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 859, "title": "Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.", "authors": "Ellis S, Bostian C, Feng W, Fischer E, Schwartz G, Eisen K, Lean M, Conlan E, Ostacher M, Aaronson S, Suppes T", "journal": "Journal of affective disorders", "publication_date": "2025-01-15", "publication_year": 2025, "doi": "10.1016/j.jad.2024.09.133", "pubmed_id": "39343309", "openalex_id": "https://openalex.org/W4402912774", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39343309/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Treatment-Resistant Depression,Veterans,Safety,Adverse Events,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39343309", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39343309/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39343309", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39343309/", "doi": "10.1016/j.jad.2024.09.133", "pmid": "39343309", "publication_date": "2025-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 858, "title": "The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis.", "authors": "Li JR, Chiang KT, Kao YC, Yu CL, Yang FC, Liang CS, Hsu TW", "journal": "Journal of affective disorders", "publication_date": "2025-01-15", "publication_year": 2025, "doi": "10.1016/j.jad.2024.10.016", "pubmed_id": "39389119", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39389119/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39389119", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39389119/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39389119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39389119/", "doi": "10.1016/j.jad.2024.10.016", "pmid": "39389119", "publication_date": "2025-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4462, "title": "What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?", "authors": "Amin Sharifan", "journal": "Cochrane Clinical Answers", "publication_date": "2025-01-13", "publication_year": 2025, "doi": "10.1002/cca.4512", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406299512", "source_url": "https://doi.org/10.1002/cca.4512", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:24", "bibtex": null, "source_record_id": "DOI:10.1002/cca.4512", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/cca.4512", "source_url": "https://doi.org/10.1002/cca.4512", "doi": "10.1002/cca.4512", "pmid": "", "publication_date": "2025-01-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4463, "title": "Study finds encouraging results in psilocybin treatment for TRD patients", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1002/mhw.34292", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406243180", "source_url": "https://doi.org/10.1002/mhw.34292", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:24", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34292", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.34292", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.34292", "source_url": "https://doi.org/10.1002/mhw.34292", "doi": "10.1002/mhw.34292", "pmid": "", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 864, "title": "Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats.", "authors": "Wang Z, Robbins B, Zhuang R, Sandini T, van Bruggen R, Li XM, Zhang Y", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2024.111243", "pubmed_id": "39756636", "openalex_id": "https://openalex.org/W4406062303", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39756636/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Biomarkers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39756636", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39756636/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39756636", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39756636/", "doi": "10.1016/j.pnpbp.2024.111243", "pmid": "39756636", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 863, "title": "Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.", "authors": "Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111249", "pubmed_id": "39778644", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39778644/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39778644", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39778644/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39778644", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39778644/", "doi": "10.1016/j.pnpbp.2025.111249", "pmid": "39778644", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 862, "title": "Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.", "authors": "Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111251", "pubmed_id": "39788410", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39788410/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39788410", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39788410/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39788410", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39788410/", "doi": "10.1016/j.pnpbp.2025.111251", "pmid": "39788410", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 861, "title": "Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.", "authors": "Destoop M, Mohr P, Butlen F, Kéri P, Samochowiec J, De Picker L, Fiorillo A, Kuypers KPC, Dom G", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1192/j.eurpsy.2024.1806", "pubmed_id": "39791347", "openalex_id": "https://openalex.org/W4406246123", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39791347/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39791347", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39791347/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39791347", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39791347/", "doi": "10.1192/j.eurpsy.2024.1806", "pmid": "39791347", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4464, "title": "PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS", "authors": "Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo", "journal": "Health and Society", "publication_date": "2025-01-08", "publication_year": 2025, "doi": "10.51249/hs.v5i01.2377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406161181", "source_url": "https://doi.org/10.51249/hs.v5i01.2377", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Receptor Pharmacology,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:24", "bibtex": null, "source_record_id": "DOI:10.51249/hs.v5i01.2377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.51249/hs.v5i01.2377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.51249/hs.v5i01.2377", "source_url": "https://doi.org/10.51249/hs.v5i01.2377", "doi": "10.51249/hs.v5i01.2377", "pmid": "", "publication_date": "2025-01-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 871, "title": "Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT receptor activation and psychedelic-like activity.", "authors": "Zhang M, Yang Y, Yang Z, Wen X, Zhang C, Xiao P, Wang Y, Sun J, Wang H, Wang X", "journal": "European journal of medicinal chemistry", "publication_date": "2025-01-05", "publication_year": 2025, "doi": "10.1016/j.ejmech.2024.117049", "pubmed_id": "39541872", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39541872/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39541872", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39541872/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39541872", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39541872/", "doi": "10.1016/j.ejmech.2024.117049", "pmid": "39541872", "publication_date": "2025-01-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3201, "title": "Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment", "authors": "Socoró Garrigosa M, Sanz Perl Y, Kringelbach ML, Carhart-Harris R, Vohryzek J, Deco G.", "journal": "bioRxiv", "publication_date": "2025-01-02", "publication_year": 2025, "doi": "10.1101/2025.01.01.631011", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.01.01.631011", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.1101/2025.01.01.631011", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.01.01.631011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.01.01.631011", "source_url": "https://doi.org/10.1101/2025.01.01.631011", "doi": "10.1101/2025.01.01.631011", "pmid": "", "publication_date": "2025-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5688, "title": "[Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?].", "authors": "Papp N, Gonda X", "journal": "Psychiatria Hungarica: A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata", "publication_date": "2025-01-01", "publication_year": 2025, "doi": null, "pubmed_id": "42412648", "openalex_id": "https://openalex.org/W7167746766", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42412648/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-11 19:28:10", "last_checked": "2026-08-09 08:34:30", "bibtex": null, "source_record_id": "PMID:42412648", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42412648/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42412648", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42412648/", "doi": "", "pmid": "42412648", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4484, "title": "Alternative therapy for neurological and psychiatric disorders using psilocybin", "authors": "Machado Henrique Tofoli Vieira, Seixas Geovana Mendes de, Silva Luis Gustavo Alves, Brito Mariana Duarte Garcia, Castro Giovanna Miziara", "journal": "São Paulo Medical Journal", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.5327/1516-3180.cpn.1123", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417514861", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Wellbeing,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:35:10", "bibtex": null, "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "doi": "10.5327/1516-3180.cpn.1123", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4483, "title": "In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor", "authors": "Kostić Marina D., Nedić Jana, Dragojević Jovana S., Divac Vera M.", "journal": "Book of Proceedings", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.46793/iccbikg25.477k", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416739362", "source_url": "https://doi.org/10.46793/iccbikg25.477k", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Drug Interactions", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:35:10", "bibtex": null, "source_record_id": "DOI:10.46793/iccbikg25.477k", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.46793/iccbikg25.477k", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.46793/iccbikg25.477k", "source_url": "https://doi.org/10.46793/iccbikg25.477k", "doi": "10.46793/iccbikg25.477k", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4482, "title": "Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies", "authors": "Madison M. H. Simounet, Joy Drinnon", "journal": "Psi Chi Journal of Psychological Research", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.24839/2325-7342.jn30.4.345", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414907947", "source_url": "https://doi.org/10.24839/2325-7342.jn30.4.345", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.24839/2325-7342.jn30.4.345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.24839/2325-7342.jn30.4.345", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.24839/2325-7342.jn30.4.345", "source_url": "https://doi.org/10.24839/2325-7342.jn30.4.345", "doi": "10.24839/2325-7342.jn30.4.345", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4475, "title": "Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression", "authors": "Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris", "journal": "Neuroscience Applied", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105421", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408526135", "source_url": "https://doi.org/10.1016/j.nsa.2025.105421", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:24", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.105421", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.105421", "source_url": "https://doi.org/10.1016/j.nsa.2025.105421", "doi": "10.1016/j.nsa.2025.105421", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4471, "title": "Therapieresistente Depression: Studie zur Psilocybin-augmentierten Psychotherapie nicht erfolgreich", "authors": "Friederike Klein", "journal": "InFo Neurologie + Psychiatrie", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1007/s15005-024-4209-z", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406591022", "source_url": "https://doi.org/10.1007/s15005-024-4209-z", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:24", "bibtex": null, "source_record_id": "DOI:10.1007/s15005-024-4209-z", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15005-024-4209-z", "source_url": "https://doi.org/10.1007/s15005-024-4209-z", "doi": "10.1007/s15005-024-4209-z", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4468, "title": "The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry", "authors": "Mile Jevtić", "journal": "Engrami", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.5937/engrami47-57385", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413629699", "source_url": "https://doi.org/10.5937/engrami47-57385", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:24", "bibtex": null, "source_record_id": "DOI:10.5937/engrami47-57385", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5937/engrami47-57385", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5937/engrami47-57385", "source_url": "https://doi.org/10.5937/engrami47-57385", "doi": "10.5937/engrami47-57385", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3687, "title": "Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study", "authors": "Joshua Woolley, MD, PhD", "journal": "ClinicalTrials.gov", "publication_date": "2025-01-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04932434", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04932434", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04932434", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04932434", "source_url": "https://clinicaltrials.gov/study/NCT04932434", "doi": "", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 919, "title": "Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.", "authors": "Bahji A, Lunsky I, Gutierrez G, Vazquez G", "journal": "Journal of psychoactive drugs", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/02791072.2023.2278586", "pubmed_id": "37968944", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37968944/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Aging,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:37968944", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37968944/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37968944", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37968944/", "doi": "10.1080/02791072.2023.2278586", "pmid": "37968944", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 917, "title": "Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.", "authors": "Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S", "journal": "Molecular biotechnology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1007/s12033-023-00994-7", "pubmed_id": "38117395", "openalex_id": "https://openalex.org/W4390005347", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38117395/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Consciousness,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:38117395", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38117395/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38117395", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38117395/", "doi": "10.1007/s12033-023-00994-7", "pmid": "38117395", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 915, "title": "Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.", "authors": "Humphreys K, Todd Korthuis P, Stjepanović D, Hall W", "journal": "Annual review of psychology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1146/annurev-psych-020124-023532", "pubmed_id": "39094057", "openalex_id": "https://openalex.org/W4401244642", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39094057/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39094057", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39094057/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39094057", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39094057/", "doi": "10.1146/annurev-psych-020124-023532", "pmid": "39094057", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 912, "title": "Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling.", "authors": "Negrine JJ, Puljević C, Ferris J, Liknaitzky P, Perlman C, Piatkowski T", "journal": "Drug and alcohol review", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1111/dar.13973", "pubmed_id": "39499579", "openalex_id": "https://openalex.org/W4404059132", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39499579/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39499579", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39499579/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39499579", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39499579/", "doi": "10.1111/dar.13973", "pmid": "39499579", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 911, "title": "Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.", "authors": "Richardson E, Patterson R, Meltzer-Brody S, McClure R, Tow A", "journal": "Annual review of medicine", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1146/annurev-med-050423-095712", "pubmed_id": "39527720", "openalex_id": "https://openalex.org/W4404236211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39527720/", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39527720", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39527720/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39527720", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39527720/", "doi": "10.1146/annurev-med-050423-095712", "pmid": "39527720", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 906, "title": "Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.", "authors": "Kirlić N, Lennard-Jones M, Atli M, Malievskaia E, Modlin NL, Peck SK, Gaillard A, Goodwin GM, Koelpin D", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20230884", "pubmed_id": "39741434", "openalex_id": "https://openalex.org/W4405978092", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741434/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741434", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741434/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741434", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741434/", "doi": "10.1176/appi.ajp.20230884", "pmid": "39741434", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 904, "title": "Psilocybin: From Psychiatric Pariah to Perceived Panacea.", "authors": "Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20230682", "pubmed_id": "39741437", "openalex_id": "https://openalex.org/W4405978069", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741437/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Eating Disorders,Mechanism of Action,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741437", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741437/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741437", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741437/", "doi": "10.1176/appi.ajp.20230682", "pmid": "39741437", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 903, "title": "Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.", "authors": "Ramaekers JG, Reckweg JT, Mason NL", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20230890", "pubmed_id": "39741439", "openalex_id": "https://openalex.org/W4405955623", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741439/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741439", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741439/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741439", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741439/", "doi": "10.1176/appi.ajp.20230890", "pmid": "39741439", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 902, "title": "Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.", "authors": "Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Suppes T, Sackeim HA", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20231063", "pubmed_id": "39741440", "openalex_id": "https://openalex.org/W4405955624", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741440/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741440", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741440/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741440", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741440/", "doi": "10.1176/appi.ajp.20231063", "pmid": "39741440", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 901, "title": "Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.", "authors": "Wolfgang AS, McClair VL, Schnurr PP, Holtzheimer PE, Woolley JD, Stauffer CS, Wolf RC, States LJ, Benedek DM, Capaldi VF, Bradley J, Fuller MA, Smyth MJ, Hermes EDA, Tenhula W, Wiechers IR", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20240751", "pubmed_id": "39741441", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741441/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Veterans", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741441", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741441/", "doi": "10.1176/appi.ajp.20240751", "pmid": "39741441", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 900, "title": "Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.", "authors": "Pagni BA, Zeifman RJ, Mennenga SE, Carrithers BM, Goldway N, Bhatt S, O'Donnell KC, Ross S, Bogenschutz MP", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20230887", "pubmed_id": "39741446", "openalex_id": "https://openalex.org/W4405955644", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741446/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Personality Change,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741446", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741446/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741446", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741446/", "doi": "10.1176/appi.ajp.20230887", "pmid": "39741446", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 899, "title": "Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.", "authors": "Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM", "journal": "Clinical neuropharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1097/wnf.0000000000000617", "pubmed_id": "39787428", "openalex_id": "https://openalex.org/W4405922737", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39787428/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article,Healthy Volunteers,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39787428", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39787428/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39787428", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39787428/", "doi": "10.1097/wnf.0000000000000617", "pmid": "39787428", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 898, "title": "Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial.", "authors": "Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL", "journal": "medRxiv: the preprint server for health sciences", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1101/2024.12.31.24319806", "pubmed_id": "39802794", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39802794/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39802794", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39802794/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39802794", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39802794/", "doi": "10.1101/2024.12.31.24319806", "pmid": "39802794", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 892, "title": "Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.", "authors": "Bires J", "journal": "Journal of psychosocial oncology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/07347332.2025.2482917", "pubmed_id": "40138527", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40138527/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40138527", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40138527/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40138527", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40138527/", "doi": "10.1080/07347332.2025.2482917", "pmid": "40138527", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 891, "title": "Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder.", "authors": "Zhu X, Zhang C, Hellerstein D, Feusner JD, Wheaton MG, Gomez GJ, Schneier F", "journal": "Psychedelics", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.61373/pp024r.0028", "pubmed_id": "40458078", "openalex_id": "https://openalex.org/W4404286681", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40458078/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40458078", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40458078/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40458078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40458078/", "doi": "10.61373/pp024r.0028", "pmid": "40458078", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 886, "title": "Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?", "authors": "Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.002", "pubmed_id": "40541311", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541311/", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Chronic Pain,Pharmacology,Microdosing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541311", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541311/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541311", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541311/", "doi": "10.1016/bs.irn.2025.03.002", "pmid": "40541311", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 885, "title": "Serotonergic psychedelics for depression: A comprehensive overview.", "authors": "Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.04.009", "pubmed_id": "40541312", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541312/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541312", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541312/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541312", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541312/", "doi": "10.1016/bs.irn.2025.04.009", "pmid": "40541312", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 882, "title": "Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.", "authors": "Tap S, Bostoen T, Breeksema J, Schoevers R", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.001", "pubmed_id": "40541316", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541316/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Emotional Processing,Spirituality", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541316", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541316/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541316", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541316/", "doi": "10.1016/bs.irn.2025.03.001", "pmid": "40541316", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 877, "title": "Brain changes associated with depression treatment: a meta-analysis.", "authors": "Perez GM, Rosenberg BM, Xu W, Oathes DJ", "journal": "NeuroImage. Clinical", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.nicl.2025.103874", "pubmed_id": "40886591", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40886591/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40886591", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40886591/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40886591", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40886591/", "doi": "10.1016/j.nicl.2025.103874", "pmid": "40886591", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 847, "title": "Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.", "authors": "Kinderlehrer DA", "journal": "Neuropsychiatric disease and treatment", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.2147/ndt.s500337", "pubmed_id": "39897712", "openalex_id": "https://openalex.org/W4406930915", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39897712/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Receptor Pharmacology,Default Mode Network,Microdosing,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39897712", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39897712/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39897712", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39897712/", "doi": "10.2147/ndt.s500337", "pmid": "39897712", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 815, "title": "A review of psychedelics trials completed in depression, informed by European regulatory perspectives.", "authors": "Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P", "journal": "Neuroscience applied", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105516", "pubmed_id": "40654583", "openalex_id": "https://openalex.org/W4407959310", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40654583/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:40654583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40654583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40654583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40654583/", "doi": "10.1016/j.nsa.2025.105516", "pmid": "40654583", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 813, "title": "Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.", "authors": "Junges LH, Müller-Santos M", "journal": "Biotechnology progress", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1002/btpr.3513", "pubmed_id": "39366919", "openalex_id": "https://openalex.org/W4403117441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39366919/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Aging,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39366919", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39366919/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39366919", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39366919/", "doi": "10.1002/btpr.3513", "pmid": "39366919", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 786, "title": "Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.", "authors": "Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L", "journal": "Frontiers in psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1508811", "pubmed_id": "40109441", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40109441/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study,Veterans", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40109441", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40109441/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40109441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40109441/", "doi": "10.3389/fpsyt.2025.1508811", "pmid": "40109441", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 719, "title": "Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.", "authors": "Mauney E, King F, Burton-Murray H, Kuo B", "journal": "Journal of clinical gastroenterology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1097/mcg.0000000000002149", "pubmed_id": "39998940", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39998940/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Default Mode Network,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39998940", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39998940/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39998940", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39998940/", "doi": "10.1097/mcg.0000000000002149", "pmid": "39998940", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 703, "title": "A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.", "authors": "Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B", "journal": "PloS one", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1371/journal.pone.0318343", "pubmed_id": "40327705", "openalex_id": "https://openalex.org/W4410112263", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40327705/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40327705", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40327705/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40327705", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40327705/", "doi": "10.1371/journal.pone.0318343", "pmid": "40327705", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 698, "title": "Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes.", "authors": "Hooper JF, Gyongyosi EL, Hutchison KE, Mueller RL", "journal": "Frontiers in psychology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1533055", "pubmed_id": "40443723", "openalex_id": "https://openalex.org/W4410417211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40443723/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40443723", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40443723/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40443723", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40443723/", "doi": "10.3389/fpsyg.2025.1533055", "pmid": "40443723", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 664, "title": "Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.", "authors": "Roseby W, Kettner H, Roseman L, Spriggs MJ, Lyons T, Peill J, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris RL", "journal": "Frontiers in psychology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1580663", "pubmed_id": "40547590", "openalex_id": "https://openalex.org/W4411107182", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40547590/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40547590", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40547590/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40547590", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40547590/", "doi": "10.3389/fpsyg.2025.1580663", "pmid": "40547590", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 663, "title": "Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.", "authors": "Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251342319", "pubmed_id": "40492108", "openalex_id": "https://openalex.org/W4411126613", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40492108/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Eating Disorders,End-of-Life Distress,Mechanism of Action,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40492108", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40492108/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40492108", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40492108/", "doi": "10.1177/20451253251342319", "pmid": "40492108", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 648, "title": "Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure.", "authors": "De Gasperi R, Perez Garcia G, Gama Sosa MA, Perez GM, Abutarboush R, Kawoos U, Hof PR, Zhu CW, Ahlers ST, Elder GA", "journal": "Frontiers in neurology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fneur.2025.1594335", "pubmed_id": "40635716", "openalex_id": "https://openalex.org/W4411662399", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40635716/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Receptor Pharmacology,Observational Study,Veterans", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40635716", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40635716/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40635716", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40635716/", "doi": "10.3389/fneur.2025.1594335", "pmid": "40635716", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 646, "title": "PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.", "authors": "Marek J, Domek-Gumprecht M, Macionga A, Szafoni S, Więckiewicz G", "journal": "Frontiers in psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1591658", "pubmed_id": "40656049", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656049/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40656049", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656049/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656049", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656049/", "doi": "10.3389/fpsyt.2025.1591658", "pmid": "40656049", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 639, "title": "Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.", "authors": "Barnett BS, Koons CJ, Van den Eynde V, Gillman PK, Bodkin JA", "journal": "Journal of psychoactive drugs", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/02791072.2024.2368617", "pubmed_id": "38903003", "openalex_id": "https://openalex.org/W4399897612", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38903003/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Headache / Migraine,Receptor Pharmacology,Randomized Controlled Trial,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:38903003", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38903003/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38903003", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38903003/", "doi": "10.1080/02791072.2024.2368617", "pmid": "38903003", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 575, "title": "Therapeutic and legal aspects of psilocybin in cancer-related depression.", "authors": "Małgorzata W, Kopczyk R, Gerlach A, Rymaszewska J", "journal": "Frontiers in psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1591864", "pubmed_id": "40831528", "openalex_id": "https://openalex.org/W4412939048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40831528/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40831528", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40831528/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40831528", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40831528/", "doi": "10.3389/fpsyt.2025.1591864", "pmid": "40831528", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 574, "title": "Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models.", "authors": "Adeyinka D, Forsyth D, Currie S, Faraone N", "journal": "Frontiers in systems neuroscience", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fnsys.2025.1585367", "pubmed_id": "40894380", "openalex_id": "https://openalex.org/W4413969371", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894380/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Animal Study,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40894380", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40894380/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40894380", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894380/", "doi": "10.3389/fnsys.2025.1585367", "pmid": "40894380", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 571, "title": "Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.", "authors": "Blest-Hopley G, Pasculli G, Ruffell SGD, Tsang W, Emmanuel O, Pate KM, Kettner H, Roseman L, Erritzoe D, Carhart-Harris R", "journal": "Frontiers in psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1594307", "pubmed_id": "40842948", "openalex_id": "https://openalex.org/W4413002573", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40842948/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Brain Imaging,Wellbeing,Emotional Processing,Veterans", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40842948", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40842948/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40842948", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40842948/", "doi": "10.3389/fpsyt.2025.1594307", "pmid": "40842948", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 553, "title": "Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (): A Systematic Review.", "authors": "Thaoboonruang N, Lohitnavy M, Lohitnavy O", "journal": "Journal of psychoactive drugs", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/02791072.2024.2399128", "pubmed_id": "39257234", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39257234/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:39257234", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39257234/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39257234", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39257234/", "doi": "10.1080/02791072.2024.2399128", "pmid": "39257234", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 531, "title": "A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy.", "authors": "Hultgren J, Hafsteinsson MH, Brulin JG", "journal": "General hospital psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.07.020", "pubmed_id": "40782561", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40782561/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40782561", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40782561/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40782561", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40782561/", "doi": "10.1016/j.genhosppsych.2025.07.020", "pmid": "40782561", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 530, "title": "Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial.", "authors": "Ross ML, Iyer R, Williams ML, Boughey M, O'Callaghan C, Hiscock R, Dwyer J", "journal": "General hospital psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.08.001", "pubmed_id": "40858059", "openalex_id": "https://openalex.org/W4413190735", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40858059/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40858059", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40858059/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40858059", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40858059/", "doi": "10.1016/j.genhosppsych.2025.08.001", "pmid": "40858059", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 521, "title": "Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.", "authors": "Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251372449", "pubmed_id": "40933784", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40933784/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40933784", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40933784/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40933784", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40933784/", "doi": "10.1177/20451253251372449", "pmid": "40933784", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 518, "title": "Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression.", "authors": "Wierzbicka M, Kopczyk R, Gerlach A, Rymaszewska J", "journal": "Frontiers in psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1698185", "pubmed_id": "41019591", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41019591/", "substance_tags": "psilocybin", "topic_tags": "Depression,Cancer Patients", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41019591", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41019591/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41019591", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41019591/", "doi": "10.3389/fpsyt.2025.1698185", "pmid": "41019591", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 515, "title": "Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire.", "authors": "Hooper JF, Ellingson JM, Hutchison KE", "journal": "Frontiers in psychology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1648968", "pubmed_id": "41030347", "openalex_id": "https://openalex.org/W4414189000", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41030347/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Consciousness,Emotional Processing,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41030347", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41030347/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41030347", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41030347/", "doi": "10.3389/fpsyg.2025.1648968", "pmid": "41030347", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 483, "title": "Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial.", "authors": "Meikle S, Carter O, Liknaitzky P, Johansen L, Iyer R, Strauss N, Williams M, Castle D, Rossell SL", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251377187", "pubmed_id": "41050149", "openalex_id": "https://openalex.org/W4414745551", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41050149/", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41050149", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41050149/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41050149", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41050149/", "doi": "10.1177/20451253251377187", "pmid": "41050149", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 473, "title": "Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.", "authors": "Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251384513", "pubmed_id": "41122434", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41122434/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41122434", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41122434/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41122434", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41122434/", "doi": "10.1177/20451253251384513", "pmid": "41122434", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 455, "title": "Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders.", "authors": "Havlik JL, Isaac S, Raman P, Tran N, Hidalgo K, Suppes T", "journal": "Journal of clinical psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1097/jcp.0000000000002095", "pubmed_id": "40994136", "openalex_id": "https://openalex.org/W4414528095", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40994136/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Emotional Processing,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40994136", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40994136/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40994136", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40994136/", "doi": "10.1097/jcp.0000000000002095", "pmid": "40994136", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 450, "title": "Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.", "authors": "Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders J, Ljuslin M, Guérin B, Sholevar R, Roddy K, Tulsky JA, Agrawal M", "journal": "General hospital psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.10.010", "pubmed_id": "41109203", "openalex_id": "https://openalex.org/W4415081303", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41109203/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41109203", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41109203/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41109203", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41109203/", "doi": "10.1016/j.genhosppsych.2025.10.010", "pmid": "41109203", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 378, "title": "Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey.", "authors": "Afsharnia S, Liang V, Lunsky Y, Orsini AP, Tint A, Lin HY", "journal": "PLOS mental health", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1371/journal.pmen.0000514", "pubmed_id": "41662127", "openalex_id": "https://openalex.org/W7117295770", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41662127/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41662127", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41662127/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41662127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41662127/", "doi": "10.1371/journal.pmen.0000514", "pmid": "41662127", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 327, "title": "Self-administered complementary and alternative methods of treating mental disorders among students in Wrocław: a cross-sectional study.", "authors": "Sobieraj J, Sleziak J, Szyszka M, Błażejewska M, Łukańko K, Soczomska P, Bodziony K, Piotrowski P", "journal": "Frontiers in public health", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpubh.2025.1734137", "pubmed_id": "41584153", "openalex_id": "https://openalex.org/W7118439662", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41584153/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41584153", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41584153/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41584153", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41584153/", "doi": "10.3389/fpubh.2025.1734137", "pmid": "41584153", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4505, "title": "Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse", "authors": "Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly", "journal": "Saudi Journal of Medicine and Public Health", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.64483/20251153", "pubmed_id": null, "openalex_id": "https://openalex.org/W7104738164", "source_url": "https://doi.org/10.64483/20251153", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.64483/20251153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.64483/20251153", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.64483/20251153", "source_url": "https://doi.org/10.64483/20251153", "doi": "10.64483/20251153", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4504, "title": "Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy", "authors": "Mohammad Ali, Urbah Viqar", "journal": "Annals of Punjab Medical College", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.29054/apmc/2024.1658", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408418352", "source_url": "https://doi.org/10.29054/apmc/2024.1658", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Case Report,Observational Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.29054/apmc/2024.1658", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29054/apmc/2024.1658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29054/apmc/2024.1658", "source_url": "https://doi.org/10.29054/apmc/2024.1658", "doi": "10.29054/apmc/2024.1658", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4494, "title": "Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration", "authors": "Muniz, John Marco D.F.", "journal": "Journal of International Crisis and Risk Communication Research", "publication_date": "2024-12-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112971088", "source_url": "https://stars.library.ucf.edu/hut2024/268", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "https://stars.library.ucf.edu/hut2024/268", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://stars.library.ucf.edu/hut2024/268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://stars.library.ucf.edu/hut2024/268", "source_url": "https://stars.library.ucf.edu/hut2024/268", "doi": "", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 922, "title": "Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.", "authors": "Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G", "journal": "Deutsches Arzteblatt international", "publication_date": "2024-12-27", "publication_year": 2024, "doi": "10.3238/arztebl.m2024.0224", "pubmed_id": "39628414", "openalex_id": "https://openalex.org/W4405029114", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39628414/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39628414", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39628414/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39628414", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39628414/", "doi": "10.3238/arztebl.m2024.0224", "pmid": "39628414", "publication_date": "2024-12-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3114, "title": "Characterizing psilocybin as an antidepressant for adolescence in male and female rats", "authors": "García-Cabrerizo R, Beruete-Fresnillo I, García-Fuster MJ.", "journal": "bioRxiv", "publication_date": "2024-12-22", "publication_year": 2024, "doi": "10.1101/2024.12.20.629571", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.12.20.629571", "substance_tags": "psilocybin", "topic_tags": "Depression,Adolescents", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:15:00", "bibtex": null, "source_record_id": "DOI:10.1101/2024.12.20.629571", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.12.20.629571", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.12.20.629571", "source_url": "https://doi.org/10.1101/2024.12.20.629571", "doi": "10.1101/2024.12.20.629571", "pmid": "", "publication_date": "2024-12-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3101, "title": "Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways", "authors": "Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD.", "journal": "bioRxiv", "publication_date": "2024-12-17", "publication_year": 2024, "doi": "10.1101/2024.12.16.628764", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.12.16.628764", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Healthcare Workers,Transcriptomics", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:58", "bibtex": null, "source_record_id": "DOI:10.1101/2024.12.16.628764", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.12.16.628764", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.12.16.628764", "source_url": "https://doi.org/10.1101/2024.12.16.628764", "doi": "10.1101/2024.12.16.628764", "pmid": "", "publication_date": "2024-12-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 925, "title": "Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2024-12-12", "publication_year": 2024, "doi": "10.1021/acsmedchemlett.4c00519", "pubmed_id": "39691516", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39691516/", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Addiction,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39691516", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39691516/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39691516", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39691516/", "doi": "10.1021/acsmedchemlett.4c00519", "pmid": "39691516", "publication_date": "2024-12-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5670, "title": "Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience.", "authors": "Wahba M, Hayes C, Kletter M, McAllister-Williams RH", "journal": "BJPsych open", "publication_date": "2024-12-10", "publication_year": 2024, "doi": "10.1192/bjo.2024.768", "pubmed_id": "39654264", "openalex_id": "https://openalex.org/W4405215942", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39654264/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Case Report,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 07:00:34", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39654264", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39654264/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39654264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39654264/", "doi": "10.1192/bjo.2024.768", "pmid": "39654264", "publication_date": "2024-12-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4510, "title": "Chronic pain education: past, present, and future of psychedelics for the management of chronic pain", "authors": "Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick", "journal": "Pain Medicine", "publication_date": "2024-12-10", "publication_year": 2024, "doi": "10.1093/pm/pnae124", "pubmed_id": "39658247", "openalex_id": "https://openalex.org/W4405231848", "source_url": "https://doi.org/10.1093/pm/pnae124", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Microdosing,Spirituality,Review Article,Animal Study,Healthcare Workers,Safety,Adverse Events,Drug Interactions,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "PMID:39658247", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/pm/pnae124", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39658247", "source_url": "https://doi.org/10.1093/pm/pnae124", "doi": "10.1093/pm/pnae124", "pmid": "39658247", "publication_date": "2024-12-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 932, "title": "Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.", "authors": "Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML", "journal": "Translational psychiatry", "publication_date": "2024-12-04", "publication_year": 2024, "doi": "10.1038/s41398-024-03187-1", "pubmed_id": "39632810", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39632810/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39632810", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39632810/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39632810", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39632810/", "doi": "10.1038/s41398-024-03187-1", "pmid": "39632810", "publication_date": "2024-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 936, "title": "Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.", "authors": "Back AL, Freeman-Young TK, Morgan L, Sethi T, Baker KK, Myers S, McGregor BA, Harvey K, Tai M, Kollefrath A, Thomas BJ, Sorta D, Kaelen M, Kelmendi B, Gooley TA", "journal": "JAMA network open", "publication_date": "2024-12-02", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.49026", "pubmed_id": "39636638", "openalex_id": "https://openalex.org/W4405031949", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39636638/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39636638", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39636638/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39636638", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39636638/", "doi": "10.1001/jamanetworkopen.2024.49026", "pmid": "39636638", "publication_date": "2024-12-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 952, "title": "Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.", "authors": "Jeffrey JK, Weintraub MJ, Grob CS", "journal": "Journal of the American Academy of Child and Adolescent Psychiatry", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1016/j.jaac.2024.03.021", "pubmed_id": "38734406", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38734406/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Adolescents,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:38734406", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38734406/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38734406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38734406/", "doi": "10.1016/j.jaac.2024.03.021", "pmid": "38734406", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 951, "title": "Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.", "authors": "Hinkle JT, Graziosi M, Nayak SM, Yaden DB", "journal": "JAMA psychiatry", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.2546", "pubmed_id": "39230883", "openalex_id": "https://openalex.org/W4402221705", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39230883/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Meta-Analysis,Systematic Review,Review Article,Healthy Volunteers,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39230883", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39230883/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39230883", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39230883/", "doi": "10.1001/jamapsychiatry.2024.2546", "pmid": "39230883", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 950, "title": "New frontiers in the biosynthesis of psychoactive specialized metabolites.", "authors": "Li G, Facchini PJ", "journal": "Current opinion in plant biology", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1016/j.pbi.2024.102626", "pubmed_id": "39288539", "openalex_id": "https://openalex.org/W4402620626", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39288539/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39288539", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39288539/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39288539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39288539/", "doi": "10.1016/j.pbi.2024.102626", "pmid": "39288539", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 949, "title": "Exploring the regulatory framework of psychedelics in the US & Europe.", "authors": "Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S", "journal": "Asian journal of psychiatry", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1016/j.ajp.2024.104242", "pubmed_id": "39305768", "openalex_id": "https://openalex.org/W39305768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39305768/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39305768", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39305768/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39305768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39305768/", "doi": "10.1016/j.ajp.2024.104242", "pmid": "39305768", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 947, "title": "Impact of psilocybin on cognitive function: A systematic review.", "authors": "Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V", "journal": "Psychiatry and clinical neurosciences", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1111/pcn.13741", "pubmed_id": "39354706", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39354706/", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Creativity,Systematic Review,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39354706", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39354706/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39354706", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39354706/", "doi": "10.1111/pcn.13741", "pmid": "39354706", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 946, "title": "Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.", "authors": "Szpręgiel I, Bysiek A", "journal": "Pharmacological reports: PR", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1007/s43440-024-00660-y", "pubmed_id": "39412581", "openalex_id": "https://openalex.org/W4403450928", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39412581/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39412581", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39412581/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39412581", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39412581/", "doi": "10.1007/s43440-024-00660-y", "pmid": "39412581", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 945, "title": "The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.", "authors": "Marwood L, Croal M, Mistry S, Simmons H, Tsai J, Young MB, Goodwin GM", "journal": "Journal of psychiatric research", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1016/j.jpsychires.2024.10.009", "pubmed_id": "39427449", "openalex_id": "https://openalex.org/W4403332337", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39427449/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39427449", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39427449/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39427449", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39427449/", "doi": "10.1016/j.jpsychires.2024.10.009", "pmid": "39427449", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 944, "title": "Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.", "authors": "Collins HM", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1093/ijnp/pyae057", "pubmed_id": "39611453", "openalex_id": "https://openalex.org/W4404836981", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39611453/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Neuroplasticity,Mechanism of Action,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39611453", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39611453/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39611453", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39611453/", "doi": "10.1093/ijnp/pyae057", "pmid": "39611453", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 943, "title": "Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.", "authors": "de Jonge D, van der Meer PB, Kramers C, Schellekens A", "journal": "Current psychiatry reports", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1007/s11920-024-01567-4", "pubmed_id": "39612154", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39612154/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Meta-Analysis,Review Article,Treatment-Resistant Depression", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39612154", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39612154/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39612154", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39612154/", "doi": "10.1007/s11920-024-01567-4", "pmid": "39612154", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 942, "title": "The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.", "authors": "Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A", "journal": "CNS spectrums", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1017/s1092852924002268", "pubmed_id": "39655426", "openalex_id": "https://openalex.org/W4405207112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39655426/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Neuroplasticity,Personality Change,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39655426", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39655426/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39655426", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39655426/", "doi": "10.1017/s1092852924002268", "pmid": "39655426", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 941, "title": "Psilocybin and hallucinogenic mushrooms.", "authors": "Fradet M, Kelly CM, Donnelly AJ, Suppes T", "journal": "CNS spectrums", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1017/s1092852924002487", "pubmed_id": "39789676", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39789676/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39789676", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39789676/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39789676", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39789676/", "doi": "10.1017/s1092852924002487", "pmid": "39789676", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 939, "title": "Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.", "authors": "Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB", "journal": "International review of psychiatry (Abingdon, England)", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1080/09540261.2024.2357668", "pubmed_id": "39980217", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39980217/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mystical Experience,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39980217", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39980217/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39980217", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39980217/", "doi": "10.1080/09540261.2024.2357668", "pmid": "39980217", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 931, "title": "Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.", "authors": "Terao I, Kodama W", "journal": "PCN reports: psychiatry and clinical neurosciences", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1002/pcn5.70042", "pubmed_id": "39641126", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39641126/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39641126", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39641126/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39641126", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39641126/", "doi": "10.1002/pcn5.70042", "pmid": "39641126", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4517, "title": "Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings", "authors": "Arman Fard, Allison Cohen", "journal": "Journal of Student Research", "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.47611/jsrhs.v13i4.7602", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413513275", "source_url": "https://doi.org/10.47611/jsrhs.v13i4.7602", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Consciousness", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.47611/jsrhs.v13i4.7602", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.47611/jsrhs.v13i4.7602", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.47611/jsrhs.v13i4.7602", "source_url": "https://doi.org/10.47611/jsrhs.v13i4.7602", "doi": "10.47611/jsrhs.v13i4.7602", "pmid": "", "publication_date": "2024-11-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 953, "title": "A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient.", "authors": "Morris SL", "journal": "Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology", "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.9758/cpn.24.1180", "pubmed_id": "39420616", "openalex_id": "https://openalex.org/W4398182074", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39420616/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Personality Change,Review Article,Case Report,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39420616", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39420616/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39420616", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39420616/", "doi": "10.9758/cpn.24.1180", "pmid": "39420616", "publication_date": "2024-11-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3157, "title": "Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration", "authors": "Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B.", "journal": "bioRxiv", "publication_date": "2024-11-28", "publication_year": 2024, "doi": "10.1101/2024.11.28.625811", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.11.28.625811", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:05", "bibtex": null, "source_record_id": "DOI:10.1101/2024.11.28.625811", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.11.28.625811", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.11.28.625811", "source_url": "https://doi.org/10.1101/2024.11.28.625811", "doi": "10.1101/2024.11.28.625811", "pmid": "", "publication_date": "2024-11-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 954, "title": "Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.", "authors": "Adams DR, Allen H, Nicol GE, Cabassa LJ", "journal": "Translational behavioral medicine", "publication_date": "2024-11-25", "publication_year": 2024, "doi": "10.1093/tbm/ibae053", "pubmed_id": "39419768", "openalex_id": "https://openalex.org/W4403502370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39419768/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39419768", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39419768/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39419768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39419768/", "doi": "10.1093/tbm/ibae053", "pmid": "39419768", "publication_date": "2024-11-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3512, "title": "A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05035927", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05035927", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "source_url": "https://clinicaltrials.gov/study/NCT05035927", "doi": "", "pmid": "", "publication_date": "2024-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4521, "title": "Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials", "authors": "Raj Nashikkar, Kavita Mane, Rajendra Patil", "journal": "International Journal for Research in Applied Science and Engineering Technology", "publication_date": "2024-11-17", "publication_year": 2024, "doi": "10.22214/ijraset.2024.65160", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404448166", "source_url": "https://doi.org/10.22214/ijraset.2024.65160", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Aging,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.22214/ijraset.2024.65160", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22214/ijraset.2024.65160", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22214/ijraset.2024.65160", "source_url": "https://doi.org/10.22214/ijraset.2024.65160", "doi": "10.22214/ijraset.2024.65160", "pmid": "", "publication_date": "2024-11-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 958, "title": "Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals.", "authors": "Wang E, Mathai DS, Gukasyan N, Nayak S, Garcia-Romeu A", "journal": "Scientific reports", "publication_date": "2024-11-14", "publication_year": 2024, "doi": "10.1038/s41598-024-78736-1", "pubmed_id": "39543323", "openalex_id": "https://openalex.org/W4404374254", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39543323/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Observational Study,Safety,Contraindications", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39543323", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39543323/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39543323", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39543323/", "doi": "10.1038/s41598-024-78736-1", "pmid": "39543323", "publication_date": "2024-11-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 957, "title": "Expanding the Therapeutic Horizons of Psilocybin in Mental Health.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2024-11-14", "publication_year": 2024, "doi": "10.1021/acsmedchemlett.4c00488", "pubmed_id": "39563826", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39563826/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39563826", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39563826/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39563826", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39563826/", "doi": "10.1021/acsmedchemlett.4c00488", "pmid": "39563826", "publication_date": "2024-11-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3430, "title": "PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout", "authors": "University of Utah", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-12", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05557643", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05557643", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05557643", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05557643", "source_url": "https://clinicaltrials.gov/study/NCT05557643", "doi": "", "pmid": "", "publication_date": "2024-11-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3108, "title": "Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits", "authors": "Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G.", "journal": "bioRxiv", "publication_date": "2024-11-07", "publication_year": 2024, "doi": "10.1101/2024.11.06.622302", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.11.06.622302", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Wellbeing,Healthy Volunteers", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:59", "bibtex": null, "source_record_id": "DOI:10.1101/2024.11.06.622302", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.11.06.622302", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.11.06.622302", "source_url": "https://doi.org/10.1101/2024.11.06.622302", "doi": "10.1101/2024.11.06.622302", "pmid": "", "publication_date": "2024-11-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 962, "title": "Amid magic and menace: psychiatrists' attitudes to psilocybin therapy.", "authors": "Gribben A, Burke T, Harrington C, Husein A, Murnane KS, Hendricks PS, Tobin K, Ivers JH, Thuery G, Harkin A, Kelly JR", "journal": "Irish journal of psychological medicine", "publication_date": "2024-11-07", "publication_year": 2024, "doi": "10.1017/ipm.2024.49", "pubmed_id": "39506378", "openalex_id": "https://openalex.org/W4404152712", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39506378/", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39506378", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39506378/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39506378", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39506378/", "doi": "10.1017/ipm.2024.49", "pmid": "39506378", "publication_date": "2024-11-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4524, "title": "Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics", "authors": "Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak", "journal": "Frontiers in Psychiatry", "publication_date": "2024-11-06", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1485337", "pubmed_id": "39568756", "openalex_id": "https://openalex.org/W4404119543", "source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Neurogenesis,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Emotional Processing,Mystical Experience,Review Article,Observational Study,Animal Study,Healthy Volunteers,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "PMID:39568756", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39568756", "source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "doi": "10.3389/fpsyt.2024.1485337", "pmid": "39568756", "publication_date": "2024-11-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 965, "title": "Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial.", "authors": "Swanson LR, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson JL, Schallmo MP", "journal": "Journal of vision", "publication_date": "2024-11-04", "publication_year": 2024, "doi": "10.1167/jov.24.12.5", "pubmed_id": "39499526", "openalex_id": "https://openalex.org/W4404059935", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39499526/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39499526", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39499526/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39499526", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39499526/", "doi": "10.1167/jov.24.12.5", "pmid": "39499526", "publication_date": "2024-11-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 967, "title": "Pyramidal cell types and 5-HT receptors are essential for psilocybin's lasting drug action.", "authors": "Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC", "journal": "bioRxiv: the preprint server for biology", "publication_date": "2024-11-03", "publication_year": 2024, "doi": "10.1101/2024.11.02.621692", "pubmed_id": "39554087", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39554087/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39554087", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39554087/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39554087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39554087/", "doi": "10.1101/2024.11.02.621692", "pmid": "39554087", "publication_date": "2024-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4529, "title": "Psilocybin-unterstützte Psychotherapie reduziert Ängste und Depressionen", "authors": "Lamia Özgör", "journal": "InFo Hämatologie + Onkologie", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1007/s15004-024-0785-9", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404556355", "source_url": "https://doi.org/10.1007/s15004-024-0785-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.1007/s15004-024-0785-9", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15004-024-0785-9", "source_url": "https://doi.org/10.1007/s15004-024-0785-9", "doi": "10.1007/s15004-024-0785-9", "pmid": "", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 980, "title": "Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.", "authors": "Kim A, Halton B, Shah A, Seecof OM, Ross S", "journal": "Annals of palliative medicine", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.21037/apm-24-35", "pubmed_id": "39168642", "openalex_id": "https://openalex.org/W4401779935", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39168642/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39168642", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39168642/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39168642", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39168642/", "doi": "10.21037/apm-24-35", "pmid": "39168642", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 977, "title": "Psychoactive substances for the treatment of neuropsychiatric disorders.", "authors": "Zhen Z, Sun X, Yuan S, Zhang J", "journal": "Asian journal of psychiatry", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1016/j.ajp.2024.104193", "pubmed_id": "39243659", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39243659/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39243659", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39243659/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39243659", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39243659/", "doi": "10.1016/j.ajp.2024.104193", "pmid": "39243659", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 971, "title": "Optimized psilocybin production in tryptophan catabolism-repressed fungi.", "authors": "Janevska S, Weiser S, Huang Y, Lin J, Hoefgen S, Jojić K, Barber AE, Schäfer T, Fricke J, Hoffmeister D, Regestein L, Valiante V, Kufs JE", "journal": "Microbial biotechnology", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1111/1751-7915.70039", "pubmed_id": "39487767", "openalex_id": "https://openalex.org/W4404004370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39487767/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Eating Disorders,Genomics", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39487767", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39487767/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39487767", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39487767/", "doi": "10.1111/1751-7915.70039", "pmid": "39487767", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 970, "title": "Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.", "authors": "Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R", "journal": "Current psychiatry reports", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1007/s11920-024-01539-8", "pubmed_id": "39532819", "openalex_id": "https://openalex.org/W4404321372", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39532819/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39532819", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39532819/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39532819", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39532819/", "doi": "10.1007/s11920-024-01539-8", "pmid": "39532819", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 969, "title": "[Depression and effectiveness of psychedelics: high-dose psilocybin has shown benefits in improving symptoms.].", "authors": "Forte V, Shaughnessy AF, Kurotschka PK", "journal": "Recenti progressi in medicina", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1701/4365.43590", "pubmed_id": "39550651", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39550651/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39550651", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39550651", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39550651/", "doi": "10.1701/4365.43590", "pmid": "39550651", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 968, "title": "Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.", "authors": "Petridis PD, Grinband J, Agin-Liebes G, Kinslow CJ, Zeifman RJ, Bogenschutz MP, Griffiths RR, Ross S", "journal": "Nature. Mental health", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1038/s44220-024-00331-0", "pubmed_id": "41969367", "openalex_id": "https://openalex.org/W4403196849", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41969367/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:41969367", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41969367/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41969367", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41969367/", "doi": "10.1038/s44220-024-00331-0", "pmid": "41969367", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 927, "title": "Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: Case report and thematic analysis of one participant's experience", "authors": "Wahba M, Hayes C, Kletter M, McAllister-Williams RH", "journal": "BJPsych Open", "publication_date": "2024-10-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7139416359", "source_url": "https://openalex.org/W7139416359", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Case Report,Treatment-Resistant Depression,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:25:59", "bibtex": null, "source_record_id": "https://openalex.org/W7139416359", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://openalex.org/W7139416359", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://openalex.org/W7139416359", "source_url": "https://openalex.org/W7139416359", "doi": "", "pmid": "", "publication_date": "2024-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3644, "title": "Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-24", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03429075", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03429075", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03429075", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03429075", "source_url": "https://clinicaltrials.gov/study/NCT03429075", "doi": "", "pmid": "", "publication_date": "2024-10-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3098, "title": "The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice", "authors": "Fleury S, Nautiyal KM.", "journal": "bioRxiv", "publication_date": "2024-10-21", "publication_year": 2024, "doi": "10.1101/2024.10.18.618582", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.10.18.618582", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Emotional Processing,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:58", "bibtex": null, "source_record_id": "DOI:10.1101/2024.10.18.618582", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.10.18.618582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.10.18.618582", "source_url": "https://doi.org/10.1101/2024.10.18.618582", "doi": "10.1101/2024.10.18.618582", "pmid": "", "publication_date": "2024-10-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3784, "title": "Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.", "authors": "Hooper J, Gyongyosi E, Hutchison K, Mueller R.", "journal": "PsyArXiv", "publication_date": "2024-10-18", "publication_year": 2024, "doi": "10.31234/osf.io/u9yeg_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/u9yeg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:23", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/u9yeg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/u9yeg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/u9yeg_v1", "source_url": "https://doi.org/10.31234/osf.io/u9yeg_v1", "doi": "10.31234/osf.io/u9yeg_v1", "pmid": "", "publication_date": "2024-10-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3320, "title": "Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.", "authors": "Hooper J, Gyongyosi E, Hutchison K, Mueller R.", "journal": "PsyArXiv", "publication_date": "2024-10-18", "publication_year": 2024, "doi": "10.31234/osf.io/u9yeg", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/u9yeg", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:15:23", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/u9yeg", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/u9yeg", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/u9yeg", "source_url": "https://doi.org/10.31234/osf.io/u9yeg", "doi": "10.31234/osf.io/u9yeg", "pmid": "", "publication_date": "2024-10-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3319, "title": "Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.", "authors": "Jake Hooper, Emily Gyongyosi, Kent Hutchison, Raeghan Mueller", "journal": "PsyArXiv", "publication_date": "2024-10-18", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "source_url": "https://osf.io/preprints/psyarxiv/u9yeg_v1", "doi": "", "pmid": "", "publication_date": "2024-10-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4537, "title": "The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment", "authors": "Hannah Douglass", "journal": "Open MIND", "publication_date": "2024-10-10", "publication_year": 2024, "doi": "10.25560/118978", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166080670", "source_url": "https://hdl.handle.net/10044/1/118978", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Resilience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.25560/118978", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/10044/1/118978", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25560/118978", "source_url": "https://hdl.handle.net/10044/1/118978", "doi": "10.25560/118978", "pmid": "", "publication_date": "2024-10-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4541, "title": "Does psilocybin reduce symptoms of depression in adults with major depressive disorder or life-threatening cancer?", "authors": "Morgan Justin, Kerry Watrin", "journal": "Evidence-Based Practice", "publication_date": "2024-10-09", "publication_year": 2024, "doi": "10.1097/ebp.0000000000002281", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403272071", "source_url": "https://doi.org/10.1097/ebp.0000000000002281", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.1097/ebp.0000000000002281", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/ebp.0000000000002281", "source_url": "https://doi.org/10.1097/ebp.0000000000002281", "doi": "10.1097/ebp.0000000000002281", "pmid": "", "publication_date": "2024-10-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3750, "title": "Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol", "authors": "Pincombe J, Williams M, Carruthers S, Rossell S.", "journal": "PsyArXiv", "publication_date": "2024-10-07", "publication_year": 2024, "doi": "10.31234/osf.io/ga9p2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/ga9p2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Review Article", "study_type": "Review Article", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-08-09 08:15:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/ga9p2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/ga9p2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/ga9p2", "source_url": "https://doi.org/10.31234/osf.io/ga9p2", "doi": "10.31234/osf.io/ga9p2", "pmid": "", "publication_date": "2024-10-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3121, "title": "Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol", "authors": "Jennifer Pincombe, Martin Williams, Sean Carruthers, Susan Rossell", "journal": "PsyArXiv", "publication_date": "2024-10-07", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Review Article", "study_type": "Review Article", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "source_url": "https://osf.io/preprints/psyarxiv/ga9p2_v1", "doi": "", "pmid": "", "publication_date": "2024-10-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 995, "title": "Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.", "authors": "Dahan JDC, Dadiomov D, Bostoen T, Dahan A", "journal": "Npj mental health research", "publication_date": "2024-10-06", "publication_year": 2024, "doi": "10.1038/s44184-024-00091-w", "pubmed_id": "39369173", "openalex_id": "https://openalex.org/W4403151209", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39369173/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39369173", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39369173/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39369173", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39369173/", "doi": "10.1038/s44184-024-00091-w", "pmid": "39369173", "publication_date": "2024-10-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4542, "title": "Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis", "authors": "Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar", "journal": "Psychoactives", "publication_date": "2024-10-03", "publication_year": 2024, "doi": "10.3390/psychoactives3040029", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403113128", "source_url": "https://doi.org/10.3390/psychoactives3040029", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Pharmacology,Aging,Personality Change,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives3040029", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives3040029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives3040029", "source_url": "https://doi.org/10.3390/psychoactives3040029", "doi": "10.3390/psychoactives3040029", "pmid": "", "publication_date": "2024-10-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3332, "title": "From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.", "authors": "Schenberg EE.", "journal": "PsyArXiv", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.31234/osf.io/uxhv7", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/uxhv7", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:15:24", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/uxhv7", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/uxhv7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/uxhv7", "source_url": "https://doi.org/10.31234/osf.io/uxhv7", "doi": "10.31234/osf.io/uxhv7", "pmid": "", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3330, "title": "From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.", "authors": "Schenberg EE.", "journal": "PsyArXiv", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.31234/osf.io/uxhv7_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/uxhv7_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:15:24", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/uxhv7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/uxhv7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/uxhv7_v1", "source_url": "https://doi.org/10.31234/osf.io/uxhv7_v1", "doi": "10.31234/osf.io/uxhv7_v1", "pmid": "", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1013, "title": "Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.", "authors": "Conn K, Milton LK, Huang K, Munguba H, Ruuska J, Lemus MB, Greaves E, Homman-Ludiye J, Oldfield BJ, Foldi CJ", "journal": "Molecular psychiatry", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1038/s41380-024-02575-9", "pubmed_id": "38678087", "openalex_id": "https://openalex.org/W4395688958", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38678087/", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:38678087", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38678087/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38678087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38678087/", "doi": "10.1038/s41380-024-02575-9", "pmid": "38678087", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1011, "title": "Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.", "authors": "Nadeem Z, Parker S, McGovern H, Oestreich LK", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1177/00048674241261779", "pubmed_id": "38907608", "openalex_id": "https://openalex.org/W4399918457", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38907608/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:38907608", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38907608/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38907608", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38907608/", "doi": "10.1177/00048674241261779", "pmid": "38907608", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1008, "title": "Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.", "authors": "Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A", "journal": "CNS drugs", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1007/s40263-024-01101-3", "pubmed_id": "39033264", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39033264/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39033264", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39033264/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39033264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39033264/", "doi": "10.1007/s40263-024-01101-3", "pmid": "39033264", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1006, "title": "Psilocybin for clinical indications: A scoping review.", "authors": "Madden K, Flood B, Young Shing D, Ade-Conde M, Kashir I, Mark M, MacKillop J, Bhandari M, Adili A", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1177/02698811241269751", "pubmed_id": "39135496", "openalex_id": "https://openalex.org/W4401554225", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39135496/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Chronic Pain,Headache / Migraine,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39135496", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39135496/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39135496", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39135496/", "doi": "10.1177/02698811241269751", "pmid": "39135496", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1004, "title": "Letter to editor regarding \"Psilocybin-assisted therapy for depression: A systematic review and meta-analysis\".", "authors": "Yang X, Kuang W", "journal": "Psychiatry research", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.116136", "pubmed_id": "39141970", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39141970/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39141970", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39141970", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39141970/", "doi": "10.1016/j.psychres.2024.116136", "pmid": "39141970", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1003, "title": "The role of psilocybin in depressive disorders.", "authors": "Najib J", "journal": "Current medical research and opinion", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1080/03007995.2024.2396536", "pubmed_id": "39177339", "openalex_id": "https://openalex.org/W4401815070", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39177339/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39177339", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39177339/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39177339", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39177339/", "doi": "10.1080/03007995.2024.2396536", "pmid": "39177339", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1001, "title": "Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response.", "authors": "Calder AE, Rausch B, Liechti ME, Holze F, Hasler G", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1177/02698811241278873", "pubmed_id": "39302087", "openalex_id": "https://openalex.org/W4402680012", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39302087/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mystical Experience,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39302087", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39302087/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39302087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39302087/", "doi": "10.1177/02698811241278873", "pmid": "39302087", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 997, "title": "Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.", "authors": "Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R", "journal": "EClinicalMedicine", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1016/j.eclinm.2024.102799", "pubmed_id": "39764567", "openalex_id": "https://openalex.org/W4402747955", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39764567/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Safety,Contraindications", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39764567", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39764567/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39764567", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39764567/", "doi": "10.1016/j.eclinm.2024.102799", "pmid": "39764567", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1016, "title": "Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats.", "authors": "Fisher EL, Smith R, Conn K, Corcoran AW, Milton LK, Hohwy J, Foldi CJ", "journal": "Translational psychiatry", "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.1038/s41398-024-03103-7", "pubmed_id": "39349428", "openalex_id": "https://openalex.org/W4402975017", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39349428/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39349428", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39349428/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39349428", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39349428/", "doi": "10.1038/s41398-024-03103-7", "pmid": "39349428", "publication_date": "2024-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4546, "title": "The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement", "authors": "Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros", "journal": "Middle East Research Journal of Biological Sciences", "publication_date": "2024-09-28", "publication_year": 2024, "doi": "10.36348/merjbs.2024.v04i05.001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403659615", "source_url": "https://doi.org/10.36348/merjbs.2024.v04i05.001", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.36348/merjbs.2024.v04i05.001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36348/merjbs.2024.v04i05.001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36348/merjbs.2024.v04i05.001", "source_url": "https://doi.org/10.36348/merjbs.2024.v04i05.001", "doi": "10.36348/merjbs.2024.v04i05.001", "pmid": "", "publication_date": "2024-09-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3099, "title": "Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity", "authors": "Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P, Vollenweider F, Diaconescu A.", "journal": "Research Square", "publication_date": "2024-09-26", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4492873/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4492873/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:58", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4492873/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4492873/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4492873/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4492873/v1", "doi": "10.21203/rs.3.rs-4492873/v1", "pmid": "", "publication_date": "2024-09-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3592, "title": "An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder", "authors": "University of California, San Francisco", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-25", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05065294", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05065294", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05065294", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05065294", "source_url": "https://clinicaltrials.gov/study/NCT05065294", "doi": "", "pmid": "", "publication_date": "2024-09-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3151, "title": "Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice", "authors": "Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF.", "journal": "bioRxiv", "publication_date": "2024-09-24", "publication_year": 2024, "doi": "10.1101/2024.09.23.614626", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.09.23.614626", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:05", "bibtex": null, "source_record_id": "DOI:10.1101/2024.09.23.614626", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.09.23.614626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.09.23.614626", "source_url": "https://doi.org/10.1101/2024.09.23.614626", "doi": "10.1101/2024.09.23.614626", "pmid": "", "publication_date": "2024-09-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3034, "title": "Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans", "authors": "Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK, Johansen A, Stenbæk DS, Knudsen GM, Fisher PM.", "journal": "medRxiv", "publication_date": "2024-09-22", "publication_year": 2024, "doi": "10.1101/2024.09.19.24313958", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.09.19.24313958", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Healthy Volunteers", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:52", "bibtex": null, "source_record_id": "DOI:10.1101/2024.09.19.24313958", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.09.19.24313958", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.09.19.24313958", "source_url": "https://doi.org/10.1101/2024.09.19.24313958", "doi": "10.1101/2024.09.19.24313958", "pmid": "", "publication_date": "2024-09-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1018, "title": "Psychedelic research at a crossroads.", "authors": "Armstrong SB, Davis AK", "journal": "Science (New York, N.Y.)", "publication_date": "2024-09-20", "publication_year": 2024, "doi": "10.1126/science.adt1024", "pubmed_id": "39298596", "openalex_id": "https://openalex.org/W4402625697", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39298596/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39298596", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39298596/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39298596", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39298596/", "doi": "10.1126/science.adt1024", "pmid": "39298596", "publication_date": "2024-09-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3528, "title": "Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus", "authors": "University Hospital, Ghent", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06378229", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06378229", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06378229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06378229", "source_url": "https://clinicaltrials.gov/study/NCT06378229", "doi": "", "pmid": "", "publication_date": "2024-09-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4551, "title": "Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials", "authors": "Danielle B Rodrigues", "journal": "Journal of Complementary Medicine & Alternative Healthcare", "publication_date": "2024-09-16", "publication_year": 2024, "doi": "10.19080/jcmah.2024.13.555852", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408545862", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "doi": "10.19080/jcmah.2024.13.555852", "pmid": "", "publication_date": "2024-09-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4553, "title": "An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States", "authors": "Syed F. Rab, Charles L. Raison, Elliot Marseille", "journal": "Psychedelics.", "publication_date": "2024-09-13", "publication_year": 2024, "doi": "10.61373/pp024r.0025", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404378875", "source_url": "https://doi.org/10.61373/pp024r.0025", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.61373/pp024r.0025", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp024r.0025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp024r.0025", "source_url": "https://doi.org/10.61373/pp024r.0025", "doi": "10.61373/pp024r.0025", "pmid": "", "publication_date": "2024-09-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1025, "title": "Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.", "authors": "Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C", "journal": "The Cochrane database of systematic reviews", "publication_date": "2024-09-12", "publication_year": 2024, "doi": "10.1002/14651858.cd015383.pub2", "pubmed_id": "39260823", "openalex_id": "https://openalex.org/W4402500386", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39260823/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Headache / Migraine,Emotional Processing,Spirituality,Randomized Controlled Trial,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39260823", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39260823/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39260823", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39260823/", "doi": "10.1002/14651858.cd015383.pub2", "pmid": "39260823", "publication_date": "2024-09-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4559, "title": "Einmalig Psilocybin: antidepressive Effekte", "authors": "Arnim Quante", "journal": "PSYCH up2date", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1055/a-2185-5208", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402347011", "source_url": "http://dx.doi.org/10.1055/a-2185-5208", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.1055/a-2185-5208", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1055/a-2185-5208", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2185-5208", "source_url": "http://dx.doi.org/10.1055/a-2185-5208", "doi": "10.1055/a-2185-5208", "pmid": "", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1041, "title": "Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.", "authors": "Gattuso JJ, Wilson C, Hannan AJ, Renoir T", "journal": "Journal of neurochemistry", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1111/jnc.16017", "pubmed_id": "38019032", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38019032/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38019032", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38019032/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38019032", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38019032/", "doi": "10.1111/jnc.16017", "pmid": "38019032", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1038, "title": "Stutterers' experiences on classic psychedelics: A preliminary self-report study.", "authors": "Jackson ES, Goldway N, Gerlach-Houck H, Gold ND", "journal": "Journal of fluency disorders", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1016/j.jfludis.2024.106062", "pubmed_id": "38833909", "openalex_id": "https://openalex.org/W4397049703", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38833909/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Eating Disorders,Aging,Emotional Processing", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38833909", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38833909/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38833909", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38833909/", "doi": "10.1016/j.jfludis.2024.106062", "pmid": "38833909", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1036, "title": "Effects of psilocybin on uncertain punishment learning.", "authors": "Jacobs DS, Bogachuk AP, Le Moing CL, Moghaddam B", "journal": "Neurobiology of learning and memory", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1016/j.nlm.2024.107954", "pubmed_id": "38909970", "openalex_id": "https://openalex.org/W4399926705", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38909970/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38909970", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38909970/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38909970", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38909970/", "doi": "10.1016/j.nlm.2024.107954", "pmid": "38909970", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1034, "title": "Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.", "authors": "Guo Q, Guo L, Wang Y, Shang S", "journal": "Psychiatry research", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.116018", "pubmed_id": "38924903", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38924903/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38924903", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38924903/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38924903", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38924903/", "doi": "10.1016/j.psychres.2024.116018", "pmid": "38924903", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1030, "title": "[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].", "authors": "Jungwirth J, Bavato F, Quednow BB", "journal": "Der Nervenarzt", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1007/s00115-024-01727-0", "pubmed_id": "39196383", "openalex_id": "https://openalex.org/W4401966685", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39196383/", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39196383", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39196383/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39196383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39196383/", "doi": "10.1007/s00115-024-01727-0", "pmid": "39196383", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1029, "title": "Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.", "authors": "Federico S, Geo M, Entela M, Bachmann S, Elisa R, Silvio C, Zoë D, Louise P, Gabriel T, Joël B, Daniele Z", "journal": "Clinical case reports", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1002/ccr3.9305", "pubmed_id": "39219779", "openalex_id": "https://openalex.org/W4402098372", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39219779/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Case Report,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39219779", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39219779/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39219779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39219779/", "doi": "10.1002/ccr3.9305", "pmid": "39219779", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1028, "title": "Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?", "authors": "Treviranus GRS", "journal": "Psychiatria Danubina", "publication_date": "2024-09-01", "publication_year": 2024, "doi": null, "pubmed_id": "39378462", "openalex_id": "https://openalex.org/W4403283802", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39378462/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Mitochondrial Function", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:39378462", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39378462/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39378462", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39378462/", "doi": "", "pmid": "39378462", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4560, "title": "G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?", "authors": "Amany E. Ayad", "journal": "Ask the expert - Psychedelic substances", "publication_date": "2024-08-31", "publication_year": 2024, "doi": "10.1136/rapm-2024-esra.582", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402766768", "source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:37:59", "bibtex": null, "source_record_id": "DOI:10.1136/rapm-2024-esra.582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/rapm-2024-esra.582", "source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "doi": "10.1136/rapm-2024-esra.582", "pmid": "", "publication_date": "2024-08-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1049, "title": "Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.", "authors": "Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS", "journal": "BMJ (Clinical research ed.)", "publication_date": "2024-08-21", "publication_year": 2024, "doi": "10.1136/bmj-2023-078607", "pubmed_id": "39168500", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39168500/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39168500", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39168500/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39168500", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39168500/", "doi": "10.1136/bmj-2023-078607", "pmid": "39168500", "publication_date": "2024-08-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5804, "title": "Psilocybin, moralization and psychotherapy: a scoping review and a case report", "authors": "Emiliano Loria, Elisabetta Lalumera, Ambra D’Imperio", "journal": "Philosophical Psychology", "publication_date": "2024-08-20", "publication_year": 2024, "doi": "10.1080/09515089.2024.2389962", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401972979", "source_url": "https://doi.org/10.1080/09515089.2024.2389962", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Systematic Review,Review Article,Case Report", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:27", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.1080/09515089.2024.2389962", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/09515089.2024.2389962", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/09515089.2024.2389962", "source_url": "https://doi.org/10.1080/09515089.2024.2389962", "doi": "10.1080/09515089.2024.2389962", "pmid": "", "publication_date": "2024-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4566, "title": "Psilocybin in the Treatment of Mental Disorders", "authors": "Doğancan Sönmez, Aslı Enzel Koç", "journal": "DergiPark (Istanbul University)", "publication_date": "2024-08-19", "publication_year": 2024, "doi": "10.30708/mantar.1535344", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414850748", "source_url": "https://dergipark.org.tr/tr/pub/mantar/issue/91439/1535344", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.30708/mantar.1535344", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://dergipark.org.tr/tr/pub/mantar/issue/91439/1535344", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.30708/mantar.1535344", "source_url": "https://dergipark.org.tr/tr/pub/mantar/issue/91439/1535344", "doi": "10.30708/mantar.1535344", "pmid": "", "publication_date": "2024-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4565, "title": "Tripping on Utopia: Margaret Mead, the Cold War, and the troubled birth of psychedelic science By BenjaminBreen. New York: Grand Central Publishing, 2024. 384 pp.", "authors": "Jim Weil", "journal": "American Anthropologist", "publication_date": "2024-08-19", "publication_year": 2024, "doi": "10.1111/aman.28009", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401690921", "source_url": "http://dx.doi.org/10.1111/aman.28009", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Personality Change,Mystical Experience,Observational Study,Veterans,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.1111/aman.28009", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1111/aman.28009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/aman.28009", "source_url": "http://dx.doi.org/10.1111/aman.28009", "doi": "10.1111/aman.28009", "pmid": "", "publication_date": "2024-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1051, "title": "Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.", "authors": "Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M", "journal": "Brain sciences", "publication_date": "2024-08-18", "publication_year": 2024, "doi": "10.3390/brainsci14080829", "pubmed_id": "39199520", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39199520/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39199520", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39199520/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39199520", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39199520/", "doi": "10.3390/brainsci14080829", "pmid": "39199520", "publication_date": "2024-08-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4569, "title": "Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression", "authors": "Rodolfo Myronn de Melo Rodrigues", "journal": "Psychedelics.", "publication_date": "2024-08-12", "publication_year": 2024, "doi": "10.61373/pp024c.0022", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404285144", "source_url": "https://doi.org/10.61373/pp024c.0022", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.61373/pp024c.0022", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp024c.0022", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp024c.0022", "source_url": "https://doi.org/10.61373/pp024c.0022", "doi": "10.61373/pp024c.0022", "pmid": "", "publication_date": "2024-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3609, "title": "An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04433858", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04433858", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04433858", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04433858", "source_url": "https://clinicaltrials.gov/study/NCT04433858", "doi": "", "pmid": "", "publication_date": "2024-08-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3438, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms", "authors": "Brugmann University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-07", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06160232", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06160232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "source_url": "https://clinicaltrials.gov/study/NCT06160232", "doi": "", "pmid": "", "publication_date": "2024-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4572, "title": "Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression", "authors": "Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach", "journal": "Nature Mental Health", "publication_date": "2024-08-05", "publication_year": 2024, "doi": "10.1038/s44220-024-00298-y", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401339608", "source_url": "https://doi.org/10.1038/s44220-024-00298-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.1038/s44220-024-00298-y", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s44220-024-00298-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1038/s44220-024-00298-y", "source_url": "https://doi.org/10.1038/s44220-024-00298-y", "doi": "10.1038/s44220-024-00298-y", "pmid": "", "publication_date": "2024-08-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4574, "title": "Insights into the efficacy of psilocybin in treating depression and other disorders", "authors": "Sarah Jane Palmer", "journal": "British Journal of Neuroscience Nursing", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.12968/bjnn.2024.0046", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401907376", "source_url": "http://dx.doi.org/10.12968/bjnn.2024.0046", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.12968/bjnn.2024.0046", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12968/bjnn.2024.0046", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12968/bjnn.2024.0046", "source_url": "http://dx.doi.org/10.12968/bjnn.2024.0046", "doi": "10.12968/bjnn.2024.0046", "pmid": "", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1066, "title": "Is it now time to prepare psychiatry for a psychedelic future?", "authors": "Nutt D, Crome I, Young AH", "journal": "The British journal of psychiatry: the journal of mental science", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1192/bjp.2024.76", "pubmed_id": "38764044", "openalex_id": "https://openalex.org/W4398137313", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38764044/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38764044", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38764044/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38764044", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38764044/", "doi": "10.1192/bjp.2024.76", "pmid": "38764044", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1065, "title": "Psychedelic-assisted psychotherapy: where is the psychotherapy research?", "authors": "Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD", "journal": "Psychopharmacology", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1007/s00213-024-06620-x", "pubmed_id": "38782821", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38782821", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38782821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "doi": "10.1007/s00213-024-06620-x", "pmid": "38782821", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1064, "title": "Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.", "authors": "Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD", "journal": "Journal of psychiatric research", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1016/j.jpsychires.2024.05.051", "pubmed_id": "38850581", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38850581/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38850581", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38850581/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38850581", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38850581/", "doi": "10.1016/j.jpsychires.2024.05.051", "pmid": "38850581", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1062, "title": "The cyclical revival of psychedelics in psychiatric treatment.", "authors": "Appiani FJ, Caroff SN", "journal": "Current medical research and opinion", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1080/03007995.2024.2368725", "pubmed_id": "38880945", "openalex_id": "https://openalex.org/W4399756902", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38880945/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38880945", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38880945/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38880945", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38880945/", "doi": "10.1080/03007995.2024.2368725", "pmid": "38880945", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1061, "title": "Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.", "authors": "Korthuis PT, Hoffman K, Wilson-Poe AR, Luoma JB, Bazinet A, Pertl K, Morgan DL, Cook RR, Bielavitz S, Myers R, Wolf RC, McCarty D, Stauffer CS", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1177/02698811241257839", "pubmed_id": "38888164", "openalex_id": "https://openalex.org/W4399780176", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38888164/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38888164", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38888164/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38888164", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38888164/", "doi": "10.1177/02698811241257839", "pmid": "38888164", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1056, "title": "CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.", "authors": "Kaiserman A, Vanderjist L, Kornreich C", "journal": "Psychiatria Danubina", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.24869/psyd.2024.174", "pubmed_id": "39546645", "openalex_id": "https://openalex.org/W4400745472", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39546645/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39546645", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39546645/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39546645", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39546645/", "doi": "10.24869/psyd.2024.174", "pmid": "39546645", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4578, "title": "Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients", "authors": "V Suresh, Jitendra Lakhani, R Balaraman", "journal": "Journal of Natural Remedies", "publication_date": "2024-07-31", "publication_year": 2024, "doi": "10.18311/jnr/2024/35676", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401276469", "source_url": "http://dx.doi.org/10.18311/jnr/2024/35676", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Review Article,Cancer Patients", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.18311/jnr/2024/35676", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.18311/jnr/2024/35676", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.18311/jnr/2024/35676", "source_url": "http://dx.doi.org/10.18311/jnr/2024/35676", "doi": "10.18311/jnr/2024/35676", "pmid": "", "publication_date": "2024-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4580, "title": "From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions", "authors": "Claire Walker, Timothy Piatkowski, Jason Ferris, Emma Davies, Monica J. Barratt, Adam Winstock, Cheneal Puljević", "journal": "Journal of Psychopharmacology", "publication_date": "2024-07-28", "publication_year": 2024, "doi": "10.1177/02698811241265762", "pubmed_id": "39075756", "openalex_id": "https://openalex.org/W4401152982", "source_url": "https://doi.org/10.1177/02698811241265762", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 06:34:42", "bibtex": null, "source_record_id": "PMID:39075756", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241265762", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39075756", "source_url": "https://doi.org/10.1177/02698811241265762", "doi": "10.1177/02698811241265762", "pmid": "39075756", "publication_date": "2024-07-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3450, "title": "Psilocybin for the Treatment of Major Depressive Disorder", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2024-07-25", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05675800", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05675800", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05675800", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05675800", "source_url": "https://clinicaltrials.gov/study/NCT05675800", "doi": "", "pmid": "", "publication_date": "2024-07-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1071, "title": "Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis.", "authors": "Bader H, Farraj H, Maghnam J, Abu Omar Y", "journal": "World journal of clinical oncology", "publication_date": "2024-07-24", "publication_year": 2024, "doi": "10.5306/wjco.v15.i7.908", "pubmed_id": "39071471", "openalex_id": "https://openalex.org/W4400697733", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39071471/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Wellbeing,Meta-Analysis,Systematic Review,Review Article,Cancer Patients", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39071471", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39071471/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39071471", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39071471/", "doi": "10.5306/wjco.v15.i7.908", "pmid": "39071471", "publication_date": "2024-07-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1074, "title": "Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.", "authors": "de la Salle S, Kettner H, Thibault Lévesque J, Garel N, Dames S, Patchett-Marble R, Rej S, Gloeckler S, Erritzoe D, Carhart-Harris R, Greenway KT", "journal": "Scientific reports", "publication_date": "2024-07-17", "publication_year": 2024, "doi": "10.1038/s41598-024-66817-0", "pubmed_id": "39019922", "openalex_id": "https://openalex.org/W4400737202", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39019922/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Wellbeing,Spirituality,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:39019922", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39019922/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39019922", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39019922/", "doi": "10.1038/s41598-024-66817-0", "pmid": "39019922", "publication_date": "2024-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1078, "title": "[Psilocybin fungi microdose treatment in major depressive disorder: a case report].", "authors": "Zarankin M, Pellegrini MS, Zenteno F", "journal": "Vertex (Buenos Aires, Argentina)", "publication_date": "2024-07-10", "publication_year": 2024, "doi": "10.53680/vertex.v35i164.544", "pubmed_id": "39024488", "openalex_id": "https://openalex.org/W4400492401", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39024488/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Emotional Processing,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:39024488", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39024488/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39024488", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39024488/", "doi": "10.53680/vertex.v35i164.544", "pmid": "39024488", "publication_date": "2024-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1079, "title": "The Black Book of Psychotropic Dosing and Monitoring.", "authors": "DeBattista C, Schatzberg AF", "journal": "Psychopharmacology bulletin", "publication_date": "2024-07-08", "publication_year": 2024, "doi": "10.64719/pb.4493", "pubmed_id": "38993656", "openalex_id": "https://openalex.org/W2983072139", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38993656/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38993656", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38993656/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38993656", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38993656/", "doi": "10.64719/pb.4493", "pmid": "38993656", "publication_date": "2024-07-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4590, "title": "Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence", "authors": "Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek", "journal": "Current Psychopharmacologye", "publication_date": "2024-07-04", "publication_year": 2024, "doi": "10.2174/0122115560288779240628043307", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400323479", "source_url": "https://doi.org/10.2174/0122115560288779240628043307", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:28", "bibtex": null, "source_record_id": "DOI:10.2174/0122115560288779240628043307", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0122115560288779240628043307", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/0122115560288779240628043307", "source_url": "https://doi.org/10.2174/0122115560288779240628043307", "doi": "10.2174/0122115560288779240628043307", "pmid": "", "publication_date": "2024-07-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1080, "title": "Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.", "authors": "Poulin JM, Bigford GE, Lanctôt KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, Husain MI, Rosenblat JD, Cao X, MacIntosh BJ, Nestor SM", "journal": "Trials", "publication_date": "2024-07-03", "publication_year": 2024, "doi": "10.1186/s13063-024-08268-6", "pubmed_id": "38956594", "openalex_id": "https://openalex.org/W4400306738", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38956594/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Randomized Controlled Trial,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38956594", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38956594/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38956594", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38956594/", "doi": "10.1186/s13063-024-08268-6", "pmid": "38956594", "publication_date": "2024-07-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4594, "title": "Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008-2019", "authors": "Lauren Gorfinkel, Julia M. Bujno, Claire Walsh, Dvora Shmulewitz, Deborah S. Hasin", "journal": "Drug and Alcohol Dependence", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1016/j.drugalcdep.2023.110267", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400574683", "source_url": "https://doi.org/10.1016/j.drugalcdep.2023.110267", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:28", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2023.110267", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2023.110267", "source_url": "https://doi.org/10.1016/j.drugalcdep.2023.110267", "doi": "10.1016/j.drugalcdep.2023.110267", "pmid": "", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1092, "title": "Psychedelic therapy in depression and substance use disorders.", "authors": "Korkmaz ND, Cikrikcili U, Akan M, Yucesan E", "journal": "The European journal of neuroscience", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1111/ejn.16421", "pubmed_id": "38773750", "openalex_id": "https://openalex.org/W4398221612", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38773750/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Receptor Pharmacology,Emotional Processing,Cancer Patients,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38773750", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38773750/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38773750", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38773750/", "doi": "10.1111/ejn.16421", "pmid": "38773750", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1091, "title": "Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.", "authors": "Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X", "journal": "Psychiatry research", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115960", "pubmed_id": "38781672", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38781672/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38781672", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38781672", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38781672/", "doi": "10.1016/j.psychres.2024.115960", "pmid": "38781672", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1089, "title": "The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.", "authors": "Ramos L, Vicente SG", "journal": "Journal of clinical and experimental neuropsychology", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1080/13803395.2024.2363343", "pubmed_id": "38842300", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38842300/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Creativity,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38842300", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38842300/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38842300", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38842300/", "doi": "10.1080/13803395.2024.2363343", "pmid": "38842300", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1081, "title": "Treating Anxiety and Depression With Psilocybin Therapy.", "authors": "Hanstein AP, Felchlin C", "journal": "Radiologic technology", "publication_date": "2024-07-01", "publication_year": 2024, "doi": null, "pubmed_id": "39079732", "openalex_id": "https://openalex.org/W4401200580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39079732/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:39079732", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39079732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39079732/", "doi": "", "pmid": "39079732", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4601, "title": "IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?", "authors": "Nauman Ashraf", "journal": "Journal of Pakistan Psychiatric Society", "publication_date": "2024-06-30", "publication_year": 2024, "doi": "10.63050/jpps.21.02.935", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400219530", "source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Spirituality,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:28", "bibtex": null, "source_record_id": "DOI:10.63050/jpps.21.02.935", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.63050/jpps.21.02.935", "source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "doi": "10.63050/jpps.21.02.935", "pmid": "", "publication_date": "2024-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1103, "title": "At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.", "authors": "Parker C, Wood BM", "journal": "Social work", "publication_date": "2024-06-21", "publication_year": 2024, "doi": "10.1093/sw/swae019", "pubmed_id": "38697188", "openalex_id": "https://openalex.org/W4396599639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38697188/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38697188", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38697188/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38697188", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38697188/", "doi": "10.1093/sw/swae019", "pmid": "38697188", "publication_date": "2024-06-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3184, "title": "Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials", "authors": "Fluyau D, Kailasam VK, Revadigar N.", "journal": "medRxiv", "publication_date": "2024-06-20", "publication_year": 2024, "doi": "10.1101/2024.06.17.24308787", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.06.17.24308787", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Aging,Personality Change,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:08", "bibtex": null, "source_record_id": "DOI:10.1101/2024.06.17.24308787", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.06.17.24308787", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.06.17.24308787", "source_url": "https://doi.org/10.1101/2024.06.17.24308787", "doi": "10.1101/2024.06.17.24308787", "pmid": "", "publication_date": "2024-06-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1104, "title": "RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-,-diisopropyltryptamine.", "authors": "Bryson N, Alexander R, Asnis-Alibozek A, Ehlers MD", "journal": "ACS chemical neuroscience", "publication_date": "2024-06-19", "publication_year": 2024, "doi": "10.1021/acschemneuro.4c00058", "pubmed_id": "38758589", "openalex_id": "https://openalex.org/W4396988535", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38758589/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38758589", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38758589/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38758589", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38758589/", "doi": "10.1021/acschemneuro.4c00058", "pmid": "38758589", "publication_date": "2024-06-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1107, "title": "Licit use of illicit drugs for treating depression: the pill and the process.", "authors": "Torrado Pacheco A, Moghaddam B", "journal": "The Journal of clinical investigation", "publication_date": "2024-06-17", "publication_year": 2024, "doi": "10.1172/jci180217", "pubmed_id": "40047885", "openalex_id": "https://openalex.org/W4399715661", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047885/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Review Article,Animal Study,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:40047885", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40047885/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40047885", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047885/", "doi": "10.1172/jci180217", "pmid": "40047885", "publication_date": "2024-06-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1108, "title": "Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.", "authors": "Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS", "journal": "Journal of affective disorders", "publication_date": "2024-06-15", "publication_year": 2024, "doi": "10.1016/j.jad.2024.03.165", "pubmed_id": "38570038", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38570038/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Systematic Review,Review Article,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38570038", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38570038/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38570038", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38570038/", "doi": "10.1016/j.jad.2024.03.165", "pmid": "38570038", "publication_date": "2024-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4605, "title": "Psychedelics’ Use as Medicine Hits Significant Roadblock", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2024-06-12", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.07.7.54", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399577191", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "doi": "10.1176/appi.pn.2024.07.7.54", "pmid": "", "publication_date": "2024-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3445, "title": "A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "University of Sydney", "journal": "ClinicalTrials.gov", "publication_date": "2024-06-10", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06444243", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06444243", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "source_url": "https://clinicaltrials.gov/study/NCT06444243", "doi": "", "pmid": "", "publication_date": "2024-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3355, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "Dan Petrovitch, Sean M. Mitchell, Jason Van Allen, Andrew K. Littlefield", "journal": "PsyArXiv", "publication_date": "2024-06-10", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "doi": "", "pmid": "", "publication_date": "2024-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4611, "title": "Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor", "authors": "Ouliana Panova, Nichols D.E, Shoichet B.K, Lyu J, Georgios Skiniotis, Che T, Roth B.L, DiBerto J.F, Daniel Wacker, Robertson M.J, Kami Kim, Krumm B.E, Seven A.B", "journal": "UNC Libraries", "publication_date": "2024-06-07", "publication_year": 2024, "doi": "10.17615/yb2v-ca64", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400050300", "source_url": "https://doi.org/10.17615/yb2v-ca64", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.17615/yb2v-ca64", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17615/yb2v-ca64", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17615/yb2v-ca64", "source_url": "https://doi.org/10.17615/yb2v-ca64", "doi": "10.17615/yb2v-ca64", "pmid": "", "publication_date": "2024-06-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3724, "title": "Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.", "authors": "Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S", "journal": "Pharmacology & therapeutics", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1016/j.pharmthera.2024.108641", "pubmed_id": "38583670", "openalex_id": "https://openalex.org/W4394009974", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38583670/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Biomarkers,Review Article,Animal Study,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 11:08:41", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38583670", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38583670/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38583670", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38583670/", "doi": "10.1016/j.pharmthera.2024.108641", "pmid": "38583670", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1126, "title": "[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].", "authors": "Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A", "journal": "Fortschritte der Neurologie-Psychiatrie", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1055/a-2046-5202", "pubmed_id": "37207669", "openalex_id": "https://openalex.org/W4377088482", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37207669/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:37207669", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37207669/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37207669", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37207669/", "doi": "10.1055/a-2046-5202", "pmid": "37207669", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1123, "title": "Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.", "authors": "Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Sackeim HA, Suppes T", "journal": "JAMA psychiatry", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2023.4685", "pubmed_id": "38055270", "openalex_id": "https://openalex.org/W4389397550", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38055270/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38055270", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38055270/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38055270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38055270/", "doi": "10.1001/jamapsychiatry.2023.4685", "pmid": "38055270", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1122, "title": "Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.", "authors": "Szigeti B, Weiss B, Rosas FE, Erritzoe D, Nutt D, Carhart-Harris R", "journal": "Psychological medicine", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1017/s0033291723003653", "pubmed_id": "38247730", "openalex_id": "https://openalex.org/W4391109410", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38247730/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38247730", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38247730/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38247730", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38247730/", "doi": "10.1017/s0033291723003653", "pmid": "38247730", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1121, "title": "Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases", "authors": "Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D, Young A, Aarsland D, Vernon A, Thuret S.", "journal": "Pharmacology & therapeutics", "publication_date": "2024-06-01", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC11847495", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:15:17", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC11847495", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC11847495", "source_url": "https://europepmc.org/article/PMC/PMC11847495", "doi": "", "pmid": "", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1120, "title": "Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.", "authors": "Fried EI, Cristea IA, Naudet F", "journal": "JAMA psychiatry", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.0420", "pubmed_id": "38598200", "openalex_id": "https://openalex.org/W4394676727", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598200/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38598200", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38598200/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38598200", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598200/", "doi": "10.1001/jamapsychiatry.2024.0420", "pmid": "38598200", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1119, "title": "Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.", "authors": "Aaronson ST, van der Vaart A, Sackeim HA", "journal": "JAMA psychiatry", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.0423", "pubmed_id": "38598225", "openalex_id": "https://openalex.org/W4394687929", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598225/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38598225", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38598225", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598225/", "doi": "10.1001/jamapsychiatry.2024.0423", "pmid": "38598225", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1117, "title": "The Intersection of Mental Health and Sexual and Gender Minority Identities for Older Adults Living with Human Immunodeficiency Virus: A Narrative Review.", "authors": "Agor D, Knettel BA, Daici K, Meanley S", "journal": "The Nursing clinics of North America", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1016/j.cnur.2024.01.005", "pubmed_id": "38670693", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38670693/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Review Article,Older Adults", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38670693", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38670693/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38670693", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38670693/", "doi": "10.1016/j.cnur.2024.01.005", "pmid": "38670693", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1105, "title": "Impact of Psilocybin on Peripheral Cytokine Production.", "authors": "DiRenzo D, Barrett FS, Perin J, Darrah E, Christopher-Stine L, Griffiths RR", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0039", "pubmed_id": "40051582", "openalex_id": "https://openalex.org/W4392242985", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051582/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:40051582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051582/", "doi": "10.1089/psymed.2023.0039", "pmid": "40051582", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1127, "title": "Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.", "authors": "Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM", "journal": "Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology", "publication_date": "2024-05-31", "publication_year": 2024, "doi": "10.9758/cpn.23.1134", "pubmed_id": "38627070", "openalex_id": "https://openalex.org/W4389203746", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38627070/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Default Mode Network,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38627070", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38627070/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38627070", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38627070/", "doi": "10.9758/cpn.23.1134", "pmid": "38627070", "publication_date": "2024-05-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3277, "title": "On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.", "authors": "Hoyer D.", "journal": "Authorea Preprints", "publication_date": "2024-05-23", "publication_year": 2024, "doi": "10.22541/au.171648613.31141136/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:18", "bibtex": null, "source_record_id": "DOI:10.22541/au.171648613.31141136/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.22541/au.171648613.31141136/v1", "source_url": "https://doi.org/10.22541/au.171648613.31141136/v1", "doi": "10.22541/au.171648613.31141136/v1", "pmid": "", "publication_date": "2024-05-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1132, "title": "Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.", "authors": "Bhagavan C, Glue P, Evans W, Reynolds L, Turner T, King C, Russell BR, Morunga E, Mills JL, Layton G, Menkes DB", "journal": "Trials", "publication_date": "2024-05-21", "publication_year": 2024, "doi": "10.1186/s13063-024-08174-x", "pubmed_id": "38773523", "openalex_id": "https://openalex.org/W4398156539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38773523/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Wellbeing,Personality Change,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38773523", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38773523/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38773523", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38773523/", "doi": "10.1186/s13063-024-08174-x", "pmid": "38773523", "publication_date": "2024-05-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3118, "title": "Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats", "authors": "Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ.", "journal": "bioRxiv", "publication_date": "2024-05-17", "publication_year": 2024, "doi": "10.1101/2024.05.16.594614", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.05.16.594614", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:00", "bibtex": null, "source_record_id": "DOI:10.1101/2024.05.16.594614", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.05.16.594614", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.05.16.594614", "source_url": "https://doi.org/10.1101/2024.05.16.594614", "doi": "10.1101/2024.05.16.594614", "pmid": "", "publication_date": "2024-05-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1133, "title": "Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor.", "authors": "Harari R, Chatterjee I, Getselter D, Elliott E", "journal": "iScience", "publication_date": "2024-05-17", "publication_year": 2024, "doi": "10.1016/j.isci.2024.109686", "pubmed_id": "38660396", "openalex_id": "https://openalex.org/W4394602238", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38660396/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38660396", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38660396/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38660396", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38660396/", "doi": "10.1016/j.isci.2024.109686", "pmid": "38660396", "publication_date": "2024-05-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4623, "title": "Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens", "authors": "Shunichiro Ikeda, Toshihiko Kinoshita", "journal": "Psychiatry and Clinical Neurosciences Reports", "publication_date": "2024-05-16", "publication_year": 2024, "doi": "10.1002/pcn5.196", "pubmed_id": null, "openalex_id": "https://openalex.org/W4397013596", "source_url": "https://doi.org/10.1002/pcn5.196", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.1002/pcn5.196", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pcn5.196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pcn5.196", "source_url": "https://doi.org/10.1002/pcn5.196", "doi": "10.1002/pcn5.196", "pmid": "", "publication_date": "2024-05-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4624, "title": "Psilocybin as a new way for depression treatment", "authors": "Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Mazurek, Wiktoria Wilanowska", "journal": "Journal of Education Health and Sport", "publication_date": "2024-05-15", "publication_year": 2024, "doi": "10.12775/jehs.2024.68.50168", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396937684", "source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2024.68.50168", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2024.68.50168", "source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "doi": "10.12775/jehs.2024.68.50168", "pmid": "", "publication_date": "2024-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1135, "title": "Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.", "authors": "Copa D, Erritzoe D, Giribaldi B, Nutt D, Carhart-Harris R, Tagliazucchi E", "journal": "Journal of affective disorders", "publication_date": "2024-05-15", "publication_year": 2024, "doi": "10.1016/j.jad.2024.02.089", "pubmed_id": "38423367", "openalex_id": "https://openalex.org/W4392203910", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38423367/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38423367", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38423367/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38423367", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38423367/", "doi": "10.1016/j.jad.2024.02.089", "pmid": "38423367", "publication_date": "2024-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4628, "title": "Calls to Poison Centers Involving Psilocybin Rising in Youth", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-05-10", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.06.6.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396797833", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.06.6.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.06.6.2", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "doi": "10.1176/appi.pn.2024.06.6.2", "pmid": "", "publication_date": "2024-05-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1138, "title": "Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT Receptor Agonists.", "authors": "M Ro Rsted E, Jensen AA, Smits G, Frydenvang K, Kristensen JL", "journal": "Journal of medicinal chemistry", "publication_date": "2024-05-09", "publication_year": 2024, "doi": "10.1021/acs.jmedchem.4c00082", "pubmed_id": "38648420", "openalex_id": "https://openalex.org/W4394993604", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38648420/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38648420", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38648420/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38648420", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38648420/", "doi": "10.1021/acs.jmedchem.4c00082", "pmid": "38648420", "publication_date": "2024-05-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3534, "title": "An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients", "authors": "Nova Mentis Life Science Corp", "journal": "ClinicalTrials.gov", "publication_date": "2024-05-08", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05832255", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Biomarkers,Microdosing,Review Article,Healthcare Workers,Toxicity,Inflammation", "study_type": "Review Article", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05832255", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05832255", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05832255", "source_url": "https://clinicaltrials.gov/study/NCT05832255", "doi": "", "pmid": "", "publication_date": "2024-05-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1139, "title": "EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.", "authors": "British Medical Journal Publishing Group", "journal": "BMJ (Clinical research ed.)", "publication_date": "2024-05-04", "publication_year": 2024, "doi": "10.1136/bmj.q1025", "pubmed_id": "38704154", "openalex_id": "https://openalex.org/W4396634501", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38704154/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38704154", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38704154/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38704154", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38704154/", "doi": "10.1136/bmj.q1025", "pmid": "38704154", "publication_date": "2024-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4631, "title": "Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders", "authors": "Brancaccio Hanna", "journal": "Research Posters", "publication_date": "2024-05-02", "publication_year": 2024, "doi": "10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401380403", "source_url": "https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Review Article,Animal Study", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:35:11", "bibtex": null, "source_record_id": "DOI:10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "source_url": "https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "doi": "10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024", "pmid": "", "publication_date": "2024-05-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4633, "title": "From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine", "authors": "Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie", "journal": "European Journal of Arts Humanities and Social Sciences", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.59324/ejahss.2024.1(3).10", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399259513", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "doi": "10.59324/ejahss.2024.1(3).10", "pmid": "", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2991, "title": "Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.", "authors": "Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maeda K, González-Maeso J, Kitagaki S, Hiramatsu M", "journal": "Naunyn-Schmiedeberg's archives of pharmacology", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1007/s00210-023-02778-x", "pubmed_id": "37874338", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37874338/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:37874338", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37874338/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37874338", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37874338/", "doi": "10.1007/s00210-023-02778-x", "pmid": "37874338", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1154, "title": "Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.", "authors": "Holze F, Singh N, Liechti ME, D'Souza DC", "journal": "Biological psychiatry. Cognitive neuroscience and neuroimaging", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1016/j.bpsc.2024.01.007", "pubmed_id": "38301886", "openalex_id": "https://openalex.org/W4391451404", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38301886/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38301886", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38301886/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38301886", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38301886/", "doi": "10.1016/j.bpsc.2024.01.007", "pmid": "38301886", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1148, "title": "Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.", "authors": "Erritzoe D, Barba T, Spriggs MJ, Rosas FE, Nutt DJ, Carhart-Harris R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1177/02698811241237870", "pubmed_id": "38520045", "openalex_id": "https://openalex.org/W4393118291", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38520045/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38520045", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38520045/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38520045", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38520045/", "doi": "10.1177/02698811241237870", "pmid": "38520045", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1147, "title": "Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.", "authors": "Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y", "journal": "Psychiatry research", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115886", "pubmed_id": "38574699", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38574699/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Headache / Migraine,Personality Change,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38574699", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38574699/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38574699", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38574699/", "doi": "10.1016/j.psychres.2024.115886", "pmid": "38574699", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1145, "title": "Psychedelics and the 'inner healer': Myth or mechanism?", "authors": "Peill J, Marguilho M, Erritzoe D, Barba T, Greenway KT, Rosas F, Timmermann C, Carhart-Harris R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1177/02698811241239206", "pubmed_id": "38605658", "openalex_id": "https://openalex.org/W4394755797", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38605658/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38605658", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38605658/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38605658", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38605658/", "doi": "10.1177/02698811241239206", "pmid": "38605658", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1143, "title": "Psilocybin for depression.", "authors": "De Giorgi R, Ede R", "journal": "BMJ (Clinical research ed.)", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1136/bmj.q798", "pubmed_id": "38692675", "openalex_id": "https://openalex.org/W4396588870", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38692675/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38692675", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38692675", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38692675/", "doi": "10.1136/bmj.q798", "pmid": "38692675", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1142, "title": "Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.", "authors": "Metaxa AM, Clarke M", "journal": "BMJ (Clinical research ed.)", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1136/bmj-2023-078084", "pubmed_id": "38692686", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38692686/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38692686", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38692686/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38692686", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38692686/", "doi": "10.1136/bmj-2023-078084", "pmid": "38692686", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1141, "title": "New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.", "authors": "Ruan Y, Yuan R, He J, Jiang Y, Chu S, Chen N", "journal": "Cell death discovery", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1038/s41420-024-01974-9", "pubmed_id": "38693106", "openalex_id": "https://openalex.org/W4396546274", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38693106/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Epigenetics,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38693106", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38693106/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38693106", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38693106/", "doi": "10.1038/s41420-024-01974-9", "pmid": "38693106", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1159, "title": "Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon.", "authors": "Bellman V", "journal": "Cancers", "publication_date": "2024-04-27", "publication_year": 2024, "doi": "10.3390/cancers16091702", "pubmed_id": "38730654", "openalex_id": "https://openalex.org/W4396230194", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38730654/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Review Article,Cancer Patients", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38730654", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38730654/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38730654", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38730654/", "doi": "10.3390/cancers16091702", "pmid": "38730654", "publication_date": "2024-04-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4638, "title": "MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-04-23", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.05.5.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4395032120", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "doi": "10.1176/appi.pn.2024.05.5.1", "pmid": "", "publication_date": "2024-04-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3434, "title": "The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2024-04-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04630964", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04630964", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "source_url": "https://clinicaltrials.gov/study/NCT04630964", "doi": "", "pmid": "", "publication_date": "2024-04-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5806, "title": "Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review", "authors": "Sarosh Nawaz, Abdulaziz Mohammed Althwanay, Esraa M. AlEdani MB Ch B, Harleen Kaur, Malik Kasapoglu, Rajesh Yadavalli, Ann Kashmer Yu", "journal": "Journal For International Medical Graduates", "publication_date": "2024-04-18", "publication_year": 2024, "doi": "10.56570/jimgs.v1i1.155", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394918793", "source_url": "http://dx.doi.org/10.56570/jimgs.v1i1.155", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Consciousness,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:30", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.56570/jimgs.v1i1.155", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56570/jimgs.v1i1.155", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56570/jimgs.v1i1.155", "source_url": "http://dx.doi.org/10.56570/jimgs.v1i1.155", "doi": "10.56570/jimgs.v1i1.155", "pmid": "", "publication_date": "2024-04-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1166, "title": "Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.", "authors": "Sloshower J, Zeifman RJ, Guss J, Krause R, Safi-Aghdam H, Pathania S, Pittman B, D'Souza DC", "journal": "Scientific reports", "publication_date": "2024-04-17", "publication_year": 2024, "doi": "10.1038/s41598-024-58318-x", "pubmed_id": "38632313", "openalex_id": "https://openalex.org/W4394886406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38632313/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Psychological Flexibility,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38632313", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38632313/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38632313", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38632313/", "doi": "10.1038/s41598-024-58318-x", "pmid": "38632313", "publication_date": "2024-04-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4639, "title": "Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression", "authors": "Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden", "journal": "Psychoactives", "publication_date": "2024-04-15", "publication_year": 2024, "doi": "10.3390/psychoactives3020014", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394855468", "source_url": "https://doi.org/10.3390/psychoactives3020014", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 06:34:43", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives3020014", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives3020014", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives3020014", "source_url": "https://doi.org/10.3390/psychoactives3020014", "doi": "10.3390/psychoactives3020014", "pmid": "", "publication_date": "2024-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4642, "title": "Who will staff the psychedelic resurgence?", "authors": "Erika Dyck", "journal": "Open Access Government", "publication_date": "2024-04-09", "publication_year": 2024, "doi": "10.56367/oag-042-10690", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394904988", "source_url": "http://dx.doi.org/10.56367/oag-042-10690", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.56367/oag-042-10690", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56367/oag-042-10690", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56367/oag-042-10690", "source_url": "http://dx.doi.org/10.56367/oag-042-10690", "doi": "10.56367/oag-042-10690", "pmid": "", "publication_date": "2024-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3726, "title": "[Psychedelic psychiatry].", "authors": "López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J", "journal": "Lakartidningen", "publication_date": "2024-04-04", "publication_year": 2024, "doi": null, "pubmed_id": "38572715", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38572715/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 11:08:41", "last_checked": "2026-08-09 08:34:30", "bibtex": null, "source_record_id": "PMID:38572715", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38572715/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38572715", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38572715/", "doi": "", "pmid": "38572715", "publication_date": "2024-04-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4658, "title": "Current situation regarding psychedelics and magic mushroom in Korea", "authors": "J. S. Seo", "journal": "European Psychiatry", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.1695", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401921810", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "doi": "10.1192/j.eurpsy.2024.1695", "pmid": "", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4655, "title": "Fallbeispiele zur Therapie der rezidivierenden Depression mit Psilocybin", "authors": "Eva Maria Schindowski, Franz X. Vollenweider", "journal": "Nervenheilkunde", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1055/a-2283-0221", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396883294", "source_url": "http://dx.doi.org/10.1055/a-2283-0221", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1055/a-2283-0221", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1055/a-2283-0221", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2283-0221", "source_url": "http://dx.doi.org/10.1055/a-2283-0221", "doi": "10.1055/a-2283-0221", "pmid": "", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4646, "title": "Microdosing psychedelics in the treatment of ADHD and comorbid disorders", "authors": "Kim P. C. Kuypers", "journal": "European Psychiatry", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.44", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401920710", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Default Mode Network,Microdosing,Personality Change,Emotional Processing,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.44", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.44", "source_url": "https://doi.org/10.1192/j.eurpsy.2024.44", "doi": "10.1192/j.eurpsy.2024.44", "pmid": "", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1186, "title": "Evidence versus expectancy: the development of psilocybin therapy.", "authors": "Rucker JJ", "journal": "BJPsych bulletin", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1192/bjb.2023.28", "pubmed_id": "37246405", "openalex_id": "https://openalex.org/W4378640469", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37246405/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:37246405", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37246405/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37246405", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37246405/", "doi": "10.1192/bjb.2023.28", "pmid": "37246405", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1185, "title": "Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala.", "authors": "Kelly TJ, Bonniwell EM, Mu L, Liu X, Hu Y, Friedman V, Yu H, Su W, McCorvy JD, Liu QS", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1038/s41386-023-01744-8", "pubmed_id": "37752222", "openalex_id": "https://openalex.org/W4387047256", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37752222/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:37752222", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37752222/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37752222", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37752222/", "doi": "10.1038/s41386-023-01744-8", "pmid": "37752222", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1183, "title": "Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.", "authors": "Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders JJ, Ljuslin M, Guérin B, Thambi P, Tulsky JA, Agrawal M", "journal": "Cancer", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1002/cncr.35024", "pubmed_id": "38105653", "openalex_id": "https://openalex.org/W4389895437", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105653/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Cancer Patients,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38105653", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38105653/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38105653", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105653/", "doi": "10.1002/cncr.35024", "pmid": "38105653", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1182, "title": "Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.", "authors": "Thrul J, Kozak Z, Carducci MA, Garcia-Romeu A, Yaden DB", "journal": "Cancer", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1002/cncr.35127", "pubmed_id": "38105654", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105654/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38105654", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38105654", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105654/", "doi": "10.1002/cncr.35127", "pmid": "38105654", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1181, "title": "Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.", "authors": "Agrawal M, Richards W, Beaussant Y, Shnayder S, Ameli R, Roddy K, Stevens N, Richards B, Schor N, Honstein H, Jenkins B, Bates M, Thambi P", "journal": "Cancer", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1002/cncr.35010", "pubmed_id": "38105655", "openalex_id": "https://openalex.org/W4389900078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105655/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38105655", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38105655/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38105655", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105655/", "doi": "10.1002/cncr.35010", "pmid": "38105655", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1177, "title": "A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.", "authors": "Wong S, Kwan ATH, Teopiz KM, Le GH, Meshkat S, Ho R, d'Andrea G, Cao B, Di Vincenzo JD, Rosenblat JD, McIntyre RS", "journal": "Journal of affective disorders", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1016/j.jad.2024.01.142", "pubmed_id": "38244804", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38244804/", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38244804", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38244804/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38244804", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38244804/", "doi": "10.1016/j.jad.2024.01.142", "pmid": "38244804", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1172, "title": "Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.", "authors": "Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J", "journal": "JAMA network open", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.5960", "pubmed_id": "38598236", "openalex_id": "https://openalex.org/W4394693583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598236/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38598236", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38598236/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38598236", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598236/", "doi": "10.1001/jamanetworkopen.2024.5960", "pmid": "38598236", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1189, "title": "Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights.", "authors": "Laabi S, LeMmon C, Vogel C, Chacon M, Jimenez VM", "journal": "International immunopharmacology", "publication_date": "2024-03-30", "publication_year": 2024, "doi": "10.1016/j.intimp.2024.111753", "pubmed_id": "38401463", "openalex_id": "https://openalex.org/W4392119029", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38401463/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Toxicity,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38401463", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38401463/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38401463", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38401463/", "doi": "10.1016/j.intimp.2024.111753", "pmid": "38401463", "publication_date": "2024-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1190, "title": "Methyl transfer in psilocybin biosynthesis.", "authors": "Hudspeth J, Rogge K, Dörner S, Müll M, Hoffmeister D, Rupp B, Werten S", "journal": "Nature communications", "publication_date": "2024-03-28", "publication_year": 2024, "doi": "10.1038/s41467-024-46997-z", "pubmed_id": "38548735", "openalex_id": "https://openalex.org/W4393270574", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38548735/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Epigenetics,Transcriptomics", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38548735", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38548735/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38548735", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38548735/", "doi": "10.1038/s41467-024-46997-z", "pmid": "38548735", "publication_date": "2024-03-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5659, "title": "Psychedelics: reconnecting the brain to heal the mind", "authors": "David Nutt", "journal": "The Biochemist", "publication_date": "2024-03-25", "publication_year": 2024, "doi": "10.1042/bio_2023_156", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393157656", "source_url": "https://doi.org/10.1042/bio_2023_156", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:11", "last_checked": "2026-08-09 08:26:01", "bibtex": null, "source_record_id": "DOI:10.1042/bio_2023_156", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1042/bio_2023_156", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1042/bio_2023_156", "source_url": "https://doi.org/10.1042/bio_2023_156", "doi": "10.1042/bio_2023_156", "pmid": "", "publication_date": "2024-03-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4661, "title": "Psychedelic Drugs: A Mind-expanding Hallucinogens", "authors": "Shreyasee Das, Rahul Shil", "journal": "Indian Journal of Behavioural Sciences", "publication_date": "2024-03-22", "publication_year": 2024, "doi": "10.55229/ijbs.v27i1.13", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396671169", "source_url": "http://dx.doi.org/10.55229/ijbs.v27i1.13", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.55229/ijbs.v27i1.13", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.55229/ijbs.v27i1.13", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.55229/ijbs.v27i1.13", "source_url": "http://dx.doi.org/10.55229/ijbs.v27i1.13", "doi": "10.55229/ijbs.v27i1.13", "pmid": "", "publication_date": "2024-03-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4663, "title": "Psychedelic Renaissance: Evidence and Culture", "authors": "Adrian Preda", "journal": "Psychiatric News", "publication_date": "2024-03-21", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.39", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393030764", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Emotional Processing,Spirituality,Clinical Trial,Animal Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "doi": "10.1176/appi.pn.2024.04.4.39", "pmid": "", "publication_date": "2024-03-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1194, "title": "Ethical considerations for psychedelic-assisted therapy in military clinical settings.", "authors": "Hoener S, Wolfgang A, Nissan D, Howe E", "journal": "Journal of medical ethics", "publication_date": "2024-03-20", "publication_year": 2024, "doi": "10.1136/jme-2023-108943", "pubmed_id": "37253556", "openalex_id": "https://openalex.org/W4378782490", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37253556/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:37253556", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37253556/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37253556", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37253556/", "doi": "10.1136/jme-2023-108943", "pmid": "37253556", "publication_date": "2024-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4665, "title": "Scanning the new frontier of mental health: psychedelic brain imaging", "authors": "Natalie Ertl, Matthew B. Wall", "journal": "The Biochemist", "publication_date": "2024-03-14", "publication_year": 2024, "doi": "10.1042/bio_2023_171", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392799517", "source_url": "http://dx.doi.org/10.1042/bio_2023_171", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Emotional Processing,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1042/bio_2023_171", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1042/bio_2023_171", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1042/bio_2023_171", "source_url": "http://dx.doi.org/10.1042/bio_2023_171", "doi": "10.1042/bio_2023_171", "pmid": "", "publication_date": "2024-03-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4664, "title": "Psychedelic drugs and the law: What’s next?", "authors": "Ben Seal", "journal": "Knowable Magazine", "publication_date": "2024-03-14", "publication_year": 2024, "doi": "10.1146/knowable-031424-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392794286", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1146/knowable-031424-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1146/knowable-031424-2", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "doi": "10.1146/knowable-031424-2", "pmid": "", "publication_date": "2024-03-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1205, "title": "New evidence for flexible psilocybin dosing in patients with treatment-resistant depression.", "authors": "Aaronson ST, Kozak Z", "journal": "Med (New York, N.Y.)", "publication_date": "2024-03-08", "publication_year": 2024, "doi": "10.1016/j.medj.2024.01.014", "pubmed_id": "38359837", "openalex_id": "https://openalex.org/W4391810224", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359837/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38359837", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38359837/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38359837", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359837/", "doi": "10.1016/j.medj.2024.01.014", "pmid": "38359837", "publication_date": "2024-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1204, "title": "Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.", "authors": "Rosenblat JD, Meshkat S, Doyle Z, Kaczmarek E, Brudner RM, Kratiuk K, Mansur RB, Schulz-Quach C, Sethi R, Abate A, Ali S, Bawks J, Blainey MG, Brietzke E, Cronin V, Danilewitz J, Dhawan S, Di Fonzo A, Di Fonzo M, Drzadzewski P, Dunlop W, Fiszter H, Gomes FA, Grewal S, Leon-Carlyle M, McCallum M, Mofidi N, Offman H, Riva-Cambrin J, Schmidt J, Smolkin M, Quinn JM, Zumrova A, Marlborough M, McIntyre RS", "journal": "Med (New York, N.Y.)", "publication_date": "2024-03-08", "publication_year": 2024, "doi": "10.1016/j.medj.2024.01.005", "pubmed_id": "38359838", "openalex_id": "https://openalex.org/W4391810199", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359838/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Personality Change,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38359838", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38359838/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38359838", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359838/", "doi": "10.1016/j.medj.2024.01.005", "pmid": "38359838", "publication_date": "2024-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4667, "title": "Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder", "authors": "Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe", "journal": "International Journal of Mental Health and Addiction", "publication_date": "2024-03-07", "publication_year": 2024, "doi": "10.1007/s11469-024-01253-9", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392550813", "source_url": "https://doi.org/10.1007/s11469-024-01253-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1007/s11469-024-01253-9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s11469-024-01253-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s11469-024-01253-9", "source_url": "https://doi.org/10.1007/s11469-024-01253-9", "doi": "10.1007/s11469-024-01253-9", "pmid": "", "publication_date": "2024-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1208, "title": "A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.", "authors": "Velit-Salazar MR, Shiroma PR, Cherian E", "journal": "Brain sciences", "publication_date": "2024-03-03", "publication_year": 2024, "doi": "10.3390/brainsci14030248", "pubmed_id": "38539636", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38539636/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Emotional Processing,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38539636", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38539636/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38539636", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38539636/", "doi": "10.3390/brainsci14030248", "pmid": "38539636", "publication_date": "2024-03-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4671, "title": "Psilocybin zur Behandlung depressiver Erkrankungen", "authors": "Henning Hintzsche", "journal": "BIOspektrum", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1007/s12268-024-2157-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393593704", "source_url": "http://dx.doi.org/10.1007/s12268-024-2157-2", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1007/s12268-024-2157-2", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s12268-024-2157-2", "source_url": "http://dx.doi.org/10.1007/s12268-024-2157-2", "doi": "10.1007/s12268-024-2157-2", "pmid": "", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1213, "title": "Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT receptor the unique player?", "authors": "Sekssaoui M, Bockaert J, Marin P, Bécamel C", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1038/s41386-024-01794-6", "pubmed_id": "38212441", "openalex_id": "https://openalex.org/W4390755783", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38212441/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38212441", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38212441/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38212441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38212441/", "doi": "10.1038/s41386-024-01794-6", "pmid": "38212441", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1202, "title": "The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item.", "authors": "Strickland JC, Garcia-Romeu A, Johnson MW", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0046", "pubmed_id": "40051759", "openalex_id": "https://openalex.org/W4392242862", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051759/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mystical Experience,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:40051759", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051759/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051759", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051759/", "doi": "10.1089/psymed.2023.0046", "pmid": "40051759", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1201, "title": "American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey.", "authors": "Barnett BS, Arakelian M, Beebe D, Ontko J, Riegal C, Siu WO, Weleff J, Pope HG", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0036", "pubmed_id": "40051760", "openalex_id": "https://openalex.org/W4386824127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051760/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:40051760", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051760/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051760", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051760/", "doi": "10.1089/psymed.2023.0036", "pmid": "40051760", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1200, "title": "Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic.", "authors": "Hibicke M, Billac G, Nichols CD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0037", "pubmed_id": "40051761", "openalex_id": "https://openalex.org/W4392231460", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051761/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Longevity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:40051761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051761/", "doi": "10.1089/psymed.2023.0037", "pmid": "40051761", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1218, "title": "Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.", "authors": "Watford T, Masood N", "journal": "Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology", "publication_date": "2024-02-29", "publication_year": 2024, "doi": "10.9758/cpn.23.1120", "pubmed_id": "38247407", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38247407/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38247407", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38247407/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38247407", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38247407/", "doi": "10.9758/cpn.23.1120", "pmid": "38247407", "publication_date": "2024-02-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1223, "title": "Effect of a single psilocybin treatment on Fos protein expression in male rat brain.", "authors": "Funk D, Araujo J, Slassi M, Lanthier J, Atkinson J, Feng D, Lau W, Lê A, Higgins GA", "journal": "Neuroscience", "publication_date": "2024-02-16", "publication_year": 2024, "doi": "10.1016/j.neuroscience.2024.01.001", "pubmed_id": "38184069", "openalex_id": "https://openalex.org/W4390590130", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38184069/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Biomarkers,Emotional Processing,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38184069", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38184069/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38184069", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38184069/", "doi": "10.1016/j.neuroscience.2024.01.001", "pmid": "38184069", "publication_date": "2024-02-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1227, "title": "Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.", "authors": "Frautschi PC, Singh AP, Stowe NA, Yu JJ", "journal": "AJNR. American journal of neuroradiology", "publication_date": "2024-02-15", "publication_year": 2024, "doi": "10.3174/ajnr.a8118", "pubmed_id": "38360790", "openalex_id": "https://openalex.org/W4391838869", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38360790/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Brain Imaging,Mechanism of Action,Aging,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38360790", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38360790/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38360790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38360790/", "doi": "10.3174/ajnr.a8118", "pmid": "38360790", "publication_date": "2024-02-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1229, "title": "Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.", "authors": "Hernandez-Leon A, Escamilla-Orozco RI, Tabal-Robles AR, Martínez-Vargas D, Romero-Bautista L, Escamilla-Soto G, González-Romero OS, Torres-Valencia M, González-Trujano ME", "journal": "Journal of ethnopharmacology", "publication_date": "2024-02-10", "publication_year": 2024, "doi": "10.1016/j.jep.2023.117415", "pubmed_id": "37977425", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37977425/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Brain Imaging,Animal Study,Toxicity", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:37977425", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37977425/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37977425", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37977425/", "doi": "10.1016/j.jep.2023.117415", "pmid": "37977425", "publication_date": "2024-02-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1233, "title": "Effects of DMT on mental health outcomes in healthy volunteers.", "authors": "Timmermann C, Zeifman RJ, Erritzoe D, Nutt DJ, Carhart-Harris RL", "journal": "Scientific reports", "publication_date": "2024-02-07", "publication_year": 2024, "doi": "10.1038/s41598-024-53363-y", "pubmed_id": "38326357", "openalex_id": "https://openalex.org/W4391610480", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38326357/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Personality Change,Observational Study,Healthy Volunteers", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38326357", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38326357/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38326357", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38326357/", "doi": "10.1038/s41598-024-53363-y", "pmid": "38326357", "publication_date": "2024-02-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1231, "title": "Psychedelics and sexual functioning: a mixed-methods study.", "authors": "Barba T, Kettner H, Radu C, Peill JM, Roseman L, Nutt DJ, Erritzoe D, Carhart-Harris R, Giribaldi B", "journal": "Scientific reports", "publication_date": "2024-02-07", "publication_year": 2024, "doi": "10.1038/s41598-023-49817-4", "pubmed_id": "38326446", "openalex_id": "https://openalex.org/W4391630740", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38326446/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38326446", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38326446/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38326446", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38326446/", "doi": "10.1038/s41598-023-49817-4", "pmid": "38326446", "publication_date": "2024-02-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1235, "title": "Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.", "authors": "Breeksema JJ, Niemeijer A, Krediet E, Karsten T, Kamphuis J, Vermetten E, van den Brink W, Schoevers R", "journal": "Scientific reports", "publication_date": "2024-02-05", "publication_year": 2024, "doi": "10.1038/s41598-024-53188-9", "pubmed_id": "38316896", "openalex_id": "https://openalex.org/W4391540455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38316896/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38316896", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38316896/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38316896", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38316896/", "doi": "10.1038/s41598-024-53188-9", "pmid": "38316896", "publication_date": "2024-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4680, "title": "Psilocybin gegen Depressionen", "authors": "Thomas Müller", "journal": "CME", "publication_date": "2024-02-01", "publication_year": 2024, "doi": "10.1007/s11298-023-3754-y", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392731896", "source_url": "https://doi.org/10.1007/s11298-023-3754-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "DOI:10.1007/s11298-023-3754-y", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s11298-023-3754-y", "source_url": "https://doi.org/10.1007/s11298-023-3754-y", "doi": "10.1007/s11298-023-3754-y", "pmid": "", "publication_date": "2024-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1247, "title": "The development of psilocybin therapy for treatment-resistant depression: an update.", "authors": "Borissova A, Rucker JJ", "journal": "BJPsych bulletin", "publication_date": "2024-02-01", "publication_year": 2024, "doi": "10.1192/bjb.2023.25", "pubmed_id": "37357767", "openalex_id": "https://openalex.org/W4382010877", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37357767/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:37357767", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37357767/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37357767", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37357767/", "doi": "10.1192/bjb.2023.25", "pmid": "37357767", "publication_date": "2024-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1246, "title": "The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.", "authors": "Videira NB, Nair V, Paquet V, Calhoun D", "journal": "Journal of applied toxicology: JAT", "publication_date": "2024-02-01", "publication_year": 2024, "doi": "10.1002/jat.4533", "pubmed_id": "37646119", "openalex_id": "https://openalex.org/W4386272089", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37646119/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Emotional Processing,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:37646119", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37646119/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37646119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37646119/", "doi": "10.1002/jat.4533", "pmid": "37646119", "publication_date": "2024-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4677, "title": "Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach", "authors": "Phil Wolfson, Gita Vaid", "journal": "Frontiers in Psychiatry", "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1209419", "pubmed_id": "38362026", "openalex_id": "https://openalex.org/W4391444130", "source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 06:34:44", "bibtex": null, "source_record_id": "PMID:38362026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38362026", "source_url": "https://doi.org/10.3389/fpsyt.2024.1209419", "doi": "10.3389/fpsyt.2024.1209419", "pmid": "38362026", "publication_date": "2024-01-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3492, "title": "The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD", "authors": "Massachusetts General Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2024-01-24", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05381974", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05381974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05381974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05381974", "source_url": "https://clinicaltrials.gov/study/NCT05381974", "doi": "", "pmid": "", "publication_date": "2024-01-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4685, "title": "Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists", "authors": "Payal Ghosh, Debjeet Sur", "journal": "Current Psychiatry Research and Reviews", "publication_date": "2024-01-21", "publication_year": 2024, "doi": "10.2174/0126660822258502231120074036", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391067287", "source_url": "https://doi.org/10.2174/0126660822258502231120074036", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "DOI:10.2174/0126660822258502231120074036", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0126660822258502231120074036", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/0126660822258502231120074036", "source_url": "https://doi.org/10.2174/0126660822258502231120074036", "doi": "10.2174/0126660822258502231120074036", "pmid": "", "publication_date": "2024-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4686, "title": "Psychedelics for mental health: a biochemical perspective", "authors": "Javier González-Maeso", "journal": "The Biochemist", "publication_date": "2024-01-19", "publication_year": 2024, "doi": "10.1042/bio_2023_161", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391026101", "source_url": "http://dx.doi.org/10.1042/bio_2023_161", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "DOI:10.1042/bio_2023_161", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1042/bio_2023_161", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1042/bio_2023_161", "source_url": "http://dx.doi.org/10.1042/bio_2023_161", "doi": "10.1042/bio_2023_161", "pmid": "", "publication_date": "2024-01-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4687, "title": "Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma", "authors": "Kelsey Klute, Lou Lukas, Soonjo Hwang, Yeongjin Gwon, Mridula Krishnan, Jean L. Grem, Sunil R. Hingorani, Jody Koenig Kellas", "journal": "Cancer Research", "publication_date": "2024-01-15", "publication_year": 2024, "doi": "10.1158/1538-7445.panca2023-c001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390915346", "source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Brain Imaging,Cancer Patients,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1158/1538-7445.panca2023-c001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1158/1538-7445.panca2023-c001", "source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "doi": "10.1158/1538-7445.panca2023-c001", "pmid": "", "publication_date": "2024-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5807, "title": "How should psychotherapy proceed when adjoined with psychedelics?", "authors": "Marc J. Weintraub, David J. Miklowitz", "journal": "World Psychiatry", "publication_date": "2024-01-12", "publication_year": 2024, "doi": "10.1002/wps.21170", "pubmed_id": "38214635", "openalex_id": "https://openalex.org/W4390795044", "source_url": "https://doi.org/10.1002/wps.21170", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Consciousness,Emotional Processing,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:31", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "PMID:38214635", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.21170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38214635", "source_url": "https://doi.org/10.1002/wps.21170", "doi": "10.1002/wps.21170", "pmid": "38214635", "publication_date": "2024-01-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3145, "title": "MicroRNAs underlying the antidepressant effect of psilocybin - Establishing an nCounter pipeline for microRNA-quantification in the pig brain", "authors": "Kaadt E, Søkilde R, Hansen H, Raval N, Lundgaard L, Just J, Knudsen G, Elfving B.", "journal": "Research Square", "publication_date": "2024-01-12", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3787179/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3787179/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Inflammation", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:04", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3787179/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3787179/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3787179/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3787179/v1", "doi": "10.21203/rs.3.rs-3787179/v1", "pmid": "", "publication_date": "2024-01-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3752, "title": "Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study", "authors": "Swanson L, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson J, Schallmo M.", "journal": "PsyArXiv", "publication_date": "2024-01-11", "publication_year": 2024, "doi": "10.31234/osf.io/5rm62", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/5rm62", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/5rm62", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/5rm62", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/5rm62", "source_url": "https://doi.org/10.31234/osf.io/5rm62", "doi": "10.31234/osf.io/5rm62", "pmid": "", "publication_date": "2024-01-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3139, "title": "Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study", "authors": "Link Swanson, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D Evans, Jessica L. Nielson, Michael-Paul Schallmo", "journal": "PsyArXiv", "publication_date": "2024-01-11", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/5rm62_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/5rm62_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/5rm62_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/5rm62_v1", "source_url": "https://osf.io/preprints/psyarxiv/5rm62_v1", "doi": "", "pmid": "", "publication_date": "2024-01-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1260, "title": "Serotonin 2A Receptor (5-HTR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.", "authors": "Duan W, Cao D, Wang S, Cheng J", "journal": "Chemical reviews", "publication_date": "2024-01-10", "publication_year": 2024, "doi": "10.1021/acs.chemrev.3c00375", "pubmed_id": "38033123", "openalex_id": "https://openalex.org/W4389164252", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38033123/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38033123", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38033123/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38033123", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38033123/", "doi": "10.1021/acs.chemrev.3c00375", "pmid": "38033123", "publication_date": "2024-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1259, "title": "Rapid-acting antidepressant drugs modulate affective bias in rats.", "authors": "Hinchcliffe JK, Stuart SA, Wood CM, Bartlett J, Kamenish K, Arban R, Thomas CW, Selimbeyoglu A, Hurley S, Hengerer B, Gilmour G, Robinson ESJ", "journal": "Science translational medicine", "publication_date": "2024-01-10", "publication_year": 2024, "doi": "10.1126/scitranslmed.adi2403", "pubmed_id": "38198569", "openalex_id": "https://openalex.org/W4390691843", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38198569/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38198569", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38198569/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38198569", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38198569/", "doi": "10.1126/scitranslmed.adi2403", "pmid": "38198569", "publication_date": "2024-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3076, "title": "Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq", "authors": "Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W.", "journal": "bioRxiv", "publication_date": "2024-01-07", "publication_year": 2024, "doi": "10.1101/2024.01.07.573163", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.01.07.573163", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.1101/2024.01.07.573163", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.01.07.573163", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.01.07.573163", "source_url": "https://doi.org/10.1101/2024.01.07.573163", "doi": "10.1101/2024.01.07.573163", "pmid": "", "publication_date": "2024-01-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3174, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial", "authors": "Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X.", "journal": "Research Square", "publication_date": "2024-01-04", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3829237/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "doi": "10.21203/rs.3.rs-3829237/v1", "pmid": "", "publication_date": "2024-01-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5811, "title": "Psilocybin as a treatment for psychiatric disorders: a review of the literature", "authors": "Verneri Pellinen", "journal": "Työväentutkimus Vuosikirja", "publication_date": "2024-01-01", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7199794686", "source_url": "http://hdl.handle.net/10138/575808", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Personality Change,Emotional Processing,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:32", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "http://hdl.handle.net/10138/575808", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/10138/575808", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/10138/575808", "source_url": "http://hdl.handle.net/10138/575808", "doi": "", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4722, "title": "Psilocybin’s Role in Major Depressive Disorder: A Scoping Review", "authors": "Barajas, Carlos", "journal": "Digital Commons - George Fox University (George Fox University)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110533292", "source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Receptor Pharmacology,Consciousness,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "https://digitalcommons.georgefox.edu/dmsc/31", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.georgefox.edu/dmsc/31", "source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "doi": "", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4721, "title": "RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?", "authors": "R.S. Treviranus, Gottfried", "journal": "University of Zagreb University Computing Centre (SRCE)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.24869/psyd.2024.134", "pubmed_id": null, "openalex_id": "https://openalex.org/W7110263788", "source_url": "https://hrcak.srce.hr/327222", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.24869/psyd.2024.134", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.24869/psyd.2024.134", "source_url": "https://hrcak.srce.hr/327222", "doi": "10.24869/psyd.2024.134", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4714, "title": "Panini and Psilocybin", "authors": "Bridget Verhaaren", "journal": "Dialogue A Journal of Mormon Thought", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.5406/15549399.57.4.08", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408422024", "source_url": "https://doi.org/10.5406/15549399.57.4.08", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Consciousness,Aging,Emotional Processing,Spirituality,Observational Study,Cancer Patients", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.5406/15549399.57.4.08", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5406/15549399.57.4.08", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5406/15549399.57.4.08", "source_url": "https://doi.org/10.5406/15549399.57.4.08", "doi": "10.5406/15549399.57.4.08", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4713, "title": "Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatment", "authors": "Matthew B. Young, J. Chai-Rees, Anna Nowakowska, Jeng-Yu Tsai, Guy M. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.104163", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405637298", "source_url": "https://doi.org/10.1016/j.nsa.2024.104163", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.104163", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.104163", "source_url": "https://doi.org/10.1016/j.nsa.2024.104163", "doi": "10.1016/j.nsa.2024.104163", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4712, "title": "Psilocybin vs Escitalopram for depression: 6-month follow-up", "authors": "Thomas Barba, David Erritzøe, Kyle T. Greenway, Rinki Murphy, John Martell, Christopher Timmermann, Ashleigh Murphy-Beiner, Bruna Giribaldi, Michelle Baker Jones, Brandon Weiss, Robin Carhart-Harris", "journal": "Neuroscience Applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.104377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405637013", "source_url": "https://doi.org/10.1016/j.nsa.2024.104377", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.104377", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.104377", "source_url": "https://doi.org/10.1016/j.nsa.2024.104377", "doi": "10.1016/j.nsa.2024.104377", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4710, "title": "Neural effects of psilocybin-treatment in patients with treatment-resistant depression", "authors": "C. Schmitz, Hana Adolphi, Michael Frank, E. Seeger, Maciej Musiał, Moritz Spangemacher, Michael Koslowski, Lea J. Mertens, Florian Schlagenhauf, Gerhard Gründer", "journal": "Neuroscience Applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.105028", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405635994", "source_url": "https://doi.org/10.1016/j.nsa.2024.105028", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.105028", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.105028", "source_url": "https://doi.org/10.1016/j.nsa.2024.105028", "doi": "10.1016/j.nsa.2024.105028", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4704, "title": "The Therapeutic Potential of Psilocybin for Depression", "authors": "Watford Tessa", "journal": "Scientia", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.33548/scientia1082", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402233221", "source_url": "https://doi.org/10.33548/scientia1082", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:35:11", "bibtex": null, "source_record_id": "DOI:10.33548/scientia1082", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.33548/scientia1082", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.33548/scientia1082", "source_url": "https://doi.org/10.33548/scientia1082", "doi": "10.33548/scientia1082", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4700, "title": "Psychedelics: The New Kid on the Block", "authors": "Prosenjit Ghosh, Avinash Desousa", "journal": "Annals of Indian Psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.4103/aip.aip_195_23", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392949566", "source_url": "https://doi.org/10.4103/aip.aip_195_23", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,End-of-Life Distress,Chronic Pain,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Adolescents,Cancer Patients,Treatment-Resistant Depression,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.4103/aip.aip_195_23", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4103/aip.aip_195_23", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4103/aip.aip_195_23", "source_url": "https://doi.org/10.4103/aip.aip_195_23", "doi": "10.4103/aip.aip_195_23", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4699, "title": "Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy", "authors": "Agata Korlatowicz, Katarzyna Latocha, Paulina Pabian, Ryszard Bugno, Adam S. Hogendorf, Tamás Kovács, Andrzej J. Bojarski, Zoltán V. Varga, Agata Faron-Górecka", "journal": "Neuroscience Applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.104020", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392405867", "source_url": "http://dx.doi.org/10.1016/j.nsa.2024.104020", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.104020", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.104020", "source_url": "http://dx.doi.org/10.1016/j.nsa.2024.104020", "doi": "10.1016/j.nsa.2024.104020", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4698, "title": "Introduction to the Special Section on Psychedelics Research and Treatment", "authors": "Dominic Sisti", "journal": "Perspectives in biology and medicine", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1353/pbm.2024.a919714", "pubmed_id": "38662067", "openalex_id": "https://openalex.org/W4391959887", "source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Spirituality,Mystical Experience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "PMID:38662067", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38662067", "source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "doi": "10.1353/pbm.2024.a919714", "pmid": "38662067", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4696, "title": "Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousness", "authors": "N. Hewitt, J. Chai-Rees, Megan Croal, S. Mistry, Jeng-Yu Tsai, Matthew B. Young, Guy M. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.104391", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405660466", "source_url": "https://doi.org/10.1016/j.nsa.2024.104391", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2024.104391", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2024.104391", "source_url": "https://doi.org/10.1016/j.nsa.2024.104391", "doi": "10.1016/j.nsa.2024.104391", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1298, "title": "Educational Materials and Image Induction Increase Treatment Credibility.", "authors": "Low F, Earleywine M", "journal": "Journal of psychoactive drugs", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/02791072.2022.2154722", "pubmed_id": "36682063", "openalex_id": "https://openalex.org/W4317708836", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36682063/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:36682063", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36682063/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36682063", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36682063/", "doi": "10.1080/02791072.2022.2154722", "pmid": "36682063", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1295, "title": "Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.", "authors": "Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D", "journal": "Psychological medicine", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1017/s0033291723001514", "pubmed_id": "37264814", "openalex_id": "https://openalex.org/W4379093876", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37264814/", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37264814", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37264814/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37264814", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37264814/", "doi": "10.1017/s0033291723001514", "pmid": "37264814", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1293, "title": "Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.", "authors": "Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D", "journal": "Psychological medicine", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1017/s0033291723002039", "pubmed_id": "37466289", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37466289/", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37466289", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37466289", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37466289/", "doi": "10.1017/s0033291723002039", "pmid": "37466289", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1288, "title": "Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.", "authors": "Heresco-Levy U, Lerer B", "journal": "Molecular psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1038/s41380-023-02312-8", "pubmed_id": "37945694", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37945694/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37945694", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37945694/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37945694", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37945694/", "doi": "10.1038/s41380-023-02312-8", "pmid": "37945694", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1286, "title": "Psilocybin and Other Classic Psychedelics in Depression.", "authors": "Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D", "journal": "Current topics in behavioral neurosciences", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1007/7854_2023_451", "pubmed_id": "37955822", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37955822/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37955822", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37955822/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37955822", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37955822/", "doi": "10.1007/7854_2023_451", "pmid": "37955822", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1280, "title": "Is there credible evidence to assert psilocybin-assisted therapy for depression?", "authors": "Nogueira GN, Vasconcelos MMA, Souza FGM, Bisol LW", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.euroneuro.2023.11.003", "pubmed_id": "38128153", "openalex_id": "https://openalex.org/W4389985589", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38128153/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38128153", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38128153", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38128153/", "doi": "10.1016/j.euroneuro.2023.11.003", "pmid": "38128153", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1277, "title": "Is Poorly Assisted Psilocybin Treatment an Increasing Risk?", "authors": "Schenberg EE, King F, da Fonseca JE, Roseman L", "journal": "The American journal of psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230664", "pubmed_id": "38161296", "openalex_id": "https://openalex.org/W4390484761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38161296/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38161296", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38161296", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38161296/", "doi": "10.1176/appi.ajp.20230664", "pmid": "38161296", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1276, "title": "Psilocybin Without Psychotherapy: A Cart Without a Horse?", "authors": "Earleywine M, De Leo J, Bhayana D, Rajanna B, Scott K", "journal": "The American journal of psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230572", "pubmed_id": "38161299", "openalex_id": "https://openalex.org/W4390484734", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38161299/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38161299", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38161299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38161299/", "doi": "10.1176/appi.ajp.20230572", "pmid": "38161299", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1275, "title": "Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.", "authors": "Goodwin GM, Malievskaia E, Fonzo GA, Nemeroff CB", "journal": "The American journal of psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230905", "pubmed_id": "38161302", "openalex_id": "https://openalex.org/W4390485012", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38161302/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38161302", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38161302", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38161302/", "doi": "10.1176/appi.ajp.20230905", "pmid": "38161302", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1272, "title": "Older adults in psychedelic-assisted therapy trials: A systematic review.", "authors": "Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1177/02698811231215420", "pubmed_id": "38240068", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38240068/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Aging,Clinical Trial,Systematic Review,Review Article,Older Adults,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38240068", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38240068/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38240068", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38240068/", "doi": "10.1177/02698811231215420", "pmid": "38240068", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1269, "title": "[Up-to-Date on clinical and preclinical studies of psilocybin therapy].", "authors": "Ibi D", "journal": "Nihon yakurigaku zasshi. Folia pharmacologica Japonica", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1254/fpj.24007", "pubmed_id": "38945903", "openalex_id": "https://openalex.org/W4400167794", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38945903/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Eating Disorders,Headache / Migraine,Receptor Pharmacology,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38945903", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38945903/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38945903", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38945903/", "doi": "10.1254/fpj.24007", "pmid": "38945903", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1268, "title": "Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).", "authors": "Olivier B, Olivier JDA", "journal": "Advances in experimental medicine and biology", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1007/978-981-97-4402-2_3", "pubmed_id": "39261423", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39261423/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:39261423", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39261423/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39261423", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39261423/", "doi": "10.1007/978-981-97-4402-2_3", "pmid": "39261423", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1264, "title": "Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals.", "authors": "Armand S, Larsen K, Madsen MK, Ozenne B, Preller KH, Knudsen GM, Stenbæk DS, Fisher PM", "journal": "Neuroscience applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2023.103934", "pubmed_id": "40656071", "openalex_id": "https://openalex.org/W4390452945", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656071/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Aging,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:40656071", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656071/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656071", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656071/", "doi": "10.1016/j.nsa.2023.103934", "pmid": "40656071", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1257, "title": "Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.", "authors": "E-Wen McCulloch D, Liechti ME, Kuypers KP, Nutt D, Lundberg J, Stenbæk DS, Goodwin GM, Gründer G, Butlen-Ducuing F, Haberkamp M, Thirstrup S, Knudsen GM", "journal": "Neuroscience applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.103938", "pubmed_id": "40656112", "openalex_id": "https://openalex.org/W4390754521", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656112/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:40656112", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656112/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656112/", "doi": "10.1016/j.nsa.2024.103938", "pmid": "40656112", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1252, "title": "Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.", "authors": "Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V", "journal": "Neuropsychiatric disease and treatment", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.2147/ndt.s432537", "pubmed_id": "38268571", "openalex_id": "https://openalex.org/W4391053730", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38268571/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38268571", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38268571/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38268571", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38268571/", "doi": "10.2147/ndt.s432537", "pmid": "38268571", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1225, "title": "Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.", "authors": "Fang S, Yang X, Zhang W", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1359088", "pubmed_id": "38426002", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38426002/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38426002", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38426002/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38426002", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38426002/", "doi": "10.3389/fpsyt.2024.1359088", "pmid": "38426002", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1210, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS", "journal": "American journal of therapeutics", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001727", "pubmed_id": "38518266", "openalex_id": "https://openalex.org/W4393098943", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518266/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthcare Workers,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38518266", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38518266/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38518266", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518266/", "doi": "10.1097/mjt.0000000000001727", "pmid": "38518266", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1209, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS", "journal": "American journal of therapeutics", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001724", "pubmed_id": "38518269", "openalex_id": "https://openalex.org/W4393098899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518269/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38518269", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38518269/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38518269", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518269/", "doi": "10.1097/mjt.0000000000001724", "pmid": "38518269", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1206, "title": "Where do the symptoms come from in depression? Topography and dynamics matter.", "authors": "Çatal Y, Northoff G", "journal": "Brain communications", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1093/braincomms/fcae067", "pubmed_id": "38515441", "openalex_id": "https://openalex.org/W4392474380", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38515441/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38515441", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38515441/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38515441", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38515441/", "doi": "10.1093/braincomms/fcae067", "pmid": "38515441", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1199, "title": "The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.", "authors": "Levin AW, Lancelotta R, Sepeda ND, Gukasyan N, Nayak S, Wagener TL, Barrett FS, Griffiths RR, Davis AK", "journal": "PloS one", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1371/journal.pone.0300501", "pubmed_id": "38483940", "openalex_id": "https://openalex.org/W4392797453", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38483940/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38483940", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38483940/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38483940", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38483940/", "doi": "10.1371/journal.pone.0300501", "pmid": "38483940", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1196, "title": "Safety pharmacology of acute psilocybin administration in healthy participants.", "authors": "Straumann I, Holze F, Becker AM, Ley L, Halter N, Liechti ME", "journal": "Neuroscience applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.104060", "pubmed_id": "40656108", "openalex_id": "https://openalex.org/W4392888270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656108/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:40656108", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656108/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656108", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656108/", "doi": "10.1016/j.nsa.2024.104060", "pmid": "40656108", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1113, "title": "Effect of oral tryptamines on the gut microbiome of rats-a preliminary study.", "authors": "Xu M, Kiss AJ, Jones JA, McMurray MS, Shi H", "journal": "PeerJ", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.7717/peerj.17517", "pubmed_id": "38846751", "openalex_id": "https://openalex.org/W4399293931", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38846751/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Microbiome", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38846751", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38846751/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38846751", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38846751/", "doi": "10.7717/peerj.17517", "pmid": "38846751", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1112, "title": "A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.", "authors": "Wang CK, Kim G, Aleksandrova LR, Panenka WJ, Barr AM", "journal": "Frontiers in pharmacology", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fphar.2024.1387158", "pubmed_id": "38887548", "openalex_id": "https://openalex.org/W4399299007", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38887548/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Systematic Review,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38887548", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38887548/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38887548", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38887548/", "doi": "10.3389/fphar.2024.1387158", "pmid": "38887548", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1110, "title": "Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.", "authors": "Szafoni S, Gręblowski P, Grabowska K, Więckiewicz G", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1406888", "pubmed_id": "38919636", "openalex_id": "https://openalex.org/W4399572299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38919636/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38919636", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38919636/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38919636", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38919636/", "doi": "10.3389/fpsyt.2024.1406888", "pmid": "38919636", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1098, "title": "Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.", "authors": "Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO", "journal": "Journal of psychoactive drugs", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/02791072.2023.2223195", "pubmed_id": "37385217", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37385217/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:37385217", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37385217/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37385217", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37385217/", "doi": "10.1080/02791072.2023.2223195", "pmid": "37385217", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1077, "title": "Psilocybin for the treatment of Alzheimer's disease.", "authors": "Zheng S, Ma R, Yang Y, Li G", "journal": "Frontiers in neuroscience", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fnins.2024.1420601", "pubmed_id": "39050672", "openalex_id": "https://openalex.org/W4400513312", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39050672/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Creativity,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:39050672", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39050672/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39050672", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39050672/", "doi": "10.3389/fnins.2024.1420601", "pmid": "39050672", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1076, "title": "Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.", "authors": "Do A, Michaud V, Stephan JF, Moreau M, Benoît É, Bérubé FA, Bibaud-De Serres A, Taillefer A, Vincent P", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1394962", "pubmed_id": "39086732", "openalex_id": "https://openalex.org/W4400695899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39086732/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Case Report,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:39086732", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39086732/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39086732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39086732/", "doi": "10.3389/fpsyt.2024.1394962", "pmid": "39086732", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1054, "title": "Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.", "authors": "VanderZwaag B, Garcia-Romeu A, Garcia-Barrera MA", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1177/20451253241264812", "pubmed_id": "39132012", "openalex_id": "https://openalex.org/W4401432739", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39132012/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Aging,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39132012", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39132012/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39132012", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39132012/", "doi": "10.1177/20451253241264812", "pmid": "39132012", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1053, "title": "The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.", "authors": "Chen MH, Cheng SL, Kao YC, Tseng PT, Hsu CW, Yu CL, Yang FC, Thompson T, Hsu TW, Liang CS", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1439347", "pubmed_id": "39193583", "openalex_id": "https://openalex.org/W4401603200", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39193583/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39193583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39193583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39193583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39193583/", "doi": "10.3389/fpsyt.2024.1439347", "pmid": "39193583", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1017, "title": "Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.", "authors": "Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1416420", "pubmed_id": "39376971", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39376971/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39376971", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39376971/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39376971", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39376971/", "doi": "10.3389/fpsyt.2024.1416420", "pmid": "39376971", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 988, "title": "Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada.", "authors": "Kim K, Yusuf A, Sud A, Persaud N, Kirubarajan A, Moller M, Lloyd T, O'Neill B", "journal": "PloS one", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1371/journal.pone.0309911", "pubmed_id": "39446753", "openalex_id": "https://openalex.org/W4403721028", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39446753/", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39446753", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39446753/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39446753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39446753/", "doi": "10.1371/journal.pone.0309911", "pmid": "39446753", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5702, "title": "Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge", "authors": "Verheijen Marcha C.T.", "journal": "Journal of the Netherlands Society of Toxicology", "publication_date": "2023-12-30", "publication_year": 2023, "doi": "10.61833/jnst.2024.0002", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399023496", "source_url": "https://doi.org/10.61833/jnst.2024.0002", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.61833/jnst.2024.0002", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.61833/jnst.2024.0002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.61833/jnst.2024.0002", "source_url": "https://doi.org/10.61833/jnst.2024.0002", "doi": "10.61833/jnst.2024.0002", "pmid": "", "publication_date": "2023-12-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4723, "title": "Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge", "authors": "Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś", "journal": "Journal of Education Health and Sport", "publication_date": "2023-12-30", "publication_year": 2023, "doi": "10.12775/jehs.2023.50.01.005", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390439845", "source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Pharmacology,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.50.01.005", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.50.01.005", "source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "doi": "10.12775/jehs.2023.50.01.005", "pmid": "", "publication_date": "2023-12-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4724, "title": "The Therapeutic Effect and Potential Application of Psilocybin", "authors": "Tianran Liu", "journal": "Highlights in Science Engineering and Technology", "publication_date": "2023-12-29", "publication_year": 2023, "doi": "10.54097/3cfwjn09", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391277213", "source_url": "http://dx.doi.org/10.54097/3cfwjn09", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Pharmacology,Cancer Patients,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.54097/3cfwjn09", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.54097/3cfwjn09", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54097/3cfwjn09", "source_url": "http://dx.doi.org/10.54097/3cfwjn09", "doi": "10.54097/3cfwjn09", "pmid": "", "publication_date": "2023-12-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1300, "title": "Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis.", "authors": "Danias G, Appel J", "journal": "JMIR formative research", "publication_date": "2023-12-29", "publication_year": 2023, "doi": "10.2196/43850", "pubmed_id": "38064635", "openalex_id": "https://openalex.org/W4389086750", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38064635/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38064635", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38064635/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38064635", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38064635/", "doi": "10.2196/43850", "pmid": "38064635", "publication_date": "2023-12-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3164, "title": "Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression", "authors": "Poulin JM, Bigford GE, Lanctot KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, MacIntosh BJ, Nestor SM.", "journal": "Research Square", "publication_date": "2023-12-28", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3474764/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3474764/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:06", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3474764/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3474764/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3474764/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3474764/v1", "doi": "10.21203/rs.3.rs-3474764/v1", "pmid": "", "publication_date": "2023-12-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3780, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": "10.31234/osf.io/byms6", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/byms6", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-08-09 08:15:20", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/byms6", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/byms6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/byms6", "source_url": "https://doi.org/10.31234/osf.io/byms6", "doi": "10.31234/osf.io/byms6", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3751, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": "10.31234/osf.io/a8xwk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-08-09 08:15:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/a8xwk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/a8xwk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/a8xwk", "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "doi": "10.31234/osf.io/a8xwk", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3572, "title": "Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.", "authors": "Multidisciplinary Association for Psychedelic Studies", "journal": "ClinicalTrials.gov", "publication_date": "2023-12-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00979693", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Spirituality,Mystical Experience,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00979693", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00979693", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00979693", "source_url": "https://clinicaltrials.gov/study/NCT00979693", "doi": "", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3293, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/byms6_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/byms6_v1", "source_url": "https://osf.io/preprints/psyarxiv/byms6_v1", "doi": "", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3133, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "doi": "", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1301, "title": "Molecular and Medical Aspects of Psychedelics.", "authors": "Wojtas A, Gołembiowska K", "journal": "International journal of molecular sciences", "publication_date": "2023-12-23", "publication_year": 2023, "doi": "10.3390/ijms25010241", "pubmed_id": "38203411", "openalex_id": "https://openalex.org/W4390176357", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38203411/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Toxicity", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38203411", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38203411/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38203411", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38203411/", "doi": "10.3390/ijms25010241", "pmid": "38203411", "publication_date": "2023-12-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4725, "title": "Application of psilocybin in mental health disorders", "authors": "Jingxuan Chen", "journal": "Theoretical and Natural Science", "publication_date": "2023-12-20", "publication_year": 2023, "doi": "10.54254/2753-8818/21/20230859", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390006951", "source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.54254/2753-8818/21/20230859", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54254/2753-8818/21/20230859", "source_url": "https://doi.org/10.54254/2753-8818/21/20230859", "doi": "10.54254/2753-8818/21/20230859", "pmid": "", "publication_date": "2023-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1303, "title": "Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity.", "authors": "Du Y, Li Y, Zhao X, Yao Y, Wang B, Zhang L, Wang G", "journal": "Chinese medical journal", "publication_date": "2023-12-20", "publication_year": 2023, "doi": "10.1097/cm9.0000000000002647", "pubmed_id": "37000971", "openalex_id": "https://openalex.org/W4362457938", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37000971/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Neurogenesis,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37000971", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37000971/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37000971", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37000971/", "doi": "10.1097/cm9.0000000000002647", "pmid": "37000971", "publication_date": "2023-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1304, "title": "Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain.", "authors": "Kolbman N, Liu T, Guzzo P, Gilligan J, Mashour GA, Vanini G, Pal D", "journal": "Current biology: CB", "publication_date": "2023-12-18", "publication_year": 2023, "doi": "10.1016/j.cub.2023.10.016", "pubmed_id": "38113836", "openalex_id": "https://openalex.org/W4389891609", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38113836/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38113836", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38113836/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38113836", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38113836/", "doi": "10.1016/j.cub.2023.10.016", "pmid": "38113836", "publication_date": "2023-12-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3152, "title": "Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms", "authors": "Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C.", "journal": "bioRxiv", "publication_date": "2023-12-13", "publication_year": 2023, "doi": "10.1101/2023.12.12.571374", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.12.12.571374", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:05", "bibtex": null, "source_record_id": "DOI:10.1101/2023.12.12.571374", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.12.12.571374", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.12.12.571374", "source_url": "https://doi.org/10.1101/2023.12.12.571374", "doi": "10.1101/2023.12.12.571374", "pmid": "", "publication_date": "2023-12-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4726, "title": "Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin", "authors": "Ivana Turek", "journal": "Medical Writing", "publication_date": "2023-12-11", "publication_year": 2023, "doi": "10.56012/tsen2260", "pubmed_id": null, "openalex_id": "https://openalex.org/W4389763815", "source_url": "http://dx.doi.org/10.56012/tsen2260", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.56012/tsen2260", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56012/tsen2260", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56012/tsen2260", "source_url": "http://dx.doi.org/10.56012/tsen2260", "doi": "10.56012/tsen2260", "pmid": "", "publication_date": "2023-12-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1330, "title": "Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.", "authors": "McCrone P, Fisher H, Knight C, Harding R, Schlag AK, Nutt DJ, Neill JC", "journal": "Psychological medicine", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1017/s0033291723001411", "pubmed_id": "37264950", "openalex_id": "https://openalex.org/W4379095570", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37264950/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37264950", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37264950/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37264950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37264950/", "doi": "10.1017/s0033291723001411", "pmid": "37264950", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1328, "title": "Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?", "authors": "Crowe M, Manuel J, Carlyle D, Lacey C", "journal": "International journal of mental health nursing", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1111/inm.13214", "pubmed_id": "37589380", "openalex_id": "https://openalex.org/W4385898071", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37589380/", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37589380", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37589380/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37589380", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37589380/", "doi": "10.1111/inm.13214", "pmid": "37589380", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1324, "title": "Potential use of psilocybin drugs in the treatment of depression.", "authors": "Śladowska K, Kawalec P, Brzostek T, Pilc A", "journal": "Expert opinion on emerging drugs", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1080/14728214.2023.2264180", "pubmed_id": "37817501", "openalex_id": "https://openalex.org/W4387516067", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817501/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37817501", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37817501/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37817501", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817501/", "doi": "10.1080/14728214.2023.2264180", "pmid": "37817501", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1323, "title": "Cardiovascular safety of psychedelic medicine: current status and future directions.", "authors": "Wsół A", "journal": "Pharmacological reports: PR", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1007/s43440-023-00539-4", "pubmed_id": "37874530", "openalex_id": "https://openalex.org/W4387893679", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37874530/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Microdosing,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37874530", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37874530/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37874530", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37874530/", "doi": "10.1007/s43440-023-00539-4", "pmid": "37874530", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1322, "title": "Preclinical models of treatment-resistant depression: challenges and perspectives.", "authors": "Kolasa M, Faron-Górecka A", "journal": "Pharmacological reports: PR", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1007/s43440-023-00542-9", "pubmed_id": "37882914", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37882914/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37882914", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37882914/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37882914", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37882914/", "doi": "10.1007/s43440-023-00542-9", "pmid": "37882914", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1321, "title": "Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.", "authors": "Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST", "journal": "Drug discovery today", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1016/j.drudis.2023.103818", "pubmed_id": "37925136", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37925136/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37925136", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37925136/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37925136", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37925136/", "doi": "10.1016/j.drudis.2023.103818", "pmid": "37925136", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1320, "title": "Mindfulness meditation and psychedelics: potential synergies and commonalities.", "authors": "Holas P, Kamińska J", "journal": "Pharmacological reports: PR", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1007/s43440-023-00551-8", "pubmed_id": "37926796", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37926796/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Consciousness,Wellbeing,Mystical Experience,Review Article,Healthy Volunteers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37926796", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37926796/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37926796", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37926796/", "doi": "10.1007/s43440-023-00551-8", "pmid": "37926796", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1319, "title": "Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.", "authors": "Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A", "journal": "Pharmacological reports: PR", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1007/s43440-023-00547-4", "pubmed_id": "37932583", "openalex_id": "https://openalex.org/W4388441865", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37932583/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37932583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37932583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37932583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37932583/", "doi": "10.1007/s43440-023-00547-4", "pmid": "37932583", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1318, "title": "The possible place for psychedelics in pharmacotherapy of mental disorders.", "authors": "Wojtas A", "journal": "Pharmacological reports: PR", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1007/s43440-023-00550-9", "pubmed_id": "37934320", "openalex_id": "https://openalex.org/W4388460814", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37934320/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37934320", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37934320/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37934320", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37934320/", "doi": "10.1007/s43440-023-00550-9", "pmid": "37934320", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1317, "title": "Psilocybin therapy to reduce depression following a terminal diagnosis.", "authors": "Boudreau E, Orlowski K", "journal": "JAAPA: official journal of the American Academy of Physician Assistants", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1097/01.jaa.0000994952.07847.2d", "pubmed_id": "37989175", "openalex_id": "https://openalex.org/W4388850907", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37989175/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37989175", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37989175/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37989175", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37989175/", "doi": "10.1097/01.jaa.0000994952.07847.2d", "pmid": "37989175", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1314, "title": "Perceptions of psychedelic-assisted therapy among Black Americans.", "authors": "Carter S, Packard G, Coghlan C, George JR, Brown AJ, Ching THW, Julian J, Maples-Keller JL", "journal": "Journal of mood and anxiety disorders", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1016/j.xjmad.2023.100023", "pubmed_id": "40656968", "openalex_id": "https://openalex.org/W4387063622", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656968/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Observational Study,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:40656968", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656968/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656968", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656968/", "doi": "10.1016/j.xjmad.2023.100023", "pmid": "40656968", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1309, "title": "Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.", "authors": "Weintraub MJ, Jeffrey JK, Grob CS, Ichinose MC, Bergman RL, Cooper ZD, Miklowitz DJ", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0018", "pubmed_id": "40046861", "openalex_id": "https://openalex.org/W4386469528", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046861/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:40046861", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046861/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046861", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046861/", "doi": "10.1089/psymed.2023.0018", "pmid": "40046861", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3629, "title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD).", "authors": "Apex Labs Ltd.", "journal": "ClinicalTrials.gov", "publication_date": "2023-11-29", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06141876", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06141876", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06141876", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06141876", "source_url": "https://clinicaltrials.gov/study/NCT06141876", "doi": "", "pmid": "", "publication_date": "2023-11-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4733, "title": "Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials", "authors": "Tahlia R. Harrison", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-20", "publication_year": 2023, "doi": "10.1556/2054.2023.00267", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388822593", "source_url": "https://doi.org/10.1556/2054.2023.00267", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00267", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2023.00267", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00267", "source_url": "https://doi.org/10.1556/2054.2023.00267", "doi": "10.1556/2054.2023.00267", "pmid": "", "publication_date": "2023-11-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4735, "title": "Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness", "authors": "Danelle Jones", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-16", "publication_year": 2023, "doi": "10.1556/2054.2023.00306", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388730617", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00306", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00306", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "doi": "10.1556/2054.2023.00306", "pmid": "", "publication_date": "2023-11-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3364, "title": "Aesthetic Chills Mitigate Maladaptive Cognition In Depression", "authors": "Schoeller F, Jain A, Adrien V, Maes P, Reggente N.", "journal": "Research Square", "publication_date": "2023-11-14", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3582420/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Emotional Processing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:27", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3582420/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3582420/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "doi": "10.21203/rs.3.rs-3582420/v1", "pmid": "", "publication_date": "2023-11-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3680, "title": "The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2023-11-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04739865", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04739865", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04739865", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04739865", "source_url": "https://clinicaltrials.gov/study/NCT04739865", "doi": "", "pmid": "", "publication_date": "2023-11-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5814, "title": "Managing expectations with psychedelic microdosing", "authors": "Omer A. Syed, Benjamin Tsang", "journal": "npj Mental Health Research", "publication_date": "2023-11-08", "publication_year": 2023, "doi": "10.1038/s44184-023-00044-9", "pubmed_id": "38609480", "openalex_id": "https://openalex.org/W4388500089", "source_url": "https://doi.org/10.1038/s44184-023-00044-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Aging,Microdosing,Wellbeing,Creativity,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:33", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "PMID:38609480", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s44184-023-00044-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38609480", "source_url": "https://doi.org/10.1038/s44184-023-00044-9", "doi": "10.1038/s44184-023-00044-9", "pmid": "38609480", "publication_date": "2023-11-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4737, "title": "Pharmacists’ perspectives on psilocybin in Canada", "authors": "Elizabeth Sugiarto, Rebecca Leung, Jamie Yuen", "journal": "JAPhA Practice Innovations", "publication_date": "2023-11-08", "publication_year": 2023, "doi": "10.1016/j.japhpi.2023.100003", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388498988", "source_url": "https://doi.org/10.1016/j.japhpi.2023.100003", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Observational Study,Treatment-Resistant Depression", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.japhpi.2023.100003", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.japhpi.2023.100003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.japhpi.2023.100003", "source_url": "https://doi.org/10.1016/j.japhpi.2023.100003", "doi": "10.1016/j.japhpi.2023.100003", "pmid": "", "publication_date": "2023-11-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1336, "title": "Beyond the 5-HT Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.", "authors": "Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A", "journal": "The Journal of neuroscience: the official journal of the Society for Neuroscience", "publication_date": "2023-11-08", "publication_year": 2023, "doi": "10.1523/jneurosci.1384-23.2023", "pubmed_id": "37940583", "openalex_id": "https://openalex.org/W4388486766", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37940583/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37940583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37940583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37940583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37940583/", "doi": "10.1523/jneurosci.1384-23.2023", "pmid": "37940583", "publication_date": "2023-11-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5815, "title": "The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review", "authors": "7450 Summit Cir, Davison, MI48423, Sarah Naher", "journal": "Journal of Sociology Psychology & Religious Studies", "publication_date": "2023-11-06", "publication_year": 2023, "doi": "10.53819/81018102t4217", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388421437", "source_url": "http://dx.doi.org/10.53819/81018102t4217", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:33", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.53819/81018102t4217", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.53819/81018102t4217", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53819/81018102t4217", "source_url": "http://dx.doi.org/10.53819/81018102t4217", "doi": "10.53819/81018102t4217", "pmid": "", "publication_date": "2023-11-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1337, "title": "LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.", "authors": "Van Der Walt J, Parker R", "journal": "South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde", "publication_date": "2023-11-06", "publication_year": 2023, "doi": "10.7196/samj.2023.v113i11.814", "pubmed_id": "38525640", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38525640/", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Aging,Review Article,Healthcare Workers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:38525640", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38525640/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38525640", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38525640/", "doi": "10.7196/samj.2023.v113i11.814", "pmid": "38525640", "publication_date": "2023-11-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1338, "title": "Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury.", "authors": "Gray JC, Murphy M, Carter SE, Johnson MW, Wolfgang AS, Roy MJ, Maples-Keller JL", "journal": "Military medicine", "publication_date": "2023-11-03", "publication_year": 2023, "doi": "10.1093/milmed/usac400", "pubmed_id": "36564939", "openalex_id": "https://openalex.org/W4312129485", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36564939/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Aging,Personality Change,Veterans", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:36564939", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36564939/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36564939", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36564939/", "doi": "10.1093/milmed/usac400", "pmid": "36564939", "publication_date": "2023-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1348, "title": "Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.", "authors": "Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1016/j.euroneuro.2023.07.011", "pubmed_id": "37557019", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37557019/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37557019", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37557019/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37557019", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37557019/", "doi": "10.1016/j.euroneuro.2023.07.011", "pmid": "37557019", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1345, "title": "Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study.", "authors": "Mason NL, Szabo A, Kuypers KPC, Mallaroni PA, de la Torre Fornell R, Reckweg JT, Tse DHY, Hutten NRPW, Feilding A, Ramaekers JG", "journal": "Brain, behavior, and immunity", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1016/j.bbi.2023.09.004", "pubmed_id": "37689275", "openalex_id": "https://openalex.org/W4386504040", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37689275/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Biomarkers,Healthy Volunteers,Inflammation,Immune Function", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37689275", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37689275/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37689275", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37689275/", "doi": "10.1016/j.bbi.2023.09.004", "pmid": "37689275", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1343, "title": "Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats.", "authors": "Malikowska-Racia N, Koniewski M, Golebiowska J, Popik P", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1177/02698811231205692", "pubmed_id": "37842884", "openalex_id": "https://openalex.org/W4387661757", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37842884/", "substance_tags": "psilocybin", "topic_tags": "Depression,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37842884", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37842884/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37842884", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37842884/", "doi": "10.1177/02698811231205692", "pmid": "37842884", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1342, "title": "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.", "authors": "Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD", "journal": "Psychiatry research", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1016/j.psychres.2023.115531", "pubmed_id": "37844352", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37844352/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37844352", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37844352/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37844352", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37844352/", "doi": "10.1016/j.psychres.2023.115531", "pmid": "37844352", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1334, "title": "Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.", "authors": "Raj P, Rauniyar S, Sapkale B", "journal": "Cureus", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.7759/cureus.48719", "pubmed_id": "38094517", "openalex_id": "https://openalex.org/W4388636814", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38094517/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Receptor Pharmacology,Consciousness,Aging", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:38094517", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38094517/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38094517", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38094517/", "doi": "10.7759/cureus.48719", "pmid": "38094517", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3798, "title": "A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues", "authors": "Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B.", "journal": "PsyArXiv", "publication_date": "2023-10-27", "publication_year": 2023, "doi": "10.31234/osf.io/4gfyd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/4gfyd", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/4gfyd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/4gfyd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/4gfyd", "source_url": "https://doi.org/10.31234/osf.io/4gfyd", "doi": "10.31234/osf.io/4gfyd", "pmid": "", "publication_date": "2023-10-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3369, "title": "A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues", "authors": "Sarah Kratina, Chris Lo, Robert Schwartz, Carol Strike, Sydney Jopling, Ayah Nayfeh, Brian Rush", "journal": "PsyArXiv", "publication_date": "2023-10-27", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "doi": "", "pmid": "", "publication_date": "2023-10-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4746, "title": "Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol", "authors": "Natasha Biscoe, Amanda Bonson, Max Slavin, Walter Busuttil, Deirdre MacManus, Andrew T. Cox, Dominic Murphy", "journal": "European Journal of Trauma & Dissociation", "publication_date": "2023-10-25", "publication_year": 2023, "doi": "10.1016/j.ejtd.2023.100359", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387941143", "source_url": "https://doi.org/10.1016/j.ejtd.2023.100359", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Veterans", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.ejtd.2023.100359", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.ejtd.2023.100359", "source_url": "https://doi.org/10.1016/j.ejtd.2023.100359", "doi": "10.1016/j.ejtd.2023.100359", "pmid": "", "publication_date": "2023-10-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4749, "title": "Is psilocybin effective for treatment of depression?", "authors": "Lucia Carbajal, Tessa E. Moore, R. H. Barry Sample, Joseph Nelson", "journal": "Evidence-Based Practice", "publication_date": "2023-10-19", "publication_year": 2023, "doi": "10.1097/ebp.0000000000002021", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387880074", "source_url": "https://doi.org/10.1097/ebp.0000000000002021", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1097/ebp.0000000000002021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/ebp.0000000000002021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/ebp.0000000000002021", "source_url": "https://doi.org/10.1097/ebp.0000000000002021", "doi": "10.1097/ebp.0000000000002021", "pmid": "", "publication_date": "2023-10-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4751, "title": "Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?", "authors": "Ian B. Hickie, Allan H. Young, F. Markus Leweke", "journal": "Research Directions Depression", "publication_date": "2023-10-13", "publication_year": 2023, "doi": "10.1017/dep.2023.21", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387617056", "source_url": "https://doi.org/10.1017/dep.2023.21", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1017/dep.2023.21", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/dep.2023.21", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1017/dep.2023.21", "source_url": "https://doi.org/10.1017/dep.2023.21", "doi": "10.1017/dep.2023.21", "pmid": "", "publication_date": "2023-10-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4752, "title": "Assessing Metro Vancouver Residents’ Knowledge and Opinions of Psilocybin", "authors": "Payman Baharmand, Amardeep Kambo", "journal": "BCIT Environmental Public Health Journal", "publication_date": "2023-10-12", "publication_year": 2023, "doi": "10.47339/ephj.2023.229", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387616208", "source_url": "http://dx.doi.org/10.47339/ephj.2023.229", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.47339/ephj.2023.229", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.47339/ephj.2023.229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.47339/ephj.2023.229", "source_url": "http://dx.doi.org/10.47339/ephj.2023.229", "doi": "10.47339/ephj.2023.229", "pmid": "", "publication_date": "2023-10-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1358, "title": "Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2023-10-12", "publication_year": 2023, "doi": "10.1021/acsmedchemlett.3c00390", "pubmed_id": "37849550", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37849550/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37849550", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37849550/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37849550", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37849550/", "doi": "10.1021/acsmedchemlett.3c00390", "pmid": "37849550", "publication_date": "2023-10-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4753, "title": "Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future", "authors": "Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter", "journal": "Georgetown Scientific Research Journal", "publication_date": "2023-10-10", "publication_year": 2023, "doi": "10.48091/gsr.v3i2.62", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387521317", "source_url": "https://doi.org/10.48091/gsr.v3i2.62", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.48091/gsr.v3i2.62", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48091/gsr.v3i2.62", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48091/gsr.v3i2.62", "source_url": "https://doi.org/10.48091/gsr.v3i2.62", "doi": "10.48091/gsr.v3i2.62", "pmid": "", "publication_date": "2023-10-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3188, "title": "Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology", "authors": "Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML.", "journal": "bioRxiv", "publication_date": "2023-10-07", "publication_year": 2023, "doi": "10.1101/2023.10.06.561183", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.10.06.561183", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:09", "bibtex": null, "source_record_id": "DOI:10.1101/2023.10.06.561183", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.10.06.561183", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.10.06.561183", "source_url": "https://doi.org/10.1101/2023.10.06.561183", "doi": "10.1101/2023.10.06.561183", "pmid": "", "publication_date": "2023-10-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4754, "title": "Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?", "authors": "Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain", "journal": "Clinical Pharmacology & Therapeutics", "publication_date": "2023-10-05", "publication_year": 2023, "doi": "10.1002/cpt.3050", "pubmed_id": "37795632", "openalex_id": "https://openalex.org/W4387357883", "source_url": "https://doi.org/10.1002/cpt.3050", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Microdosing,Wellbeing,Clinical Trial,Healthcare Workers,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "PMID:37795632", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cpt.3050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37795632", "source_url": "https://doi.org/10.1002/cpt.3050", "doi": "10.1002/cpt.3050", "pmid": "37795632", "publication_date": "2023-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1360, "title": "An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).", "authors": "Donegan CJ, Daldegan-Bueno D, Sumner R, Menkes D, Evans W, Hoeh N, Sundram F, Reynolds L, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Forsyth A, Bansal M, Muthukumaraswamy S", "journal": "Pilot and feasibility studies", "publication_date": "2023-10-05", "publication_year": 2023, "doi": "10.1186/s40814-023-01399-8", "pubmed_id": "37798662", "openalex_id": "https://openalex.org/W4387372869", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37798662/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37798662", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37798662/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37798662", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37798662/", "doi": "10.1186/s40814-023-01399-8", "pmid": "37798662", "publication_date": "2023-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4763, "title": "UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBIN", "authors": "Chloé Galipeau, Miguel Farinha-Ferreira, Jean-Charles Mariani, Samuel Diebolt, Louis Barthe, Renata Santos, Zsolt Lenkei, Ana M. Sebastião", "journal": "IBRO Neuroscience Reports", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1016/j.ibneur.2023.08.1116", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388366064", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1116", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.ibneur.2023.08.1116", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1116", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.ibneur.2023.08.1116", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1116", "doi": "10.1016/j.ibneur.2023.08.1116", "pmid": "", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4762, "title": "MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS", "authors": "Aneta Petrušková, Eva-Maria Weiss, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló, Renato Frischknecht, Tomáš Páleníček, Anna Fejtová", "journal": "IBRO Neuroscience Reports", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1016/j.ibneur.2023.08.608", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388365459", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.608", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.ibneur.2023.08.608", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.ibneur.2023.08.608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.ibneur.2023.08.608", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.608", "doi": "10.1016/j.ibneur.2023.08.608", "pmid": "", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4761, "title": "PSILOCYBIN EXERTS ANTIDEPRESSANT EFFECTS IN A CHRONIC UNPREDICTABLE MILD STRESS (CUMS) ANIMAL MODEL", "authors": "Ines Erkizia-Santamaría, J. Javier Meana, Igor Horrillo, Jorge E. Ortega", "journal": "IBRO Neuroscience Reports", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1016/j.ibneur.2023.08.1097", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388363773", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1097", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.ibneur.2023.08.1097", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.ibneur.2023.08.1097", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1097", "doi": "10.1016/j.ibneur.2023.08.1097", "pmid": "", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4760, "title": "DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?", "authors": "Tomáš Páleníček, Tereza Klučková, M. Nikolič, Čestmír Vejmola, Filip Tylš, Vojtěch Viktorin, Jiřı́ Horáček, Martin Brunovský", "journal": "IBRO Neuroscience Reports", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1016/j.ibneur.2023.08.1240", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388363682", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1240", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Wellbeing,Spirituality,Healthy Volunteers", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.ibneur.2023.08.1240", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1240", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.ibneur.2023.08.1240", "source_url": "https://doi.org/10.1016/j.ibneur.2023.08.1240", "doi": "10.1016/j.ibneur.2023.08.1240", "pmid": "", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3300, "title": "Psilocybin kann offenbar Depressionen lindern.", "authors": "Müller T.", "journal": "MMW Fortschritte der Medizin", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1007/s15006-023-3025-6", "pubmed_id": "37758991", "openalex_id": "https://openalex.org/W4387081757", "source_url": "https://doi.org/10.1007/s15006-023-3025-6", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "PMID:37758991", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37758991", "source_url": "https://doi.org/10.1007/s15006-023-3025-6", "doi": "10.1007/s15006-023-3025-6", "pmid": "37758991", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1366, "title": "Letter to the editor on \"Increased low-frequency brain responses to music after psilocybin therapy for depression\".", "authors": "Brown O", "journal": "Journal of affective disorders", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.05.088", "pubmed_id": "37257781", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37257781/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37257781", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37257781/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37257781", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37257781/", "doi": "10.1016/j.jad.2023.05.088", "pmid": "37257781", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1364, "title": "Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.", "authors": "Wolfgang AS, Hoge CW", "journal": "Current psychiatry reports", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1007/s11920-023-01446-4", "pubmed_id": "37682446", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37682446/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Review Article,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37682446", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37682446/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37682446", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37682446/", "doi": "10.1007/s11920-023-01446-4", "pmid": "37682446", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3667, "title": "Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT01534494", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT01534494", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT01534494", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT01534494", "source_url": "https://clinicaltrials.gov/study/NCT01534494", "doi": "", "pmid": "", "publication_date": "2023-09-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3150, "title": "Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study", "authors": "Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Maćkowiak M, Gołembiowska K.", "journal": "Preprints.org", "publication_date": "2023-09-25", "publication_year": 2023, "doi": "10.20944/preprints202309.1649.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202309.1649.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:05", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202309.1649.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202309.1649.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202309.1649.v1", "source_url": "https://doi.org/10.20944/preprints202309.1649.v1", "doi": "10.20944/preprints202309.1649.v1", "pmid": "", "publication_date": "2023-09-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4764, "title": "Expectancies for Subjective and Antidepressant Effects in Psilocybin Users", "authors": "Mitch Earleywine, Maha N. Mian, Joseph A. De Leo", "journal": "Journal of Humanistic Psychology", "publication_date": "2023-09-22", "publication_year": 2023, "doi": "10.1177/00221678231194798", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386958768", "source_url": "https://doi.org/10.1177/00221678231194798", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "DOI:10.1177/00221678231194798", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678231194798", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678231194798", "source_url": "https://doi.org/10.1177/00221678231194798", "doi": "10.1177/00221678231194798", "pmid": "", "publication_date": "2023-09-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4769, "title": "The psychedelic experience and treatment-resistant depression", "authors": "Guy M. Goodwin", "journal": "World Psychiatry", "publication_date": "2023-09-15", "publication_year": 2023, "doi": "10.1002/wps.21140", "pubmed_id": "37713542", "openalex_id": "https://openalex.org/W4386765441", "source_url": "http://dx.doi.org/10.1002/wps.21140", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "PMID:37713542", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/wps.21140", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37713542", "source_url": "http://dx.doi.org/10.1002/wps.21140", "doi": "10.1002/wps.21140", "pmid": "37713542", "publication_date": "2023-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1374, "title": "Psychedelics: Threshold of a Therapeutic Revolution.", "authors": "Heal DJ, Smith SL, Belouin SJ, Henningfield JE", "journal": "Neuropharmacology", "publication_date": "2023-09-15", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109610", "pubmed_id": "37247807", "openalex_id": "https://openalex.org/W4378549583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37247807/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37247807", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37247807/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37247807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37247807/", "doi": "10.1016/j.neuropharm.2023.109610", "pmid": "37247807", "publication_date": "2023-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4775, "title": "Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training", "authors": "Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout, Jeremy Weleff", "journal": "American Journal of Psychiatry Residents Journal", "publication_date": "2023-09-08", "publication_year": 2023, "doi": "10.1176/appi.ajp-rj.2023.190103", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386544759", "source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "DOI:10.1176/appi.ajp-rj.2023.190103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.ajp-rj.2023.190103", "source_url": "http://dx.doi.org/10.1176/appi.ajp-rj.2023.190103", "doi": "10.1176/appi.ajp-rj.2023.190103", "pmid": "", "publication_date": "2023-09-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1379, "title": "Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.", "authors": "Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR", "journal": "JAMA", "publication_date": "2023-09-05", "publication_year": 2023, "doi": "10.1001/jama.2023.14530", "pubmed_id": "37651119", "openalex_id": "https://openalex.org/W4386305655", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37651119", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37651119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "doi": "10.1001/jama.2023.14530", "pmid": "37651119", "publication_date": "2023-09-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3728, "title": "Neuroimaging in psychedelic drug development: past, present, and future.", "authors": "Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D", "journal": "Molecular psychiatry", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1038/s41380-023-02271-0", "pubmed_id": "37759038", "openalex_id": "https://openalex.org/W4387105816", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37759038/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 11:08:42", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37759038", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37759038/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37759038", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37759038/", "doi": "10.1038/s41380-023-02271-0", "pmid": "37759038", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1592, "title": "Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models", "authors": "Ezeaka Udoka C., Kim Hye Ji J., Laprairie Robert B.", "journal": "Current Topics in Medicinal Chemistry", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.2174/1568026623666230705151922", "pubmed_id": "37409550", "openalex_id": "https://openalex.org/W4383301604", "source_url": "https://doi.org/10.2174/1568026623666230705151922", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Review Article", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:37409550", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.2174/1568026623666230705151922", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:37409550", "source_url": "https://doi.org/10.2174/1568026623666230705151922", "doi": "10.2174/1568026623666230705151922", "pmid": "37409550", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1398, "title": "Psychedelics for Patients With Cancer: A Comprehensive Literature Review.", "authors": "White CM, Weisman N, Dalo J", "journal": "The Annals of pharmacotherapy", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1177/10600280221144055", "pubmed_id": "36635883", "openalex_id": "https://openalex.org/W4315928547", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36635883/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:36635883", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36635883/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36635883", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36635883/", "doi": "10.1177/10600280221144055", "pmid": "36635883", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1397, "title": "HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.", "authors": "Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking P", "journal": "Journal of pain and symptom management", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1016/j.jpainsymman.2023.06.006", "pubmed_id": "37302533", "openalex_id": "https://openalex.org/W4380151127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37302533/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Review Article,Observational Study,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37302533", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37302533/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37302533", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37302533/", "doi": "10.1016/j.jpainsymman.2023.06.006", "pmid": "37302533", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1393, "title": "Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.", "authors": "Goodwin GM, Croal M, Feifel D, Kelly JR, Marwood L, Mistry S, O'Keane V, Peck SK, Simmons H, Sisa C, Stansfield SC, Tsai J, Williams S, Malievskaia E", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1038/s41386-023-01648-7", "pubmed_id": "37443386", "openalex_id": "https://openalex.org/W4384130479", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37443386/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37443386", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37443386/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37443386", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37443386/", "doi": "10.1038/s41386-023-01648-7", "pmid": "37443386", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1392, "title": "Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins.", "authors": "Szigeti B, Phillips LD, Nutt D", "journal": "British journal of clinical pharmacology", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1111/bcp.15841", "pubmed_id": "37455605", "openalex_id": "https://openalex.org/W4384493160", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37455605/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37455605", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37455605/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37455605", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37455605/", "doi": "10.1111/bcp.15841", "pmid": "37455605", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1391, "title": "Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.", "authors": "Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A", "journal": "Fitoterapia", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1016/j.fitote.2023.105620", "pubmed_id": "37490982", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37490982/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37490982", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37490982/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37490982", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37490982/", "doi": "10.1016/j.fitote.2023.105620", "pmid": "37490982", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1390, "title": "Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.", "authors": "Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB", "journal": "Psychiatry research", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1016/j.psychres.2023.115349", "pubmed_id": "37523886", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37523886/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37523886", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37523886/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37523886", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37523886/", "doi": "10.1016/j.psychres.2023.115349", "pmid": "37523886", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1387, "title": "Psilocybin history, action and reaction: A narrative clinical review.", "authors": "Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1177/02698811231190858", "pubmed_id": "37650489", "openalex_id": "https://openalex.org/W4386305913", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37650489/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37650489", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37650489/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37650489", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37650489/", "doi": "10.1177/02698811231190858", "pmid": "37650489", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1386, "title": "Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.", "authors": "Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA", "journal": "Journal of psychiatric practice", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1097/pra.0000000000000729", "pubmed_id": "37678363", "openalex_id": "https://openalex.org/W4386469135", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37678363/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Review Article,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37678363", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37678363/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37678363", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37678363/", "doi": "10.1097/pra.0000000000000729", "pmid": "37678363", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1377, "title": "Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.", "authors": "Bhuiya NMA, Jacobs RJ, Wang K, Sun Y, Nava B, Sampiere L, Yerubandi A, Caballero J", "journal": "Cureus", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.7759/cureus.45169", "pubmed_id": "37842360", "openalex_id": "https://openalex.org/W4386702998", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37842360/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,End-of-Life Distress,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37842360", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37842360/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37842360", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37842360/", "doi": "10.7759/cureus.45169", "pmid": "37842360", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1376, "title": "Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?", "authors": "Pagán AF, Lex C, Soares JC, Meyer TD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0022", "pubmed_id": "40046569", "openalex_id": "https://openalex.org/W4385987387", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046569/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:40046569", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046569/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046569", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046569/", "doi": "10.1089/psymed.2023.0022", "pmid": "40046569", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1375, "title": "Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0030", "pubmed_id": "40046570", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Resilience,Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:40046570", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046570", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046570/", "doi": "10.1089/psymed.2023.0030", "pmid": "40046570", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4784, "title": "Pharmacology and Therapeutic Effects of Psilocybin", "authors": "Xuehan Du", "journal": "Highlights in Science Engineering and Technology", "publication_date": "2023-08-29", "publication_year": 2023, "doi": "10.54097/hset.v65i.11331", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386519663", "source_url": "http://dx.doi.org/10.54097/hset.v65i.11331", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "DOI:10.54097/hset.v65i.11331", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.54097/hset.v65i.11331", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54097/hset.v65i.11331", "source_url": "http://dx.doi.org/10.54097/hset.v65i.11331", "doi": "10.54097/hset.v65i.11331", "pmid": "", "publication_date": "2023-08-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4787, "title": "use of psilocybin in the treatment of psychiatric disorders - review", "authors": "Justyna Woźniak, Rafał BOGACZ, Magdalena Gaik, Ewa URAM, Inga MAGDA, Karol Womperski, Magdalena OSUCH", "journal": "Journal of Education Health and Sport", "publication_date": "2023-08-15", "publication_year": 2023, "doi": "10.12775/jehs.2023.43.01.009", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385645939", "source_url": "https://doi.org/10.12775/jehs.2023.43.01.009", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Headache / Migraine,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.43.01.009", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2023.43.01.009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.43.01.009", "source_url": "https://doi.org/10.12775/jehs.2023.43.01.009", "doi": "10.12775/jehs.2023.43.01.009", "pmid": "", "publication_date": "2023-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4786, "title": "Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2023-08-15", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.09.9.20", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385829163", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "doi": "10.1176/appi.pn.2023.09.9.20", "pmid": "", "publication_date": "2023-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1409, "title": "Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy.", "authors": "Thase ME", "journal": "The Journal of clinical psychiatry", "publication_date": "2023-08-14", "publication_year": 2023, "doi": "10.4088/jcp.mulmdd3048sho", "pubmed_id": "37585245", "openalex_id": "https://openalex.org/W4385689299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37585245/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37585245", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37585245/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37585245", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37585245/", "doi": "10.4088/jcp.mulmdd3048sho", "pmid": "37585245", "publication_date": "2023-08-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1412, "title": "Emerging Perspectives in Addiction Psychiatry.", "authors": "Jordan A", "journal": "The Journal of clinical psychiatry", "publication_date": "2023-08-09", "publication_year": 2023, "doi": "10.4088/jcp. muladx3048sho", "pubmed_id": "37555675", "openalex_id": "https://openalex.org/W4385517336", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37555675/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37555675", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37555675/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37555675", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37555675/", "doi": "10.4088/jcp. muladx3048sho", "pmid": "37555675", "publication_date": "2023-08-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4788, "title": "Psilocybin's Emerging Role in Combating Depressive Disorder", "authors": "Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek", "journal": "Journal of Education Health and Sport", "publication_date": "2023-08-08", "publication_year": 2023, "doi": "10.12775/jehs.2023.40.01.011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385658334", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Neurogenesis,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Review Article,Animal Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "doi": "10.12775/jehs.2023.40.01.011", "pmid": "", "publication_date": "2023-08-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1415, "title": "Psilocybin-assisted psychotherapy for cancer-related anxiety and depression.", "authors": "Yaniv D, Ramondetta LM, Cohen L, Amit M", "journal": "International journal of gynecological cancer: official journal of the International Gynecological Cancer Society", "publication_date": "2023-08-07", "publication_year": 2023, "doi": "10.1136/ijgc-2023-004659", "pubmed_id": "37463745", "openalex_id": "https://openalex.org/W4384661659", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37463745/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Cancer Patients", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37463745", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37463745", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37463745/", "doi": "10.1136/ijgc-2023-004659", "pmid": "37463745", "publication_date": "2023-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1414, "title": "A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.", "authors": "Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X", "journal": "International journal of molecular sciences", "publication_date": "2023-08-07", "publication_year": 2023, "doi": "10.3390/ijms241512513", "pubmed_id": "37569888", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37569888/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Microdosing,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37569888", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37569888/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37569888", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37569888/", "doi": "10.3390/ijms241512513", "pmid": "37569888", "publication_date": "2023-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1413, "title": "[Not Available].", "authors": "Ibrahim IB, Videbech P, Straszek SPV", "journal": "Ugeskrift for laeger", "publication_date": "2023-08-07", "publication_year": 2023, "doi": null, "pubmed_id": "37615227", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37615227/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:37615227", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37615227/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37615227", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37615227/", "doi": "", "pmid": "37615227", "publication_date": "2023-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4789, "title": "Psilocybin und Funktionalität bei Depression", "authors": "Moritz Spangemacher", "journal": "InFo Neurologie + Psychiatrie", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1007/s15005-023-3336-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386013106", "source_url": "http://dx.doi.org/10.1007/s15005-023-3336-2", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1007/s15005-023-3336-2", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15005-023-3336-2", "source_url": "http://dx.doi.org/10.1007/s15005-023-3336-2", "doi": "10.1007/s15005-023-3336-2", "pmid": "", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1426, "title": "Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.", "authors": "Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M", "journal": "CNS spectrums", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1017/s1092852922000888", "pubmed_id": "35811423", "openalex_id": "https://openalex.org/W4285007883", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35811423/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:35811423", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35811423/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35811423", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35811423/", "doi": "10.1017/s1092852922000888", "pmid": "35811423", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1425, "title": "Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis.", "authors": "Crowe M, Manuel J, Carlyle D, Lacey C", "journal": "International journal of mental health nursing", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1111/inm.13127", "pubmed_id": "36779424", "openalex_id": "https://openalex.org/W4320491739", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36779424/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:36779424", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36779424/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36779424", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36779424/", "doi": "10.1111/inm.13127", "pmid": "36779424", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1424, "title": "Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.", "authors": "Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A", "journal": "Neuropharmacology", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109528", "pubmed_id": "37015315", "openalex_id": "https://openalex.org/W4362508370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37015315/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Spirituality,Clinical Trial,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37015315", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37015315/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37015315", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37015315/", "doi": "10.1016/j.neuropharm.2023.109528", "pmid": "37015315", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1422, "title": "How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change.", "authors": "Zeifman RJ, Wagner AC, Monson CM, Carhart-Harris RL", "journal": "Journal of affective disorders", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.04.105", "pubmed_id": "37146908", "openalex_id": "https://openalex.org/W4367840575", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37146908/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37146908", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37146908/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37146908", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37146908/", "doi": "10.1016/j.jad.2023.04.105", "pmid": "37146908", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1420, "title": "Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.", "authors": "Jing X, Hoeh NR, Menkes DB", "journal": "Palliative & supportive care", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1017/s147895152300069x", "pubmed_id": "37334486", "openalex_id": "https://openalex.org/W4381158131", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37334486/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37334486", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37334486/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37334486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37334486/", "doi": "10.1017/s147895152300069x", "pmid": "37334486", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1418, "title": "Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.", "authors": "Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L", "journal": "Pharmacological research", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1016/j.phrs.2023.106837", "pubmed_id": "37379962", "openalex_id": "https://openalex.org/W4382133350", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37379962/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37379962", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37379962/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37379962", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37379962/", "doi": "10.1016/j.phrs.2023.106837", "pmid": "37379962", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3519, "title": "The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study", "authors": "Brain and Cognition Discovery Foundation", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-27", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05029466", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05029466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "source_url": "https://clinicaltrials.gov/study/NCT05029466", "doi": "", "pmid": "", "publication_date": "2023-07-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1427, "title": "Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.", "authors": "Husain MI, Blumberger DM, Castle DJ, Ledwos N, Fellows E, Jones BDM, Ortiz A, Kloiber S, Wang W, Rosenblat JD, Mulsant BH", "journal": "BJPsych open", "publication_date": "2023-07-25", "publication_year": 2023, "doi": "10.1192/bjo.2023.535", "pubmed_id": "37489299", "openalex_id": "https://openalex.org/W4385230722", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37489299/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Consciousness,Randomized Controlled Trial,Animal Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37489299", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37489299/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37489299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37489299/", "doi": "10.1192/bjo.2023.535", "pmid": "37489299", "publication_date": "2023-07-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3382, "title": "Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression", "authors": "Goodwin G, Marwood L, Mistry S, Nowakowska A, Simmons H, Tsai J, Williams S, Young M, Malievskaia E.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2023-07-19", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC10595939", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:30", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC10595939", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC10595939", "source_url": "https://europepmc.org/article/PMC/PMC10595939", "doi": "", "pmid": "", "publication_date": "2023-07-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3349, "title": "Psychedelics for depression: from neurobiology to treatment", "authors": "Kuypers K.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2023-07-19", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC10417770", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:26", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC10417770", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC10417770", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC10417770", "source_url": "https://europepmc.org/article/PMC/PMC10417770", "doi": "", "pmid": "", "publication_date": "2023-07-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3310, "title": "The therapeutic potential of psilocybin in depression resistant to psychotropic drugs", "authors": "Ramírez González J, Fernández Márquez I, Ferreiro González S, Ruíz E.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2023-07-19", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC10479004", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:15:22", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC10479004", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC10479004", "source_url": "https://europepmc.org/article/PMC/PMC10479004", "doi": "", "pmid": "", "publication_date": "2023-07-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3146, "title": "Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression", "authors": "Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2023-07-19", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC10434693", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:04", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC10434693", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC10434693", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC10434693", "source_url": "https://europepmc.org/article/PMC/PMC10434693", "doi": "", "pmid": "", "publication_date": "2023-07-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5703, "title": "Psilocybin Therapy for Major Depressive Disorder: A Systematic Review", "authors": "Venugopal Kaden L.", "journal": "Undergraduate Research in Natural and Clinical Science and Technology Journal", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.26685/urncst.489", "pubmed_id": null, "openalex_id": "https://openalex.org/W4384826415", "source_url": "https://doi.org/10.26685/urncst.489", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.26685/urncst.489", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.26685/urncst.489", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.26685/urncst.489", "source_url": "https://doi.org/10.26685/urncst.489", "doi": "10.26685/urncst.489", "pmid": "", "publication_date": "2023-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4792, "title": "Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings", "authors": "Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway", "journal": "Frontiers in Human Neuroscience", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.3389/fnhum.2023.1200393", "pubmed_id": "37533588", "openalex_id": "https://openalex.org/W4384695430", "source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 06:34:45", "bibtex": null, "source_record_id": "PMID:37533588", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37533588", "source_url": "https://doi.org/10.3389/fnhum.2023.1200393", "doi": "10.3389/fnhum.2023.1200393", "pmid": "37533588", "publication_date": "2023-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5816, "title": "Outcomes of usage of psychedelics by people reporting an eating disorder in clinical and non-clinical settings: a scoping review", "authors": "Jorge Valdiviezo-Oña, Lizbeth Toscano-Molina, Juan Fernando Chávez, Jonathan Elias Herrera Criollo, Clara Paz", "journal": "Advances in Mental Health", "publication_date": "2023-07-13", "publication_year": 2023, "doi": "10.1080/18387357.2023.2235030", "pubmed_id": null, "openalex_id": "https://openalex.org/W4384154266", "source_url": "http://dx.doi.org/10.1080/18387357.2023.2235030", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Receptor Pharmacology,Wellbeing,Spirituality,Clinical Trial,Randomized Controlled Trial,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:35", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1080/18387357.2023.2235030", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1080/18387357.2023.2235030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/18387357.2023.2235030", "source_url": "http://dx.doi.org/10.1080/18387357.2023.2235030", "doi": "10.1080/18387357.2023.2235030", "pmid": "", "publication_date": "2023-07-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1431, "title": "Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.", "authors": "Nogrady B", "journal": "BMJ (Clinical research ed.)", "publication_date": "2023-07-11", "publication_year": 2023, "doi": "10.1136/bmj.p1599", "pubmed_id": "37433614", "openalex_id": "https://openalex.org/W4383874233", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37433614/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37433614", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37433614", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37433614/", "doi": "10.1136/bmj.p1599", "pmid": "37433614", "publication_date": "2023-07-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1156, "title": "Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.", "authors": "Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maede K, González-Maeso J, Kitagaki S, Hiramatsu M", "journal": "Research square", "publication_date": "2023-07-07", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3138705/v1", "pubmed_id": "37461593", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37461593/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37461593", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37461593/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37461593", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37461593/", "doi": "10.21203/rs.3.rs-3138705/v1", "pmid": "37461593", "publication_date": "2023-07-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3755, "title": "Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin", "authors": "Tetem J, Fischmann T, Möller TJ.", "journal": "PsyArXiv", "publication_date": "2023-07-06", "publication_year": 2023, "doi": "10.31234/osf.io/ztyxh", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/ztyxh", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/ztyxh", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/ztyxh", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/ztyxh", "source_url": "https://doi.org/10.31234/osf.io/ztyxh", "doi": "10.31234/osf.io/ztyxh", "pmid": "", "publication_date": "2023-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3449, "title": "Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)", "authors": "Cybin Therapeutics Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-06", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05594667", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05594667", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05594667", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05594667", "source_url": "https://clinicaltrials.gov/study/NCT05594667", "doi": "", "pmid": "", "publication_date": "2023-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3161, "title": "Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin", "authors": "Jenny Tetem, Tamara Fischmann, Tim Julian Möller", "journal": "PsyArXiv", "publication_date": "2023-07-06", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "doi": "", "pmid": "", "publication_date": "2023-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1452, "title": "Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.", "authors": "Sloshower J, Skosnik PD, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D'Souza DC", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231154852", "pubmed_id": "36938991", "openalex_id": "https://openalex.org/W4327895864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36938991/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mystical Experience", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:36938991", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36938991/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36938991", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36938991/", "doi": "10.1177/02698811231154852", "pmid": "36938991", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1451, "title": "The need for establishing best practices and gold standards in psychedelic medicine.", "authors": "Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM", "journal": "Journal of affective disorders", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.03.083", "pubmed_id": "37003433", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37003433/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37003433", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37003433/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37003433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37003433/", "doi": "10.1016/j.jad.2023.03.083", "pmid": "37003433", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1449, "title": "A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.", "authors": "Weiss B, Erritzoe D, Giribaldi B, Nutt DJ, Carhart-Harris RL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231167848", "pubmed_id": "37122239", "openalex_id": "https://openalex.org/W4367053025", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37122239/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37122239", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37122239/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37122239", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37122239/", "doi": "10.1177/02698811231167848", "pmid": "37122239", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1448, "title": "Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?", "authors": "Rossell SL, Meikle SE, Williams ML, Castle DJ", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/00048674231172691", "pubmed_id": "37139585", "openalex_id": "https://openalex.org/W4368356691", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37139585/", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37139585", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37139585/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37139585", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37139585/", "doi": "10.1177/00048674231172691", "pmid": "37139585", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1445, "title": "New Pharmacologic Approaches to the Treatment of Bipolar Depression.", "authors": "Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN", "journal": "Drugs", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1007/s40265-023-01872-x", "pubmed_id": "37227597", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37227597/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Mitochondrial Function,Randomized Controlled Trial,Review Article,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37227597", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37227597/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37227597", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37227597/", "doi": "10.1007/s40265-023-01872-x", "pmid": "37227597", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1443, "title": "Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.", "authors": "Gukasyan N, Griffiths RR, Yaden DB, Antoine DG, Nayak SM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231179910", "pubmed_id": "37291890", "openalex_id": "https://openalex.org/W4379967727", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37291890/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Observational Study,Drug Interactions", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37291890", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37291890/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37291890", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37291890/", "doi": "10.1177/02698811231179910", "pmid": "37291890", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1441, "title": "Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.", "authors": "Haridy R", "journal": "Nature", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1038/d41586-023-02093-8", "pubmed_id": "37386185", "openalex_id": "https://openalex.org/W4382515410", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37386185/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37386185", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37386185", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37386185/", "doi": "10.1038/d41586-023-02093-8", "pmid": "37386185", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1440, "title": "Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.", "authors": "Skosnik PD, Sloshower J, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D'Souza DC", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231179800", "pubmed_id": "37392016", "openalex_id": "https://openalex.org/W4382776629", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37392016/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37392016", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37392016/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37392016", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37392016/", "doi": "10.1177/02698811231179800", "pmid": "37392016", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1438, "title": "Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.", "authors": "Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231180276", "pubmed_id": "37403379", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37403379/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37403379", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37403379/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37403379", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37403379/", "doi": "10.1177/02698811231180276", "pmid": "37403379", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3538, "title": "Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder", "authors": "Halucenex Life Sciences Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2023-06-29", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05243329", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Neurogenesis,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05243329", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "source_url": "https://clinicaltrials.gov/study/NCT05243329", "doi": "", "pmid": "", "publication_date": "2023-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4803, "title": "Experts Offer Tips on Talking With Patients About Psychedelics", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-06-28", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.07.7.51", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382360061", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "doi": "10.1176/appi.pn.2023.07.7.51", "pmid": "", "publication_date": "2023-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1459, "title": "Psychedelics, Meaningfulness, and the \"Proper Scope\" of Medicine: Continuing the Conversation.", "authors": "Cheung K, Patch K, Earp BD, Yaden DB", "journal": "Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees", "publication_date": "2023-06-27", "publication_year": 2023, "doi": "10.1017/s0963180123000270", "pubmed_id": "37366110", "openalex_id": "https://openalex.org/W4382182909", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37366110/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37366110", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37366110/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37366110", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37366110/", "doi": "10.1017/s0963180123000270", "pmid": "37366110", "publication_date": "2023-06-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1465, "title": "Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.", "authors": "Wulff AB, Nichols CD, Thompson SM", "journal": "Neuropharmacology", "publication_date": "2023-06-15", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109504", "pubmed_id": "36921889", "openalex_id": "https://openalex.org/W4324045013", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36921889/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:36921889", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36921889/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36921889", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36921889/", "doi": "10.1016/j.neuropharm.2023.109504", "pmid": "36921889", "publication_date": "2023-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4805, "title": "Psychedelics reopen the social reward learning critical period", "authors": "Romain Nardou, Edward J. Sawyer, Young Jun Song, M. F. Wilkinson, Yasmin Padovan-Hernandez, Júnia L. de Deus, Noelle Wright, Carine Lama, Sehr Faltin, Loyal A. Goff, Genevieve Stein-O’Brien, Gül Dölen", "journal": "Nature", "publication_date": "2023-06-13", "publication_year": 2023, "doi": "10.1038/s41586-023-06204-3", "pubmed_id": "37316665", "openalex_id": "https://openalex.org/W4380684709", "source_url": "https://doi.org/10.1038/s41586-023-06204-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Consciousness,Spirituality,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 06:34:45", "bibtex": null, "source_record_id": "PMID:37316665", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41586-023-06204-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37316665", "source_url": "https://doi.org/10.1038/s41586-023-06204-3", "doi": "10.1038/s41586-023-06204-3", "pmid": "37316665", "publication_date": "2023-06-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4806, "title": "A regulatory framework review of Schedule I psychedelics in the United States", "authors": "Kevin Herkenham", "journal": "JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY", "publication_date": "2023-06-12", "publication_year": 2023, "doi": "10.1002/jac5.1841", "pubmed_id": null, "openalex_id": "https://openalex.org/W4380357539", "source_url": "https://doi.org/10.1002/jac5.1841", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1002/jac5.1841", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jac5.1841", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/jac5.1841", "source_url": "https://doi.org/10.1002/jac5.1841", "doi": "10.1002/jac5.1841", "pmid": "", "publication_date": "2023-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3771, "title": "Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-06-09", "publication_year": 2023, "doi": "10.31234/osf.io/qyce5", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/qyce5", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-08-09 08:15:13", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/qyce5", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/qyce5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/qyce5", "source_url": "https://doi.org/10.31234/osf.io/qyce5", "doi": "10.31234/osf.io/qyce5", "pmid": "", "publication_date": "2023-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3387, "title": "The treatment of abandonment anxiety with MDMA and LSD", "authors": "Mika Turkia", "journal": "PsyArXiv", "publication_date": "2023-06-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "source_url": "https://osf.io/preprints/psyarxiv/pw2tf_v1", "doi": "", "pmid": "", "publication_date": "2023-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3229, "title": "Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study", "authors": "Mika Turkia", "journal": "PsyArXiv", "publication_date": "2023-06-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/qyce5_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/qyce5_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/qyce5_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/qyce5_v1", "source_url": "https://osf.io/preprints/psyarxiv/qyce5_v1", "doi": "", "pmid": "", "publication_date": "2023-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3153, "title": "Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression", "authors": "Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL.", "journal": "medRxiv", "publication_date": "2023-06-03", "publication_year": 2023, "doi": "10.1101/2023.05.29.23290667", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.05.29.23290667", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Biomarkers,Aging,Emotional Processing,Drug Interactions", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:05", "bibtex": null, "source_record_id": "DOI:10.1101/2023.05.29.23290667", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.05.29.23290667", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2023.05.29.23290667", "source_url": "https://doi.org/10.1101/2023.05.29.23290667", "doi": "10.1101/2023.05.29.23290667", "pmid": "", "publication_date": "2023-06-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4808, "title": "Psilocybin therapy: A novel approach to treating depression", "authors": "Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala", "journal": "International Journal of Surgery Global Health", "publication_date": "2023-06-02", "publication_year": 2023, "doi": "10.1097/gh9.0000000000000175", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379142909", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000175", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000175", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "doi": "10.1097/gh9.0000000000000175", "pmid": "", "publication_date": "2023-06-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1476, "title": "In silico characterization of the psilocybin biosynthesis pathway.", "authors": "Irvine W, Tyler M, Delgoda R", "journal": "Computational biology and chemistry", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1016/j.compbiolchem.2023.107854", "pubmed_id": "36990027", "openalex_id": "https://openalex.org/W4360616011", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36990027/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,In Vitro Study,Drug Interactions", "study_type": "In Vitro Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:36990027", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36990027/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36990027", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36990027/", "doi": "10.1016/j.compbiolchem.2023.107854", "pmid": "36990027", "publication_date": "2023-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1475, "title": "Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.", "authors": "Agrawal M, Emanuel E, Richards B, Richards W, Roddy K, Thambi P", "journal": "JAMA oncology", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1001/jamaoncol.2023.0351", "pubmed_id": "37052904", "openalex_id": "https://openalex.org/W4365444032", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37052904/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37052904", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37052904/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37052904", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37052904/", "doi": "10.1001/jamaoncol.2023.0351", "pmid": "37052904", "publication_date": "2023-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1474, "title": "Role of Psychedelics in Treatment-Resistant Depression.", "authors": "Kamal S, Jha MK, Radhakrishnan R", "journal": "The Psychiatric clinics of North America", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1016/j.psc.2023.02.004", "pubmed_id": "37149346", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37149346/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37149346", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37149346/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37149346", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37149346/", "doi": "10.1016/j.psc.2023.02.004", "pmid": "37149346", "publication_date": "2023-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1466, "title": "Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.", "authors": "Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1089/psymed.2022.0011", "pubmed_id": "40046728", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Clinical Trial,Review Article,Cancer Patients,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:40046728", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046728", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "doi": "10.1089/psymed.2022.0011", "pmid": "40046728", "publication_date": "2023-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4810, "title": "Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).", "authors": "Manish Agrawal, Sarah Shnayder, Heather Honstein, Ezekiel Emanuel, Paul Thambi", "journal": "Journal of Clinical Oncology", "publication_date": "2023-05-31", "publication_year": 2023, "doi": "10.1200/jco.2023.41.16_suppl.12021", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379281082", "source_url": "http://dx.doi.org/10.1200/jco.2023.41.16_suppl.12021", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study,Cancer Patients", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1200/jco.2023.41.16_suppl.12021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1200/jco.2023.41.16_suppl.12021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1200/jco.2023.41.16_suppl.12021", "source_url": "http://dx.doi.org/10.1200/jco.2023.41.16_suppl.12021", "doi": "10.1200/jco.2023.41.16_suppl.12021", "pmid": "", "publication_date": "2023-05-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3475, "title": "Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans", "authors": "Combat Stress", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05876481", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05876481", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05876481", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05876481", "source_url": "https://clinicaltrials.gov/study/NCT05876481", "doi": "", "pmid": "", "publication_date": "2023-05-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1481, "title": "Neurobiological Correlates of Psilocybin Response in Depression.", "authors": "Qasim S, Zaheer Z, Jawad MY, Shad MU", "journal": "The primary care companion for CNS disorders", "publication_date": "2023-05-23", "publication_year": 2023, "doi": "10.4088/pcc.22r03419", "pubmed_id": "37230065", "openalex_id": "https://openalex.org/W4377233162", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37230065/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37230065", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37230065/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37230065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37230065/", "doi": "10.4088/pcc.22r03419", "pmid": "37230065", "publication_date": "2023-05-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3683, "title": "Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-19", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04842045", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04842045", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "source_url": "https://clinicaltrials.gov/study/NCT04842045", "doi": "", "pmid": "", "publication_date": "2023-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1482, "title": "Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.", "authors": "Fonseka LN, Woo BK", "journal": "World journal of psychiatry", "publication_date": "2023-05-19", "publication_year": 2023, "doi": "10.5498/wjp.v13.i5.182", "pubmed_id": "37303932", "openalex_id": "https://openalex.org/W4377096690", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37303932/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Review Article,Treatment-Resistant Depression,Healthcare Workers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37303932", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37303932/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37303932", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37303932/", "doi": "10.5498/wjp.v13.i5.182", "pmid": "37303932", "publication_date": "2023-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3063, "title": "Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders", "authors": "Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ.", "journal": "bioRxiv", "publication_date": "2023-05-18", "publication_year": 2023, "doi": "10.1101/2023.05.16.540994", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.05.16.540994", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:54", "bibtex": null, "source_record_id": "DOI:10.1101/2023.05.16.540994", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.05.16.540994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.05.16.540994", "source_url": "https://doi.org/10.1101/2023.05.16.540994", "doi": "10.1101/2023.05.16.540994", "pmid": "", "publication_date": "2023-05-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5818, "title": "THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE", "authors": "Chirag Ambaliya, Dimple Gupta, Ashok Vala, Krupa Mukeshbhai Unadkat", "journal": "PARIPEX-INDIAN JOURNAL OF RESEARCH", "publication_date": "2023-05-15", "publication_year": 2023, "doi": "10.36106/paripex/6712845", "pubmed_id": null, "openalex_id": "https://openalex.org/W4381744623", "source_url": "https://doi.org/10.36106/paripex/6712845", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:36", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "DOI:10.36106/paripex/6712845", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36106/paripex/6712845", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36106/paripex/6712845", "source_url": "https://doi.org/10.36106/paripex/6712845", "doi": "10.36106/paripex/6712845", "pmid": "", "publication_date": "2023-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3634, "title": "A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-15", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05467761", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05467761", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "source_url": "https://clinicaltrials.gov/study/NCT05467761", "doi": "", "pmid": "", "publication_date": "2023-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3167, "title": "Exposure therapy under psilocybin for general anxiety disorder and claustrophobia", "authors": "THORENS G, PENZENSTADLER l, FURTADO LCDC, SERAGNOLI F, ROTHEN S, MABILAIS C, ZULLINO D.", "journal": "Research Square", "publication_date": "2023-05-12", "publication_year": 2023, "doi": "10.21203/rs.3.rs-2859973/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-2859973/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Case Report", "study_type": "Case Report", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-2859973/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-2859973/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-2859973/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-2859973/v1", "doi": "10.21203/rs.3.rs-2859973/v1", "pmid": "", "publication_date": "2023-05-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1489, "title": "The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey.", "authors": "Więckiewicz G, Marek J, Stokłosa I, Szafoni S, Pluta S, Smukowska K, Żebrowska G, Stokłosa M, Gorczyca P, Pudlo R", "journal": "Medicina (Kaunas, Lithuania)", "publication_date": "2023-05-09", "publication_year": 2023, "doi": "10.3390/medicina59050908", "pubmed_id": "37241141", "openalex_id": "https://openalex.org/W4378515555", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37241141/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37241141", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37241141/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37241141", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37241141/", "doi": "10.3390/medicina59050908", "pmid": "37241141", "publication_date": "2023-05-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3463, "title": "Effects of Psilocybin in Anorexia Nervosa", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-06", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04052568", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04052568", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04052568", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04052568", "source_url": "https://clinicaltrials.gov/study/NCT04052568", "doi": "", "pmid": "", "publication_date": "2023-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1497, "title": "Unblinding and demand characteristics in the treatment of depression.", "authors": "Goodwin GM, Croal M, Marwood L, Malievskaia E", "journal": "Journal of affective disorders", "publication_date": "2023-05-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.02.030", "pubmed_id": "36781142", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36781142", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36781142", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36781142/", "doi": "10.1016/j.jad.2023.02.030", "pmid": "36781142", "publication_date": "2023-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1495, "title": "Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.", "authors": "Rosenblat JD, Leon-Carlyle M, Ali S, Husain MI, McIntyre RS", "journal": "The American journal of psychiatry", "publication_date": "2023-05-01", "publication_year": 2023, "doi": "10.1176/appi.ajp.20220835", "pubmed_id": "36945824", "openalex_id": "https://openalex.org/W4353017554", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36945824/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36945824", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36945824", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36945824/", "doi": "10.1176/appi.ajp.20220835", "pmid": "36945824", "publication_date": "2023-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1494, "title": "[Contribution of serotonin 5-HT receptor to antidepressant effect of serotonergic psychedelics].", "authors": "Ibi D", "journal": "Nihon yakurigaku zasshi. Folia pharmacologica Japonica", "publication_date": "2023-05-01", "publication_year": 2023, "doi": "10.1254/fpj.22141", "pubmed_id": "36990794", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36990794/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36990794", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36990794/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36990794", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36990794/", "doi": "10.1254/fpj.22141", "pmid": "36990794", "publication_date": "2023-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1493, "title": "Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.", "authors": "Schneier FR, Feusner J, Wheaton MG, Gomez GJ, Cornejo G, Naraindas AM, Hellerstein DJ", "journal": "Journal of psychiatric research", "publication_date": "2023-05-01", "publication_year": 2023, "doi": "10.1016/j.jpsychires.2023.03.031", "pubmed_id": "37004409", "openalex_id": "https://openalex.org/W4361279088", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37004409/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37004409", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37004409/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37004409", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37004409/", "doi": "10.1016/j.jpsychires.2023.03.031", "pmid": "37004409", "publication_date": "2023-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4819, "title": "A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history", "authors": "Eric N. Kramer, Kalyn Reddy, Bryan Shapiro", "journal": "Psychiatry Research Case Reports", "publication_date": "2023-04-26", "publication_year": 2023, "doi": "10.1016/j.psycr.2023.100118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367043450", "source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.psycr.2023.100118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psycr.2023.100118", "source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "doi": "10.1016/j.psycr.2023.100118", "pmid": "", "publication_date": "2023-04-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3563, "title": "The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2023-04-24", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03775200", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03775200", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03775200", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03775200", "source_url": "https://clinicaltrials.gov/study/NCT03775200", "doi": "", "pmid": "", "publication_date": "2023-04-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1502, "title": "Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Atli M, Bennett JC, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Lennard-Jones MR, Licht RW, Marwood L, Mistry S, Páleníček T, Redjep O, Repantis D, Schoevers RA, Septimus B, Simmons HJ, Soares JC, Somers M, Stansfield SC, Stuart JR, Tadley HH, Thiara NK, Tsai J, Wahba M, Williams S, Winzer RI, Young AH, Young MB, Zisook S, Malievskaia E", "journal": "Journal of affective disorders", "publication_date": "2023-04-14", "publication_year": 2023, "doi": "10.1016/j.jad.2023.01.108", "pubmed_id": "36740140", "openalex_id": "https://openalex.org/W4319067008", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36740140/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36740140", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36740140/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36740140", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36740140/", "doi": "10.1016/j.jad.2023.01.108", "pmid": "36740140", "publication_date": "2023-04-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4823, "title": "347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder", "authors": "Xi Zhu, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria Gómez, Franklin R. Schneier", "journal": "Biological Psychiatry", "publication_date": "2023-04-10", "publication_year": 2023, "doi": "10.1016/j.biopsych.2023.02.587", "pubmed_id": null, "openalex_id": "https://openalex.org/W4362733849", "source_url": "https://doi.org/10.1016/j.biopsych.2023.02.587", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2023.02.587", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2023.02.587", "source_url": "https://doi.org/10.1016/j.biopsych.2023.02.587", "doi": "10.1016/j.biopsych.2023.02.587", "pmid": "", "publication_date": "2023-04-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4822, "title": "96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression", "authors": "Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Audrey Shoultz, Trisha Suppes", "journal": "Biological Psychiatry", "publication_date": "2023-04-10", "publication_year": 2023, "doi": "10.1016/j.biopsych.2023.02.336", "pubmed_id": null, "openalex_id": "https://openalex.org/W4363675215", "source_url": "https://doi.org/10.1016/j.biopsych.2023.02.336", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2023.02.336", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2023.02.336", "source_url": "https://doi.org/10.1016/j.biopsych.2023.02.336", "doi": "10.1016/j.biopsych.2023.02.336", "pmid": "", "publication_date": "2023-04-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3318, "title": "Psilocybin zeigt Wirkung bei Depression.", "authors": "Julia Mertens L.", "journal": "MMW Fortschritte der Medizin", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1007/s15006-023-2540-9", "pubmed_id": "37016226", "openalex_id": "https://openalex.org/W4362597408", "source_url": "https://doi.org/10.1007/s15006-023-2540-9", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "PMID:37016226", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37016226", "source_url": "https://doi.org/10.1007/s15006-023-2540-9", "doi": "10.1007/s15006-023-2540-9", "pmid": "37016226", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1520, "title": "Microdosing psilocybin for chronic pain: a case series.", "authors": "Lyes M, Yang KH, Castellanos J, Furnish T", "journal": "Pain", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1097/j.pain.0000000000002778", "pubmed_id": "36066961", "openalex_id": "https://openalex.org/W4294804950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36066961/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Microdosing,Clinical Trial,Case Report", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36066961", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36066961/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36066961", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36066961/", "doi": "10.1097/j.pain.0000000000002778", "pmid": "36066961", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1519, "title": "The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.", "authors": "VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ", "journal": "Neurochemical research", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1007/s11064-022-03772-0", "pubmed_id": "36327017", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36327017/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Drug Interactions,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36327017", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36327017/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36327017", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36327017/", "doi": "10.1007/s11064-022-03772-0", "pmid": "36327017", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1517, "title": "Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.", "authors": "Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ", "journal": "Neurosurgery", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1227/neu.0000000000002275", "pubmed_id": "36512813", "openalex_id": "https://openalex.org/W4311273096", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36512813/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36512813", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36512813/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36512813", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36512813/", "doi": "10.1227/neu.0000000000002275", "pmid": "36512813", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1513, "title": "Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.", "authors": "Modlin NL, Miller TM, Rucker JJ, Kirlic N, Lennard-Jones M, Schlosser D, Aaronson ST", "journal": "Journal of affective disorders", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.01.077", "pubmed_id": "36707036", "openalex_id": "https://openalex.org/W4318393298", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36707036/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,End-of-Life Distress,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36707036", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36707036/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36707036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36707036/", "doi": "10.1016/j.jad.2023.01.077", "pmid": "36707036", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1524, "title": "Psychotherapy with Psilocybin for Depression: Systematic Review.", "authors": "Dawood Hristova JJ, Pérez-Jover V", "journal": "Behavioral sciences (Basel, Switzerland)", "publication_date": "2023-03-31", "publication_year": 2023, "doi": "10.3390/bs13040297", "pubmed_id": "37102811", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37102811/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Wellbeing,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37102811", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37102811/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37102811", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37102811/", "doi": "10.3390/bs13040297", "pmid": "37102811", "publication_date": "2023-03-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1527, "title": "Default Mode Network Modulation by Psychedelics: A Systematic Review.", "authors": "Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2023-03-22", "publication_year": 2023, "doi": "10.1093/ijnp/pyac074", "pubmed_id": "36272145", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36272145/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Mechanism of Action,Default Mode Network,Mystical Experience,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36272145", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36272145/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36272145", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36272145/", "doi": "10.1093/ijnp/pyac074", "pmid": "36272145", "publication_date": "2023-03-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3433, "title": "Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects (\"MELO\"): A Blinded, Placebo-Controlled, Dose-Finding Study", "authors": "Optimi Health Corporation", "journal": "ClinicalTrials.gov", "publication_date": "2023-03-20", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05252598", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05252598", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05252598", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05252598", "source_url": "https://clinicaltrials.gov/study/NCT05252598", "doi": "", "pmid": "", "publication_date": "2023-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1531, "title": "The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.", "authors": "Zanikov T, Gerasymchuk M, Ghasemi Gojani E, Robinson GI, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cameron M, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I", "journal": "Molecules (Basel, Switzerland)", "publication_date": "2023-03-14", "publication_year": 2023, "doi": "10.3390/molecules28062624", "pubmed_id": "36985596", "openalex_id": "https://openalex.org/W4324147331", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36985596/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Biomarkers,Animal Study,Inflammation", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36985596", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36985596/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36985596", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36985596/", "doi": "10.3390/molecules28062624", "pmid": "36985596", "publication_date": "2023-03-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3524, "title": "Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder", "authors": "New York State Psychiatric Institute", "journal": "ClinicalTrials.gov", "publication_date": "2023-03-13", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04656301", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04656301", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04656301", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04656301", "source_url": "https://clinicaltrials.gov/study/NCT04656301", "doi": "", "pmid": "", "publication_date": "2023-03-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3772, "title": "Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": "10.31234/osf.io/wupvy", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/wupvy", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-08-09 08:15:13", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/wupvy", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/wupvy", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/wupvy", "source_url": "https://doi.org/10.31234/osf.io/wupvy", "doi": "10.31234/osf.io/wupvy", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3767, "title": "Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": "10.31234/osf.io/t6k9b", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/t6k9b", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/t6k9b", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/t6k9b", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/t6k9b", "source_url": "https://doi.org/10.31234/osf.io/t6k9b", "doi": "10.31234/osf.io/t6k9b", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3233, "title": "Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study", "authors": "Mika Turkia", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/wupvy_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/wupvy_v1", "source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "doi": "", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3207, "title": "Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study", "authors": "Mika Turkia", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "source_url": "https://osf.io/preprints/psyarxiv/t6k9b_v1", "doi": "", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4833, "title": "Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?", "authors": "Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand", "journal": "Clinical Chemistry", "publication_date": "2023-03-07", "publication_year": 2023, "doi": "10.1093/clinchem/hvad016", "pubmed_id": "36881769", "openalex_id": "https://openalex.org/W4323351497", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "PMID:36881769", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36881769", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "doi": "10.1093/clinchem/hvad016", "pmid": "36881769", "publication_date": "2023-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1536, "title": "Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.", "authors": "Kalkman HO", "journal": "Biomedicines", "publication_date": "2023-03-07", "publication_year": 2023, "doi": "10.3390/biomedicines11030806", "pubmed_id": "36979785", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,In Vitro Study,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36979785", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36979785", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "doi": "10.3390/biomedicines11030806", "pmid": "36979785", "publication_date": "2023-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4834, "title": "How psychedelics spark neuronal growth", "authors": "Shi En Kim", "journal": "C&EN Global Enterprise", "publication_date": "2023-03-05", "publication_year": 2023, "doi": "10.1021/cen-10108-scicon1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4323321700", "source_url": "http://dx.doi.org/10.1021/cen-10108-scicon1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10108-scicon1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-10108-scicon1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10108-scicon1", "source_url": "http://dx.doi.org/10.1021/cen-10108-scicon1", "doi": "10.1021/cen-10108-scicon1", "pmid": "", "publication_date": "2023-03-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1539, "title": "Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training?", "authors": "Emmerich N, Humphries B", "journal": "Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees", "publication_date": "2023-03-02", "publication_year": 2023, "doi": "10.1017/s0963180123000099", "pubmed_id": "36861394", "openalex_id": "https://openalex.org/W4322757924", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36861394/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36861394", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36861394/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36861394", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36861394/", "doi": "10.1017/s0963180123000099", "pmid": "36861394", "publication_date": "2023-03-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1538, "title": "Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.", "authors": "Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B", "journal": "Antioxidants (Basel, Switzerland)", "publication_date": "2023-03-02", "publication_year": 2023, "doi": "10.3390/antiox12030623", "pubmed_id": "36978872", "openalex_id": "https://openalex.org/W4323047575", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36978872/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36978872", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36978872/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36978872", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36978872/", "doi": "10.3390/antiox12030623", "pmid": "36978872", "publication_date": "2023-03-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3730, "title": "A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.", "authors": "Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1089/psymed.2022.0002", "pubmed_id": "37337526", "openalex_id": "https://openalex.org/W4307481727", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37337526/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 11:08:42", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:37337526", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37337526/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37337526", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37337526/", "doi": "10.1089/psymed.2022.0002", "pmid": "37337526", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1552, "title": "A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.", "authors": "Kisely S, Connor M, Somogyi AA, Siskind D", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1177/00048674221083868", "pubmed_id": "35285280", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285280/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:35285280", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35285280/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35285280", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285280/", "doi": "10.1177/00048674221083868", "pmid": "35285280", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1551, "title": "[Attitudes of Mental Health Experts Towards Psilocybin].", "authors": "Schmidt C, Wolff M, Gründer G, Jungaberle H", "journal": "Fortschritte der Neurologie-Psychiatrie", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1055/a-1846-1161", "pubmed_id": "35724682", "openalex_id": "https://openalex.org/W4283204986", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35724682/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:35724682", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35724682/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35724682", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35724682/", "doi": "10.1055/a-1846-1161", "pmid": "35724682", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1547, "title": "Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.", "authors": "McTaggart AR, James TY, Slot JC, Barlow C, Fechner N, Shuey LS, Drenth A", "journal": "Fungal genetics and biology: FG & B", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1016/j.fgb.2022.103769", "pubmed_id": "36587787", "openalex_id": "https://openalex.org/W4313334084", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36587787/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Wellbeing,Genomics", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36587787", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36587787/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36587787", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36587787/", "doi": "10.1016/j.fgb.2022.103769", "pmid": "36587787", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1546, "title": "Interaction of psychedelic tryptamine derivatives with a lipid bilayer.", "authors": "Zohairi F, Khandelia H, Hakami Zanjani AA", "journal": "Chemistry and physics of lipids", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1016/j.chemphyslip.2023.105279", "pubmed_id": "36627076", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36627076/", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36627076", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36627076/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36627076", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36627076/", "doi": "10.1016/j.chemphyslip.2023.105279", "pmid": "36627076", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1542, "title": "Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.", "authors": "Jha MK, Mathew SJ", "journal": "The American journal of psychiatry", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1176/appi.ajp.20230025", "pubmed_id": "36855876", "openalex_id": "https://openalex.org/W4322719045", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36855876/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36855876", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36855876/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36855876", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36855876/", "doi": "10.1176/appi.ajp.20230025", "pmid": "36855876", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1534, "title": "A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression.", "authors": "Hibicke M, Kramer HM, Nichols CD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1089/psymed.2022.0012", "pubmed_id": "40047006", "openalex_id": "https://openalex.org/W4323041020", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047006/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Adolescents", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:40047006", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40047006/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40047006", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047006/", "doi": "10.1089/psymed.2022.0012", "pmid": "40047006", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1533, "title": "Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.", "authors": "Aday JS, Skiles Z, Eaton N, Fredenburg L, Pleet M, Mantia J, Bradley ER, Fernandes-Osterhold G, Woolley JD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1089/psymed.2022.0004", "pubmed_id": "40047007", "openalex_id": "https://openalex.org/W4321016287", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047007/", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Review Article,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:40047007", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40047007/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40047007", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40047007/", "doi": "10.1089/psymed.2022.0004", "pmid": "40047007", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1555, "title": "Psilocybin for Treatment-Resistant Depression.", "authors": "Østergaard SD, Hieronymus F", "journal": "The New England journal of medicine", "publication_date": "2023-02-23", "publication_year": 2023, "doi": "10.1056/nejmc2215459", "pubmed_id": "36812443", "openalex_id": "https://openalex.org/W4321482687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36812443/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36812443", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36812443", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36812443/", "doi": "10.1056/nejmc2215459", "pmid": "36812443", "publication_date": "2023-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4846, "title": "Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First", "authors": "Jacques Ambrose, J.S. Zabinski", "journal": "Psychiatric News", "publication_date": "2023-02-16", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.03.3.43", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321033113", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.43", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.43", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "doi": "10.1176/appi.pn.2023.03.3.43", "pmid": "", "publication_date": "2023-02-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4844, "title": "Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease", "authors": "Ashish Sarangi, Omotola Akinkunmi", "journal": "American Journal of Geriatric Psychiatry", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1016/j.jagp.2022.12.201", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321014012", "source_url": "https://doi.org/10.1016/j.jagp.2022.12.201", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 06:34:46", "bibtex": null, "source_record_id": "DOI:10.1016/j.jagp.2022.12.201", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jagp.2022.12.201", "source_url": "https://doi.org/10.1016/j.jagp.2022.12.201", "doi": "10.1016/j.jagp.2022.12.201", "pmid": "", "publication_date": "2023-02-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1558, "title": "Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.", "authors": "Shnayder S, Ameli R, Sinaii N, Berger A, Agrawal M", "journal": "Journal of affective disorders", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1016/j.jad.2022.11.046", "pubmed_id": "36513161", "openalex_id": "https://openalex.org/W4312196530", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36513161/", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Spirituality,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36513161", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36513161/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36513161", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36513161/", "doi": "10.1016/j.jad.2022.11.046", "pmid": "36513161", "publication_date": "2023-02-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4848, "title": "The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy", "authors": "Jeffery Heilman", "journal": "Journal of Scientific Exploration", "publication_date": "2023-02-11", "publication_year": 2023, "doi": "10.31275/20222633", "pubmed_id": null, "openalex_id": "https://openalex.org/W4320035163", "source_url": "http://dx.doi.org/10.31275/20222633", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.31275/20222633", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.31275/20222633", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31275/20222633", "source_url": "http://dx.doi.org/10.31275/20222633", "doi": "10.31275/20222633", "pmid": "", "publication_date": "2023-02-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1573, "title": "Novel antidepressant drugs: Beyond monoamine targets.", "authors": "Gonda X, Dome P, Neill JC, Tarazi FI", "journal": "CNS spectrums", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1017/s1092852921000791", "pubmed_id": "34588093", "openalex_id": "https://openalex.org/W3204478846", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34588093/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:34588093", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34588093/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34588093", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34588093/", "doi": "10.1017/s1092852921000791", "pmid": "34588093", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1572, "title": "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.", "authors": "Ko K, Kopra EI, Cleare AJ, Rucker JJ", "journal": "Journal of affective disorders", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1016/j.jad.2022.09.168", "pubmed_id": "36209780", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36209780/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36209780", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36209780/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36209780", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36209780/", "doi": "10.1016/j.jad.2022.09.168", "pmid": "36209780", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1570, "title": "Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation.", "authors": "Burmester DR, Madsen MK, Szabo A, Aripaka SS, Stenbæk DS, Frokjaer VG, Elfving B, Mikkelsen JD, Knudsen GM, Fisher PM", "journal": "Comprehensive psychoneuroendocrinology", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1016/j.cpnec.2022.100163", "pubmed_id": "36545240", "openalex_id": "https://openalex.org/W4312056223", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36545240/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Biomarkers,Observational Study,Healthy Volunteers,Inflammation,Immune Function", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36545240", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36545240/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36545240", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36545240/", "doi": "10.1016/j.cpnec.2022.100163", "pmid": "36545240", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1569, "title": "5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.", "authors": "Cameron LP, Patel SD, Vargas MV, Barragan EV, Saeger HN, Warren HT, Chow WL, Gray JA, Olson DE", "journal": "ACS chemical neuroscience", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1021/acschemneuro.2c00718", "pubmed_id": "36630260", "openalex_id": "https://openalex.org/W4315620747", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36630260/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36630260", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36630260/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36630260", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36630260/", "doi": "10.1021/acschemneuro.2c00718", "pmid": "36630260", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1567, "title": "Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.", "authors": "von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX", "journal": "EClinicalMedicine", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1016/j.eclinm.2022.101809", "pubmed_id": "36636296", "openalex_id": "https://openalex.org/W4313530670", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36636296/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36636296", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36636296/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36636296", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36636296/", "doi": "10.1016/j.eclinm.2022.101809", "pmid": "36636296", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1566, "title": "Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.", "authors": "von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX", "journal": "EClinicalMedicine", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1016/j.eclinm.2023.101841", "pubmed_id": "36747965", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36747965/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36747965", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36747965/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36747965", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36747965/", "doi": "10.1016/j.eclinm.2023.101841", "pmid": "36747965", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1565, "title": "Psilocybin therapy for depression. A good trip?", "authors": "Rucker JJ", "journal": "Journal of mental health (Abingdon, England)", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1080/09638237.2023.2183492", "pubmed_id": "36913702", "openalex_id": "https://openalex.org/W4324125719", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36913702/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36913702", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36913702", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36913702/", "doi": "10.1080/09638237.2023.2183492", "pmid": "36913702", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4852, "title": "Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health", "authors": "Jennings Hernandez", "journal": "Advances in Research", "publication_date": "2023-01-30", "publication_year": 2023, "doi": "10.9734/air/2023/v24i1931", "pubmed_id": null, "openalex_id": "https://openalex.org/W4318591507", "source_url": "http://dx.doi.org/10.9734/air/2023/v24i1931", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Receptor Pharmacology,Observational Study,Adverse Events", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.9734/air/2023/v24i1931", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.9734/air/2023/v24i1931", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.9734/air/2023/v24i1931", "source_url": "http://dx.doi.org/10.9734/air/2023/v24i1931", "doi": "10.9734/air/2023/v24i1931", "pmid": "", "publication_date": "2023-01-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3695, "title": "SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression", "authors": "Washington University School of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2023-01-30", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05601648", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05601648", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05601648", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05601648", "source_url": "https://clinicaltrials.gov/study/NCT05601648", "doi": "", "pmid": "", "publication_date": "2023-01-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4855, "title": "Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial", "authors": "Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-01-18", "publication_year": 2023, "doi": "10.1556/2054.2022.00222", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317355030", "source_url": "https://doi.org/10.1556/2054.2022.00222", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00222", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00222", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00222", "source_url": "https://doi.org/10.1556/2054.2022.00222", "doi": "10.1556/2054.2022.00222", "pmid": "", "publication_date": "2023-01-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4856, "title": "Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder", "authors": "Dragana Marković, Eleonora Čapelja", "journal": "AIDASCO Reviews", "publication_date": "2023-01-17", "publication_year": 2023, "doi": "10.59783/aire.2023.15", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406142619", "source_url": "https://doi.org/10.59783/aire.2023.15", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.59783/aire.2023.15", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59783/aire.2023.15", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59783/aire.2023.15", "source_url": "https://doi.org/10.59783/aire.2023.15", "doi": "10.59783/aire.2023.15", "pmid": "", "publication_date": "2023-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1576, "title": "Is psilocybin an effective antidepressant and what is its Mechanism of action?", "authors": "Mann JJ", "journal": "Cell reports. Medicine", "publication_date": "2023-01-17", "publication_year": 2023, "doi": "10.1016/j.xcrm.2022.100906", "pubmed_id": "36652915", "openalex_id": "https://openalex.org/W4316876990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36652915/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36652915", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36652915/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36652915", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36652915/", "doi": "10.1016/j.xcrm.2022.100906", "pmid": "36652915", "publication_date": "2023-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1577, "title": "On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression.", "authors": "Gukasyan N", "journal": "Med (New York, N.Y.)", "publication_date": "2023-01-13", "publication_year": 2023, "doi": "10.1016/j.medj.2022.12.003", "pubmed_id": "36640755", "openalex_id": "https://openalex.org/W4315874306", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36640755/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36640755", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36640755/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36640755", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36640755/", "doi": "10.1016/j.medj.2022.12.003", "pmid": "36640755", "publication_date": "2023-01-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1580, "title": "The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.", "authors": "Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M", "journal": "International journal of molecular sciences", "publication_date": "2023-01-10", "publication_year": 2023, "doi": "10.3390/ijms24021329", "pubmed_id": "36674849", "openalex_id": "https://openalex.org/W4315649535", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36674849/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36674849", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36674849/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36674849", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36674849/", "doi": "10.3390/ijms24021329", "pmid": "36674849", "publication_date": "2023-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1478, "title": "Acute psilocybin enhances cognitive flexibility in rats.", "authors": "Torrado Pacheco A, Olson RJ, Garza G, Moghaddam B", "journal": "bioRxiv: the preprint server for biology", "publication_date": "2023-01-09", "publication_year": 2023, "doi": "10.1101/2023.01.09.523291", "pubmed_id": "36712091", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36712091/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Healthcare Workers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36712091", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36712091/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36712091", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36712091/", "doi": "10.1101/2023.01.09.523291", "pmid": "36712091", "publication_date": "2023-01-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3354, "title": "Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst", "authors": "Sidsel Andersen", "journal": "PsyArXiv", "publication_date": "2023-01-04", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/f26ce_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Personality Change,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/f26ce_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/f26ce_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/f26ce_v1", "source_url": "https://osf.io/preprints/psyarxiv/f26ce_v1", "doi": "", "pmid": "", "publication_date": "2023-01-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4888, "title": "Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model", "authors": "Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega", "journal": "Neuroscience Applied", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/j.nsa.2023.102452", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390223807", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102452", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.102452", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.102452", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102452", "doi": "10.1016/j.nsa.2023.102452", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4887, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study", "authors": "Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons, E.K. Teoh, Jeng-Yu Tsai, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/j.nsa.2023.102906", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390223380", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102906", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.102906", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.102906", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102906", "doi": "10.1016/j.nsa.2023.102906", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4886, "title": "Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression", "authors": "Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk, Andrzej Pilc", "journal": "Neuroscience Applied", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/j.nsa.2023.102939", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390223307", "source_url": "https://doi.org/10.1016/j.nsa.2023.102939", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.102939", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.102939", "source_url": "https://doi.org/10.1016/j.nsa.2023.102939", "doi": "10.1016/j.nsa.2023.102939", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4883, "title": "Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls", "authors": "Miriam L. Navarro, Alberte Wollesen Breum, Annette Johansen, Brice Ozenne, Vibe G. Frøkjær, Gitte M. Knudsen", "journal": "Neuroscience Applied", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/j.nsa.2023.103646", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390222237", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103646", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Personality Change", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.103646", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.103646", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103646", "doi": "10.1016/j.nsa.2023.103646", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4879, "title": "Italian psychedelic therapies of the past century: An historical overview", "authors": "Adriana D’Arienzo, Giorgio Samorini", "journal": "Drug Science Policy and Law", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/20503245231179687", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379659828", "source_url": "https://doi.org/10.1177/20503245231179687", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1177/20503245231179687", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245231179687", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245231179687", "source_url": "https://doi.org/10.1177/20503245231179687", "doi": "10.1177/20503245231179687", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4876, "title": "Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders.", "authors": "O. Shahar, A. Botvinik, T. Lifschytz, B. Lerer", "journal": "Neuroscience Applied", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/j.nsa.2023.101067", "pubmed_id": null, "openalex_id": "https://openalex.org/W4327497830", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.101067", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.101067", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.101067", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.101067", "doi": "10.1016/j.nsa.2023.101067", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4870, "title": "Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change", "authors": "Nadiia Omelchenko, Anton Kurapov", "journal": "Bulletin of Taras Shevchenko National University of Kyiv Psychology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.17721/bpsy.2023.1(17).8", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386903146", "source_url": "https://doi.org/10.17721/bpsy.2023.1(17).8", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Emotional Processing", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.17721/bpsy.2023.1(17).8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17721/bpsy.2023.1(17).8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17721/bpsy.2023.1(17).8", "source_url": "https://doi.org/10.17721/bpsy.2023.1(17).8", "doi": "10.17721/bpsy.2023.1(17).8", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4869, "title": "Psychedelic Drug Therapy for Mental Disorders?", "authors": "John R. Rossiter", "journal": "Open Journal of Medical Psychology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.4236/ojmp.2023.123010", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386593692", "source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.4236/ojmp.2023.123010", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4236/ojmp.2023.123010", "source_url": "http://dx.doi.org/10.4236/ojmp.2023.123010", "doi": "10.4236/ojmp.2023.123010", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1611, "title": "The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.", "authors": "Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2022.2044096", "pubmed_id": "35225726", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225726/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35225726", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35225726/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35225726", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225726/", "doi": "10.1080/02791072.2022.2044096", "pmid": "35225726", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1610, "title": "How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?", "authors": "Earleywine M, Low F, Altman BR, De Leo J", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2022.2047842", "pubmed_id": "35318904", "openalex_id": "https://openalex.org/W4220813054", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35318904/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35318904", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35318904/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35318904", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35318904/", "doi": "10.1080/02791072.2022.2047842", "pmid": "35318904", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1609, "title": "Sustained effects of single doses of classical psychedelics in humans.", "authors": "Knudsen GM", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1038/s41386-022-01361-x", "pubmed_id": "35729252", "openalex_id": "https://openalex.org/W4283211919", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35729252/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Personality Change,Emotional Processing,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35729252", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35729252/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35729252", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35729252/", "doi": "10.1038/s41386-022-01361-x", "pmid": "35729252", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1608, "title": "The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.", "authors": "Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/07067437221111371", "pubmed_id": "35975555", "openalex_id": "https://openalex.org/W4292262959", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975555/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35975555", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35975555/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35975555", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975555/", "doi": "10.1177/07067437221111371", "pmid": "35975555", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1607, "title": "Towards an understanding of psychedelic-induced neuroplasticity.", "authors": "Calder AE, Hasler G", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1038/s41386-022-01389-z", "pubmed_id": "36123427", "openalex_id": "https://openalex.org/W4296373810", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36123427/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Neurogenesis,Mechanism of Action,Microdosing,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36123427", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36123427/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36123427", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36123427/", "doi": "10.1038/s41386-022-01389-z", "pmid": "36123427", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1604, "title": "Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.", "authors": "Jones GM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/02698811221127304", "pubmed_id": "36314881", "openalex_id": "https://openalex.org/W4307773202", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36314881/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Drug Interactions", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36314881", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36314881/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36314881", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36314881/", "doi": "10.1177/02698811221127304", "pmid": "36314881", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1600, "title": "Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.", "authors": "Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/02698811221125354", "pubmed_id": "36433778", "openalex_id": "https://openalex.org/W4310295919", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36433778/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36433778", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36433778/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36433778", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36433778/", "doi": "10.1177/02698811221125354", "pmid": "36433778", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1597, "title": "Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.", "authors": "Morton E, Sakai K, Ashtari A, Pleet M, Michalak EE, Woolley J", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/02698811221131997", "pubmed_id": "36515370", "openalex_id": "https://openalex.org/W4311477082", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36515370/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36515370", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36515370/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36515370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36515370/", "doi": "10.1177/02698811221131997", "pmid": "36515370", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1596, "title": "Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.", "authors": "Meccia J, Lopez J, Bagot RC", "journal": "Psychopharmacology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1007/s00213-022-06297-0", "pubmed_id": "36564671", "openalex_id": "https://openalex.org/W4312129061", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36564671/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Aging,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36564671", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36564671/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36564671", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36564671/", "doi": "10.1007/s00213-022-06297-0", "pmid": "36564671", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1591, "title": "Functional MRI markers for treatment-resistant depression: Insights and challenges.", "authors": "Kotoula V, Evans JW, Punturieri C, Johnson SC, Zarate CA", "journal": "Progress in brain research", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/bs.pbr.2023.04.001", "pubmed_id": "37414490", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37414490/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:37414490", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37414490/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37414490", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37414490/", "doi": "10.1016/bs.pbr.2023.04.001", "pmid": "37414490", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1590, "title": "Next generation antidepressants with novel mechanisms for treatment resistant depression.", "authors": "Chen MH, Tu PC, Su TP", "journal": "Progress in brain research", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/bs.pbr.2023.02.005", "pubmed_id": "37414491", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37414491/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:37414491", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37414491/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37414491", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37414491/", "doi": "10.1016/bs.pbr.2023.02.005", "pmid": "37414491", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1586, "title": "UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.", "authors": "Ahmed H, Mushahid H, Arshad T", "journal": "Psychiatria Danubina", "publication_date": "2023-01-01", "publication_year": 2023, "doi": null, "pubmed_id": "37992112", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37992112/", "substance_tags": "psilocybin", "topic_tags": "Depression,Cancer Patients", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:37992112", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37992112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37992112/", "doi": "", "pmid": "37992112", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1584, "title": "Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment.", "authors": "Edelsohn GA, Sisti D", "journal": "Perspectives in biology and medicine", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1353/pbm.2023.0007", "pubmed_id": "38662012", "openalex_id": "https://openalex.org/W4324007078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38662012/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Personality Change,Clinical Trial,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:38662012", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38662012/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38662012", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38662012/", "doi": "10.1353/pbm.2023.0007", "pmid": "38662012", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1509, "title": "The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.", "authors": "IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I", "journal": "Innovations in clinical neuroscience", "publication_date": "2023-01-01", "publication_year": 2023, "doi": null, "pubmed_id": "37387703", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37387703/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:37387703", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37387703/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37387703", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37387703/", "doi": "", "pmid": "37387703", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1480, "title": "Acute psilocybin increased cortical activities in rats.", "authors": "Liu J, Wang Y, Xia K, Wu J, Zheng D, Cai A, Yan H, Su R", "journal": "Frontiers in neuroscience", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fnins.2023.1168911", "pubmed_id": "37287797", "openalex_id": "https://openalex.org/W4378084778", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37287797/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37287797", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37287797/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37287797", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37287797/", "doi": "10.3389/fnins.2023.1168911", "pmid": "37287797", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1435, "title": "Adapting psychedelic medicine for headache and chronic pain disorders.", "authors": "Schindler EAD, Hendricks PS", "journal": "Expert review of neurotherapeutics", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/14737175.2023.2246655", "pubmed_id": "37652000", "openalex_id": "https://openalex.org/W4386317658", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37652000/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Clinical Trial,Review Article,Case Report,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37652000", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37652000/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37652000", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37652000/", "doi": "10.1080/14737175.2023.2246655", "pmid": "37652000", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1434, "title": "Assessing potential of psilocybin for depressive disorders.", "authors": "Kozak Z, Johnson MW, Aaronson ST", "journal": "Expert opinion on investigational drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/13543784.2023.2273493", "pubmed_id": "37869790", "openalex_id": "https://openalex.org/W4387866078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869790/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37869790", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37869790/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37869790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869790/", "doi": "10.1080/13543784.2023.2273493", "pmid": "37869790", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1402, "title": "Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.", "authors": "Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2022.2125467", "pubmed_id": "36127639", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Consciousness,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:36127639", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36127639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36127639/", "doi": "10.1080/02791072.2022.2125467", "pmid": "36127639", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1380, "title": "Psychedelics for treatment resistant depression: are they game changers?", "authors": "Kalfas M, Taylor RH, Tsapekos D, Young AH", "journal": "Expert opinion on pharmacotherapy", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/14656566.2023.2281582", "pubmed_id": "37947195", "openalex_id": "https://openalex.org/W4388574768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37947195/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37947195", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37947195/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37947195", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37947195/", "doi": "10.1080/14656566.2023.2281582", "pmid": "37947195", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1372, "title": "Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.", "authors": "Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, Garcia-Romeu A", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1199642", "pubmed_id": "37795509", "openalex_id": "https://openalex.org/W4386861633", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37795509/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Emotional Processing,Spirituality,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37795509", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37795509/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37795509", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37795509/", "doi": "10.3389/fpsyt.2023.1199642", "pmid": "37795509", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1370, "title": "Manic episode following psilocybin use in a man with bipolar II disorder: a case report.", "authors": "Halim HJ, Burk BG, Fargason RE, Birur B", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1221131", "pubmed_id": "37810598", "openalex_id": "https://openalex.org/W4386961159", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37810598/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Case Report,Treatment-Resistant Depression,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37810598", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37810598/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37810598", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37810598/", "doi": "10.3389/fpsyt.2023.1221131", "pmid": "37810598", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1361, "title": "Bedside to bench: the outlook for psychedelic research.", "authors": "Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK", "journal": "Frontiers in pharmacology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fphar.2023.1240295", "pubmed_id": "37869749", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Epigenetics,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37869749", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37869749", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869749/", "doi": "10.3389/fphar.2023.1240295", "pmid": "37869749", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1359, "title": "Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.", "authors": "Ko K, Carter B, Cleare AJ, Rucker JJ", "journal": "Neuropsychiatric disease and treatment", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.2147/ndt.s426193", "pubmed_id": "37818448", "openalex_id": "https://openalex.org/W4387389328", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37818448/", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Mystical Experience,Clinical Trial,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37818448", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37818448/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37818448", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37818448/", "doi": "10.2147/ndt.s426193", "pmid": "37818448", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1347, "title": "A Proposal to Study the Safety and Efficacy of in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder.", "authors": "Escamilla R, González-Trujano ME, González Mariscal JM, Torres-Valencia JM, Guzmán-González H, Vega JL, Loizaga-Velder A", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2023.2246459", "pubmed_id": "37594163", "openalex_id": "https://openalex.org/W4385969211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37594163/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Animal Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37594163", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37594163/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37594163", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37594163/", "doi": "10.1080/02791072.2023.2246459", "pmid": "37594163", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1312, "title": "Group psychedelic therapy: empirical estimates of cost-savings and improved access.", "authors": "Marseille E, Stauffer CS, Agrawal M, Thambi P, Roddy K, Mithoefer M, Bertozzi SM, Kahn JG", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1293243", "pubmed_id": "38125286", "openalex_id": "https://openalex.org/W4389392873", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38125286/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Healthcare Workers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38125286", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38125286/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38125286", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38125286/", "doi": "10.3389/fpsyt.2023.1293243", "pmid": "38125286", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1615, "title": "Psilocybin for Depression: From Credibility to Feasibility, What's Missing?", "authors": "Munafò A, Arillotta D, Mannaioni G, Schifano F, Bernardini R, Cantarella G", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3390/ph16010068", "pubmed_id": "36678564", "openalex_id": "https://openalex.org/W4313471532", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36678564/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36678564", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36678564/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36678564", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36678564/", "doi": "10.3390/ph16010068", "pmid": "36678564", "publication_date": "2022-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4892, "title": "The Potential of Psilocybe Genus Fungi to Treat Depression and Some Addictions", "authors": "Vanessa Eveline VLAIC, Andreea ONA", "journal": "Hop and Medicinal Plants", "publication_date": "2022-12-28", "publication_year": 2022, "doi": "10.15835/hpm.v30i1-2.14453", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405141401", "source_url": "https://doi.org/10.15835/hpm.v30i1-2.14453", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.15835/hpm.v30i1-2.14453", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.15835/hpm.v30i1-2.14453", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.15835/hpm.v30i1-2.14453", "source_url": "https://doi.org/10.15835/hpm.v30i1-2.14453", "doi": "10.15835/hpm.v30i1-2.14453", "pmid": "", "publication_date": "2022-12-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4894, "title": "Depression Improves Following Single Dose of Psilocybin", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2022-12-26", "publication_year": 2022, "doi": "10.1176/appi.pn.2023.01.1.50", "pubmed_id": null, "openalex_id": "https://openalex.org/W4312194249", "source_url": "https://doi.org/10.1176/appi.pn.2023.01.1.50", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.01.1.50", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.01.1.50", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.01.1.50", "source_url": "https://doi.org/10.1176/appi.pn.2023.01.1.50", "doi": "10.1176/appi.pn.2023.01.1.50", "pmid": "", "publication_date": "2022-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1617, "title": "DNA Authentication and Chemical Analysis of Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites.", "authors": "Bradshaw AJ, Backman TA, Ramírez-Cruz V, Forrister DL, Winter JM, Guzmán-Dávalos L, Furci G, Stamets P, Dentinger BTM", "journal": "Applied and environmental microbiology", "publication_date": "2022-12-20", "publication_year": 2022, "doi": "10.1128/aem.01498-22", "pubmed_id": "36445079", "openalex_id": "https://openalex.org/W4310466310", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36445079/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Metabolomics", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36445079", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36445079/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36445079", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36445079/", "doi": "10.1128/aem.01498-22", "pmid": "36445079", "publication_date": "2022-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1619, "title": "Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis.", "authors": "Schäfer T, Kramer K, Werten S, Rupp B, Hoffmeister D", "journal": "Chembiochem: a European journal of chemical biology", "publication_date": "2022-12-16", "publication_year": 2022, "doi": "10.1002/cbic.202200551", "pubmed_id": "36327140", "openalex_id": "https://openalex.org/W4308053113", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36327140/", "substance_tags": "psilocybin", "topic_tags": "Depression,In Vitro Study", "study_type": "In Vitro Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36327140", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36327140/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36327140", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36327140/", "doi": "10.1002/cbic.202200551", "pmid": "36327140", "publication_date": "2022-12-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1623, "title": "Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice.", "authors": "Pędzich BD, Medrano M, Buckinx A, Smolders I, De Bundel D", "journal": "International journal of molecular sciences", "publication_date": "2022-12-04", "publication_year": 2022, "doi": "10.3390/ijms232315284", "pubmed_id": "36499610", "openalex_id": "https://openalex.org/W4310675742", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36499610/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36499610", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36499610/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36499610", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36499610/", "doi": "10.3390/ijms232315284", "pmid": "36499610", "publication_date": "2022-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1633, "title": "The psychedelic renaissance: the next trip for psychiatry?", "authors": "Kelly JR, Baker A, Babiker M, Burke L, Brennan C, O'Keane V", "journal": "Irish journal of psychological medicine", "publication_date": "2022-12-01", "publication_year": 2022, "doi": "10.1017/ipm.2019.39", "pubmed_id": "31543078", "openalex_id": "https://openalex.org/W2975755375", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31543078/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Default Mode Network,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:31543078", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31543078/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31543078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31543078/", "doi": "10.1017/ipm.2019.39", "pmid": "31543078", "publication_date": "2022-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1626, "title": "A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability.", "authors": "Barber G, Nemeroff CB, Siegel S", "journal": "The American journal of psychiatry", "publication_date": "2022-12-01", "publication_year": 2022, "doi": "10.1176/appi.ajp.22010073", "pubmed_id": "36453037", "openalex_id": "https://openalex.org/W4310598708", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36453037/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36453037", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36453037", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36453037/", "doi": "10.1176/appi.ajp.22010073", "pmid": "36453037", "publication_date": "2022-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4901, "title": "Fast and sustained effect of 2 administrations of psilocybin on depression", "authors": "Dooper Marten", "journal": "Medicom Conference Report ECNP 2022", "publication_date": "2022-11-28", "publication_year": 2022, "doi": "10.55788/0629715f", "pubmed_id": null, "openalex_id": "https://openalex.org/W4310033391", "source_url": "https://doi.org/10.55788/0629715f", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:35:29", "bibtex": null, "source_record_id": "DOI:10.55788/0629715f", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.55788/0629715f", "source_url": "https://doi.org/10.55788/0629715f", "doi": "10.55788/0629715f", "pmid": "", "publication_date": "2022-11-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3639, "title": "NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.", "authors": "NWTraumatherapies", "journal": "ClinicalTrials.gov", "publication_date": "2022-11-16", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05042466", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Microdosing,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05042466", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05042466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05042466", "source_url": "https://clinicaltrials.gov/study/NCT05042466", "doi": "", "pmid": "", "publication_date": "2022-11-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3794, "title": "Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine", "authors": "Guss J, Krause R, Sloshower J.", "journal": "PsyArXiv", "publication_date": "2022-11-15", "publication_year": 2022, "doi": "10.31234/osf.io/r96tc", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/r96tc", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:27", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/r96tc", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/r96tc", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/r96tc", "source_url": "https://doi.org/10.31234/osf.io/r96tc", "doi": "10.31234/osf.io/r96tc", "pmid": "", "publication_date": "2022-11-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3360, "title": "Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine", "authors": "Jeffrey Guss, Robert Krause, Jordan Sloshower", "journal": "PsyArXiv", "publication_date": "2022-11-15", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/r96tc_v1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/r96tc_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/r96tc_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/r96tc_v1", "source_url": "https://osf.io/preprints/psyarxiv/r96tc_v1", "doi": "", "pmid": "", "publication_date": "2022-11-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3442, "title": "A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2022-11-08", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02061293", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02061293", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02061293", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02061293", "source_url": "https://clinicaltrials.gov/study/NCT02061293", "doi": "", "pmid": "", "publication_date": "2022-11-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3314, "title": "5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice", "authors": "Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC.", "journal": "bioRxiv", "publication_date": "2022-11-03", "publication_year": 2022, "doi": "10.1101/2022.11.03.515044", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.11.03.515044", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:15:22", "bibtex": null, "source_record_id": "DOI:10.1101/2022.11.03.515044", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.11.03.515044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.11.03.515044", "source_url": "https://doi.org/10.1101/2022.11.03.515044", "doi": "10.1101/2022.11.03.515044", "pmid": "", "publication_date": "2022-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1642, "title": "Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E", "journal": "The New England journal of medicine", "publication_date": "2022-11-03", "publication_year": 2022, "doi": "10.1056/nejmoa2206443", "pubmed_id": "36322843", "openalex_id": "https://openalex.org/W4308146982", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36322843/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36322843", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36322843/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36322843", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36322843/", "doi": "10.1056/nejmoa2206443", "pmid": "36322843", "publication_date": "2022-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1641, "title": "Psilocybin in Treatment-Resistant Depression.", "authors": "Madras BK", "journal": "The New England journal of medicine", "publication_date": "2022-11-03", "publication_year": 2022, "doi": "10.1056/nejme2210975", "pubmed_id": "36322849", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36322849/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36322849", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36322849", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36322849/", "doi": "10.1056/nejme2210975", "pmid": "36322849", "publication_date": "2022-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1643, "title": "Psilocybin reduces symptoms in treatment resistant depression, trial results show.", "authors": "Iacobucci G", "journal": "BMJ (Clinical research ed.)", "publication_date": "2022-11-02", "publication_year": 2022, "doi": "10.1136/bmj.o2623", "pubmed_id": "36411539", "openalex_id": "https://openalex.org/W4308444860", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36411539/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36411539", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36411539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36411539/", "doi": "10.1136/bmj.o2623", "pmid": "36411539", "publication_date": "2022-11-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4910, "title": "The psychedelic renaissance: can psilocybin possibly combat depression?", "authors": "Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh", "journal": "International Journal of Surgery Global Health", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1097/gh9.0000000000000089", "pubmed_id": null, "openalex_id": "https://openalex.org/W4318965036", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Wellbeing,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:25:39", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000089", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000089", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "doi": "10.1097/gh9.0000000000000089", "pmid": "", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3191, "title": "Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers", "authors": "Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J, Tse D, Hutten N, Feilding A, Ramaekers J.", "journal": "medRxiv", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1101/2022.10.31.22281688", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.10.31.22281688", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Biomarkers,Healthy Volunteers,Inflammation,Immune Function", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:09", "bibtex": null, "source_record_id": "DOI:10.1101/2022.10.31.22281688", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.10.31.22281688", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.10.31.22281688", "source_url": "https://doi.org/10.1101/2022.10.31.22281688", "doi": "10.1101/2022.10.31.22281688", "pmid": "", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1653, "title": "Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.", "authors": "Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR", "journal": "Pharmacology & therapeutics", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1016/j.pharmthera.2022.108195", "pubmed_id": "35489438", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35489438/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35489438", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35489438/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35489438", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35489438/", "doi": "10.1016/j.pharmthera.2022.108195", "pmid": "35489438", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1652, "title": "Rapid-Response Treatments for Depression and Requests for Physician-Assisted Death: An Ethical Analysis.", "authors": "Berens N, Kim SY", "journal": "The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1016/j.jagp.2022.07.003", "pubmed_id": "35927119", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35927119/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Case Report,Healthcare Workers", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35927119", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35927119/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35927119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35927119/", "doi": "10.1016/j.jagp.2022.07.003", "pmid": "35927119", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1651, "title": "The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.", "authors": "Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L", "journal": "Psychopharmacology", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06187-5", "pubmed_id": "35939083", "openalex_id": "https://openalex.org/W4290631853", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35939083/", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35939083", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35939083/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35939083", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35939083/", "doi": "10.1007/s00213-022-06187-5", "pmid": "35939083", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1635, "title": "Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.", "authors": "Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J", "journal": "Cureus", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.7759/cureus.31796", "pubmed_id": "36569662", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36569662/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36569662", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36569662/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36569662", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36569662/", "doi": "10.7759/cureus.31796", "pmid": "36569662", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3756, "title": "Serotonergic antidepressant use is associated with weaker psilocybin effects", "authors": "Gukasyan N, Griffiths RR, Yaden DB, Antoine D, Nayak SM.", "journal": "PsyArXiv", "publication_date": "2022-10-28", "publication_year": 2022, "doi": "10.31234/osf.io/2zys9", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/2zys9", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/2zys9", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/2zys9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/2zys9", "source_url": "https://doi.org/10.31234/osf.io/2zys9", "doi": "10.31234/osf.io/2zys9", "pmid": "", "publication_date": "2022-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3170, "title": "Serotonergic antidepressant use is associated with weaker psilocybin effects", "authors": "Natalie Gukasyan, Roland R. Griffiths, David Bryce Yaden, Denis Antoine, Sandeep M Nayak", "journal": "PsyArXiv", "publication_date": "2022-10-28", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/2zys9_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Observational Study,Drug Interactions", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/2zys9_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/2zys9_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/2zys9_v1", "source_url": "https://osf.io/preprints/psyarxiv/2zys9_v1", "doi": "", "pmid": "", "publication_date": "2022-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3461, "title": "The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2022-10-25", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04433845", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04433845", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04433845", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04433845", "source_url": "https://clinicaltrials.gov/study/NCT04433845", "doi": "", "pmid": "", "publication_date": "2022-10-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4920, "title": "19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations", "authors": "Natalie Gukasyan", "journal": "Journal of the American Academy of Child & Adolescent Psychiatry", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1016/j.jaac.2022.07.664", "pubmed_id": null, "openalex_id": "https://openalex.org/W4304633208", "source_url": "https://doi.org/10.1016/j.jaac.2022.07.664", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:25:40", "bibtex": null, "source_record_id": "DOI:10.1016/j.jaac.2022.07.664", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jaac.2022.07.664", "source_url": "https://doi.org/10.1016/j.jaac.2022.07.664", "doi": "10.1016/j.jaac.2022.07.664", "pmid": "", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1688, "title": "Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.", "authors": "Meyer TD, Meir P, Lex C, Soares JC", "journal": "Psychiatry research", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1016/j.psychres.2022.114727", "pubmed_id": "35878481", "openalex_id": "https://openalex.org/W4285605468", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35878481/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35878481", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35878481/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35878481", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35878481/", "doi": "10.1016/j.psychres.2022.114727", "pmid": "35878481", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1687, "title": "Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.", "authors": "Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM", "journal": "Expert opinion on drug discovery", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1080/17460441.2022.2111415", "pubmed_id": "35934973", "openalex_id": "https://openalex.org/W4290613434", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35934973/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35934973", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35934973/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35934973", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35934973/", "doi": "10.1080/17460441.2022.2111415", "pmid": "35934973", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1686, "title": "Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.", "authors": "Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J", "journal": "Current psychiatry reports", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1007/s11920-022-01361-0", "pubmed_id": "35953638", "openalex_id": "https://openalex.org/W4291162385", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35953638/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35953638", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35953638/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35953638", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35953638/", "doi": "10.1007/s11920-022-01361-0", "pmid": "35953638", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1683, "title": "New investigational agents for the treatment of major depressive disorder.", "authors": "Pochwat B, Krupa AJ, Siwek M, Szewczyk B", "journal": "Expert opinion on investigational drugs", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1080/13543784.2022.2113376", "pubmed_id": "35975761", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975761/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35975761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35975761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35975761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975761/", "doi": "10.1080/13543784.2022.2113376", "pmid": "35975761", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1674, "title": "The Emerging Field of Psychedelic Psychotherapy.", "authors": "Barber GS, Aaronson ST", "journal": "Current psychiatry reports", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1007/s11920-022-01363-y", "pubmed_id": "36129571", "openalex_id": "https://openalex.org/W4296613147", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36129571/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36129571", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36129571/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36129571", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36129571/", "doi": "10.1007/s11920-022-01363-y", "pmid": "36129571", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1673, "title": "Animal Behavior in Psychedelic Research.", "authors": "Odland AU, Kristensen JL, Andreasen JT", "journal": "Pharmacological reviews", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1124/pharmrev.122.000590", "pubmed_id": "36180111", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36180111/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Consciousness,Emotional Processing,Review Article,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36180111", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36180111/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36180111", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36180111/", "doi": "10.1124/pharmrev.122.000590", "pmid": "36180111", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1672, "title": "Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?", "authors": "Dupuis D, Veissière S", "journal": "Transcultural psychiatry", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1177/13634615221131465", "pubmed_id": "36263513", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36263513/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36263513", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36263513/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36263513", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36263513/", "doi": "10.1177/13634615221131465", "pmid": "36263513", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1660, "title": "Potential Therapeutic Effects of Psilocybin: A Systematic Review.", "authors": "Goel DB, Zilate S", "journal": "Cureus", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.7759/cureus.30214", "pubmed_id": "36381758", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36381758/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Spirituality,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Contraindications", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36381758", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36381758/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36381758", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36381758/", "doi": "10.7759/cureus.30214", "pmid": "36381758", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3244, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA.", "journal": "PsyArXiv", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.31234/osf.io/kh3cx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:14", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/kh3cx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/kh3cx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/kh3cx", "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "doi": "10.31234/osf.io/kh3cx", "pmid": "", "publication_date": "2022-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 643, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "Robert F. Dougherty, Patrick Clarke, Merve Alti, Joanna Kuc, Danielle Schlosser, Boadie W. Dunlop, David J. Hellerstein, Scott T. Aaronson, Sidney Zisook, Allan H Young", "journal": "PsyArXiv", "publication_date": "2022-09-30", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "doi": "", "pmid": "", "publication_date": "2022-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1691, "title": "Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.", "authors": "Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M", "journal": "International journal of molecular sciences", "publication_date": "2022-09-28", "publication_year": 2022, "doi": "10.3390/ijms231911450", "pubmed_id": "36232748", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36232748/", "substance_tags": "psilocybin", "topic_tags": "Depression,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36232748", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36232748/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36232748", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36232748/", "doi": "10.3390/ijms231911450", "pmid": "36232748", "publication_date": "2022-09-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4923, "title": "The psychedelic escape from depression", "authors": "Michael Eisenstein", "journal": "Nature", "publication_date": "2022-09-27", "publication_year": 2022, "doi": "10.1038/d41586-022-02872-9", "pubmed_id": "36171370", "openalex_id": "https://openalex.org/W4297493645", "source_url": "https://doi.org/10.1038/d41586-022-02872-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 06:51:56", "bibtex": null, "source_record_id": "PMID:36171370", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36171370", "source_url": "https://doi.org/10.1038/d41586-022-02872-9", "doi": "10.1038/d41586-022-02872-9", "pmid": "36171370", "publication_date": "2022-09-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1692, "title": "Differences across sexes on head-twitch behavior and 5-HT receptor signaling in C57BL/6J mice.", "authors": "Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J", "journal": "Neuroscience letters", "publication_date": "2022-09-25", "publication_year": 2022, "doi": "10.1016/j.neulet.2022.136836", "pubmed_id": "35963476", "openalex_id": "https://openalex.org/W4291398459", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35963476/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35963476", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35963476/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35963476", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35963476/", "doi": "10.1016/j.neulet.2022.136836", "pmid": "35963476", "publication_date": "2022-09-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3477, "title": "Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU)", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2022-09-22", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04519957", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04519957", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04519957", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04519957", "source_url": "https://clinicaltrials.gov/study/NCT04519957", "doi": "", "pmid": "", "publication_date": "2022-09-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3126, "title": "Brain dynamics predictive of response to psilocybin for treatment-resistant depression", "authors": "Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M.", "journal": "Research Square", "publication_date": "2022-09-20", "publication_year": 2022, "doi": "10.21203/rs.3.rs-2060381/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-2060381/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-2060381/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-2060381/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-2060381/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-2060381/v1", "doi": "10.21203/rs.3.rs-2060381/v1", "pmid": "", "publication_date": "2022-09-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1693, "title": "Psychedelic drugs for psychiatric disorders.", "authors": "da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M", "journal": "Journal of the neurological sciences", "publication_date": "2022-09-15", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120332", "pubmed_id": "35841696", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35841696/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Consciousness,Aging,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35841696", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35841696/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35841696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35841696/", "doi": "10.1016/j.jns.2022.120332", "pmid": "35841696", "publication_date": "2022-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4929, "title": "Psilocybin as a healer", "authors": "Kavita Golia", "journal": "Consciousness Spirituality & Transpersonal Psychology", "publication_date": "2022-09-12", "publication_year": 2022, "doi": "10.53074/cstp.2022.37", "pubmed_id": null, "openalex_id": "https://openalex.org/W4297872378", "source_url": "https://doi.org/10.53074/cstp.2022.37", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:25:40", "bibtex": null, "source_record_id": "DOI:10.53074/cstp.2022.37", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.53074/cstp.2022.37", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53074/cstp.2022.37", "source_url": "https://doi.org/10.53074/cstp.2022.37", "doi": "10.53074/cstp.2022.37", "pmid": "", "publication_date": "2022-09-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3178, "title": "Effective connectivity of emotion and cognition under psilocybin", "authors": "Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A.", "journal": "medRxiv", "publication_date": "2022-09-09", "publication_year": 2022, "doi": "10.1101/2022.09.06.22279626", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.09.06.22279626", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Default Mode Network,Biomarkers,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.1101/2022.09.06.22279626", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.09.06.22279626", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.09.06.22279626", "source_url": "https://doi.org/10.1101/2022.09.06.22279626", "doi": "10.1101/2022.09.06.22279626", "pmid": "", "publication_date": "2022-09-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1697, "title": "Skepticism about Recent Evidence That Psilocybin \"Liberates\" Depressed Minds.", "authors": "Doss MK, Barrett FS, Corlett PR", "journal": "ACS chemical neuroscience", "publication_date": "2022-09-07", "publication_year": 2022, "doi": "10.1021/acschemneuro.2c00461", "pubmed_id": "36001741", "openalex_id": "https://openalex.org/W4293101872", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36001741/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36001741", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36001741/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36001741", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36001741/", "doi": "10.1021/acschemneuro.2c00461", "pmid": "36001741", "publication_date": "2022-09-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1698, "title": "Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.", "authors": "Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R", "journal": "BJPsych open", "publication_date": "2022-09-06", "publication_year": 2022, "doi": "10.1192/bjo.2022.565", "pubmed_id": "36065128", "openalex_id": "https://openalex.org/W4294808278", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36065128/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36065128", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36065128/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36065128", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36065128/", "doi": "10.1192/bjo.2022.565", "pmid": "36065128", "publication_date": "2022-09-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5632, "title": "Psychedelics’ binding depends on receptor mutations", "authors": "special to C EN Attabey Rodríguez Benítez", "journal": "C&EN Global Enterprise", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.1021/cen-10031-scicon6", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294310361", "source_url": "https://doi.org/10.1021/cen-10031-scicon6", "substance_tags": "psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Emotional Processing,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:10", "last_checked": "2026-07-04 06:52:10", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10031-scicon6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10031-scicon6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10031-scicon6", "source_url": "https://doi.org/10.1021/cen-10031-scicon6", "doi": "10.1021/cen-10031-scicon6", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4933, "title": "Psychedelics for Psychiatric Disorders: Promise, Not Panacea", "authors": "Mitch Earleywine, Zachary Herrmann", "journal": "Psychiatric Annals", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.3928/00485713-20220810-01", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294911993", "source_url": "https://doi.org/10.3928/00485713-20220810-01", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Mechanism of Action,Cancer Patients,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:25:40", "bibtex": null, "source_record_id": "DOI:10.3928/00485713-20220810-01", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3928/00485713-20220810-01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3928/00485713-20220810-01", "source_url": "https://doi.org/10.3928/00485713-20220810-01", "doi": "10.3928/00485713-20220810-01", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3377, "title": "Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions", "authors": "Girala N.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2022-09-01", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9567945", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Mystical Experience,Review Article", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:29", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9567945", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9567945", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9567945", "source_url": "https://europepmc.org/article/PMC/PMC9567945", "doi": "", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3376, "title": "Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop", "authors": "National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders.", "journal": "National Academies Press (US), Washington (DC)", "publication_date": "2022-09-01", "publication_year": 2022, "doi": null, "pubmed_id": "36049038", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36049038", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:29", "bibtex": null, "source_record_id": "PMID:36049038", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36049038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36049038", "source_url": "https://europepmc.org/article/MED/36049038", "doi": "", "pmid": "36049038", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3169, "title": "Association of Psilocybin Use in Adolescents with Major Depressive Episode", "authors": "Shah K, Trivedi C, Kamrai D, Akbar M, Tankersley W.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2022-09-01", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9563652", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Adolescents", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9563652", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9563652", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9563652", "source_url": "https://europepmc.org/article/PMC/PMC9563652", "doi": "", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1707, "title": "The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.", "authors": "Lehto RH, Miller M, Sender J", "journal": "Journal of holistic nursing: official journal of the American Holistic Nurses' Association", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.1177/08980101211039086", "pubmed_id": "34482761", "openalex_id": "https://openalex.org/W3196833323", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34482761/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Aging,Spirituality,Review Article,Healthcare Workers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:34482761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34482761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34482761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34482761/", "doi": "10.1177/08980101211039086", "pmid": "34482761", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1705, "title": "Magic mushroom extracts in lipid membranes.", "authors": "Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H", "journal": "Biochimica et biophysica acta. Biomembranes", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.1016/j.bbamem.2022.183957", "pubmed_id": "35561790", "openalex_id": "https://openalex.org/W4280500709", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35561790/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Treatment-Resistant Depression,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35561790", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35561790/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35561790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35561790/", "doi": "10.1016/j.bbamem.2022.183957", "pmid": "35561790", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1702, "title": "[The use of psilocybin for treatment-resistant depression].", "authors": "Johannesdottir A, Sigurdsson E", "journal": "Laeknabladid", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.17992/lbl.2022.09.706", "pubmed_id": "36040772", "openalex_id": "https://openalex.org/W4293778673", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36040772/", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36040772", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36040772/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36040772", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36040772/", "doi": "10.17992/lbl.2022.09.706", "pmid": "36040772", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1694, "title": "The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.", "authors": "Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME", "journal": "Cureus", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.7759/cureus.29167", "pubmed_id": "36259015", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36259015", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36259015", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36259015/", "doi": "10.7759/cureus.29167", "pmid": "36259015", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1168, "title": "Psychedelic Psychiatry", "authors": "Nutt D.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2022-09-01", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9565852", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:15:26", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9565852", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9565852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9565852", "source_url": "https://europepmc.org/article/PMC/PMC9565852", "doi": "", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5707, "title": "‘Shrooms for the Blues: Psilocybin to alleviate difficult-to-treat depression", "authors": "Graham Zoe", "journal": "Journal of High School Science", "publication_date": "2022-08-23", "publication_year": 2022, "doi": "10.64336/001c.37945", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64336/001c.37945", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Cancer Patients,Treatment-Resistant Depression,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.64336/001c.37945", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.64336/001c.37945", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.64336/001c.37945", "source_url": "https://doi.org/10.64336/001c.37945", "doi": "10.64336/001c.37945", "pmid": "", "publication_date": "2022-08-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4938, "title": "Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative", "authors": "Neşe Devenot, Trey Conner, Richard Doyle", "journal": "Anthropology of Consciousness", "publication_date": "2022-08-22", "publication_year": 2022, "doi": "10.1111/anoc.12154", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292574083", "source_url": "https://doi.org/10.1111/anoc.12154", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:25:40", "bibtex": null, "source_record_id": "DOI:10.1111/anoc.12154", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/anoc.12154", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/anoc.12154", "source_url": "https://doi.org/10.1111/anoc.12154", "doi": "10.1111/anoc.12154", "pmid": "", "publication_date": "2022-08-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1711, "title": "Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Mushroom via Amino Acid Metabolism Pathways.", "authors": "Yao S, Wei C, Lin H, Zhang P, Liu Y, Deng Y, Huang Q, Xie B", "journal": "Journal of fungi (Basel, Switzerland)", "publication_date": "2022-08-18", "publication_year": 2022, "doi": "10.3390/jof8080870", "pubmed_id": "36012858", "openalex_id": "https://openalex.org/W4292248697", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36012858/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Transcriptomics", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36012858", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36012858/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36012858", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36012858/", "doi": "10.3390/jof8080870", "pmid": "36012858", "publication_date": "2022-08-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4941, "title": "A-118 Psychedelic Interventions for Neuropsychological Conditions", "authors": "Brian Peacock", "journal": "Archives of Clinical Neuropsychology", "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1093/arclin/acac060.118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292089187", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety,Contraindications", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1093/arclin/acac060.118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/arclin/acac060.118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/arclin/acac060.118", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "doi": "10.1093/arclin/acac060.118", "pmid": "", "publication_date": "2022-08-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4946, "title": "Med Check: Psilocybin for OCD, Nuplazid Vote, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.08.8.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4289781881", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Headache / Migraine,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "doi": "10.1176/appi.pn.2022.08.8.2", "pmid": "", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1729, "title": "Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.", "authors": "Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y", "journal": "Journal of palliative medicine", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1089/jpm.2022.0036", "pubmed_id": "35285721", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35285721", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35285721", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "doi": "10.1089/jpm.2022.0036", "pmid": "35285721", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1724, "title": "Postpartum depression: A role for psychedelics?", "authors": "Jairaj C, Rucker JJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1177/02698811221093793", "pubmed_id": "35638179", "openalex_id": "https://openalex.org/W4281640359", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35638179/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35638179", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35638179/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35638179", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35638179/", "doi": "10.1177/02698811221093793", "pmid": "35638179", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1719, "title": "Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.", "authors": "Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1177/02698811221101061", "pubmed_id": "35924888", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35924888/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35924888", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35924888/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35924888", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35924888/", "doi": "10.1177/02698811221101061", "pmid": "35924888", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1731, "title": "Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.", "authors": "Golden CT, Chadderton P", "journal": "Scientific reports", "publication_date": "2022-07-26", "publication_year": 2022, "doi": "10.1038/s41598-022-16325-w", "pubmed_id": "35882885", "openalex_id": "https://openalex.org/W4287981303", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35882885/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Default Mode Network,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35882885", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35882885/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35882885", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35882885/", "doi": "10.1038/s41598-022-16325-w", "pmid": "35882885", "publication_date": "2022-07-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3594, "title": "Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2022-07-25", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04661514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04661514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "source_url": "https://clinicaltrials.gov/study/NCT04661514", "doi": "", "pmid": "", "publication_date": "2022-07-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1739, "title": "Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines", "authors": "Lenz Claudius, Dörner Sebastian, Trottmann Felix, Hertweck Christian, Sherwood Alexander, Hoffmeister Dirk", "journal": "ChemBioChem", "publication_date": "2022-07-05", "publication_year": 2022, "doi": "10.1002/cbic.202200183", "pubmed_id": "35483009", "openalex_id": "https://openalex.org/W4225114051", "source_url": "https://doi.org/10.1002/cbic.202200183", "substance_tags": "psilocin", "topic_tags": "Depression,Pharmacology,Consciousness,Drug Interactions", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:50", "bibtex": null, "source_record_id": "PMID:35483009", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/cbic.202200183", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:35483009", "source_url": "https://doi.org/10.1002/cbic.202200183", "doi": "10.1002/cbic.202200183", "pmid": "35483009", "publication_date": "2022-07-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1738, "title": "Psychedelics in the treatment of unipolar and bipolar depression.", "authors": "Bosch OG, Halm S, Seifritz E", "journal": "International journal of bipolar disorders", "publication_date": "2022-07-05", "publication_year": 2022, "doi": "10.1186/s40345-022-00265-5", "pubmed_id": "35788817", "openalex_id": "https://openalex.org/W4283813871", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35788817/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35788817", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35788817/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35788817", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35788817/", "doi": "10.1186/s40345-022-00265-5", "pmid": "35788817", "publication_date": "2022-07-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3131, "title": "Brain dynamics predictive of response to psilocybin for treatment-resistant depression", "authors": "Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML.", "journal": "bioRxiv", "publication_date": "2022-07-04", "publication_year": 2022, "doi": "10.1101/2022.06.30.497950", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.06.30.497950", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:01", "bibtex": null, "source_record_id": "DOI:10.1101/2022.06.30.497950", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.06.30.497950", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.06.30.497950", "source_url": "https://doi.org/10.1101/2022.06.30.497950", "doi": "10.1101/2022.06.30.497950", "pmid": "", "publication_date": "2022-07-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3384, "title": "Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM", "authors": "Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL.", "journal": "bioRxiv", "publication_date": "2022-07-03", "publication_year": 2022, "doi": "10.1101/2022.06.29.498015", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.06.29.498015", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:31", "bibtex": null, "source_record_id": "DOI:10.1101/2022.06.29.498015", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.06.29.498015", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.06.29.498015", "source_url": "https://doi.org/10.1101/2022.06.29.498015", "doi": "10.1101/2022.06.29.498015", "pmid": "", "publication_date": "2022-07-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4951, "title": "Psychedelic use in India, its pattern and personal significance - findings from an online survey", "authors": "Gokul Raj", "journal": "Indian Journal of Psychiatry", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "pubmed_id": "36060724", "openalex_id": "https://openalex.org/W4285412529", "source_url": "https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Personality Change,Spirituality,Mystical Experience,Observational Study,Treatment-Resistant Depression", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "PMID:36060724", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36060724", "source_url": "https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "doi": "10.4103/indianjpsychiatry.indianjpsychiatry_447_21", "pmid": "36060724", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3187, "title": "A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression", "authors": "Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas F, Peill JM, Giribaldi B, Erritzoe D, Nutt D, Carhart-Harris R.", "journal": "PsyArXiv", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.31234/osf.io/sb5ur", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/sb5ur", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:08", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/sb5ur", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/sb5ur", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/sb5ur", "source_url": "https://doi.org/10.31234/osf.io/sb5ur", "doi": "10.31234/osf.io/sb5ur", "pmid": "", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1751, "title": "Psilocybin: A brief overview for psychiatric mental health nurse practitioners.", "authors": "Fradkin D", "journal": "Perspectives in psychiatric care", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1111/ppc.12888", "pubmed_id": "34101846", "openalex_id": "https://openalex.org/W3169192423", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34101846/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34101846", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34101846/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34101846", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34101846/", "doi": "10.1111/ppc.12888", "pmid": "34101846", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1750, "title": "From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.", "authors": "Kozlowska U, Nichols C, Wiatr K, Figiel M", "journal": "Journal of neurochemistry", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1111/jnc.15509", "pubmed_id": "34519052", "openalex_id": "https://openalex.org/W3201526264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34519052/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Review Article,Animal Study,Drug Interactions,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34519052", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34519052/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34519052", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34519052/", "doi": "10.1111/jnc.15509", "pmid": "34519052", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1749, "title": "Molecular insights into psychedelic drug action.", "authors": "Slocum ST, DiBerto JF, Roth BL", "journal": "Journal of neurochemistry", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1111/jnc.15540", "pubmed_id": "34797943", "openalex_id": "https://openalex.org/W3213217218", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34797943/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34797943", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34797943/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34797943", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34797943/", "doi": "10.1111/jnc.15540", "pmid": "34797943", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1748, "title": "Psychedelic-inspired approaches for treating neurodegenerative disorders.", "authors": "Saeger HN, Olson DE", "journal": "Journal of neurochemistry", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1111/jnc.15544", "pubmed_id": "34816433", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34816433/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Inflammation,Immune Function", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34816433", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34816433/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34816433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34816433/", "doi": "10.1111/jnc.15544", "pmid": "34816433", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1747, "title": "A systematic literature review of clinical trials and therapeutic applications of ibogaine.", "authors": "Köck P, Froelich K, Walter M, Lang U, Dürsteler KM", "journal": "Journal of substance abuse treatment", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1016/j.jsat.2021.108717", "pubmed_id": "35012793", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35012793/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Systematic Review,Review Article,Case Report,Observational Study", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35012793", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35012793/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35012793", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35012793/", "doi": "10.1016/j.jsat.2021.108717", "pmid": "35012793", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1746, "title": "Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.", "authors": "Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H", "journal": "Pharmacopsychiatry", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1055/a-1714-9097", "pubmed_id": "35045580", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35045580/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35045580", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35045580/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35045580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35045580/", "doi": "10.1055/a-1714-9097", "pmid": "35045580", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1744, "title": "The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.", "authors": "Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS", "journal": "Psychiatry research", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1016/j.psychres.2022.114577", "pubmed_id": "35580433", "openalex_id": "https://openalex.org/W4224751771", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35580433/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35580433", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35580433/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35580433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35580433/", "doi": "10.1016/j.psychres.2022.114577", "pmid": "35580433", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1742, "title": "Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.", "authors": "Smausz R, Neill J, Gigg J", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1177/02698811221092508", "pubmed_id": "35638159", "openalex_id": "https://openalex.org/W4282931386", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35638159/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35638159", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35638159/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35638159", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35638159/", "doi": "10.1177/02698811221092508", "pmid": "35638159", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1540, "title": "A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression", "authors": "Sandeep M Nayak, Bilal A Bari, David Bryce Yaden, Meg J Spriggs, Fernando Rosas, Joseph M Peill, Bruna Giribaldi, David Erritzoe, David Nutt, Robin Carhart-Harris", "journal": "PsyArXiv", "publication_date": "2022-07-01", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "source_url": "https://osf.io/preprints/psyarxiv/sb5ur_v1", "doi": "", "pmid": "", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4952, "title": "Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls", "authors": "Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P.C. Kuypers, Zach Walsh", "journal": "VIUspace", "publication_date": "2022-06-30", "publication_year": 2022, "doi": "10.25316/ir-20556", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125943988", "source_url": "https://doi.org/10.25316/ir-20556", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Microdosing,Observational Study,Older Adults,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.25316/ir-20556", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.25316/ir-20556", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25316/ir-20556", "source_url": "https://doi.org/10.25316/ir-20556", "doi": "10.25316/ir-20556", "pmid": "", "publication_date": "2022-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3653, "title": "Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults", "authors": "Wake Network, Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2022-06-30", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04989972", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04989972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "source_url": "https://clinicaltrials.gov/study/NCT04989972", "doi": "", "pmid": "", "publication_date": "2022-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3381, "title": "Neuroimaging in psychedelic drug development: Past, present, and future", "authors": "Wall M, Harding R, Zafar R, Rabiner EA, Nutt D, Erritzoe D.", "journal": "PsyArXiv", "publication_date": "2022-06-30", "publication_year": 2022, "doi": "10.31234/osf.io/xwu4j", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/xwu4j", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Aging", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:30", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/xwu4j", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/xwu4j", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/xwu4j", "source_url": "https://doi.org/10.31234/osf.io/xwu4j", "doi": "10.31234/osf.io/xwu4j", "pmid": "", "publication_date": "2022-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1383, "title": "Neuroimaging in psychedelic drug development: Past, present, and future", "authors": "Matthew B. Wall, Rebecca Harding, Rayyan Zafar, Eugenii A. Rabiner, David Nutt, David Erritzoe", "journal": "PsyArXiv", "publication_date": "2022-06-30", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Aging", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "source_url": "https://osf.io/preprints/psyarxiv/xwu4j_v1", "doi": "", "pmid": "", "publication_date": "2022-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4954, "title": "MSR20 Challenges in the Development of Economic Evaluations for Psychedelics in Treatment of Depression", "authors": "J Schneider, JP Cooper, S Davies, K Beltran", "journal": "Value in Health", "publication_date": "2022-06-24", "publication_year": 2022, "doi": "10.1016/j.jval.2022.04.1227", "pubmed_id": null, "openalex_id": "https://openalex.org/W4283528627", "source_url": "https://doi.org/10.1016/j.jval.2022.04.1227", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 06:51:57", "bibtex": null, "source_record_id": "DOI:10.1016/j.jval.2022.04.1227", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jval.2022.04.1227", "source_url": "https://doi.org/10.1016/j.jval.2022.04.1227", "doi": "10.1016/j.jval.2022.04.1227", "pmid": "", "publication_date": "2022-06-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4956, "title": "Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions", "authors": "Annie M. McCartney, H. T. McGovern, Alexander De Foe", "journal": "Journal of Psychedelic Studies", "publication_date": "2022-06-09", "publication_year": 2022, "doi": "10.1556/2054.2022.00211", "pubmed_id": null, "openalex_id": "https://openalex.org/W4282040347", "source_url": "https://doi.org/10.1556/2054.2022.00211", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00211", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00211", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00211", "source_url": "https://doi.org/10.1556/2054.2022.00211", "doi": "10.1556/2054.2022.00211", "pmid": "", "publication_date": "2022-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4961, "title": "Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin", "authors": "Anthony Principe", "journal": "SURG Journal", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.21083/surg.v14i1.6870", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281736251", "source_url": "https://doi.org/10.21083/surg.v14i1.6870", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.21083/surg.v14i1.6870", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21083/surg.v14i1.6870", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21083/surg.v14i1.6870", "source_url": "https://doi.org/10.21083/surg.v14i1.6870", "doi": "10.21083/surg.v14i1.6870", "pmid": "", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4958, "title": "Association of Psilocybin Use in Adolescents with Major Depressive Episode", "authors": "Kaushal Shah, C. Trivedi, D. Kamrai, M. Akbar, W. Tankersley", "journal": "European Psychiatry", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1192/j.eurpsy.2022.837", "pubmed_id": null, "openalex_id": "https://openalex.org/W4294189301", "source_url": "https://doi.org/10.1192/j.eurpsy.2022.837", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Adolescents", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2022.837", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2022.837", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2022.837", "source_url": "https://doi.org/10.1192/j.eurpsy.2022.837", "doi": "10.1192/j.eurpsy.2022.837", "pmid": "", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1777, "title": "Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.", "authors": "Corrigan K, Haran M, McCandliss C, McManus R, Cleary S, Trant R, Kelly Y, Ledden K, Rush G, O'Keane V, Kelly JR", "journal": "Irish journal of medical science", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s11845-021-02668-2", "pubmed_id": "34131812", "openalex_id": "https://openalex.org/W3171384877", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34131812/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34131812", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34131812/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34131812", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34131812/", "doi": "10.1007/s11845-021-02668-2", "pmid": "34131812", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1773, "title": "Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.", "authors": "Bender D, Hellerstein DJ", "journal": "Psychopharmacology", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s00213-021-06049-6", "pubmed_id": "35022823", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35022823/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article,Case Report,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35022823", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35022823/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35022823", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35022823/", "doi": "10.1007/s00213-021-06049-6", "pmid": "35022823", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1772, "title": "Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.", "authors": "Miceli McMillan R, Jordens C", "journal": "Medicine, health care, and philosophy", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s11019-022-10070-7", "pubmed_id": "35064398", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35064398/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35064398", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35064398/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35064398", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35064398/", "doi": "10.1007/s11019-022-10070-7", "pmid": "35064398", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1769, "title": "The therapeutic potential of psilocybin: a systematic review.", "authors": "van Amsterdam J, van den Brink W", "journal": "Expert opinion on drug safety", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2047929", "pubmed_id": "35225143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225143/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35225143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35225143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35225143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225143/", "doi": "10.1080/14740338.2022.2047929", "pmid": "35225143", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1768, "title": "Effects of the 5-HT receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.", "authors": "Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J", "journal": "Psychopharmacology", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06092-x", "pubmed_id": "35233648", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35233648/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35233648", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35233648/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35233648", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35233648/", "doi": "10.1007/s00213-022-06092-x", "pmid": "35233648", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1766, "title": "Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.", "authors": "Sarparast A, Thomas K, Malcolm B, Stauffer CS", "journal": "Psychopharmacology", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06083-y", "pubmed_id": "35253070", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35253070/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35253070", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35253070/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35253070", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35253070/", "doi": "10.1007/s00213-022-06083-y", "pmid": "35253070", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1765, "title": "The promises and perils of psychedelic pharmacology for psychiatry.", "authors": "McClure-Begley TD, Roth BL", "journal": "Nature reviews. Drug discovery", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1038/s41573-022-00421-7", "pubmed_id": "35301459", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35301459/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35301459", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35301459/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35301459", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35301459/", "doi": "10.1038/s41573-022-00421-7", "pmid": "35301459", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1764, "title": "Development of an -based norbaeocystin production platform and evaluation of behavioral effects in rats.", "authors": "Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA", "journal": "Metabolic engineering communications", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1016/j.mec.2022.e00196", "pubmed_id": "35310468", "openalex_id": "https://openalex.org/W4220669239", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35310468/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Animal Study,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35310468", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35310468/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35310468", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35310468/", "doi": "10.1016/j.mec.2022.e00196", "pmid": "35310468", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1763, "title": "How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.", "authors": "van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH", "journal": "Psychopharmacology", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06106-8", "pubmed_id": "35348806", "openalex_id": "https://openalex.org/W4220677776", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35348806/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mystical Experience,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35348806", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35348806/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35348806", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35348806/", "doi": "10.1007/s00213-022-06106-8", "pmid": "35348806", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1762, "title": "Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?", "authors": "Husain MI, Umer M, Mulsant BH", "journal": "Expert opinion on drug safety", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2063274", "pubmed_id": "35387542", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35387542/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35387542", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35387542", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35387542/", "doi": "10.1080/14740338.2022.2063274", "pmid": "35387542", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1761, "title": "Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.", "authors": "Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG", "journal": "Expert opinion on drug safety", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2066650", "pubmed_id": "35426754", "openalex_id": "https://openalex.org/W4223893856", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35426754/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35426754", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35426754/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35426754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35426754/", "doi": "10.1080/14740338.2022.2066650", "pmid": "35426754", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1753, "title": "3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.", "authors": "Inouye A, Wolfgang A", "journal": "Cureus", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.7759/cureus.26402", "pubmed_id": "35915689", "openalex_id": "https://openalex.org/W4283698346", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35915689/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35915689", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35915689/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35915689", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35915689/", "doi": "10.7759/cureus.26402", "pmid": "35915689", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4959, "title": "The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.", "authors": "Manish Agrawal, Paul Thambi, Sarah Shnayder", "journal": "Journal of Clinical Oncology", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1200/jco.2022.40.16_suppl.12097", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281784879", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "doi": "10.1200/jco.2022.40.16_suppl.12097", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4967, "title": "Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits", "authors": "Richard Karel", "journal": "Psychiatric News", "publication_date": "2022-05-23", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.06.6.30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281400661", "source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Consciousness,Wellbeing,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:42", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.06.6.30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.06.6.30", "source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "doi": "10.1176/appi.pn.2022.06.6.30", "pmid": "", "publication_date": "2022-05-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1784, "title": "New Paradigms of Old Psychedelics in Schizophrenia.", "authors": "Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2022-05-23", "publication_year": 2022, "doi": "10.3390/ph15050640", "pubmed_id": "35631466", "openalex_id": "https://openalex.org/W4282930656", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35631466/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Microdosing,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35631466", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35631466/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35631466", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35631466/", "doi": "10.3390/ph15050640", "pmid": "35631466", "publication_date": "2022-05-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3676, "title": "Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression", "authors": "National Institute of Mental Health, Czech Republic", "journal": "ClinicalTrials.gov", "publication_date": "2022-05-20", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05383313", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05383313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "source_url": "https://clinicaltrials.gov/study/NCT05383313", "doi": "", "pmid": "", "publication_date": "2022-05-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4968, "title": "The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis", "authors": "Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan", "journal": "Current Psychiatry Research and Reviews", "publication_date": "2022-05-15", "publication_year": 2022, "doi": "10.2174/2666082218666220513142002", "pubmed_id": null, "openalex_id": "https://openalex.org/W4280584826", "source_url": "https://doi.org/10.2174/2666082218666220513142002", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.2174/2666082218666220513142002", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/2666082218666220513142002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/2666082218666220513142002", "source_url": "https://doi.org/10.2174/2666082218666220513142002", "doi": "10.2174/2666082218666220513142002", "pmid": "", "publication_date": "2022-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1789, "title": "The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.", "authors": "Johansen L, Liknaitzky P, Nedeljkovic M, Mastin-Purcell L, Murray G", "journal": "Systematic reviews", "publication_date": "2022-05-05", "publication_year": 2022, "doi": "10.1186/s13643-022-01930-7", "pubmed_id": "35513876", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35513876/", "substance_tags": "psilocybin", "topic_tags": "Depression,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35513876", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35513876/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35513876", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35513876/", "doi": "10.1186/s13643-022-01930-7", "pmid": "35513876", "publication_date": "2022-05-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1790, "title": "The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.", "authors": "Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M", "journal": "Journal of midwifery & women's health", "publication_date": "2022-05-01", "publication_year": 2022, "doi": "10.1111/jmwh.13371", "pubmed_id": "35522087", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35522087/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35522087", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35522087/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35522087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35522087/", "doi": "10.1111/jmwh.13371", "pmid": "35522087", "publication_date": "2022-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1780, "title": "Unraveling the Mysteries of Mental Illness With Psilocybin.", "authors": "Sotille R, Singh H, Weisman A, Vida T", "journal": "Cureus", "publication_date": "2022-05-01", "publication_year": 2022, "doi": "10.7759/cureus.25414", "pubmed_id": "35769681", "openalex_id": "https://openalex.org/W4281664591", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35769681/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35769681", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35769681/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35769681", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35769681/", "doi": "10.7759/cureus.25414", "pmid": "35769681", "publication_date": "2022-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4972, "title": "Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States", "authors": "Claudia Schwarz-Plaschg", "journal": "European Journal of Futures Research", "publication_date": "2022-04-30", "publication_year": 2022, "doi": "10.1186/s40309-022-00199-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4225266953", "source_url": "https://doi.org/10.1186/s40309-022-00199-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:42", "bibtex": null, "source_record_id": "DOI:10.1186/s40309-022-00199-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40309-022-00199-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1186/s40309-022-00199-2", "source_url": "https://doi.org/10.1186/s40309-022-00199-2", "doi": "10.1186/s40309-022-00199-2", "pmid": "", "publication_date": "2022-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3659, "title": "Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2022-04-29", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03715127", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Resilience,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03715127", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03715127", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03715127", "source_url": "https://clinicaltrials.gov/study/NCT03715127", "doi": "", "pmid": "", "publication_date": "2022-04-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3365, "title": "Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds", "authors": "Manoj Doss, Frederick Streeter Barrett, Philip R. Corlett", "journal": "PsyArXiv", "publication_date": "2022-04-28", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/a25wb_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/a25wb_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/a25wb_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/a25wb_v1", "source_url": "https://osf.io/preprints/psyarxiv/a25wb_v1", "doi": "", "pmid": "", "publication_date": "2022-04-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4974, "title": "P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression", "authors": "Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes", "journal": "Biological Psychiatry", "publication_date": "2022-04-27", "publication_year": 2022, "doi": "10.1016/j.biopsych.2022.02.624", "pubmed_id": null, "openalex_id": "https://openalex.org/W4225010514", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.624", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2022.02.624", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2022.02.624", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.624", "doi": "10.1016/j.biopsych.2022.02.624", "pmid": "", "publication_date": "2022-04-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1795, "title": "Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.", "authors": "Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W", "journal": "Molecules (Basel, Switzerland)", "publication_date": "2022-04-14", "publication_year": 2022, "doi": "10.3390/molecules27082520", "pubmed_id": "35458717", "openalex_id": "https://openalex.org/W4224106670", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35458717/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Spirituality,Review Article,Cancer Patients,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35458717", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35458717/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35458717", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35458717/", "doi": "10.3390/molecules27082520", "pmid": "35458717", "publication_date": "2022-04-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2016, "title": "Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms", "authors": "Lemos Martins Sofia, Machado Brito-da-Costa Andreia, Madureira-Carvalho Áurea, Dinis-Oliveira Ricardo Jorge, Dias da Silva Diana", "journal": "RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia", "publication_date": "2022-04-06", "publication_year": 2022, "doi": "10.51126/revsalus.v4isup.271", "pubmed_id": null, "openalex_id": "https://openalex.org/W4223588025", "source_url": "https://doi.org/10.51126/revsalus.v4isup.271", "substance_tags": "psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:50", "bibtex": null, "source_record_id": "DOI:10.51126/revsalus.v4isup.271", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.51126/revsalus.v4isup.271", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.51126/revsalus.v4isup.271", "source_url": "https://doi.org/10.51126/revsalus.v4isup.271", "doi": "10.51126/revsalus.v4isup.271", "pmid": "", "publication_date": "2022-04-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4978, "title": "Psilocybe mexicana R. Heim - Mexikanischer Kahlkopf", "authors": "Antonia Kuhn, Matthias F. Melzig", "journal": "Zeitschrift für Phytotherapie", "publication_date": "2022-04-01", "publication_year": 2022, "doi": "10.1055/a-1540-9907", "pubmed_id": null, "openalex_id": "https://openalex.org/W4224935312", "source_url": "https://doi.org/10.1055/a-1540-9907", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:42", "bibtex": null, "source_record_id": "DOI:10.1055/a-1540-9907", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-1540-9907", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-1540-9907", "source_url": "https://doi.org/10.1055/a-1540-9907", "doi": "10.1055/a-1540-9907", "pmid": "", "publication_date": "2022-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1800, "title": "Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.", "authors": "Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Grünblatt E, Liechti ME", "journal": "Clinical pharmacology and therapeutics", "publication_date": "2022-04-01", "publication_year": 2022, "doi": "10.1002/cpt.2487", "pubmed_id": "34743319", "openalex_id": "https://openalex.org/W3213378850", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34743319/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34743319", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34743319/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34743319", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34743319/", "doi": "10.1002/cpt.2487", "pmid": "34743319", "publication_date": "2022-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1798, "title": "Increased global integration in the brain after psilocybin therapy for depression.", "authors": "Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R", "journal": "Nature medicine", "publication_date": "2022-04-01", "publication_year": 2022, "doi": "10.1038/s41591-022-01744-z", "pubmed_id": "35411074", "openalex_id": "https://openalex.org/W4223491164", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35411074/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35411074", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35411074/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35411074", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35411074/", "doi": "10.1038/s41591-022-01744-z", "pmid": "35411074", "publication_date": "2022-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4980, "title": "Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?", "authors": "Michael Avissar, Adrian Jacques H. Ambrose", "journal": "Psychiatric News", "publication_date": "2022-03-24", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.04.4.35", "pubmed_id": null, "openalex_id": "https://openalex.org/W4220982704", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:42", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "doi": "10.1176/appi.pn.2022.04.4.35", "pmid": "", "publication_date": "2022-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1808, "title": "Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.", "authors": "Pearson C, Siegel J, Gold JA", "journal": "Journal of the neurological sciences", "publication_date": "2022-03-15", "publication_year": 2022, "doi": "10.1016/j.jns.2021.120096", "pubmed_id": "34942586", "openalex_id": "https://openalex.org/W4200117112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34942586/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34942586", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34942586/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34942586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34942586/", "doi": "10.1016/j.jns.2021.120096", "pmid": "34942586", "publication_date": "2022-03-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1809, "title": "Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.", "authors": "Meade E, Hehir S, Rowan N, Garvey M", "journal": "Journal of fungi (Basel, Switzerland)", "publication_date": "2022-03-11", "publication_year": 2022, "doi": "10.3390/jof8030290", "pubmed_id": "35330292", "openalex_id": "https://openalex.org/W4220724929", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35330292/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Review Article,Safety,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35330292", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35330292/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35330292", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35330292/", "doi": "10.3390/jof8030290", "pmid": "35330292", "publication_date": "2022-03-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3198, "title": "Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro", "authors": "Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K, Brodin A, von Kieseritzky F, Olson L, Karlsson T.", "journal": "Research Square", "publication_date": "2022-03-08", "publication_year": 2022, "doi": "10.21203/rs.3.rs-1321542/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-1321542/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Neuroplasticity,Mechanism of Action,Animal Study,In Vitro Study,Inflammation", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-1321542/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-1321542/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-1321542/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-1321542/v1", "doi": "10.21203/rs.3.rs-1321542/v1", "pmid": "", "publication_date": "2022-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4985, "title": "Rediscovering psychedelics", "authors": "Bethany Halford", "journal": "C&EN Global Enterprise", "publication_date": "2022-03-07", "publication_year": 2022, "doi": "10.1021/cen-10009-cover", "pubmed_id": null, "openalex_id": "https://openalex.org/W4220835321", "source_url": "https://doi.org/10.1021/cen-10009-cover", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:42", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10009-cover", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10009-cover", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10009-cover", "source_url": "https://doi.org/10.1021/cen-10009-cover", "doi": "10.1021/cen-10009-cover", "pmid": "", "publication_date": "2022-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1818, "title": "[Rapid-acting antidepressants-neurobiological mechanisms of action].", "authors": "Gass P, Vasilescu AN, Inta D", "journal": "Der Nervenarzt", "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1007/s00115-021-01225-7", "pubmed_id": "34766186", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34766186/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34766186", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34766186/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34766186", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34766186/", "doi": "10.1007/s00115-021-01225-7", "pmid": "34766186", "publication_date": "2022-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1817, "title": "Beating pain with psychedelics: Matter over mind?", "authors": "Elman I, Pustilnik A, Borsook D", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1016/j.neubiorev.2021.12.005", "pubmed_id": "34922987", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34922987/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Emotional Processing,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34922987", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34922987/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34922987", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34922987/", "doi": "10.1016/j.neubiorev.2021.12.005", "pmid": "34922987", "publication_date": "2022-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1816, "title": "[Are psychedelics fast acting antidepressant agents?].", "authors": "Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M, Mertens LJ", "journal": "Der Nervenarzt", "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1007/s00115-021-01255-1", "pubmed_id": "35103814", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35103814/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35103814", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35103814/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35103814", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35103814/", "doi": "10.1007/s00115-021-01255-1", "pmid": "35103814", "publication_date": "2022-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1813, "title": "Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.", "authors": "Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF", "journal": "Current treatment options in oncology", "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1007/s11864-022-00954-4", "pubmed_id": "35254595", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35254595/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Aging,Cancer Patients,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35254595", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35254595/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35254595", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35254595/", "doi": "10.1007/s11864-022-00954-4", "pmid": "35254595", "publication_date": "2022-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1819, "title": "Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice", "authors": "Thomas Christopher W., Blanco-Duque Cristina, Bréant Benjamin J., Goodwin Guy M., Sharp Trevor, Bannerman David M., Vyazovskiy Vladyslav V.", "journal": "Translational Psychiatry", "publication_date": "2022-02-23", "publication_year": 2022, "doi": "10.1038/s41398-022-01846-9", "pubmed_id": "35197453", "openalex_id": "https://openalex.org/W4214570845", "source_url": "https://doi.org/10.1038/s41398-022-01846-9", "substance_tags": "psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Wellbeing,Animal Study", "study_type": "Animal Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:50", "bibtex": null, "source_record_id": "PMID:35197453", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s41398-022-01846-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:35197453", "source_url": "https://doi.org/10.1038/s41398-022-01846-9", "doi": "10.1038/s41398-022-01846-9", "pmid": "35197453", "publication_date": "2022-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3227, "title": "Increased low-frequency brain responses to music after psilocybin therapy for depression", "authors": "Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL.", "journal": "bioRxiv", "publication_date": "2022-02-15", "publication_year": 2022, "doi": "10.1101/2022.02.13.480302", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.02.13.480302", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:12", "bibtex": null, "source_record_id": "DOI:10.1101/2022.02.13.480302", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.02.13.480302", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.02.13.480302", "source_url": "https://doi.org/10.1101/2022.02.13.480302", "doi": "10.1101/2022.02.13.480302", "pmid": "", "publication_date": "2022-02-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1821, "title": "Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).", "authors": "Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S", "journal": "ACS omega", "publication_date": "2022-02-15", "publication_year": 2022, "doi": "10.1021/acsomega.1c06708", "pubmed_id": "35187358", "openalex_id": "https://openalex.org/W4210846812", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35187358/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35187358", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35187358/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35187358", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35187358/", "doi": "10.1021/acsomega.1c06708", "pmid": "35187358", "publication_date": "2022-02-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1822, "title": "Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.", "authors": "Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP", "journal": "Journal of clinical medicine", "publication_date": "2022-02-11", "publication_year": 2022, "doi": "10.3390/jcm11040938", "pubmed_id": "35207210", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35207210/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35207210", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35207210/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35207210", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35207210/", "doi": "10.3390/jcm11040938", "pmid": "35207210", "publication_date": "2022-02-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1823, "title": "Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?", "authors": "Coppola M, Bevione F, Mondola R", "journal": "Journal of xenobiotics", "publication_date": "2022-02-07", "publication_year": 2022, "doi": "10.3390/jox12010004", "pubmed_id": "35225956", "openalex_id": "https://openalex.org/W4210913256", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225956/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35225956", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35225956/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35225956", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225956/", "doi": "10.3390/jox12010004", "pmid": "35225956", "publication_date": "2022-02-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4989, "title": "Hallucinogen chemistry guides antidepressant drug discovery", "authors": "Bethany Halford", "journal": "C&EN Global Enterprise", "publication_date": "2022-02-06", "publication_year": 2022, "doi": "10.1021/cen-10005-leadcon", "pubmed_id": null, "openalex_id": "https://openalex.org/W4210908417", "source_url": "https://doi.org/10.1021/cen-10005-leadcon", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-10005-leadcon", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-10005-leadcon", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-10005-leadcon", "source_url": "https://doi.org/10.1021/cen-10005-leadcon", "doi": "10.1021/cen-10005-leadcon", "pmid": "", "publication_date": "2022-02-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1827, "title": "Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.", "authors": "Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-02-01", "publication_year": 2022, "doi": "10.1177/02698811211073759", "pubmed_id": "35166158", "openalex_id": "https://openalex.org/W4212903385", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35166158/", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Spirituality,Mystical Experience,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35166158", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35166158/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35166158", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35166158/", "doi": "10.1177/02698811211073759", "pmid": "35166158", "publication_date": "2022-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1825, "title": "Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.", "authors": "Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR", "journal": "Cureus", "publication_date": "2022-02-01", "publication_year": 2022, "doi": "10.7759/cureus.21944", "pubmed_id": "35273885", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35273885/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35273885", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35273885/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35273885", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35273885/", "doi": "10.7759/cureus.21944", "pmid": "35273885", "publication_date": "2022-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4992, "title": "Psychedelics hold promise for primary care research", "authors": "James Bailey Sanford", "journal": "Family Practice", "publication_date": "2022-01-24", "publication_year": 2022, "doi": "10.1093/fampra/cmac009", "pubmed_id": "35137025", "openalex_id": "https://openalex.org/W4207062049", "source_url": "https://doi.org/10.1093/fampra/cmac009", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Receptor Pharmacology,Cancer Patients", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "PMID:35137025", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/fampra/cmac009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:35137025", "source_url": "https://doi.org/10.1093/fampra/cmac009", "doi": "10.1093/fampra/cmac009", "pmid": "35137025", "publication_date": "2022-01-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4993, "title": "Psilocybine vergeleken met escitalopram bij depressie", "authors": "Jurriaan F. M. Strous", "journal": "Pure Amsterdam UMC", "publication_date": "2022-01-17", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7132220122", "source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "source_url": "https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae", "doi": "", "pmid": "", "publication_date": "2022-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1834, "title": "[Psilocybin compared with escitalopram for depression].", "authors": "Strous JFM", "journal": "Nederlands tijdschrift voor geneeskunde", "publication_date": "2022-01-17", "publication_year": 2022, "doi": null, "pubmed_id": "35138714", "openalex_id": "https://openalex.org/W4221159545", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35138714/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:29", "bibtex": null, "source_record_id": "PMID:35138714", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35138714/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35138714", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35138714/", "doi": "", "pmid": "35138714", "publication_date": "2022-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5823, "title": "Classic psychedelics in the treatment of depression: mechanisms of action and the role of therapy", "authors": "Ellen Saikku", "journal": "Työväentutkimus Vuosikirja", "publication_date": "2022-01-01", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7200887802", "source_url": "http://hdl.handle.net/10138/606412", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:43", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "http://hdl.handle.net/10138/606412", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/10138/606412", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/10138/606412", "source_url": "http://hdl.handle.net/10138/606412", "doi": "", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5023, "title": "Neurochemical properties of psilocybin in comparison to ketamine in vivo", "authors": "A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100408", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313201121", "source_url": "https://doi.org/10.1016/j.nsa.2022.100408", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100408", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100408", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100408", "source_url": "https://doi.org/10.1016/j.nsa.2022.100408", "doi": "10.1016/j.nsa.2022.100408", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5018, "title": "The role of psilocybin in memory consolidation in the animal model", "authors": "K. Šíchová, K. Chona, Lucie Olejníková Ladislavová, T. Páleníček", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100953", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313199409", "source_url": "https://doi.org/10.1016/j.nsa.2022.100953", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Wellbeing,Creativity,Animal Study,Drug Interactions", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100953", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100953", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100953", "source_url": "https://doi.org/10.1016/j.nsa.2022.100953", "doi": "10.1016/j.nsa.2022.100953", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5016, "title": "Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics", "authors": "Daisuke Ibi", "journal": "Proceedings for Annual Meeting of The Japanese Pharmacological Society", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1254/jpssuppl.96.0_4-b-s43-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313199284", "source_url": "https://doi.org/10.1254/jpssuppl.96.0_4-b-s43-2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1254/jpssuppl.96.0_4-b-s43-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1254/jpssuppl.96.0_4-b-s43-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1254/jpssuppl.96.0_4-b-s43-2", "source_url": "https://doi.org/10.1254/jpssuppl.96.0_4-b-s43-2", "doi": "10.1254/jpssuppl.96.0_4-b-s43-2", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5015, "title": "SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?", "authors": "Jeff Tarrant", "journal": "Biofeedback", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.5298/1081-5937-50.03.03", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313148936", "source_url": "https://doi.org/10.5298/1081-5937-50.03.03", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Wellbeing,Emotional Processing,Spirituality,Mystical Experience,Psychological Flexibility,Healthy Volunteers,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.5298/1081-5937-50.03.03", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5298/1081-5937-50.03.03", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5298/1081-5937-50.03.03", "source_url": "https://doi.org/10.5298/1081-5937-50.03.03", "doi": "10.5298/1081-5937-50.03.03", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5008, "title": "Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics", "authors": "Daisuke Ibi", "journal": "Proceedings for Annual Meeting of The Japanese Pharmacological Society", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1254/jpssuppl.95.0_3-s35-1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4225709710", "source_url": "https://doi.org/10.1254/jpssuppl.95.0_3-s35-1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1254/jpssuppl.95.0_3-s35-1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1254/jpssuppl.95.0_3-s35-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1254/jpssuppl.95.0_3-s35-1", "source_url": "https://doi.org/10.1254/jpssuppl.95.0_3-s35-1", "doi": "10.1254/jpssuppl.95.0_3-s35-1", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5007, "title": "Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjects", "authors": "Friederike Holze, Laura Ley, F. Müller, V. Nimmy, Anne Eckert, Matthias E. Liechti", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100075", "pubmed_id": null, "openalex_id": "https://openalex.org/W4221097544", "source_url": "https://doi.org/10.1016/j.nsa.2022.100075", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Biomarkers,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100075", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100075", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100075", "source_url": "https://doi.org/10.1016/j.nsa.2022.100075", "doi": "10.1016/j.nsa.2022.100075", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5005, "title": "The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial", "authors": "G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100213", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313200620", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "doi": "10.1016/j.nsa.2022.100213", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5002, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial", "authors": "G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313199626", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "doi": "10.1016/j.nsa.2022.100511", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1867, "title": "Psychedelics and health behaviour change.", "authors": "Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211008554", "pubmed_id": "34053342", "openalex_id": "https://openalex.org/W3164067847", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34053342/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34053342", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34053342/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34053342", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34053342/", "doi": "10.1177/02698811211008554", "pmid": "34053342", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1864, "title": "Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.", "authors": "Leger RF, Unterwald EM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211044688", "pubmed_id": "34519567", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34519567/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34519567", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34519567/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34519567", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34519567/", "doi": "10.1177/02698811211044688", "pmid": "34519567", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1863, "title": "Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.", "authors": "Li NX, Hu YR, Chen WN, Zhang B", "journal": "Journal of affective disorders", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.jad.2021.09.041", "pubmed_id": "34587546", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34587546/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34587546", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34587546/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34587546", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34587546/", "doi": "10.1016/j.jad.2021.09.041", "pmid": "34587546", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1860, "title": "Dosing Psychedelics and MDMA.", "authors": "Liechti ME, Holze F", "journal": "Current topics in behavioral neurosciences", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/7854_2021_270", "pubmed_id": "34734392", "openalex_id": "https://openalex.org/W3210796807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34734392/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Headache / Migraine,Microdosing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34734392", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34734392/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34734392", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34734392/", "doi": "10.1007/7854_2021_270", "pmid": "34734392", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1858, "title": "Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.", "authors": "Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS", "journal": "CNS drugs", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/s40263-021-00877-y", "pubmed_id": "34791625", "openalex_id": "https://openalex.org/W3213007658", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34791625/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34791625", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34791625/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34791625", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34791625/", "doi": "10.1007/s40263-021-00877-y", "pmid": "34791625", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1857, "title": "Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.", "authors": "Agin-Liebes G, Davis AK", "journal": "Current topics in behavioral neurosciences", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/7854_2021_282", "pubmed_id": "34811715", "openalex_id": "https://openalex.org/W3216485471", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34811715/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34811715", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34811715/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34811715", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34811715/", "doi": "10.1007/7854_2021_282", "pmid": "34811715", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1856, "title": "Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.", "authors": "Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA", "journal": "Psychopharmacology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/s00213-021-06027-y", "pubmed_id": "34812901", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34812901/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34812901", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34812901/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34812901", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34812901/", "doi": "10.1007/s00213-021-06027-y", "pmid": "34812901", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1855, "title": "Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.", "authors": "Sousa TR, Rema J, Machado S, Novais F", "journal": "Current topics in medicinal chemistry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.2174/1568026621666211201145800", "pubmed_id": "34852736", "openalex_id": "https://openalex.org/W3215301772", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34852736/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mechanism of Action,Default Mode Network,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34852736", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34852736/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34852736", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34852736/", "doi": "10.2174/1568026621666211201145800", "pmid": "34852736", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1854, "title": "Psychedelic medicines for mood disorders: current evidence and clinical considerations.", "authors": "Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D", "journal": "Current opinion in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1097/yco.0000000000000759", "pubmed_id": "34855694", "openalex_id": "https://openalex.org/W3214407741", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34855694/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Neurogenesis,Mechanism of Action,Aging,Microdosing,Clinical Trial,Animal Study,Treatment-Resistant Depression,Genomics,Microbiome,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34855694", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34855694/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34855694", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34855694/", "doi": "10.1097/yco.0000000000000759", "pmid": "34855694", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1852, "title": "Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.", "authors": "Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211050556", "pubmed_id": "34915762", "openalex_id": "https://openalex.org/W4200583144", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34915762/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Microdosing,Emotional Processing,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34915762", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34915762/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34915762", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34915762/", "doi": "10.1177/02698811211050556", "pmid": "34915762", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1851, "title": "The Potential of Psychedelics for End of Life and Palliative Care.", "authors": "Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR", "journal": "Current topics in behavioral neurosciences", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/7854_2021_278", "pubmed_id": "34958455", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34958455/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Wellbeing,Review Article,Healthcare Workers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34958455", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34958455/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34958455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34958455/", "doi": "10.1007/7854_2021_278", "pmid": "34958455", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1848, "title": "Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.", "authors": "Jones GM, Nock MK", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211066714", "pubmed_id": "34983261", "openalex_id": "https://openalex.org/W4205618858", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34983261/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34983261", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34983261/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34983261", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34983261/", "doi": "10.1177/02698811211066714", "pmid": "34983261", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1847, "title": "The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.", "authors": "Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211064720", "pubmed_id": "35090363", "openalex_id": "https://openalex.org/W4205906672", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35090363/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35090363", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35090363/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35090363", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35090363/", "doi": "10.1177/02698811211064720", "pmid": "35090363", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1845, "title": "Human behavioral pharmacology of psychedelics.", "authors": "Strickland JC, Johnson MW", "journal": "Advances in pharmacology (San Diego, Calif.)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/bs.apha.2021.10.003", "pubmed_id": "35341564", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35341564/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Abuse Liability", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35341564", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35341564/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35341564", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35341564/", "doi": "10.1016/bs.apha.2021.10.003", "pmid": "35341564", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1840, "title": "Psilocybin for Trauma-Related Disorders.", "authors": "Khan AJ, Bradley E, O'Donovan A, Woolley J", "journal": "Current topics in behavioral neurosciences", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/7854_2022_366", "pubmed_id": "35711024", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35711024/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Emotional Processing,Veterans,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35711024", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35711024/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35711024", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35711024/", "doi": "10.1007/7854_2022_366", "pmid": "35711024", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1812, "title": "Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.", "authors": "Sekula AD, Downey L, Puspanathan P", "journal": "Frontiers in psychology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyg.2022.813746", "pubmed_id": "35310225", "openalex_id": "https://openalex.org/W4214940428", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35310225/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Consciousness,Spirituality,Mystical Experience,Treatment-Resistant Depression,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35310225", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35310225/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35310225", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35310225/", "doi": "10.3389/fpsyg.2022.813746", "pmid": "35310225", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1811, "title": "Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.", "authors": "Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G", "journal": "Neuroscience applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100104", "pubmed_id": "40656230", "openalex_id": "https://openalex.org/W4220708535", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656230/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:40656230", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656230/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656230", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656230/", "doi": "10.1016/j.nsa.2022.100104", "pmid": "40656230", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1807, "title": "Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Raison CL, Jain R, Penn AD, Cole SP, Jain S", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.831092", "pubmed_id": "35370864", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35370864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35370864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "doi": "10.3389/fpsyt.2022.831092", "pmid": "35370864", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1805, "title": "Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.", "authors": "Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.877390", "pubmed_id": "35401265", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35401265/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35401265", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35401265/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35401265", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35401265/", "doi": "10.3389/fpsyt.2022.877390", "pmid": "35401265", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1803, "title": "Psilocybin-Assisted Compassion Focused Therapy for Depression.", "authors": "Pots W, Chakhssi F", "journal": "Frontiers in psychology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyg.2022.812930", "pubmed_id": "35401294", "openalex_id": "https://openalex.org/W4221031753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35401294/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35401294", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35401294/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35401294", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35401294/", "doi": "10.3389/fpsyg.2022.812930", "pmid": "35401294", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1792, "title": "Will psilocybin lose its magic in the clinical setting?", "authors": "Hayes C, Wahba M, Watson S", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/20451253221090822", "pubmed_id": "35480296", "openalex_id": "https://openalex.org/W4225982601", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35480296/", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35480296", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35480296/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35480296", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35480296/", "doi": "10.1177/20451253221090822", "pmid": "35480296", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1754, "title": "Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.", "authors": "Vorobyeva N, Kozlova AA", "journal": "Frontiers in pharmacology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fphar.2022.927984", "pubmed_id": "35837277", "openalex_id": "https://openalex.org/W4283657643", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35837277/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35837277", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35837277/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35837277", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35837277/", "doi": "10.3389/fphar.2022.927984", "pmid": "35837277", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1740, "title": "Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.", "authors": "Lyons A", "journal": "Innovations in clinical neuroscience", "publication_date": "2022-01-01", "publication_year": 2022, "doi": null, "pubmed_id": "36204170", "openalex_id": "https://openalex.org/W4303509980", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36204170/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Randomized Controlled Trial,Treatment-Resistant Depression,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:36204170", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36204170/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36204170", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36204170/", "doi": "", "pmid": "36204170", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1736, "title": "Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.", "authors": "Ko K, Knight G, Rucker JJ, Cleare AJ", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.917199", "pubmed_id": "35923458", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35923458/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mystical Experience,Systematic Review,Review Article,Cancer Patients", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35923458", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35923458/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35923458", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35923458/", "doi": "10.3389/fpsyt.2022.917199", "pmid": "35923458", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1716, "title": "Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.", "authors": "Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V", "journal": "Chronic stress (Thousand Oaks, Calif.)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/24705470221115342", "pubmed_id": "35936944", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35936944/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35936944", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35936944/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35936944", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35936944/", "doi": "10.1177/24705470221115342", "pmid": "35936944", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1667, "title": "3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.", "authors": "López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.990405", "pubmed_id": "36262632", "openalex_id": "https://openalex.org/W4300962019", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36262632/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Consciousness,Review Article,Treatment-Resistant Depression,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36262632", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36262632/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36262632", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36262632/", "doi": "10.3389/fpsyt.2022.990405", "pmid": "36262632", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1654, "title": "Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.", "authors": "Altman BR, Earleywine M, De Leo J", "journal": "Journal of psychoactive drugs", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1080/02791072.2021.2020382", "pubmed_id": "34979875", "openalex_id": "https://openalex.org/W4206767983", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34979875/", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:34979875", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34979875/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34979875", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34979875/", "doi": "10.1080/02791072.2021.2020382", "pmid": "34979875", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1649, "title": "A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.", "authors": "Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI", "journal": "Journal of clinical psychopharmacology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1097/jcp.0000000000001608", "pubmed_id": "36193898", "openalex_id": "https://openalex.org/W4301392523", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36193898/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36193898", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36193898/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36193898", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36193898/", "doi": "10.1097/jcp.0000000000001608", "pmid": "36193898", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1648, "title": "Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.", "authors": "Balon R", "journal": "Journal of clinical psychopharmacology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1097/jcp.0000000000001610", "pubmed_id": "36251379", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36251379/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36251379", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36251379", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36251379/", "doi": "10.1097/jcp.0000000000001610", "pmid": "36251379", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1644, "title": "[Treatment-resistant depression. From classification to new therapies.].", "authors": "Paganin W, Signorini S, Leccese V, Sciarretta A", "journal": "Rivista di psichiatria", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1708/3922.39072", "pubmed_id": "36503940", "openalex_id": "https://openalex.org/W4311667760", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36503940/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36503940", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36503940/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36503940", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36503940/", "doi": "10.1708/3922.39072", "pmid": "36503940", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1622, "title": "The economics of psychedelic-assisted therapies: A research agenda.", "authors": "Marseille E, Bertozzi S, Kahn JG", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.1025726", "pubmed_id": "36545038", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36545038/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36545038", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36545038/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36545038", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36545038/", "doi": "10.3389/fpsyt.2022.1025726", "pmid": "36545038", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1620, "title": "\"A sense of the bigger picture:\" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.", "authors": "DellaCrosse M, Pleet M, Morton E, Ashtari A, Sakai K, Woolley J, Michalak E", "journal": "PloS one", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1371/journal.pone.0279073", "pubmed_id": "36516137", "openalex_id": "https://openalex.org/W4311439362", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36516137/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36516137", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36516137/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36516137", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36516137/", "doi": "10.1371/journal.pone.0279073", "pmid": "36516137", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1561, "title": "Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?", "authors": "Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.1076459", "pubmed_id": "36844032", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36844032/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36844032", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36844032/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36844032", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36844032/", "doi": "10.3389/fpsyt.2022.1076459", "pmid": "36844032", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3526, "title": "LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2021-12-22", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03153579", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03153579", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03153579", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03153579", "source_url": "https://clinicaltrials.gov/study/NCT03153579", "doi": "", "pmid": "", "publication_date": "2021-12-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3500, "title": "Effects of Psilocybin in Major Depressive Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2021-12-15", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03181529", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03181529", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03181529", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03181529", "source_url": "https://clinicaltrials.gov/study/NCT03181529", "doi": "", "pmid": "", "publication_date": "2021-12-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5030, "title": "Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs", "authors": "Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek", "journal": "Behavioural Pharmacology", "publication_date": "2021-12-13", "publication_year": 2021, "doi": "10.1097/fbp.0000000000000662", "pubmed_id": "35007231", "openalex_id": "https://openalex.org/W4200050959", "source_url": "https://doi.org/10.1097/fbp.0000000000000662", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "PMID:35007231", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000662", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:35007231", "source_url": "https://doi.org/10.1097/fbp.0000000000000662", "doi": "10.1097/fbp.0000000000000662", "pmid": "35007231", "publication_date": "2021-12-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5037, "title": "P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status", "authors": "Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Max Wolff, Andreas Ströhle, Stefan Wellek, Gerhard Gründer", "journal": "European Neuropsychopharmacology", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.394", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200326768", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.394", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.394", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.394", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.394", "doi": "10.1016/j.euroneuro.2021.10.394", "pmid": "", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5033, "title": "P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music", "authors": "Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris", "journal": "European Neuropsychopharmacology", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.741", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200025628", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.741", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.741", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.741", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.741", "doi": "10.1016/j.euroneuro.2021.10.741", "pmid": "", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5032, "title": "P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review", "authors": "Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo, M. Magalhães, L. Moreno, N. Ribeiro, Inês Fonseca, Ana Margarida Romão Franco, Luís Madruga, A. Gamito", "journal": "European Neuropsychopharmacology", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.797", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200007802", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.797", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.797", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.797", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.797", "doi": "10.1016/j.euroneuro.2021.10.797", "pmid": "", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1880, "title": "Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.", "authors": "Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1177/0004867421998785", "pubmed_id": "33745287", "openalex_id": "https://openalex.org/W3134642859", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33745287/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:33745287", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33745287/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33745287", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33745287/", "doi": "10.1177/0004867421998785", "pmid": "33745287", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1876, "title": "Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?", "authors": "Gibbons WJ, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA", "journal": "Bioengineered", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1080/21655979.2021.1987090", "pubmed_id": "34607532", "openalex_id": "https://openalex.org/W3203128580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34607532/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34607532", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34607532/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34607532", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34607532/", "doi": "10.1080/21655979.2021.1987090", "pmid": "34607532", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1875, "title": "Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.", "authors": "Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A", "journal": "BMJ open", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1136/bmjopen-2021-056091", "pubmed_id": "34853114", "openalex_id": "https://openalex.org/W3215511316", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34853114/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34853114", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34853114/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34853114", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34853114/", "doi": "10.1136/bmjopen-2021-056091", "pmid": "34853114", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5041, "title": "Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.11.29", "pubmed_id": null, "openalex_id": "https://openalex.org/W3216860842", "source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.11.29", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.11.29", "source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "doi": "10.1176/appi.pn.2021.11.29", "pmid": "", "publication_date": "2021-11-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5045, "title": "Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea", "authors": "David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman", "journal": "Psychiatric News", "publication_date": "2021-11-29", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.12.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3216344082", "source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.12.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.12.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "doi": "10.1176/appi.pn.2021.12.14", "pmid": "", "publication_date": "2021-11-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1885, "title": "Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.", "authors": "Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Polito V, Bourzat F, Walsh Z", "journal": "Scientific reports", "publication_date": "2021-11-18", "publication_year": 2021, "doi": "10.1038/s41598-021-01811-4", "pubmed_id": "34795334", "openalex_id": "https://openalex.org/W3211842562", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34795334/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34795334", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34795334/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34795334", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34795334/", "doi": "10.1038/s41598-021-01811-4", "pmid": "34795334", "publication_date": "2021-11-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1887, "title": "Daily briefing: Largest trial shows psilocybin is effective to treat depression.", "authors": "Graham F", "journal": "Nature", "publication_date": "2021-11-10", "publication_year": 2021, "doi": "10.1038/d41586-021-03413-6", "pubmed_id": "34764467", "openalex_id": "https://openalex.org/W4200395175", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34764467/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34764467", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34764467", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34764467/", "doi": "10.1038/d41586-021-03413-6", "pmid": "34764467", "publication_date": "2021-11-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5824, "title": "Psychedelics and their therapeutic effects", "authors": "Karim Ashraf ElAgamy", "journal": "University of Debrecen Electronic Archive", "publication_date": "2021-11-09", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7199239574", "source_url": "http://hdl.handle.net/2437/336821", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:44", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "http://hdl.handle.net/2437/336821", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/2437/336821", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/2437/336821", "source_url": "http://hdl.handle.net/2437/336821", "doi": "", "pmid": "", "publication_date": "2021-11-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1888, "title": "Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.", "authors": "Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS", "journal": "Translational psychiatry", "publication_date": "2021-11-08", "publication_year": 2021, "doi": "10.1038/s41398-021-01706-y", "pubmed_id": "34750350", "openalex_id": "https://openalex.org/W3213458191", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34750350/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34750350", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34750350/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34750350", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34750350/", "doi": "10.1038/s41398-021-01706-y", "pmid": "34750350", "publication_date": "2021-11-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1890, "title": "Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.", "authors": "Aleksandrova LR, Phillips AG", "journal": "Trends in pharmacological sciences", "publication_date": "2021-11-01", "publication_year": 2021, "doi": "10.1016/j.tips.2021.08.003", "pubmed_id": "34565579", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34565579/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34565579", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34565579/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34565579", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34565579/", "doi": "10.1016/j.tips.2021.08.003", "pmid": "34565579", "publication_date": "2021-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5052, "title": "Finding the divine within: exploring the role of the sacred in psychedelic integration therapy for sexual trauma and dysfunction", "authors": "Dee Dee Goldpaugh", "journal": "Sexual & Relationship Therapy", "publication_date": "2021-10-20", "publication_year": 2021, "doi": "10.1080/14681994.2021.1994138", "pubmed_id": null, "openalex_id": "https://openalex.org/W3214272829", "source_url": "https://doi.org/10.1080/14681994.2021.1994138", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Wellbeing", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1080/14681994.2021.1994138", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/14681994.2021.1994138", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/14681994.2021.1994138", "source_url": "https://doi.org/10.1080/14681994.2021.1994138", "doi": "10.1080/14681994.2021.1994138", "pmid": "", "publication_date": "2021-10-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3459, "title": "The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder", "authors": "Maryland Oncology Hematology, PA", "journal": "ClinicalTrials.gov", "publication_date": "2021-10-15", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04593563", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04593563", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "source_url": "https://clinicaltrials.gov/study/NCT04593563", "doi": "", "pmid": "", "publication_date": "2021-10-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5054, "title": "Delix to synthesize psychedelic drugs", "authors": "Ryan Cross", "journal": "C&EN Global Enterprise", "publication_date": "2021-10-03", "publication_year": 2021, "doi": "10.1021/cen-09936-buscon3", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367158646", "source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09936-buscon3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09936-buscon3", "source_url": "http://dx.doi.org/10.1021/cen-09936-buscon3", "doi": "10.1021/cen-09936-buscon3", "pmid": "", "publication_date": "2021-10-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1901, "title": "Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.", "authors": "Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT", "journal": "Experimental and clinical psychopharmacology", "publication_date": "2021-10-01", "publication_year": 2021, "doi": "10.1037/pha0000490", "pubmed_id": "34096755", "openalex_id": "https://openalex.org/W3171546624", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34096755/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34096755", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34096755/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34096755", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34096755/", "doi": "10.1037/pha0000490", "pmid": "34096755", "publication_date": "2021-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1904, "title": "Rediscovering Psilocybin as an Antidepressive Treatment Strategy.", "authors": "Zeiss R, Gahr M, Graf H", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2021-09-28", "publication_year": 2021, "doi": "10.3390/ph14100985", "pubmed_id": "34681209", "openalex_id": "https://openalex.org/W3204600425", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34681209/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34681209", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34681209/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34681209", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34681209/", "doi": "10.3390/ph14100985", "pmid": "34681209", "publication_date": "2021-09-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5059, "title": "Psilocybin: Next to treat depression, OCD and nicotine addiction", "authors": "Alison Knopf", "journal": "Alcoholism & Drug Abuse Weekly", "publication_date": "2021-09-24", "publication_year": 2021, "doi": "10.1002/adaw.33204", "pubmed_id": null, "openalex_id": "https://openalex.org/W3202550363", "source_url": "https://doi.org/10.1002/adaw.33204", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1002/adaw.33204", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/adaw.33204", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/adaw.33204", "source_url": "https://doi.org/10.1002/adaw.33204", "doi": "10.1002/adaw.33204", "pmid": "", "publication_date": "2021-09-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5061, "title": "New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances", "authors": "Matthias Forstmann, Christina Sagioglou", "journal": "European Psychologist", "publication_date": "2021-09-17", "publication_year": 2021, "doi": "10.1027/1016-9040/a000447", "pubmed_id": null, "openalex_id": "https://openalex.org/W3161737512", "source_url": "https://doi.org/10.1027/1016-9040/a000447", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Wellbeing,Personality Change,Creativity,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1027/1016-9040/a000447", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1027/1016-9040/a000447", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1027/1016-9040/a000447", "source_url": "https://doi.org/10.1027/1016-9040/a000447", "doi": "10.1027/1016-9040/a000447", "pmid": "", "publication_date": "2021-09-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5064, "title": "The therapeutical role of psychedelic drugs in treatment of mental disorders", "authors": "Dan Cătălin Oprea, Loretta Epure, Vasile Chiriță, Adrian Cantemir", "journal": "Bulletin of Integrative Psychiatry", "publication_date": "2021-09-15", "publication_year": 2021, "doi": "10.36219/bpi.2021.3.09", "pubmed_id": null, "openalex_id": "https://openalex.org/W3202248738", "source_url": "https://doi.org/10.36219/bpi.2021.3.09", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Receptor Pharmacology,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.36219/bpi.2021.3.09", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36219/bpi.2021.3.09", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36219/bpi.2021.3.09", "source_url": "https://doi.org/10.36219/bpi.2021.3.09", "doi": "10.36219/bpi.2021.3.09", "pmid": "", "publication_date": "2021-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5063, "title": "Is MDD the right target for early-stage psychedelic-assisted therapy trials?", "authors": "Benjamin R. Lewis, Kevin Byrne", "journal": "Journal of Psychedelic Studies", "publication_date": "2021-09-15", "publication_year": 2021, "doi": "10.1556/2054.2021.00180", "pubmed_id": null, "openalex_id": "https://openalex.org/W3199274122", "source_url": "https://doi.org/10.1556/2054.2021.00180", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2021.00180", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2021.00180", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2021.00180", "source_url": "https://doi.org/10.1556/2054.2021.00180", "doi": "10.1556/2054.2021.00180", "pmid": "", "publication_date": "2021-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5065, "title": "New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy", "authors": "Tehseen Noorani, Jonny Martell", "journal": "Frontiers in Psychiatry", "publication_date": "2021-09-10", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.727050", "pubmed_id": "34566724", "openalex_id": "https://openalex.org/W3201103091", "source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "PMID:34566724", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34566724", "source_url": "https://doi.org/10.3389/fpsyt.2021.727050", "doi": "10.3389/fpsyt.2021.727050", "pmid": "34566724", "publication_date": "2021-09-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5066, "title": "Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?", "authors": "Gonçalo Cotovio, Ana Maia, Ana Velosa, Carolina Seybert, Albino J. Oliveira-Maia", "journal": "Revista Portuguesa de Psiquiatria e Saúde Mental", "publication_date": "2021-09-08", "publication_year": 2021, "doi": "10.51338/rppsm.2021.v7.i3.241", "pubmed_id": null, "openalex_id": "https://openalex.org/W3200752577", "source_url": "https://doi.org/10.51338/rppsm.2021.v7.i3.241", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.51338/rppsm.2021.v7.i3.241", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.51338/rppsm.2021.v7.i3.241", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.51338/rppsm.2021.v7.i3.241", "source_url": "https://doi.org/10.51338/rppsm.2021.v7.i3.241", "doi": "10.51338/rppsm.2021.v7.i3.241", "pmid": "", "publication_date": "2021-09-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1914, "title": "Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.", "authors": "Magaraggia I, Kuiperes Z, Schreiber R", "journal": "Neurobiology of learning and memory", "publication_date": "2021-09-01", "publication_year": 2021, "doi": "10.1016/j.nlm.2021.107467", "pubmed_id": "34048913", "openalex_id": "https://openalex.org/W3165684389", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34048913/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Resilience,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34048913", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34048913/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34048913", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34048913/", "doi": "10.1016/j.nlm.2021.107467", "pmid": "34048913", "publication_date": "2021-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1911, "title": "Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.", "authors": "Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR", "journal": "Pharmacopsychiatry", "publication_date": "2021-09-01", "publication_year": 2021, "doi": "10.1055/a-1524-2794", "pubmed_id": "34348413", "openalex_id": "https://openalex.org/W3160183306", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34348413/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34348413", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34348413/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34348413", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34348413/", "doi": "10.1055/a-1524-2794", "pmid": "34348413", "publication_date": "2021-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1910, "title": "Treatment-Resistant Depression: Approaches to Treatment.", "authors": "Kverno KS, Mangano E", "journal": "Journal of psychosocial nursing and mental health services", "publication_date": "2021-09-01", "publication_year": 2021, "doi": "10.3928/02793695-20210816-01", "pubmed_id": "34459676", "openalex_id": "https://openalex.org/W3196802696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34459676/", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34459676", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34459676/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34459676", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34459676/", "doi": "10.3928/02793695-20210816-01", "pmid": "34459676", "publication_date": "2021-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1919, "title": "Psilocybin for Depression.", "authors": "Wiley JF, Bei B", "journal": "The New England journal of medicine", "publication_date": "2021-08-26", "publication_year": 2021, "doi": "10.1056/nejmc2108082", "pubmed_id": "34437794", "openalex_id": "https://openalex.org/W3193440797", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34437794/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34437794", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34437794", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34437794/", "doi": "10.1056/nejmc2108082", "pmid": "34437794", "publication_date": "2021-08-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5069, "title": "Beckley raises funds for psychedelic drugs", "authors": "Ryan Cross", "journal": "C&EN Global Enterprise", "publication_date": "2021-08-22", "publication_year": 2021, "doi": "10.1021/cen-09930-buscon17", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367017439", "source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09930-buscon17", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09930-buscon17", "source_url": "http://dx.doi.org/10.1021/cen-09930-buscon17", "doi": "10.1021/cen-09930-buscon17", "pmid": "", "publication_date": "2021-08-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5070, "title": "Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review", "authors": "Frederico Marques Silveira, Amanda Pereira Mendes, Mayara Rodrigues dos Santos, Júlia Ramos Cerchi, IRIS TIYONO TAVARES UMEDA, Breno Basílio de Melo, Luiza Elena Casaburi, Mateus Nóbrega Oliveira, Douglas Reis Abdalla", "journal": "Research Society and Development", "publication_date": "2021-08-19", "publication_year": 2021, "doi": "10.33448/rsd-v10i10.19297", "pubmed_id": null, "openalex_id": "https://openalex.org/W3194848852", "source_url": "https://doi.org/10.33448/rsd-v10i10.19297", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Observational Study,Cancer Patients", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.33448/rsd-v10i10.19297", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.33448/rsd-v10i10.19297", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.33448/rsd-v10i10.19297", "source_url": "https://doi.org/10.33448/rsd-v10i10.19297", "doi": "10.33448/rsd-v10i10.19297", "pmid": "", "publication_date": "2021-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3371, "title": "Psychedelics and psychiatric disorders: A emerging role", "authors": "Peixoto C, Santos F, Rego D, Medeiros H.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2021-08-13", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9470409", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9470409", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9470409", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9470409", "source_url": "https://europepmc.org/article/PMC/PMC9470409", "doi": "", "pmid": "", "publication_date": "2021-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3339, "title": "Psychedelics: A new era of treatment?", "authors": "Torres S.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2021-08-13", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9475866", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Consciousness,Emotional Processing,Randomized Controlled Trial,Review Article,Cancer Patients,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:25", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9475866", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9475866", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9475866", "source_url": "https://europepmc.org/article/PMC/PMC9475866", "doi": "", "pmid": "", "publication_date": "2021-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3211, "title": "Effects of psilocybin-assisted therapy on treatment-resistant depression", "authors": "Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2021-08-13", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9480034", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:11", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9480034", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9480034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9480034", "source_url": "https://europepmc.org/article/PMC/PMC9480034", "doi": "", "pmid": "", "publication_date": "2021-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3156, "title": "Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?", "authors": "Descalço N, Medeiros A, Santos C, Borges G.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2021-08-13", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9476072", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,OCD,Receptor Pharmacology,Aging,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9476072", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9476072", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9476072", "source_url": "https://europepmc.org/article/PMC/PMC9476072", "doi": "", "pmid": "", "publication_date": "2021-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5071, "title": "What can we learn from the history of research on psychedelic drugs in the addictions?", "authors": "Wayne Hall, Michael Farrell", "journal": "Addiction", "publication_date": "2021-08-12", "publication_year": 2021, "doi": "10.1111/add.15560", "pubmed_id": "34382252", "openalex_id": "https://openalex.org/W3187445852", "source_url": "https://doi.org/10.1111/add.15560", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Healthcare Workers,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "PMID:34382252", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.15560", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34382252", "source_url": "https://doi.org/10.1111/add.15560", "doi": "10.1111/add.15560", "pmid": "34382252", "publication_date": "2021-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2132, "title": "Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.", "authors": "Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2021-08-12", "publication_year": 2021, "doi": "10.3390/ph14080793", "pubmed_id": "34451890", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34451890/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34451890", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34451890/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34451890", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34451890/", "doi": "10.3390/ph14080793", "pmid": "34451890", "publication_date": "2021-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5072, "title": "Mit Psilocybin gegen Depression", "authors": "Markus Weih", "journal": "InFo Neurologie + Psychiatrie", "publication_date": "2021-08-01", "publication_year": 2021, "doi": "10.1007/s15005-021-2012-7", "pubmed_id": null, "openalex_id": "https://openalex.org/W3194236679", "source_url": "https://doi.org/10.1007/s15005-021-2012-7", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1007/s15005-021-2012-7", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s15005-021-2012-7", "source_url": "https://doi.org/10.1007/s15005-021-2012-7", "doi": "10.1007/s15005-021-2012-7", "pmid": "", "publication_date": "2021-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2138, "title": "[Efficacy of psychedelics in psychiatry, a systematic review of the literature].", "authors": "Berkovitch L, Roméo B, Karila L, Gaillard R, Benyamina A", "journal": "L'Encephale", "publication_date": "2021-08-01", "publication_year": 2021, "doi": "10.1016/j.encep.2020.12.002", "pubmed_id": "33888297", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33888297/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Personality Change,Emotional Processing,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33888297", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33888297/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33888297", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33888297/", "doi": "10.1016/j.encep.2020.12.002", "pmid": "33888297", "publication_date": "2021-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2139, "title": "The Potential Role of Serotonergic Hallucinogens in Depression Treatment.", "authors": "Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M", "journal": "Life (Basel, Switzerland)", "publication_date": "2021-07-29", "publication_year": 2021, "doi": "10.3390/life11080765", "pubmed_id": "34440508", "openalex_id": "https://openalex.org/W3193251618", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34440508/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34440508", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34440508/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34440508", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34440508/", "doi": "10.3390/life11080765", "pmid": "34440508", "publication_date": "2021-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2140, "title": "Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.", "authors": "Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K", "journal": "Cells", "publication_date": "2021-07-27", "publication_year": 2021, "doi": "10.3390/cells10081902", "pubmed_id": "34440670", "openalex_id": "https://openalex.org/W3184995356", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34440670/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34440670", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34440670/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34440670", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34440670/", "doi": "10.3390/cells10081902", "pmid": "34440670", "publication_date": "2021-07-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5075, "title": "Psychedelic Therapy Hits Another Milestone, But Caution Urged", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2021-07-22", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.7.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3193219878", "source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Review Article,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.7.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.7.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "doi": "10.1176/appi.pn.2021.7.14", "pmid": "", "publication_date": "2021-07-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3481, "title": "A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2021-07-22", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04959253", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04959253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "source_url": "https://clinicaltrials.gov/study/NCT04959253", "doi": "", "pmid": "", "publication_date": "2021-07-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3769, "title": "Psilocybin for Depression: The ACE Model Manual", "authors": "Watts R.", "journal": "PsyArXiv", "publication_date": "2021-07-05", "publication_year": 2021, "doi": "10.31234/osf.io/5x2bu", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/5x2bu", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-08-09 08:15:11", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/5x2bu", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/5x2bu", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/5x2bu", "source_url": "https://doi.org/10.31234/osf.io/5x2bu", "doi": "10.31234/osf.io/5x2bu", "pmid": "", "publication_date": "2021-07-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3214, "title": "Psilocybin for Depression: The ACE Model Manual", "authors": "Marta Kaczmarczyk, Rosalind Watts", "journal": "PsyArXiv", "publication_date": "2021-07-05", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "source_url": "https://osf.io/preprints/psyarxiv/5x2bu_v1", "doi": "", "pmid": "", "publication_date": "2021-07-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2148, "title": "Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.", "authors": "Mertens LJ, Preller KH", "journal": "Pharmacopsychiatry", "publication_date": "2021-07-01", "publication_year": 2021, "doi": "10.1055/a-1341-1907", "pubmed_id": "33472250", "openalex_id": "https://openalex.org/W3124059976", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33472250/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33472250", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33472250/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33472250", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33472250/", "doi": "10.1055/a-1341-1907", "pmid": "33472250", "publication_date": "2021-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2147, "title": "Cannabis-induced oceanic boundlessness.", "authors": "Earleywine M, Ueno LF, Mian MN, Altman BR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2021-07-01", "publication_year": 2021, "doi": "10.1177/0269881121997099", "pubmed_id": "33779383", "openalex_id": "https://openalex.org/W3151652679", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33779383/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Mystical Experience,Clinical Trial,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33779383", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33779383/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33779383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33779383/", "doi": "10.1177/0269881121997099", "pmid": "33779383", "publication_date": "2021-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2145, "title": "Registered clinical studies investigating psychedelic drugs for psychiatric disorders.", "authors": "Siegel AN, Meshkat S, Benitah K, Lipsitz O, Gill H, Lui LMW, Teopiz KM, McIntyre RS, Rosenblat JD", "journal": "Journal of psychiatric research", "publication_date": "2021-07-01", "publication_year": 2021, "doi": "10.1016/j.jpsychires.2021.05.019", "pubmed_id": "34048997", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34048997/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Consciousness", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34048997", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34048997/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34048997", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34048997/", "doi": "10.1016/j.jpsychires.2021.05.019", "pmid": "34048997", "publication_date": "2021-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3232, "title": "Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?", "authors": "Coppola M, Bevione F, Mondola R.", "journal": "Preprints.org", "publication_date": "2021-06-28", "publication_year": 2021, "doi": "10.20944/preprints202106.0682.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202106.0682.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:13", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202106.0682.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202106.0682.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202106.0682.v1", "source_url": "https://doi.org/10.20944/preprints202106.0682.v1", "doi": "10.20944/preprints202106.0682.v1", "pmid": "", "publication_date": "2021-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3786, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "McCartney A, McGovern H, De Foe A.", "journal": "PsyArXiv", "publication_date": "2021-06-27", "publication_year": 2021, "doi": "10.31234/osf.io/9kuhs", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:25", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/9kuhs", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/9kuhs", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/9kuhs", "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "doi": "10.31234/osf.io/9kuhs", "pmid": "", "publication_date": "2021-06-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3336, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "Annie McCartney, Hugh McGovern, Alexander De Foe", "journal": "PsyArXiv", "publication_date": "2021-06-27", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "doi": "", "pmid": "", "publication_date": "2021-06-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5080, "title": "Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa", "authors": "Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire", "journal": "OBM Neurobiology", "publication_date": "2021-06-24", "publication_year": 2021, "doi": "10.21926/obm.neurobiol.2102102", "pubmed_id": null, "openalex_id": "https://openalex.org/W3174884462", "source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Receptor Pharmacology,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.21926/obm.neurobiol.2102102", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21926/obm.neurobiol.2102102", "source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "doi": "10.21926/obm.neurobiol.2102102", "pmid": "", "publication_date": "2021-06-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3208, "title": "Psilocybin: the magic medicine for depression?", "authors": "Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L.", "journal": "BJPsych open", "publication_date": "2021-06-18", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC8770735", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Personality Change,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:11", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC8770735", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC8770735", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC8770735", "source_url": "https://europepmc.org/article/PMC/PMC8770735", "doi": "", "pmid": "", "publication_date": "2021-06-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5087, "title": "Psilocybin: the magic medicine for depression?", "authors": "Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft", "journal": "BJPsych Open", "publication_date": "2021-06-01", "publication_year": 2021, "doi": "10.1192/bjo.2021.456", "pubmed_id": null, "openalex_id": "https://openalex.org/W3173209673", "source_url": "https://doi.org/10.1192/bjo.2021.456", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Personality Change,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1192/bjo.2021.456", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2021.456", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/bjo.2021.456", "source_url": "https://doi.org/10.1192/bjo.2021.456", "doi": "10.1192/bjo.2021.456", "pmid": "", "publication_date": "2021-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3385, "title": "Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders", "authors": "Chao YS, Horton J.", "journal": "Canadian Agency for Drugs and Technologies in Health, Ottawa (ON)", "publication_date": "2021-06-01", "publication_year": 2021, "doi": null, "pubmed_id": "36170470", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36170470", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:31", "bibtex": null, "source_record_id": "PMID:36170470", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36170470", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36170470", "source_url": "https://europepmc.org/article/MED/36170470", "doi": "", "pmid": "36170470", "publication_date": "2021-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2151, "title": "Psychedelic science in post-COVID-19 psychiatry.", "authors": "Kelly JR, Crockett MT, Alexander L, Haran M, Baker A, Burke L, Brennan C, O'Keane V", "journal": "Irish journal of psychological medicine", "publication_date": "2021-06-01", "publication_year": 2021, "doi": "10.1017/ipm.2020.94", "pubmed_id": "32811575", "openalex_id": "https://openalex.org/W3054886531", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32811575/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:32811575", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32811575/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32811575", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32811575/", "doi": "10.1017/ipm.2020.94", "pmid": "32811575", "publication_date": "2021-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3230, "title": "Decreased brain modularity after psilocybin therapy for depression.", "authors": "Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R.", "journal": "Research Square", "publication_date": "2021-05-20", "publication_year": 2021, "doi": "10.21203/rs.3.rs-513323/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:13", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-513323/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-513323/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-513323/v1", "doi": "10.21203/rs.3.rs-513323/v1", "pmid": "", "publication_date": "2021-05-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3420, "title": "Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network", "authors": "Evan Lewis-Healey, Ruben Eero Laukkonen, Michiel van Elk", "journal": "PsyArXiv", "publication_date": "2021-05-19", "publication_year": 2021, "doi": "10.1037/pne0000290", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281568156", "source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:04:24", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1037/pne0000290", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1037/pne0000290", "source_url": "https://osf.io/preprints/psyarxiv/q3ymd_v1", "doi": "10.1037/pne0000290", "pmid": "", "publication_date": "2021-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3247, "title": "Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network", "authors": "Lewis-Healey E, Laukkonen RE, van Elk M.", "journal": "PsyArXiv", "publication_date": "2021-05-19", "publication_year": 2021, "doi": "10.31234/osf.io/q3ymd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/q3ymd", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:14", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/q3ymd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/q3ymd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/q3ymd", "source_url": "https://doi.org/10.31234/osf.io/q3ymd", "doi": "10.31234/osf.io/q3ymd", "pmid": "", "publication_date": "2021-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5091, "title": "The need for publicly funded research on therapeutic use of psychedelic drugs", "authors": "Wayne Hall", "journal": "World Psychiatry", "publication_date": "2021-05-18", "publication_year": 2021, "doi": "10.1002/wps.20847", "pubmed_id": "34002493", "openalex_id": "https://openalex.org/W3162774823", "source_url": "https://doi.org/10.1002/wps.20847", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "PMID:34002493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20847", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34002493", "source_url": "https://doi.org/10.1002/wps.20847", "doi": "10.1002/wps.20847", "pmid": "34002493", "publication_date": "2021-05-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2152, "title": "The Therapeutic Potential of Psilocybin.", "authors": "Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L", "journal": "Molecules (Basel, Switzerland)", "publication_date": "2021-05-15", "publication_year": 2021, "doi": "10.3390/molecules26102948", "pubmed_id": "34063505", "openalex_id": "https://openalex.org/W3161556967", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34063505/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Spirituality,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34063505", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34063505/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34063505", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34063505/", "doi": "10.3390/molecules26102948", "pmid": "34063505", "publication_date": "2021-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3805, "title": "New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review", "authors": "Forstmann M, Sagioglou C.", "journal": "PsyArXiv", "publication_date": "2021-05-05", "publication_year": 2021, "doi": "10.31234/osf.io/2489x", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/2489x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Wellbeing,Personality Change,Creativity,Review Article", "study_type": "Review Article", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-08-09 08:15:31", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/2489x", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/2489x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/2489x", "source_url": "https://doi.org/10.31234/osf.io/2489x", "doi": "10.31234/osf.io/2489x", "pmid": "", "publication_date": "2021-05-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3393, "title": "New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review", "authors": "Matthias Forstmann, Christina Sagioglou", "journal": "PsyArXiv", "publication_date": "2021-05-05", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/2489x_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Wellbeing,Personality Change,Creativity,Review Article", "study_type": "Review Article", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/2489x_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/2489x_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/2489x_v1", "source_url": "https://osf.io/preprints/psyarxiv/2489x_v1", "doi": "", "pmid": "", "publication_date": "2021-05-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5093, "title": "A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review", "authors": "Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa, Maria Carolaine Souza da Silva, Rafaela da Conceição de Lemos, Elisângela Marcionilo Da Conceição, Joyce Kelly Soares da Silva, Carlos Alberto Tiburcio Valeriano, David Filipe de Santana", "journal": "Brazilian Journal of Health Review", "publication_date": "2021-05-03", "publication_year": 2021, "doi": "10.34119/bjhrv4n3-012", "pubmed_id": null, "openalex_id": "https://openalex.org/W3164004836", "source_url": "https://doi.org/10.34119/bjhrv4n3-012", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.34119/bjhrv4n3-012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.34119/bjhrv4n3-012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34119/bjhrv4n3-012", "source_url": "https://doi.org/10.34119/bjhrv4n3-012", "doi": "10.34119/bjhrv4n3-012", "pmid": "", "publication_date": "2021-05-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2160, "title": "Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.", "authors": "Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR", "journal": "JAMA psychiatry", "publication_date": "2021-05-01", "publication_year": 2021, "doi": "10.1001/jamapsychiatry.2020.3285", "pubmed_id": "33146667", "openalex_id": "https://openalex.org/W3096208965", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33146667/", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33146667", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33146667/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33146667", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33146667/", "doi": "10.1001/jamapsychiatry.2020.3285", "pmid": "33146667", "publication_date": "2021-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2159, "title": "Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression-Quo Vadis?", "authors": "Reynolds CF", "journal": "JAMA psychiatry", "publication_date": "2021-05-01", "publication_year": 2021, "doi": "10.1001/jamapsychiatry.2020.2901", "pubmed_id": "33146675", "openalex_id": "https://openalex.org/W3094637780", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33146675/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33146675", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33146675", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33146675/", "doi": "10.1001/jamapsychiatry.2020.2901", "pmid": "33146675", "publication_date": "2021-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2158, "title": "Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.", "authors": "Davis AK, Griffiths RR", "journal": "JAMA psychiatry", "publication_date": "2021-05-01", "publication_year": 2021, "doi": "10.1001/jamapsychiatry.2020.4638", "pubmed_id": "33566073", "openalex_id": "https://openalex.org/W3128054002", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33566073/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33566073", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33566073", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33566073/", "doi": "10.1001/jamapsychiatry.2020.4638", "pmid": "33566073", "publication_date": "2021-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2157, "title": "Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.", "authors": "Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A", "journal": "Journal of psychiatric research", "publication_date": "2021-05-01", "publication_year": 2021, "doi": "10.1016/j.jpsychires.2021.03.002", "pubmed_id": "33730602", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33730602/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Receptor Pharmacology,Default Mode Network,Systematic Review,Review Article,Treatment-Resistant Depression,Inflammation", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33730602", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33730602/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33730602", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33730602/", "doi": "10.1016/j.jpsychires.2021.03.002", "pmid": "33730602", "publication_date": "2021-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2154, "title": "Psilocybin and MDMA for the treatment of trauma-related psychopathology.", "authors": "Bird CIV, Modlin NL, Rucker JJH", "journal": "International review of psychiatry (Abingdon, England)", "publication_date": "2021-05-01", "publication_year": 2021, "doi": "10.1080/09540261.2021.1919062", "pubmed_id": "34121583", "openalex_id": "https://openalex.org/W3169261903", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34121583/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34121583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34121583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34121583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34121583/", "doi": "10.1080/09540261.2021.1919062", "pmid": "34121583", "publication_date": "2021-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3487, "title": "Characterization of Altered Waking States of Consciousness in Healthy Humans", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2021-04-29", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03853577", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03853577", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03853577", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03853577", "source_url": "https://clinicaltrials.gov/study/NCT03853577", "doi": "", "pmid": "", "publication_date": "2021-04-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5100, "title": "Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing", "authors": "Katrin H. Preller", "journal": "Biological Psychiatry", "publication_date": "2021-04-27", "publication_year": 2021, "doi": "10.1016/j.biopsych.2021.02.036", "pubmed_id": null, "openalex_id": "https://openalex.org/W3159723459", "source_url": "https://doi.org/10.1016/j.biopsych.2021.02.036", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2021.02.036", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2021.02.036", "source_url": "https://doi.org/10.1016/j.biopsych.2021.02.036", "doi": "10.1016/j.biopsych.2021.02.036", "pmid": "", "publication_date": "2021-04-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5098, "title": "Effectiveness of Psilocybin on Depression: A Qualitative Study", "authors": "Hisham Alshaikhli, Redhwan Ahmed Al-Naggar, Gwen Erlam", "journal": "Electronic Journal of General Medicine", "publication_date": "2021-04-27", "publication_year": 2021, "doi": "10.29333/ejgm/10862", "pubmed_id": null, "openalex_id": "https://openalex.org/W3157692430", "source_url": "https://doi.org/10.29333/ejgm/10862", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Emotional Processing,Spirituality", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.29333/ejgm/10862", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29333/ejgm/10862", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29333/ejgm/10862", "source_url": "https://doi.org/10.29333/ejgm/10862", "doi": "10.29333/ejgm/10862", "pmid": "", "publication_date": "2021-04-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2161, "title": "Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.", "authors": "Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM", "journal": "Proceedings of the National Academy of Sciences of the United States of America", "publication_date": "2021-04-27", "publication_year": 2021, "doi": "10.1073/pnas.2022489118", "pubmed_id": "33850049", "openalex_id": "https://openalex.org/W3155245221", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33850049/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Consciousness,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33850049", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33850049/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33850049", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33850049/", "doi": "10.1073/pnas.2022489118", "pmid": "33850049", "publication_date": "2021-04-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5101, "title": "Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of Treatment", "authors": "Andrew Penn, Janis Phelps, William E. Rosa, Jean Watson", "journal": "Journal of Humanistic Psychology", "publication_date": "2021-04-23", "publication_year": 2021, "doi": "10.1177/00221678211011013", "pubmed_id": null, "openalex_id": "https://openalex.org/W3159796563", "source_url": "https://doi.org/10.1177/00221678211011013", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Spirituality", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1177/00221678211011013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678211011013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678211011013", "source_url": "https://doi.org/10.1177/00221678211011013", "doi": "10.1177/00221678211011013", "pmid": "", "publication_date": "2021-04-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5104, "title": "O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depression", "authors": "Giovanni Pereira Pio, Aline Moreira Vitorino, Naira Braga Aidar, Alissa Amoras Magalhães, Eduardo Cammerer Mombelli, Gabriela Marques Ferraz, Rodrigo Pereira Pio", "journal": "Brazilian Journal of Health Review", "publication_date": "2021-04-19", "publication_year": 2021, "doi": "10.34119/bjhrv4n2-395", "pubmed_id": null, "openalex_id": "https://openalex.org/W3164048627", "source_url": "https://doi.org/10.34119/bjhrv4n2-395", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.34119/bjhrv4n2-395", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.34119/bjhrv4n2-395", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34119/bjhrv4n2-395", "source_url": "https://doi.org/10.34119/bjhrv4n2-395", "doi": "10.34119/bjhrv4n2-395", "pmid": "", "publication_date": "2021-04-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2165, "title": "Trial of Psilocybin versus Escitalopram for Depression.", "authors": "Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ", "journal": "The New England journal of medicine", "publication_date": "2021-04-15", "publication_year": 2021, "doi": "10.1056/nejmoa2032994", "pubmed_id": "33852780", "openalex_id": "https://openalex.org/W3156937150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33852780/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33852780", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33852780/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33852780", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33852780/", "doi": "10.1056/nejmoa2032994", "pmid": "33852780", "publication_date": "2021-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2170, "title": "Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience.", "authors": "Stauffer CS, Anderson BT, Ortigo KM, Woolley J", "journal": "ACS pharmacology & translational science", "publication_date": "2021-04-09", "publication_year": 2021, "doi": "10.1021/acsptsci.0c00169", "pubmed_id": "33860182", "openalex_id": "https://openalex.org/W3112557491", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860182/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mystical Experience,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33860182", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33860182/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33860182", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860182/", "doi": "10.1021/acsptsci.0c00169", "pmid": "33860182", "publication_date": "2021-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2168, "title": "Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.", "authors": "Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE", "journal": "ACS pharmacology & translational science", "publication_date": "2021-04-09", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00020", "pubmed_id": "33860185", "openalex_id": "https://openalex.org/W3138429576", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860185/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33860185", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33860185/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33860185", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860185/", "doi": "10.1021/acsptsci.1c00020", "pmid": "33860185", "publication_date": "2021-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2167, "title": "Ethical Concerns about Psilocybin Intellectual Property.", "authors": "Gerber K, Flores IG, Ruiz AC, Ali I, Ginsberg NL, Schenberg EE", "journal": "ACS pharmacology & translational science", "publication_date": "2021-04-09", "publication_year": 2021, "doi": "10.1021/acsptsci.0c00171", "pubmed_id": "33860186", "openalex_id": "https://openalex.org/W3114414169", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860186/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33860186", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33860186/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33860186", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860186/", "doi": "10.1021/acsptsci.0c00171", "pmid": "33860186", "publication_date": "2021-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3255, "title": "Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies", "authors": "Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD.", "journal": "medRxiv", "publication_date": "2021-04-07", "publication_year": 2021, "doi": "10.1101/2021.04.02.21254838", "pubmed_id": null, "openalex_id": "https://openalex.org/W3201512146", "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1101/2021.04.02.21254838", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.04.02.21254838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2021.04.02.21254838", "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "doi": "10.1101/2021.04.02.21254838", "pmid": "", "publication_date": "2021-04-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3800, "title": "Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)", "authors": "Dworatzyk K, Jansen T, Schmidt TT.", "journal": "PsyArXiv", "publication_date": "2021-04-02", "publication_year": 2021, "doi": "10.31234/osf.io/kxmgq", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/kxmgq", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-08-09 08:15:29", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/kxmgq", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/kxmgq", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/kxmgq", "source_url": "https://doi.org/10.31234/osf.io/kxmgq", "doi": "10.31234/osf.io/kxmgq", "pmid": "", "publication_date": "2021-04-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3378, "title": "Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)", "authors": "Katharina Dworatzyk, Tallulah Jansen, Timo Torsten Schmidt", "journal": "PsyArXiv", "publication_date": "2021-04-02", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "source_url": "https://osf.io/preprints/psyarxiv/kxmgq_v1", "doi": "", "pmid": "", "publication_date": "2021-04-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5113, "title": "Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?", "authors": "Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges", "journal": "European Psychiatry", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1192/j.eurpsy.2021.1114", "pubmed_id": null, "openalex_id": "https://openalex.org/W4212954018", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,OCD,Receptor Pharmacology,Aging,Clinical Trial,Systematic Review,Review Article,Case Report,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2021.1114", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2021.1114", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1114", "doi": "10.1192/j.eurpsy.2021.1114", "pmid": "", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5112, "title": "Effects of psilocybin-assisted therapy on treatment-resistant depression", "authors": "A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho", "journal": "European Psychiatry", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1192/j.eurpsy.2021.1836", "pubmed_id": null, "openalex_id": "https://openalex.org/W3212256162", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2021.1836", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2021.1836", "source_url": "https://doi.org/10.1192/j.eurpsy.2021.1836", "doi": "10.1192/j.eurpsy.2021.1836", "pmid": "", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2187, "title": "Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin.", "authors": "Jefsen OH, Elfving B, Wegener G, Müller HK", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1177/0269881120959614", "pubmed_id": "33143539", "openalex_id": "https://openalex.org/W3094714065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33143539/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Neuroplasticity,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33143539", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33143539/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33143539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33143539/", "doi": "10.1177/0269881120959614", "pmid": "33143539", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2186, "title": "[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?].", "authors": "Bottemanne H, Claret A, Fossati P", "journal": "L'Encephale", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1016/j.encep.2020.08.006", "pubmed_id": "33190819", "openalex_id": "https://openalex.org/W3102629752", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33190819/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Healthcare Workers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33190819", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33190819/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33190819", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33190819/", "doi": "10.1016/j.encep.2020.08.006", "pmid": "33190819", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2183, "title": "A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.", "authors": "Savalia NK, Shao LX, Kwan AC", "journal": "Trends in neurosciences", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1016/j.tins.2020.11.008", "pubmed_id": "33358035", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33358035/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33358035", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33358035/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33358035", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33358035/", "doi": "10.1016/j.tins.2020.11.008", "pmid": "33358035", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2179, "title": "Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.", "authors": "Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1177/0269881121991822", "pubmed_id": "33611977", "openalex_id": "https://openalex.org/W3129221857", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33611977/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33611977", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33611977/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33611977", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33611977/", "doi": "10.1177/0269881121991822", "pmid": "33611977", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2175, "title": "Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.", "authors": "Dos Santos RG, Hallak JE, Baker G, Dursun S", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1177/0269881120986422", "pubmed_id": "33740877", "openalex_id": "https://openalex.org/W3137933781", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33740877/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33740877", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33740877/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33740877", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33740877/", "doi": "10.1177/0269881120986422", "pmid": "33740877", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5115, "title": "The Return of Psychedelics: Still Time to Prevent Tragedy", "authors": "Stanley N. Caroff", "journal": "Psychiatric News", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.4.8", "pubmed_id": null, "openalex_id": "https://openalex.org/W3147930394", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Case Report,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "doi": "10.1176/appi.pn.2021.4.8", "pmid": "", "publication_date": "2021-03-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3799, "title": "Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)", "authors": "Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R.", "journal": "PsyArXiv", "publication_date": "2021-03-24", "publication_year": 2021, "doi": "10.31234/osf.io/8vks6", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/8vks6", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-08-09 08:15:29", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/8vks6", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/8vks6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/8vks6", "source_url": "https://doi.org/10.31234/osf.io/8vks6", "doi": "10.31234/osf.io/8vks6", "pmid": "", "publication_date": "2021-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3374, "title": "Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)", "authors": "Pedro Teixeira, Matthew Johnson, Christopher Timmermann, Rosalind Watts, David Erritzoe, Hannah Douglass, Hannes Kettner, Robin Carhart-Harris", "journal": "PsyArXiv", "publication_date": "2021-03-24", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/8vks6_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/8vks6_v1", "source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "doi": "", "pmid": "", "publication_date": "2021-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3212, "title": "The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype", "authors": "Kozłowska U, Klimczak A, Wiatr K, Figiel M.", "journal": "bioRxiv", "publication_date": "2021-03-08", "publication_year": 2021, "doi": "10.1101/2021.03.07.434103", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2021.03.07.434103", "substance_tags": "psilocin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Biomarkers,Treatment-Resistant Depression,Inflammation,Immune Function", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.1101/2021.03.07.434103", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.03.07.434103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2021.03.07.434103", "source_url": "https://doi.org/10.1101/2021.03.07.434103", "doi": "10.1101/2021.03.07.434103", "pmid": "", "publication_date": "2021-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5118, "title": "Stroke and Adverse Effects on The Immune and Cardiovascular Systems: The Danger of the Rise and Use of Psychedelic Drugs for Depression and PTSD", "authors": "Burton M. Altura, Bella T. Altura", "journal": "Journal of Clinical & Experimental Immunology", "publication_date": "2021-03-03", "publication_year": 2021, "doi": "10.33140/jcei.06.02.01", "pubmed_id": null, "openalex_id": "https://openalex.org/W4254506988", "source_url": "https://doi.org/10.33140/jcei.06.02.01", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Adolescents,Immune Function", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "DOI:10.33140/jcei.06.02.01", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.33140/jcei.06.02.01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.33140/jcei.06.02.01", "source_url": "https://doi.org/10.33140/jcei.06.02.01", "doi": "10.33140/jcei.06.02.01", "pmid": "", "publication_date": "2021-03-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5119, "title": "Session on Psychedelics Sure to Be Enlightening", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2021-03-01", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.3.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3133604748", "source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Consciousness,Wellbeing,Emotional Processing,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.3.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.3.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "doi": "10.1176/appi.pn.2021.3.14", "pmid": "", "publication_date": "2021-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3370, "title": "Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports", "authors": "Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR.", "journal": "PsyArXiv", "publication_date": "2021-02-24", "publication_year": 2021, "doi": "10.31234/osf.io/r726d", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/r726d", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/r726d", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/r726d", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/r726d", "source_url": "https://doi.org/10.31234/osf.io/r726d", "doi": "10.31234/osf.io/r726d", "pmid": "", "publication_date": "2021-02-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5827, "title": "Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2", "authors": "Avinash Hosanagar, Joseph Cusimano, Rajiv Radhakrishnan", "journal": "The Journal of Clinical Psychiatry", "publication_date": "2021-02-23", "publication_year": 2021, "doi": "10.4088/jcp.20ac13787", "pubmed_id": "33988930", "openalex_id": "https://openalex.org/W3135459718", "source_url": "https://doi.org/10.4088/jcp.20ac13787", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:46", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "PMID:33988930", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4088/jcp.20ac13787", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33988930", "source_url": "https://doi.org/10.4088/jcp.20ac13787", "doi": "10.4088/jcp.20ac13787", "pmid": "33988930", "publication_date": "2021-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5123, "title": "How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence", "authors": "Peter G. Brindley", "journal": "Anesthesia & Analgesia", "publication_date": "2021-02-17", "publication_year": 2021, "doi": "10.1213/ane.0000000000005349", "pubmed_id": null, "openalex_id": "https://openalex.org/W3129763680", "source_url": "https://doi.org/10.1213/ane.0000000000005349", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Spirituality,Mystical Experience,Review Article,Healthcare Workers", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1213/ane.0000000000005349", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1213/ane.0000000000005349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1213/ane.0000000000005349", "source_url": "https://doi.org/10.1213/ane.0000000000005349", "doi": "10.1213/ane.0000000000005349", "pmid": "", "publication_date": "2021-02-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3203, "title": "Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice", "authors": "Thomas CW, Blanco-Duque C, Bréant B, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV.", "journal": "bioRxiv", "publication_date": "2021-02-17", "publication_year": 2021, "doi": "10.1101/2021.02.16.431276", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2021.02.16.431276", "substance_tags": "psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Consciousness,Wellbeing,Animal Study", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.1101/2021.02.16.431276", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.02.16.431276", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2021.02.16.431276", "source_url": "https://doi.org/10.1101/2021.02.16.431276", "doi": "10.1101/2021.02.16.431276", "pmid": "", "publication_date": "2021-02-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2199, "title": "Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.", "authors": "De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G", "journal": "The Journal of neuroscience: the official journal of the Society for Neuroscience", "publication_date": "2021-02-03", "publication_year": 2021, "doi": "10.1523/jneurosci.1659-20.2020", "pubmed_id": "33257322", "openalex_id": "https://openalex.org/W3109908198", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33257322/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33257322", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33257322/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33257322", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33257322/", "doi": "10.1523/jneurosci.1659-20.2020", "pmid": "33257322", "publication_date": "2021-02-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2201, "title": "Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.", "authors": "Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D", "journal": "Acta psychiatrica Scandinavica", "publication_date": "2021-02-01", "publication_year": 2021, "doi": "10.1111/acps.13249", "pubmed_id": "33125716", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33125716/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33125716", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33125716/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33125716", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33125716/", "doi": "10.1111/acps.13249", "pmid": "33125716", "publication_date": "2021-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2200, "title": "Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.", "authors": "Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J", "journal": "Psychopharmacology", "publication_date": "2021-02-01", "publication_year": 2021, "doi": "10.1007/s00213-020-05719-1", "pubmed_id": "33427944", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33427944/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Healthy Volunteers", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33427944", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33427944/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33427944", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33427944/", "doi": "10.1007/s00213-020-05719-1", "pmid": "33427944", "publication_date": "2021-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5126, "title": "Behandeling met psilocybine", "authors": "Joost J. Breeksema, Martijn H B Koolen, Metten Somers, Robert A. Schoevers", "journal": "Data Archiving and Networked Services (DANS)", "publication_date": "2021-01-21", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3169076037", "source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "source_url": "https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429", "doi": "", "pmid": "", "publication_date": "2021-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2203, "title": "[Treatment with psilocybin: applications for patients with psychiatric disorders].", "authors": "Breeksema JJ, Koolen MHB, Somers M, Schoevers RA", "journal": "Nederlands tijdschrift voor geneeskunde", "publication_date": "2021-01-21", "publication_year": 2021, "doi": null, "pubmed_id": "33560605", "openalex_id": "https://openalex.org/W3127548368", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33560605/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Mechanism of Action,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:34:29", "bibtex": null, "source_record_id": "PMID:33560605", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33560605/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33560605", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33560605/", "doi": "", "pmid": "33560605", "publication_date": "2021-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2204, "title": "A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain.", "authors": "Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM", "journal": "International journal of molecular sciences", "publication_date": "2021-01-15", "publication_year": 2021, "doi": "10.3390/ijms22020835", "pubmed_id": "33467676", "openalex_id": "https://openalex.org/W3108222140", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33467676/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33467676", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33467676/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33467676", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33467676/", "doi": "10.3390/ijms22020835", "pmid": "33467676", "publication_date": "2021-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3556, "title": "Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors", "authors": "Joshua Woolley", "journal": "ClinicalTrials.gov", "publication_date": "2021-01-07", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02950467", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02950467", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02950467", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02950467", "source_url": "https://clinicaltrials.gov/study/NCT02950467", "doi": "", "pmid": "", "publication_date": "2021-01-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5828, "title": "POTENCIAL USO DA PSILOCIBINA NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO / POTENTIAL USE OF PSILOCYBIN IN THE DEPRESSION TREATMENT: A REVIEW", "authors": "Vagner Fagnani Linartevichi, Matheus Gonzales Froza, Rafael de Morais Cury, Francisney Pinto do Nascimento", "journal": "Brazilian Journal of Development", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.34117/bjdv7n3-783", "pubmed_id": null, "openalex_id": "https://openalex.org/W3145893950", "source_url": "https://doi.org/10.34117/bjdv7n3-783", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Review Article,Older Adults,Adolescents", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:47", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "DOI:10.34117/bjdv7n3-783", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.34117/bjdv7n3-783", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34117/bjdv7n3-783", "source_url": "https://doi.org/10.34117/bjdv7n3-783", "doi": "10.34117/bjdv7n3-783", "pmid": "", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5141, "title": "Unmet need in depression: Psilocybin, a breakthrough treatment option", "authors": "Yogesh Kumar Chahar", "journal": "International Journal of Advanced Research in Medicine", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.22271/27069567.2021.v3.i1f.159", "pubmed_id": null, "openalex_id": "https://openalex.org/W3164081616", "source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "DOI:10.22271/27069567.2021.v3.i1f.159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22271/27069567.2021.v3.i1f.159", "source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "doi": "10.22271/27069567.2021.v3.i1f.159", "pmid": "", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5132, "title": "Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety", "authors": "Harmony I. Risca", "journal": "Western Michigan University ScholarWorks", "publication_date": "2021-01-01", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3209570117", "source_url": "https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777&context=dissertations", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777&context=dissertations", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777&context=dissertations", "source_url": "https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777&context=dissertations", "doi": "", "pmid": "", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2219, "title": "Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.", "authors": "Varker T, Watson L, Gibson K, Forbes D, O'Donnell ML", "journal": "Journal of psychoactive drugs", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1080/02791072.2020.1817639", "pubmed_id": "32931403", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32931403/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32931403", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32931403/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32931403", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32931403/", "doi": "10.1080/02791072.2020.1817639", "pmid": "32931403", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2215, "title": "Effects of a single dose of psilocybin on behaviour, brain 5-HT receptor occupancy and gene expression in the pig.", "authors": "Donovan LL, Johansen JV, Ros NF, Jaberi E, Linnet K, Johansen SS, Ozenne B, Issazadeh-Navikas S, Hansen HD, Knudsen GM", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2020.11.013", "pubmed_id": "33288378", "openalex_id": "https://openalex.org/W3112700248", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33288378/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Personality Change,Immune Function", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33288378", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33288378/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33288378", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33288378/", "doi": "10.1016/j.euroneuro.2020.11.013", "pmid": "33288378", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2213, "title": "How ecstasy and psilocybin are shaking up psychiatry.", "authors": "Tullis P", "journal": "Nature", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1038/d41586-021-00187-9", "pubmed_id": "33505033", "openalex_id": "https://openalex.org/W3125143320", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33505033/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33505033", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33505033", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33505033/", "doi": "10.1038/d41586-021-00187-9", "pmid": "33505033", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2211, "title": "Psychedelic Medicines in Major Depression: Progress and Future Challenges.", "authors": "Bouso JC, Ona G, Dos Santos RG, Hallak JEC", "journal": "Advances in experimental medicine and biology", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1007/978-981-33-6044-0_26", "pubmed_id": "33834416", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33834416/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33834416", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33834416/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33834416", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33834416/", "doi": "10.1007/978-981-33-6044-0_26", "pmid": "33834416", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2210, "title": "People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.", "authors": "Williams MT, Davis AK, Xin Y, Sepeda ND, Grigas PC, Sinnott S, Haeny AM", "journal": "Drugs (Abingdon, England)", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1080/09687637.2020.1854688", "pubmed_id": "34349358", "openalex_id": "https://openalex.org/W3112172827", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34349358/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:34349358", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34349358/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34349358", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34349358/", "doi": "10.1080/09687637.2020.1854688", "pmid": "34349358", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2208, "title": "A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.", "authors": "Sheppard B", "journal": "Journal of law and health", "publication_date": "2021-01-01", "publication_year": 2021, "doi": null, "pubmed_id": "35026878", "openalex_id": "https://openalex.org/W4206882396", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35026878/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:34:29", "bibtex": null, "source_record_id": "PMID:35026878", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35026878/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35026878", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35026878/", "doi": "", "pmid": "35026878", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2198, "title": "Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.", "authors": "Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.586682", "pubmed_id": "33643087", "openalex_id": "https://openalex.org/W3127909847", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33643087/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33643087", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33643087/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33643087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33643087/", "doi": "10.3389/fpsyt.2021.586682", "pmid": "33643087", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2197, "title": "What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.", "authors": "Castro Santos H, Gama Marques J", "journal": "Porto biomedical journal", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1097/j.pbj.0000000000000128", "pubmed_id": "33884324", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33884324/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33884324", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33884324/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33884324", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33884324/", "doi": "10.1097/j.pbj.0000000000000128", "pmid": "33884324", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2194, "title": "Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.", "authors": "Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM", "journal": "Frontiers in pharmacology", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fphar.2021.640241", "pubmed_id": "33716753", "openalex_id": "https://openalex.org/W3134320342", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33716753/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Microdosing,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33716753", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33716753/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33716753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33716753/", "doi": "10.3389/fphar.2021.640241", "pmid": "33716753", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2184, "title": "Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT).", "authors": "Diab H, Malcolm B", "journal": "Journal of psychoactive drugs", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1080/02791072.2020.1847366", "pubmed_id": "33242285", "openalex_id": "https://openalex.org/W3109167753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33242285/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Microdosing,Review Article,Case Report", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33242285", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33242285/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33242285", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33242285/", "doi": "10.1080/02791072.2020.1847366", "pmid": "33242285", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2164, "title": "Psilocybin: From Serendipity to Credibility?", "authors": "Rucker JJ, Young AH", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.659044", "pubmed_id": "33967860", "openalex_id": "https://openalex.org/W3154999065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33967860/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33967860", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33967860/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33967860", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33967860/", "doi": "10.3389/fpsyt.2021.659044", "pmid": "33967860", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2144, "title": "Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.", "authors": "Barnett BS, Greer GR", "journal": "Journal of the Academy of Consultation-Liaison Psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1016/j.jaclp.2020.12.011", "pubmed_id": "34210406", "openalex_id": "https://openalex.org/W3123670341", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34210406/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34210406", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34210406/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34210406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34210406/", "doi": "10.1016/j.jaclp.2020.12.011", "pmid": "34210406", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2133, "title": "Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.", "authors": "Eleftheriou ME, Thomas E", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.707057", "pubmed_id": "34456763", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34456763/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Wellbeing,Healthy Volunteers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34456763", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34456763/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34456763", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34456763/", "doi": "10.3389/fpsyt.2021.707057", "pmid": "34456763", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2036, "title": "Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin", "authors": "Dahmane Elyes, Hutson Paul R., Gobburu Jogarao V. S.", "journal": "Clinical Pharmacology in Drug Development", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1002/cpdd.796", "pubmed_id": "32250059", "openalex_id": "https://openalex.org/W3014341075", "source_url": "https://doi.org/10.1002/cpdd.796", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:50", "bibtex": null, "source_record_id": "PMID:32250059", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/cpdd.796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:32250059", "source_url": "https://doi.org/10.1002/cpdd.796", "doi": "10.1002/cpdd.796", "pmid": "32250059", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1896, "title": "Psychedelics and Other Psychoplastogens for Treating Mental Illness.", "authors": "Vargas MV, Meyer R, Avanes AA, Rus M, Olson DE", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.727117", "pubmed_id": "34671279", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34671279/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34671279", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34671279/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34671279", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34671279/", "doi": "10.3389/fpsyt.2021.727117", "pmid": "34671279", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1889, "title": "Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.", "authors": "Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.737738", "pubmed_id": "34803761", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "substance_tags": "psilocybin", "topic_tags": "Depression,Creativity,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34803761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34803761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "doi": "10.3389/fpsyt.2021.737738", "pmid": "34803761", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1874, "title": "A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.", "authors": "Whitfield HJ", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.727572", "pubmed_id": "34950063", "openalex_id": "https://openalex.org/W4200524305", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34950063/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Psychological Flexibility,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34950063", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34950063/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34950063", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34950063/", "doi": "10.3389/fpsyt.2021.727572", "pmid": "34950063", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1873, "title": "H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?", "authors": "Vilca-Melendez S, Uthaug MV, Griffin JL", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.742856", "pubmed_id": "34966300", "openalex_id": "https://openalex.org/W4200180816", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34966300/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Systematic Review,Review Article,Metabolomics,Microbiome", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34966300", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34966300/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34966300", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34966300/", "doi": "10.3389/fpsyt.2021.742856", "pmid": "34966300", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1872, "title": "Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.", "authors": "Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.800072", "pubmed_id": "34975593", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34975593/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Pharmacology,Mechanism of Action,Emotional Processing,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34975593", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34975593/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34975593", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34975593/", "doi": "10.3389/fpsyt.2021.800072", "pmid": "34975593", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1836, "title": "Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.", "authors": "Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.780696", "pubmed_id": "35046855", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35046855/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35046855", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35046855/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35046855", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35046855/", "doi": "10.3389/fpsyt.2021.780696", "pmid": "35046855", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1832, "title": "Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.", "authors": "Markopoulos A, Inserra A, De Gregorio D, Gobbi G", "journal": "Frontiers in pharmacology", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fphar.2021.749068", "pubmed_id": "35177979", "openalex_id": "https://openalex.org/W4210379385", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35177979/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35177979", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35177979/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35177979", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35177979/", "doi": "10.3389/fphar.2021.749068", "pmid": "35177979", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1802, "title": "Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.", "authors": "Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R", "journal": "Frontiers in pharmacology", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fphar.2021.788155", "pubmed_id": "35431912", "openalex_id": "https://openalex.org/W4221001769", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35431912/", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Mystical Experience,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35431912", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35431912/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35431912", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35431912/", "doi": "10.3389/fphar.2021.788155", "pmid": "35431912", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5140, "title": "We Need a Cole Memorandum for Magic Mushrooms", "authors": "Robert A. Mikos", "journal": "SSRN Electronic Journal", "publication_date": "2020-12-31", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3162478297", "source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3839551", "doi": "", "pmid": "", "publication_date": "2020-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2221, "title": "Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.", "authors": "Nkadimeng SM, Steinmann CML, Eloff JN", "journal": "Scientific reports", "publication_date": "2020-12-18", "publication_year": 2020, "doi": "10.1038/s41598-020-79328-5", "pubmed_id": "33339902", "openalex_id": "https://openalex.org/W3115524456", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33339902/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33339902", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33339902/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33339902", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33339902/", "doi": "10.1038/s41598-020-79328-5", "pmid": "33339902", "publication_date": "2020-12-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3491, "title": "Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2020-12-01", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03912974", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Consciousness,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03912974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03912974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03912974", "source_url": "https://clinicaltrials.gov/study/NCT03912974", "doi": "", "pmid": "", "publication_date": "2020-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2228, "title": "The emerging role of psilocybin and MDMA in the treatment of mental illness.", "authors": "Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS", "journal": "Expert review of neurotherapeutics", "publication_date": "2020-12-01", "publication_year": 2020, "doi": "10.1080/14737175.2020.1826931", "pubmed_id": "32954860", "openalex_id": "https://openalex.org/W3087462486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32954860/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32954860", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32954860/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32954860", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32954860/", "doi": "10.1080/14737175.2020.1826931", "pmid": "32954860", "publication_date": "2020-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2225, "title": "Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.", "authors": "Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, Raison CL", "journal": "Psychological medicine", "publication_date": "2020-12-01", "publication_year": 2020, "doi": "10.1017/s003329172000389x", "pubmed_id": "33143790", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33143790/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Personality Change,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33143790", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33143790/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33143790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33143790/", "doi": "10.1017/s003329172000389x", "pmid": "33143790", "publication_date": "2020-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3271, "title": "A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain", "authors": "Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM.", "journal": "Preprints.org", "publication_date": "2020-11-30", "publication_year": 2020, "doi": "10.20944/preprints202011.0742.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202011.0742.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:17", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202011.0742.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202011.0742.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202011.0742.v1", "source_url": "https://doi.org/10.20944/preprints202011.0742.v1", "doi": "10.20944/preprints202011.0742.v1", "pmid": "", "publication_date": "2020-11-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2233, "title": "Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.", "authors": "Mason NL, Kuypers KPC, Müller F, Reckweg J, Tse DHY, Toennes SW, Hutten NRPW, Jansen JFA, Stiers P, Feilding A, Ramaekers JG", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2020-11-01", "publication_year": 2020, "doi": "10.1038/s41386-020-0718-8", "pubmed_id": "32446245", "openalex_id": "https://openalex.org/W3027590463", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32446245/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32446245", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32446245/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32446245", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32446245/", "doi": "10.1038/s41386-020-0718-8", "pmid": "32446245", "publication_date": "2020-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3402, "title": "A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy", "authors": "Luoma JB, Chwyl C, Bathje G, Davis AK, Lancelotta RL.", "journal": "PsyArXiv", "publication_date": "2020-10-28", "publication_year": 2020, "doi": "10.31234/osf.io/nhbjk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/nhbjk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:33", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/nhbjk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/nhbjk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/nhbjk", "source_url": "https://doi.org/10.31234/osf.io/nhbjk", "doi": "10.31234/osf.io/nhbjk", "pmid": "", "publication_date": "2020-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3429, "title": "Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2020-10-20", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00957359", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Review Article,Cancer Patients,Safety", "study_type": "Review Article", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00957359", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00957359", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00957359", "source_url": "https://clinicaltrials.gov/study/NCT00957359", "doi": "", "pmid": "", "publication_date": "2020-10-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3831, "title": "The Role of Psychedelics and Counseling in Mental Health Treatment", "authors": "Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch", "journal": "Journal of Mental Health Counseling", "publication_date": "2020-10-01", "publication_year": 2020, "doi": "10.17744/mehc.42.4.03", "pubmed_id": null, "openalex_id": "https://openalex.org/W3094549229", "source_url": "https://doi.org/10.17744/mehc.42.4.03", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "DOI:10.17744/mehc.42.4.03", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17744/mehc.42.4.03", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17744/mehc.42.4.03", "source_url": "https://doi.org/10.17744/mehc.42.4.03", "doi": "10.17744/mehc.42.4.03", "pmid": "", "publication_date": "2020-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2243, "title": "Psilocybin: from ancient magic to modern medicine.", "authors": "Nichols DE", "journal": "The Journal of antibiotics", "publication_date": "2020-10-01", "publication_year": 2020, "doi": "10.1038/s41429-020-0311-8", "pubmed_id": "32398764", "openalex_id": "https://openalex.org/W3025824861", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32398764/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32398764", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32398764/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32398764", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32398764/", "doi": "10.1038/s41429-020-0311-8", "pmid": "32398764", "publication_date": "2020-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2242, "title": "Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.", "authors": "Romeo B, Karila L, Martelli C, Benyamina A", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2020-10-01", "publication_year": 2020, "doi": "10.1177/0269881120919957", "pubmed_id": "32448048", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32448048/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32448048", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32448048/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32448048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32448048/", "doi": "10.1177/0269881120919957", "pmid": "32448048", "publication_date": "2020-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2241, "title": "Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials.", "authors": "Cozzi NV, Daley PF", "journal": "Drug testing and analysis", "publication_date": "2020-10-01", "publication_year": 2020, "doi": "10.1002/dta.2889", "pubmed_id": "32608093", "openalex_id": "https://openalex.org/W3038172304", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32608093/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32608093", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32608093/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32608093", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32608093/", "doi": "10.1002/dta.2889", "pmid": "32608093", "publication_date": "2020-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2238, "title": "Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.", "authors": "Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J", "journal": "EClinicalMedicine", "publication_date": "2020-10-01", "publication_year": 2020, "doi": "10.1016/j.eclinm.2020.100538", "pubmed_id": "33150319", "openalex_id": "https://openalex.org/W3087859780", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33150319/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Veterans,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33150319", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33150319/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33150319", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33150319/", "doi": "10.1016/j.eclinm.2020.100538", "pmid": "33150319", "publication_date": "2020-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3834, "title": "Wait for the Science Before Widespread Use of Psilocybin", "authors": "Nicole Harrington Cirino", "journal": "Psychiatric News", "publication_date": "2020-09-29", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.10a32", "pubmed_id": null, "openalex_id": "https://openalex.org/W3091539953", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "doi": "10.1176/appi.pn.2020.10a32", "pmid": "", "publication_date": "2020-09-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2246, "title": "Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.", "authors": "Vitkauskas M, Mathuru AS", "journal": "International journal of molecular sciences", "publication_date": "2020-09-07", "publication_year": 2020, "doi": "10.3390/ijms21186525", "pubmed_id": "32906643", "openalex_id": "https://openalex.org/W3083433593", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32906643/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32906643", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32906643/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32906643", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32906643/", "doi": "10.3390/ijms21186525", "pmid": "32906643", "publication_date": "2020-09-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2247, "title": "Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.", "authors": "Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L", "journal": "Biomedicines", "publication_date": "2020-09-05", "publication_year": 2020, "doi": "10.3390/biomedicines8090331", "pubmed_id": "32899469", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32899469/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32899469", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32899469/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32899469", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32899469/", "doi": "10.3390/biomedicines8090331", "pmid": "32899469", "publication_date": "2020-09-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2248, "title": "Psilocybin Can Diminish Depression.", "authors": "Jones TK, Lippmann S", "journal": "The primary care companion for CNS disorders", "publication_date": "2020-09-03", "publication_year": 2020, "doi": "10.4088/pcc.19br02580", "pubmed_id": "32898345", "openalex_id": "https://openalex.org/W3082563060", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32898345/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32898345", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32898345", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32898345/", "doi": "10.4088/pcc.19br02580", "pmid": "32898345", "publication_date": "2020-09-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2249, "title": "Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.", "authors": "Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA", "journal": "CNS drugs", "publication_date": "2020-09-01", "publication_year": 2020, "doi": "10.1007/s40263-020-00748-y", "pubmed_id": "32803732", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32803732/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Pharmacology,Emotional Processing,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32803732", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32803732/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32803732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32803732/", "doi": "10.1007/s40263-020-00748-y", "pmid": "32803732", "publication_date": "2020-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2256, "title": "Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Magic Mushroom.", "authors": "Nkadimeng SM, Nabatanzi A, Steinmann CML, Eloff JN", "journal": "Plants (Basel, Switzerland)", "publication_date": "2020-08-31", "publication_year": 2020, "doi": "10.3390/plants9091127", "pubmed_id": "32878164", "openalex_id": "https://openalex.org/W3081977832", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32878164/", "substance_tags": "psilocybin", "topic_tags": "Depression,Toxicity,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32878164", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32878164/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32878164", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32878164/", "doi": "10.3390/plants9091127", "pmid": "32878164", "publication_date": "2020-08-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3839, "title": "Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin", "authors": "James D. Tucker", "journal": "SSRN Electronic Journal", "publication_date": "2020-08-13", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3157248359", "source_url": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "source_url": "https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3783484_code4550530.pdf?abstractid=3783484&mirid=1", "doi": "", "pmid": "", "publication_date": "2020-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3778, "title": "The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)", "authors": "Guss J, Krause R, Sloshower J.", "journal": "PsyArXiv", "publication_date": "2020-08-13", "publication_year": 2020, "doi": "10.31234/osf.io/u6v9y", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/u6v9y", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-08-09 08:15:18", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/u6v9y", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/u6v9y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/u6v9y", "source_url": "https://doi.org/10.31234/osf.io/u6v9y", "doi": "10.31234/osf.io/u6v9y", "pmid": "", "publication_date": "2020-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3276, "title": "The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)", "authors": "Jeffrey Guss, Robert Krause, Jordan Sloshower", "journal": "PsyArXiv", "publication_date": "2020-08-13", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "source_url": "https://osf.io/preprints/psyarxiv/u6v9y_v1", "doi": "", "pmid": "", "publication_date": "2020-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3842, "title": "4 Psychedelics: therapeutic mechanisms", "authors": "Robin Carhart-Harris", "journal": "Journal of Neurology Neurosurgery & Psychiatry", "publication_date": "2020-07-20", "publication_year": 2020, "doi": "10.1136/jnnp-2020-bnpa.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W3044110502", "source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1136/jnnp-2020-bnpa.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/jnnp-2020-bnpa.4", "source_url": "https://doi.org/10.1136/jnnp-2020-bnpa.4", "doi": "10.1136/jnnp-2020-bnpa.4", "pmid": "", "publication_date": "2020-07-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2265, "title": "Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin.", "authors": "Fricke J, Kargbo R, Regestein L, Lenz C, Peschel G, Rosenbaum MA, Sherwood A, Hoffmeister D", "journal": "Chemistry (Weinheim an der Bergstrasse, Germany)", "publication_date": "2020-07-02", "publication_year": 2020, "doi": "10.1002/chem.202000134", "pubmed_id": "32101345", "openalex_id": "https://openalex.org/W3007311584", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32101345/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32101345", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32101345/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32101345", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32101345/", "doi": "10.1002/chem.202000134", "pmid": "32101345", "publication_date": "2020-07-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3404, "title": "A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy", "authors": "Luoma JB.", "journal": "PsyArXiv", "publication_date": "2020-06-12", "publication_year": 2020, "doi": "10.31234/osf.io/sgujx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/sgujx", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Meta-Analysis", "study_type": "Meta-Analysis", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:33", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/sgujx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/sgujx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/sgujx", "source_url": "https://doi.org/10.31234/osf.io/sgujx", "doi": "10.31234/osf.io/sgujx", "pmid": "", "publication_date": "2020-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2271, "title": "Long-term effects of psychedelic drugs: A systematic review.", "authors": "Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2020-06-01", "publication_year": 2020, "doi": "10.1016/j.neubiorev.2020.03.017", "pubmed_id": "32194129", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32194129/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Personality Change,Emotional Processing,Spirituality,Mystical Experience,Systematic Review,Review Article,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32194129", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32194129/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32194129", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32194129/", "doi": "10.1016/j.neubiorev.2020.03.017", "pmid": "32194129", "publication_date": "2020-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3848, "title": "Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2020-05-28", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.6a34", "pubmed_id": null, "openalex_id": "https://openalex.org/W3033314635", "source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Consciousness,Aging,Creativity,Case Report,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.6a34", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.6a34", "source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "doi": "10.1176/appi.pn.2020.6a34", "pmid": "", "publication_date": "2020-05-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3854, "title": "Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor", "authors": "Katie R. Barnes, Stephanie N. Lewis", "journal": "VTechWorks (Virginia Tech)", "publication_date": "2020-05-05", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3048778283", "source_url": "http://hdl.handle.net/10919/99299", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "http://hdl.handle.net/10919/99299", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/10919/99299", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/10919/99299", "source_url": "http://hdl.handle.net/10919/99299", "doi": "", "pmid": "", "publication_date": "2020-05-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2279, "title": "Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.", "authors": "Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M", "journal": "Psychopharmacology", "publication_date": "2020-05-01", "publication_year": 2020, "doi": "10.1007/s00213-020-05477-0", "pubmed_id": "32043165", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32043165", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32043165", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32043165/", "doi": "10.1007/s00213-020-05477-0", "pmid": "32043165", "publication_date": "2020-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2209, "title": "Psychedelics and Psychedelic-Assisted Psychotherapy.", "authors": "Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research", "journal": "The American journal of psychiatry", "publication_date": "2020-05-01", "publication_year": 2020, "doi": "10.1176/appi.ajp.2019.19010035", "pubmed_id": "32098487", "openalex_id": "https://openalex.org/W32098487", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32098487/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Brain Imaging,Aging,Clinical Trial,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32098487", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32098487/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32098487", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32098487/", "doi": "10.1176/appi.ajp.2019.19010035", "pmid": "32098487", "publication_date": "2020-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2281, "title": "Dynamic coupling of whole-brain neuronal and neurotransmitter systems.", "authors": "Kringelbach ML, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris R, Whybrow PC, Logothetis NK, Deco G", "journal": "Proceedings of the National Academy of Sciences of the United States of America", "publication_date": "2020-04-28", "publication_year": 2020, "doi": "10.1073/pnas.1921475117", "pubmed_id": "32284420", "openalex_id": "https://openalex.org/W3015902292", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32284420/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Aging", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32284420", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32284420/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32284420", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32284420/", "doi": "10.1073/pnas.1921475117", "pmid": "32284420", "publication_date": "2020-04-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3451, "title": "Pharmacokinetics of Psilocybin in Normal Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2020-04-15", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02163707", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02163707", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02163707", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02163707", "source_url": "https://clinicaltrials.gov/study/NCT02163707", "doi": "", "pmid": "", "publication_date": "2020-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2282, "title": "A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.", "authors": "Chi T, Gold JA", "journal": "Journal of the neurological sciences", "publication_date": "2020-04-15", "publication_year": 2020, "doi": "10.1016/j.jns.2020.116715", "pubmed_id": "32044687", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32044687/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32044687", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32044687/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32044687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32044687/", "doi": "10.1016/j.jns.2020.116715", "pmid": "32044687", "publication_date": "2020-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3858, "title": "Psychedelics for Psychiatric Disorders: More Research Needed", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2020-04-13", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.4a14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3017294991", "source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.4a14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.4a14", "source_url": "https://doi.org/10.1176/appi.pn.2020.4a14", "doi": "10.1176/appi.pn.2020.4a14", "pmid": "", "publication_date": "2020-04-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2283, "title": "Psilocybin Therapeutic Research: The Present and Future Paradigm.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2020-04-09", "publication_year": 2020, "doi": "10.1021/acsmedchemlett.0c00048", "pubmed_id": "32292538", "openalex_id": "https://openalex.org/W3009264042", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32292538/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32292538", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32292538/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32292538", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32292538/", "doi": "10.1021/acsmedchemlett.0c00048", "pmid": "32292538", "publication_date": "2020-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2284, "title": "Psychedelic Psychiatry's Brave New World.", "authors": "Nutt D, Erritzoe D, Carhart-Harris R", "journal": "Cell", "publication_date": "2020-04-02", "publication_year": 2020, "doi": "10.1016/j.cell.2020.03.020", "pubmed_id": "32243793", "openalex_id": "https://openalex.org/W3015140823", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32243793/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32243793", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32243793/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32243793", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32243793/", "doi": "10.1016/j.cell.2020.03.020", "pmid": "32243793", "publication_date": "2020-04-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3859, "title": "One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats", "authors": "Meghan Hibicke, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2020-03-31", "publication_year": 2020, "doi": "10.1096/fasebj.2020.34.s1.02912", "pubmed_id": null, "openalex_id": "https://openalex.org/W3016993897", "source_url": "https://doi.org/10.1096/fasebj.2020.34.s1.02912", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Adolescents", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.2020.34.s1.02912", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.2020.34.s1.02912", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.2020.34.s1.02912", "source_url": "https://doi.org/10.1096/fasebj.2020.34.s1.02912", "doi": "10.1096/fasebj.2020.34.s1.02912", "pmid": "", "publication_date": "2020-03-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3861, "title": "Long-Term Analysis of Psilocybin in Cancer Patients With Distress", "authors": "Richard Simoneaux", "journal": "Oncology Times", "publication_date": "2020-03-26", "publication_year": 2020, "doi": "10.1097/01.cot.0000660232.19098.7f", "pubmed_id": null, "openalex_id": "https://openalex.org/W3013419105", "source_url": "https://doi.org/10.1097/01.cot.0000660232.19098.7f", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Cancer Patients", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1097/01.cot.0000660232.19098.7f", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/01.cot.0000660232.19098.7f", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/01.cot.0000660232.19098.7f", "source_url": "https://doi.org/10.1097/01.cot.0000660232.19098.7f", "doi": "10.1097/01.cot.0000660232.19098.7f", "pmid": "", "publication_date": "2020-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2289, "title": "Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression.", "authors": "Hibicke M, Landry AN, Kramer HM, Talman ZK, Nichols CD", "journal": "ACS chemical neuroscience", "publication_date": "2020-03-18", "publication_year": 2020, "doi": "10.1021/acschemneuro.9b00493", "pubmed_id": "32133835", "openalex_id": "https://openalex.org/W3010499243", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32133835/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32133835", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32133835/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32133835", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32133835/", "doi": "10.1021/acschemneuro.9b00493", "pmid": "32133835", "publication_date": "2020-03-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2290, "title": "Natural Psychoplastogens As Antidepressant Agents.", "authors": "Benko J, Vranková S", "journal": "Molecules (Basel, Switzerland)", "publication_date": "2020-03-05", "publication_year": 2020, "doi": "10.3390/molecules25051172", "pubmed_id": "32150976", "openalex_id": "https://openalex.org/W3010070566", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32150976/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32150976", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32150976/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32150976", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32150976/", "doi": "10.3390/molecules25051172", "pmid": "32150976", "publication_date": "2020-03-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2292, "title": "Psilocybin-assisted therapy for depression: How do we advance the field?", "authors": "Meikle SE, Liknaitzky P, Rossell SL, Ross M, Strauss N, Thomas N, Murray G, Williams M, Castle DJ", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2020-03-01", "publication_year": 2020, "doi": "10.1177/0004867419888575", "pubmed_id": "31752499", "openalex_id": "https://openalex.org/W2989680519", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31752499/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31752499", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31752499/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31752499", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31752499/", "doi": "10.1177/0004867419888575", "pmid": "31752499", "publication_date": "2020-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2291, "title": "The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.", "authors": "Mathai DS, Meyer MJ, Storch EA, Kosten TR", "journal": "Journal of affective disorders", "publication_date": "2020-03-01", "publication_year": 2020, "doi": "10.1016/j.jad.2019.12.023", "pubmed_id": "32056741", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32056741/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Systematic Review,Review Article,Healthcare Workers", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32056741", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32056741/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32056741", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32056741/", "doi": "10.1016/j.jad.2019.12.023", "pmid": "32056741", "publication_date": "2020-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2302, "title": "Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.", "authors": "Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Ponté KL, Guss J, Bossis AP, Grigsby J, Fischer S, Ross S", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2020-02-01", "publication_year": 2020, "doi": "10.1177/0269881119897615", "pubmed_id": "31916890", "openalex_id": "https://openalex.org/W3000636165", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31916890/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Emotional Processing,Spirituality,Randomized Controlled Trial,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31916890", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31916890/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31916890", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31916890/", "doi": "10.1177/0269881119897615", "pmid": "31916890", "publication_date": "2020-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2301, "title": "The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.", "authors": "Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR", "journal": "Psychiatry research", "publication_date": "2020-02-01", "publication_year": 2020, "doi": "10.1016/j.psychres.2020.112749", "pubmed_id": "31931272", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31931272/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Meta-Analysis,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31931272", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31931272/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31931272", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31931272/", "doi": "10.1016/j.psychres.2020.112749", "pmid": "31931272", "publication_date": "2020-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2300, "title": "Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.", "authors": "Mertens LJ, Wall MB, Roseman L, Demetriou L, Nutt DJ, Carhart-Harris RL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2020-02-01", "publication_year": 2020, "doi": "10.1177/0269881119895520", "pubmed_id": "31941394", "openalex_id": "https://openalex.org/W3000549374", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31941394/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Emotional Processing,Treatment-Resistant Depression,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31941394", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31941394/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31941394", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31941394/", "doi": "10.1177/0269881119895520", "pmid": "31941394", "publication_date": "2020-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3872, "title": "Psychedelic therapy: Fresh promise for mental health", "authors": "Heidi Bush", "journal": "Mental Health Weekly", "publication_date": "2020-01-24", "publication_year": 2020, "doi": "10.1002/mhw.32207", "pubmed_id": null, "openalex_id": "https://openalex.org/W3001867576", "source_url": "https://doi.org/10.1002/mhw.32207", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.32207", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.32207", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.32207", "source_url": "https://doi.org/10.1002/mhw.32207", "doi": "10.1002/mhw.32207", "pmid": "", "publication_date": "2020-01-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5713, "title": "Psilocybin Therapy for Depression: A Scoping Review Protocol", "authors": "Dalton Budhram, Preet Dhaliwal", "journal": "Open MIND", "publication_date": "2020-01-01", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7167303937", "source_url": "https://osf.io/4syt6", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Review Article,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "https://osf.io/4syt6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/4syt6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://osf.io/4syt6", "source_url": "https://osf.io/4syt6", "doi": "", "pmid": "", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3897, "title": "Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?", "authors": "Brooke Reichenbach", "journal": "Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)", "publication_date": "2020-01-01", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3137131474", "source_url": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Systematic Review,Review Article,Cancer Patients", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "source_url": "https://digitalcommons.pcom.edu/pa_systematic_reviews/531", "doi": "", "pmid": "", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3884, "title": "Psilocybin may help cancer patients with depression and anxiety for years", "authors": "Laura Sanders", "journal": "Access Science", "publication_date": "2020-01-01", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3005367189", "source_url": "https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Cancer Patients", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031", "source_url": "https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031", "doi": "", "pmid": "", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2316, "title": "The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging.", "authors": "Germann CB", "journal": "Medical hypotheses", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1016/j.mehy.2019.109406", "pubmed_id": "31634774", "openalex_id": "https://openalex.org/W2975681496", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31634774/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Neuroplasticity,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Telomeres,Epigenetics,Cellular Senescence,Wellbeing,Healthy Volunteers", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31634774", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31634774/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31634774", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31634774/", "doi": "10.1016/j.mehy.2019.109406", "pmid": "31634774", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2315, "title": "Microdosing psychedelics: Motivations, subjective effects and harm reduction.", "authors": "Lea T, Amada N, Jungaberle H, Schecke H, Klein M", "journal": "The International journal on drug policy", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1016/j.drugpo.2019.11.008", "pubmed_id": "31778967", "openalex_id": "https://openalex.org/W2990036135", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31778967/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Clinical Trial,Randomized Controlled Trial,Observational Study", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31778967", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31778967/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31778967", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31778967/", "doi": "10.1016/j.drugpo.2019.11.008", "pmid": "31778967", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2313, "title": "Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.", "authors": "Dos Santos RG, Hallak JEC", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1016/j.neubiorev.2019.12.001", "pubmed_id": "31809772", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31809772/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Personality Change,Emotional Processing,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31809772", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31809772/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31809772", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31809772/", "doi": "10.1016/j.neubiorev.2019.12.001", "pmid": "31809772", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2309, "title": "[Psychedelics for existential distress in terminally ill patients].", "authors": "Schimmel N, Breeksema JJ, Veraart JKE, van den Brink W, Schoevers RA", "journal": "Tijdschrift voor psychiatrie", "publication_date": "2020-01-01", "publication_year": 2020, "doi": null, "pubmed_id": "32816294", "openalex_id": "https://openalex.org/W3080105950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32816294/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:34:29", "bibtex": null, "source_record_id": "PMID:32816294", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32816294/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32816294", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32816294/", "doi": "", "pmid": "32816294", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2304, "title": "Management of Treatment-Resistant Depression: Challenges and Strategies.", "authors": "Voineskos D, Daskalakis ZJ, Blumberger DM", "journal": "Neuropsychiatric disease and treatment", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.2147/ndt.s198774", "pubmed_id": "32021216", "openalex_id": "https://openalex.org/W3000386776", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32021216/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Aging,Review Article,Treatment-Resistant Depression", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32021216", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32021216/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32021216", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32021216/", "doi": "10.2147/ndt.s198774", "pmid": "32021216", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2295, "title": "Self-reported negative outcomes of psilocybin users: A quantitative textual analysis.", "authors": "Bienemann B, Ruschel NS, Campos ML, Negreiros MA, Mograbi DC", "journal": "PloS one", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1371/journal.pone.0229067", "pubmed_id": "32084160", "openalex_id": "https://openalex.org/W3007379062", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32084160/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32084160", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32084160/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32084160", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32084160/", "doi": "10.1371/journal.pone.0229067", "pmid": "32084160", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2288, "title": "Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.", "authors": "Heuschkel K, Kuypers KPC", "journal": "Frontiers in psychiatry", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.3389/fpsyt.2020.00224", "pubmed_id": "32296353", "openalex_id": "https://openalex.org/W3014277121", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32296353/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Biomarkers,Review Article,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32296353", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32296353/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32296353", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32296353/", "doi": "10.3389/fpsyt.2020.00224", "pmid": "32296353", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2287, "title": "Psychedelic Microdosing: A Subreddit Analysis.", "authors": "Lea T, Amada N, Jungaberle H", "journal": "Journal of psychoactive drugs", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1080/02791072.2019.1683260", "pubmed_id": "31648596", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Creativity,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31648596", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31648596", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "doi": "10.1080/02791072.2019.1683260", "pmid": "31648596", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2257, "title": "The therapeutic potential of microdosing psychedelics in depression.", "authors": "Kuypers KPC", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1177/2045125320950567", "pubmed_id": "32922736", "openalex_id": "https://openalex.org/W3082721315", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32922736/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Review Article,Healthy Volunteers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32922736", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32922736/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32922736", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32922736/", "doi": "10.1177/2045125320950567", "pmid": "32922736", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1083, "title": "Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.", "authors": "Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ", "journal": "Frontiers in neuroscience", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.3389/fnins.2020.00043", "pubmed_id": "32116500", "openalex_id": "https://openalex.org/W3005218696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32116500/", "substance_tags": "psilocybin", "topic_tags": "Depression,Eating Disorders,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32116500", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32116500/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32116500", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32116500/", "doi": "10.3389/fnins.2020.00043", "pmid": "32116500", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3893, "title": "Psilocybin and LSD in the Treatment of Depression and Anxiety", "authors": "Marcus Allgulin", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3093826296", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Mystical Experience,Review Article", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3891, "title": "The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder", "authors": "Sofia Gyllvik", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3083741926", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3889, "title": "Psilocybin's effects on the brain and implications for depression treatment", "authors": "Katariina Sarajärvi", "journal": "Epubl LTU", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3046649178", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Consciousness,Wellbeing,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3883, "title": "Development of an improved psilocybin synthesis", "authors": "Reham Shaba", "journal": "Uppsala University Publications (Uppsala University)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3089446948", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3902, "title": "Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin", "authors": "Krishna Kumar Varshney", "journal": "SSRN Electronic Journal", "publication_date": "2019-12-29", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3135591988", "source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Toxicity,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "source_url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3528349", "doi": "", "pmid": "", "publication_date": "2019-12-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3285, "title": "Mapping Psilocybin-Assisted Therapies: A Scoping Review", "authors": "Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On.", "journal": "medRxiv", "publication_date": "2019-12-12", "publication_year": 2019, "doi": "10.1101/2019.12.04.19013896", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:18", "bibtex": null, "source_record_id": "DOI:10.1101/2019.12.04.19013896", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2019.12.04.19013896", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2019.12.04.19013896", "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "doi": "10.1101/2019.12.04.19013896", "pmid": "", "publication_date": "2019-12-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3905, "title": "P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression", "authors": "Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris", "journal": "European Neuropsychopharmacology", "publication_date": "2019-12-01", "publication_year": 2019, "doi": "10.1016/j.euroneuro.2019.09.593", "pubmed_id": null, "openalex_id": "https://openalex.org/W4248055189", "source_url": "https://doi.org/10.1016/j.euroneuro.2019.09.593", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2019.09.593", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2019.09.593", "source_url": "https://doi.org/10.1016/j.euroneuro.2019.09.593", "doi": "10.1016/j.euroneuro.2019.09.593", "pmid": "", "publication_date": "2019-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2317, "title": "In vivo production of psilocybin in E. coli.", "authors": "Adams AM, Kaplan NA, Wei Z, Brinton JD, Monnier CS, Enacopol AL, Ramelot TA, Jones JA", "journal": "Metabolic engineering", "publication_date": "2019-12-01", "publication_year": 2019, "doi": "10.1016/j.ymben.2019.09.009", "pubmed_id": "31550507", "openalex_id": "https://openalex.org/W2973895336", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31550507/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31550507", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31550507/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31550507", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31550507/", "doi": "10.1016/j.ymben.2019.09.009", "pmid": "31550507", "publication_date": "2019-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2318, "title": "Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.", "authors": "Andersson M, Kjellgren A", "journal": "Harm reduction journal", "publication_date": "2019-11-28", "publication_year": 2019, "doi": "10.1186/s12954-019-0333-3", "pubmed_id": "31779667", "openalex_id": "https://openalex.org/W2991503240", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31779667/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Emotional Processing,Safety,Drug Interactions", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31779667", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31779667/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31779667", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31779667/", "doi": "10.1186/s12954-019-0333-3", "pmid": "31779667", "publication_date": "2019-11-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2319, "title": "Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin.", "authors": "Fricke J, Sherwood A, Kargbo R, Orry A, Blei F, Naschberger A, Rupp B, Hoffmeister D", "journal": "Chembiochem: a European journal of chemical biology", "publication_date": "2019-11-18", "publication_year": 2019, "doi": "10.1002/cbic.201900358", "pubmed_id": "31150155", "openalex_id": "https://openalex.org/W2948005519", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31150155/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Epigenetics,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31150155", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31150155/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31150155", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31150155/", "doi": "10.1002/cbic.201900358", "pmid": "31150155", "publication_date": "2019-11-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3913, "title": "Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame", "authors": "Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed, Matthew D. Skinta", "journal": "Journal of Contextual Behavioral Science", "publication_date": "2019-11-05", "publication_year": 2019, "doi": "10.1016/j.jcbs.2019.11.002", "pubmed_id": null, "openalex_id": "https://openalex.org/W2984820573", "source_url": "https://doi.org/10.1016/j.jcbs.2019.11.002", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1016/j.jcbs.2019.11.002", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jcbs.2019.11.002", "source_url": "https://doi.org/10.1016/j.jcbs.2019.11.002", "doi": "10.1016/j.jcbs.2019.11.002", "pmid": "", "publication_date": "2019-11-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2321, "title": "Replication and extension of a model predicting response to psilocybin.", "authors": "Russ SL, Carhart-Harris RL, Maruyama G, Elliott MS", "journal": "Psychopharmacology", "publication_date": "2019-11-01", "publication_year": 2019, "doi": "10.1007/s00213-019-05279-z", "pubmed_id": "31203401", "openalex_id": "https://openalex.org/W2950747661", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31203401/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31203401", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31203401/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31203401", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31203401/", "doi": "10.1007/s00213-019-05279-z", "pmid": "31203401", "publication_date": "2019-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2320, "title": "Classical psychedelics for the treatment of depression and anxiety: A systematic review.", "authors": "Muttoni S, Ardissino M, John C", "journal": "Journal of affective disorders", "publication_date": "2019-11-01", "publication_year": 2019, "doi": "10.1016/j.jad.2019.07.076", "pubmed_id": "31382100", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31382100/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31382100", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31382100/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31382100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31382100/", "doi": "10.1016/j.jad.2019.07.076", "pmid": "31382100", "publication_date": "2019-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2322, "title": "Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.", "authors": "Dos Santos RG, Bouso JC, Hallak JEC", "journal": "BMC psychiatry", "publication_date": "2019-10-28", "publication_year": 2019, "doi": "10.1186/s12888-019-2288-z", "pubmed_id": "31660905", "openalex_id": "https://openalex.org/W2981489145", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31660905/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Review Article,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31660905", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31660905/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31660905", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31660905/", "doi": "10.1186/s12888-019-2288-z", "pmid": "31660905", "publication_date": "2019-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3915, "title": "Johns Hopkins Opens Research Center on Psychedelics", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-10-27", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.10a16", "pubmed_id": null, "openalex_id": "https://openalex.org/W2982427347", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Consciousness,Biomarkers,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "doi": "10.1176/appi.pn.2019.10a16", "pmid": "", "publication_date": "2019-10-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3917, "title": "Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease", "authors": "Kernel Networks Inc.", "journal": "Case Medical Research", "publication_date": "2019-10-10", "publication_year": 2019, "doi": "10.31525/ct1-nct04123314", "pubmed_id": null, "openalex_id": "https://openalex.org/W4247147096", "source_url": "https://doi.org/10.31525/ct1-nct04123314", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.31525/ct1-nct04123314", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31525/ct1-nct04123314", "source_url": "https://doi.org/10.31525/ct1-nct04123314", "doi": "10.31525/ct1-nct04123314", "pmid": "", "publication_date": "2019-10-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3918, "title": "Modified E. coli pump out psilocybin", "authors": "Megha Satyanarayana", "journal": "C&EN Global Enterprise", "publication_date": "2019-10-06", "publication_year": 2019, "doi": "10.1021/cen-09739-scicon9", "pubmed_id": null, "openalex_id": "https://openalex.org/W2981873322", "source_url": "https://doi.org/10.1021/cen-09739-scicon9", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Clinical Trial", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09739-scicon9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-09739-scicon9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09739-scicon9", "source_url": "https://doi.org/10.1021/cen-09739-scicon9", "doi": "10.1021/cen-09739-scicon9", "pmid": "", "publication_date": "2019-10-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3920, "title": "Psilocybin for depression: Considerations for clinical trial design", "authors": "Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz", "journal": "Journal of Psychedelic Studies", "publication_date": "2019-09-01", "publication_year": 2019, "doi": "10.1556/2054.2019.026", "pubmed_id": null, "openalex_id": "https://openalex.org/W2974814938", "source_url": "https://doi.org/10.1556/2054.2019.026", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2019.026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2019.026", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2019.026", "source_url": "https://doi.org/10.1556/2054.2019.026", "doi": "10.1556/2054.2019.026", "pmid": "", "publication_date": "2019-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3287, "title": "Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice", "authors": "Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M.", "journal": "bioRxiv", "publication_date": "2019-09-01", "publication_year": 2019, "doi": "10.1101/751255", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/751255", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Animal Study,Drug Interactions", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:19", "bibtex": null, "source_record_id": "DOI:10.1101/751255", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/751255", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/751255", "source_url": "https://doi.org/10.1101/751255", "doi": "10.1101/751255", "pmid": "", "publication_date": "2019-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2330, "title": "Hallucinogens and Their Therapeutic Use: A Literature Review.", "authors": "Begola MJ, Schillerstrom JE", "journal": "Journal of psychiatric practice", "publication_date": "2019-09-01", "publication_year": 2019, "doi": "10.1097/pra.0000000000000409", "pubmed_id": "31505518", "openalex_id": "https://openalex.org/W2986818733", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31505518/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31505518", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31505518/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31505518", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31505518/", "doi": "10.1097/pra.0000000000000409", "pmid": "31505518", "publication_date": "2019-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3923, "title": "Beyond Cannabis: Psychedelic Decriminalization and Social Justice", "authors": "Dustin Marlan", "journal": "eYLS (Yale Law School)", "publication_date": "2019-08-15", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2969663209", "source_url": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Wellbeing", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "source_url": "https://lawcommons.lclark.edu/lclr/vol23/iss3/4", "doi": "", "pmid": "", "publication_date": "2019-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2334, "title": "Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.", "authors": "Jefsen O, Højgaard K, Christiansen SL, Elfving B, Nutt DJ, Wegener G, Müller HK", "journal": "Acta neuropsychiatrica", "publication_date": "2019-08-01", "publication_year": 2019, "doi": "10.1017/neu.2019.15", "pubmed_id": "31106729", "openalex_id": "https://openalex.org/W2945318261", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31106729/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31106729", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31106729/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31106729", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31106729/", "doi": "10.1017/neu.2019.15", "pmid": "31106729", "publication_date": "2019-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3927, "title": "Disruptive Psychopharmacology.", "authors": "Heifets BD, Malenka RC.", "journal": "JAMA Psychiatry", "publication_date": "2019-07-30", "publication_year": 2019, "doi": "10.1001/jamapsychiatry.2019.1145", "pubmed_id": "31241740", "openalex_id": "https://openalex.org/W4231328231", "source_url": "https://doi.org/10.1001/jamapsychiatry.2019.1145", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "PMID:31241740", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2019.1145", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31241740", "source_url": "https://doi.org/10.1001/jamapsychiatry.2019.1145", "doi": "10.1001/jamapsychiatry.2019.1145", "pmid": "31241740", "publication_date": "2019-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2337, "title": "Psychedelic microdosing benefits and challenges: an empirical codebook.", "authors": "Anderson T, Petranker R, Christopher A, Rosenbaum D, Weissman C, Dinh-Williams LA, Hui K, Hapke E", "journal": "Harm reduction journal", "publication_date": "2019-07-10", "publication_year": 2019, "doi": "10.1186/s12954-019-0308-4", "pubmed_id": "31288862", "openalex_id": "https://openalex.org/W2957955970", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31288862/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Aging,Microdosing,Healthcare Workers,Adverse Events", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31288862", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31288862/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31288862", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31288862/", "doi": "10.1186/s12954-019-0308-4", "pmid": "31288862", "publication_date": "2019-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5829, "title": "A SYSTEMATIC REVIEW OF PSILOCYBIN IN THE TREATMENT OF DEPRESSION AND ANXIETY", "authors": "Jihun Lyu, Benjamin C. Hambro, Trisha Suppes", "journal": "Journal of Affective Disorders", "publication_date": "2019-07-01", "publication_year": 2019, "doi": "10.1016/j.jad.2018.10.335", "pubmed_id": null, "openalex_id": "https://openalex.org/W2955416807", "source_url": "https://doi.org/10.1016/j.jad.2018.10.335", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:49", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1016/j.jad.2018.10.335", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.jad.2018.10.335", "source_url": "https://doi.org/10.1016/j.jad.2018.10.335", "doi": "10.1016/j.jad.2018.10.335", "pmid": "", "publication_date": "2019-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3926, "title": "The Potential of Psilocybin Administration in Terminal Cancer Patients", "authors": "Richard Simoneaux", "journal": "Oncology Times", "publication_date": "2019-06-28", "publication_year": 2019, "doi": "10.1097/01.cot.0000574916.46844.cf", "pubmed_id": null, "openalex_id": "https://openalex.org/W2956046898", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "doi": "10.1097/01.cot.0000574916.46844.cf", "pmid": "", "publication_date": "2019-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2343, "title": "Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.", "authors": "Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2019-06-08", "publication_year": 2019, "doi": "10.1016/j.pnpbp.2019.01.002", "pubmed_id": "30611836", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30611836/", "substance_tags": "psilocybin", "topic_tags": "Depression,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30611836", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30611836/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30611836", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30611836/", "doi": "10.1016/j.pnpbp.2019.01.002", "pmid": "30611836", "publication_date": "2019-06-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2344, "title": "Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.", "authors": "Sakloth F, Leggett E, Moerke MJ, Townsend EA, Banks ML, Negus SS", "journal": "Experimental and clinical psychopharmacology", "publication_date": "2019-06-01", "publication_year": 2019, "doi": "10.1037/pha0000253", "pubmed_id": "30628811", "openalex_id": "https://openalex.org/W2909121609", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30628811/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Microdosing,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30628811", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30628811/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30628811", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30628811/", "doi": "10.1037/pha0000253", "pmid": "30628811", "publication_date": "2019-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2347, "title": "Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.", "authors": "Johnson MW, Hendricks PS, Barrett FS, Griffiths RR", "journal": "Pharmacology & therapeutics", "publication_date": "2019-05-01", "publication_year": 2019, "doi": "10.1016/j.pharmthera.2018.11.010", "pubmed_id": "30521880", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30521880/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Mystical Experience,Review Article,Healthy Volunteers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30521880", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30521880/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30521880", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30521880/", "doi": "10.1016/j.pharmthera.2018.11.010", "pmid": "30521880", "publication_date": "2019-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2346, "title": "Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.", "authors": "Stenbaek DS, Kristiansen S, Burmester D, Madsen MK, Frokjaer VG, Knudsen GM, Fisher PM", "journal": "Human brain mapping", "publication_date": "2019-05-01", "publication_year": 2019, "doi": "10.1002/hbm.24511", "pubmed_id": "30633430", "openalex_id": "https://openalex.org/W2909396647", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30633430/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Personality Change,Healthy Volunteers,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30633430", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30633430/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30633430", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30633430/", "doi": "10.1002/hbm.24511", "pmid": "30633430", "publication_date": "2019-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3935, "title": "T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors", "authors": "B. Anderson, Alicia Danforth, Robert B. Daroff, Christopher S. Stauffer, James Dilley, Jennifer Mitchell, Joshua Woolley", "journal": "Biological Psychiatry", "publication_date": "2019-04-30", "publication_year": 2019, "doi": "10.1016/j.biopsych.2019.03.460", "pubmed_id": null, "openalex_id": "https://openalex.org/W2946285292", "source_url": "https://doi.org/10.1016/j.biopsych.2019.03.460", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2019.03.460", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2019.03.460", "source_url": "https://doi.org/10.1016/j.biopsych.2019.03.460", "doi": "10.1016/j.biopsych.2019.03.460", "pmid": "", "publication_date": "2019-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3938, "title": "Attitudes Toward Medical Psychedelics", "authors": "McKenna Silva", "journal": "Dominican Scholar (Dominican University of California)", "publication_date": "2019-04-17", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2936920827", "source_url": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Wellbeing,Spirituality,Observational Study", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "source_url": "https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83", "doi": "", "pmid": "", "publication_date": "2019-04-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3940, "title": "Psychedelics Improve the Mental Health of Rats", "authors": "Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2019-04-01", "publication_year": 2019, "doi": "10.1096/fasebj.2019.33.1_supplement.666.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W3175025894", "source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.2019.33.1_supplement.666.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.2019.33.1_supplement.666.1", "source_url": "https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1", "doi": "10.1096/fasebj.2019.33.1_supplement.666.1", "pmid": "", "publication_date": "2019-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3942, "title": "A Study of Psilocybin for Major Depressive Disorder (MDD)", "authors": "Kernel Networks Inc.", "journal": "Case Medical Research", "publication_date": "2019-03-07", "publication_year": 2019, "doi": "10.31525/ct1-nct03866174", "pubmed_id": null, "openalex_id": "https://openalex.org/W4235066019", "source_url": "https://doi.org/10.31525/ct1-nct03866174", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.31525/ct1-nct03866174", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31525/ct1-nct03866174", "source_url": "https://doi.org/10.31525/ct1-nct03866174", "doi": "10.31525/ct1-nct03866174", "pmid": "", "publication_date": "2019-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3943, "title": "Is Psychedelic Medicine on the Horizon?", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-02-28", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.1b1", "pubmed_id": null, "openalex_id": "https://openalex.org/W2918650357", "source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Consciousness,Review Article,Case Report,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.1b1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.1b1", "source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "doi": "10.1176/appi.pn.2019.1b1", "pmid": "", "publication_date": "2019-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5830, "title": "Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens", "authors": "Jenna Varley", "journal": "Journal of Psychedelic Studies", "publication_date": "2019-02-25", "publication_year": 2019, "doi": "10.1556/2054.2019.005", "pubmed_id": null, "openalex_id": "https://openalex.org/W2915910581", "source_url": "https://doi.org/10.1556/2054.2019.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Review Article", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:50", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2019.005", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2019.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2019.005", "source_url": "https://doi.org/10.1556/2054.2019.005", "doi": "10.1556/2054.2019.005", "pmid": "", "publication_date": "2019-02-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3732, "title": "Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.", "authors": "Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS", "journal": "Psychopharmacology", "publication_date": "2019-02-01", "publication_year": 2019, "doi": "10.1007/s00213-018-5106-2", "pubmed_id": "30604183", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30604183/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 11:08:44", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30604183", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30604183/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30604183", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30604183/", "doi": "10.1007/s00213-018-5106-2", "pmid": "30604183", "publication_date": "2019-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2361, "title": "Production Options for Psilocybin: Making of the Magic.", "authors": "Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D", "journal": "Chemistry (Weinheim an der Bergstrasse, Germany)", "publication_date": "2019-01-18", "publication_year": 2019, "doi": "10.1002/chem.201802758", "pubmed_id": "30011099", "openalex_id": "https://openalex.org/W2884828036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30011099/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Clinical Trial,In Vitro Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30011099", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30011099/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30011099", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30011099/", "doi": "10.1002/chem.201802758", "pmid": "30011099", "publication_date": "2019-01-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3957, "title": "Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality", "authors": "William G. Crane", "journal": "Furman University Scholar Exchange (Furman University)", "publication_date": "2019-01-01", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3005336267", "source_url": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "source_url": "https://scholarexchange.furman.edu/furmanengaged/2019/all/522", "doi": "", "pmid": "", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3952, "title": "Psilocybin induces aberrant prediction error processing for tactile mismatch responses", "authors": "P. Dürler", "journal": "European Neuropsychopharmacology", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1016/j.euroneuro.2018.11.477", "pubmed_id": null, "openalex_id": "https://openalex.org/W2912928498", "source_url": "https://doi.org/10.1016/j.euroneuro.2018.11.477", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2018.11.477", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2018.11.477", "source_url": "https://doi.org/10.1016/j.euroneuro.2018.11.477", "doi": "10.1016/j.euroneuro.2018.11.477", "pmid": "", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3947, "title": "2018: A watershed year for psychedelic science", "authors": "Jacob S. Aday, Christopher C. Davoli, Emily K. Bloesch", "journal": "Drug Science Policy and Law", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1177/2050324519872284", "pubmed_id": null, "openalex_id": "https://openalex.org/W2971831602", "source_url": "https://doi.org/10.1177/2050324519872284", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.1177/2050324519872284", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/2050324519872284", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/2050324519872284", "source_url": "https://doi.org/10.1177/2050324519872284", "doi": "10.1177/2050324519872284", "pmid": "", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2363, "title": "Psychedelic drugs-a new era in psychiatry?.", "authors": "Nutt D", "journal": "Dialogues in clinical neuroscience", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.31887/dcns.2019.21.2/dnutt", "pubmed_id": "31636488", "openalex_id": "https://openalex.org/W2985843276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31636488/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31636488", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31636488/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31636488", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31636488/", "doi": "10.31887/dcns.2019.21.2/dnutt", "pmid": "31636488", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2362, "title": "[Neurotrophic mechanisms of psychedelic therapy].", "authors": "Corne R, Mongeau R", "journal": "Biologie aujourd'hui", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1051/jbio/2019015", "pubmed_id": "31829932", "openalex_id": "https://openalex.org/W2995066639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31829932/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Toxicity", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31829932", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31829932/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31829932", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31829932/", "doi": "10.1051/jbio/2019015", "pmid": "31829932", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2354, "title": "Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being.", "authors": "Mason NL, Mischler E, Uthaug MV, Kuypers KPC", "journal": "Journal of psychoactive drugs", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1080/02791072.2019.1580804", "pubmed_id": "30905276", "openalex_id": "https://openalex.org/W2917218353", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30905276/", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Emotional Processing,Creativity,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30905276", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30905276/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30905276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30905276/", "doi": "10.1080/02791072.2019.1580804", "pmid": "30905276", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2353, "title": "Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.", "authors": "Fadiman J, Korb S", "journal": "Journal of psychoactive drugs", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1080/02791072.2019.1593561", "pubmed_id": "30925850", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30925850/", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Microdosing,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30925850", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30925850/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30925850", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30925850/", "doi": "10.1080/02791072.2019.1593561", "pmid": "30925850", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2351, "title": "The Past and Future of Psychedelic Science: An Introduction to This Issue.", "authors": "Doblin RE, Christiansen M, Jerome L, Burge B", "journal": "Journal of psychoactive drugs", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1080/02791072.2019.1606472", "pubmed_id": "31132970", "openalex_id": "https://openalex.org/W2947995541", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31132970/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Creativity,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31132970", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31132970/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31132970", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31132970/", "doi": "10.1080/02791072.2019.1606472", "pmid": "31132970", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2348, "title": "Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.", "authors": "Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1177/2045125319845774", "pubmed_id": "31065350", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31065350/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31065350", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31065350/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31065350", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31065350/", "doi": "10.1177/2045125319845774", "pmid": "31065350", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2329, "title": "Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.", "authors": "Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC", "journal": "Frontiers in psychiatry", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.3389/fpsyt.2019.00672", "pubmed_id": "31572246", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Microdosing,Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31572246", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31572246", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31572246/", "doi": "10.3389/fpsyt.2019.00672", "pmid": "31572246", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3958, "title": "THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression", "authors": "Isabella Stendahl", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2018-12-31", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3045370936", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Emotional Processing,Creativity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749", "doi": "", "pmid": "", "publication_date": "2018-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2371, "title": "Psychedelic drugs in the treatment of anxiety, depression and addiction.", "authors": "Kvam TM, Stewart LH, Andreassen OA", "journal": "Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke", "publication_date": "2018-11-13", "publication_year": 2018, "doi": "10.4045/tidsskr.17.1110", "pubmed_id": "30421744", "openalex_id": "https://openalex.org/W2900730712", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30421744/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Biomarkers,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30421744", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30421744/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30421744", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30421744/", "doi": "10.4045/tidsskr.17.1110", "pmid": "30421744", "publication_date": "2018-11-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3405, "title": "Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers", "authors": "Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K, Hapke E, Farb NAS.", "journal": "PsyArXiv", "publication_date": "2018-11-02", "publication_year": 2018, "doi": "10.31234/osf.io/gk4jd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/gk4jd", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:33", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/gk4jd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/gk4jd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/gk4jd", "source_url": "https://doi.org/10.31234/osf.io/gk4jd", "doi": "10.31234/osf.io/gk4jd", "pmid": "", "publication_date": "2018-11-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2360, "title": "Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers", "authors": "Thomas Anderson, Rotem Petranker, Daniel Rosenbaum, Cory Weissman, Le-Anh Dinh-Williams, Katrina Hui, Emma Hapke, Norman Farb", "journal": "PsyArXiv", "publication_date": "2018-11-02", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "doi": "", "pmid": "", "publication_date": "2018-11-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2376, "title": "Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.", "authors": "Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL", "journal": "Neuropharmacology", "publication_date": "2018-11-01", "publication_year": 2018, "doi": "10.1016/j.neuropharm.2017.12.041", "pubmed_id": "29288686", "openalex_id": "https://openalex.org/W2781340150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29288686/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Emotional Processing,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29288686", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29288686/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29288686", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29288686/", "doi": "10.1016/j.neuropharm.2017.12.041", "pmid": "29288686", "publication_date": "2018-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2375, "title": "The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.", "authors": "Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE", "journal": "Neuropharmacology", "publication_date": "2018-11-01", "publication_year": 2018, "doi": "10.1016/j.neuropharm.2018.05.012", "pubmed_id": "29753748", "openalex_id": "https://openalex.org/W2806419184", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29753748/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Review Article,Cancer Patients,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29753748", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29753748/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29753748", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29753748/", "doi": "10.1016/j.neuropharm.2018.05.012", "pmid": "29753748", "publication_date": "2018-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2374, "title": "Effects of psilocybin therapy on personality structure.", "authors": "Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL", "journal": "Acta psychiatrica Scandinavica", "publication_date": "2018-11-01", "publication_year": 2018, "doi": "10.1111/acps.12904", "pubmed_id": "29923178", "openalex_id": "https://openalex.org/W2807534705", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29923178/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Personality Change,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29923178", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29923178/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29923178", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29923178/", "doi": "10.1111/acps.12904", "pmid": "29923178", "publication_date": "2018-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2384, "title": "Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).", "authors": "Nichols DE", "journal": "ACS chemical neuroscience", "publication_date": "2018-10-17", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00043", "pubmed_id": "29461039", "openalex_id": "https://openalex.org/W2788130744", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29461039/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Mystical Experience,Clinical Trial,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29461039", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29461039/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29461039", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29461039/", "doi": "10.1021/acschemneuro.8b00043", "pmid": "29461039", "publication_date": "2018-10-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2382, "title": "DARK Classics in Chemical Neuroscience: Psilocybin.", "authors": "Geiger HA, Wurst MG, Daniels RN", "journal": "ACS chemical neuroscience", "publication_date": "2018-10-17", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00186", "pubmed_id": "29956917", "openalex_id": "https://openalex.org/W2810710828", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29956917/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Pharmacology,Review Article,Cancer Patients", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29956917", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29956917/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29956917", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29956917/", "doi": "10.1021/acschemneuro.8b00186", "pmid": "29956917", "publication_date": "2018-10-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2380, "title": "DARK Classics in Chemical Neuroscience: Ibogaine.", "authors": "Wasko MJ, Witt-Enderby PA, Surratt CK", "journal": "ACS chemical neuroscience", "publication_date": "2018-10-17", "publication_year": 2018, "doi": "10.1021/acschemneuro.8b00294", "pubmed_id": "30216039", "openalex_id": "https://openalex.org/W2891949993", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30216039/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30216039", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30216039/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30216039", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30216039/", "doi": "10.1021/acschemneuro.8b00294", "pmid": "30216039", "publication_date": "2018-10-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5157, "title": "Serotonin, psychedelics and psychiatry", "authors": "Robin Carhart-Harris", "journal": "World Psychiatry", "publication_date": "2018-09-07", "publication_year": 2018, "doi": "10.1002/wps.20555", "pubmed_id": "30192100", "openalex_id": "https://openalex.org/W2891343109", "source_url": "https://doi.org/10.1002/wps.20555", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:01", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "PMID:30192100", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20555", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:30192100", "source_url": "https://doi.org/10.1002/wps.20555", "doi": "10.1002/wps.20555", "pmid": "30192100", "publication_date": "2018-09-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2389, "title": "Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.", "authors": "Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC", "journal": "Expert review of clinical pharmacology", "publication_date": "2018-09-01", "publication_year": 2018, "doi": "10.1080/17512433.2018.1511424", "pubmed_id": "30102078", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102078/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30102078", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30102078/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30102078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102078/", "doi": "10.1080/17512433.2018.1511424", "pmid": "30102078", "publication_date": "2018-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5158, "title": "The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients", "authors": "Chu Hsien Lim, Brian D. Kangas, Jack Bergman", "journal": "Biochemistry and Molecular Biology Education", "publication_date": "2018-08-01", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2900545389", "source_url": "https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Cancer Patients", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:01", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients", "source_url": "https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients", "doi": "", "pmid": "", "publication_date": "2018-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2395, "title": "Psychedelics as anti-inflammatory agents.", "authors": "Flanagan TW, Nichols CD", "journal": "International review of psychiatry (Abingdon, England)", "publication_date": "2018-08-01", "publication_year": 2018, "doi": "10.1080/09540261.2018.1481827", "pubmed_id": "30102081", "openalex_id": "https://openalex.org/W2886249511", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102081/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30102081", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30102081/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30102081", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102081/", "doi": "10.1080/09540261.2018.1481827", "pmid": "30102081", "publication_date": "2018-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2394, "title": "Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.", "authors": "Ross S", "journal": "International review of psychiatry (Abingdon, England)", "publication_date": "2018-08-01", "publication_year": 2018, "doi": "10.1080/09540261.2018.1482261", "pubmed_id": "30102082", "openalex_id": "https://openalex.org/W2886232664", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102082/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30102082", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30102082/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30102082", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102082/", "doi": "10.1080/09540261.2018.1482261", "pmid": "30102082", "publication_date": "2018-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3290, "title": "Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms", "authors": "Awan AR, Winter JM, Turner D, Shaw WM, Suz LM, Bradshaw AJ, Ellis T, Dentinger BT.", "journal": "bioRxiv", "publication_date": "2018-07-25", "publication_year": 2018, "doi": "10.1101/374199", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/374199", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Genomics,Transcriptomics", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:15:19", "bibtex": null, "source_record_id": "DOI:10.1101/374199", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/374199", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/374199", "source_url": "https://doi.org/10.1101/374199", "doi": "10.1101/374199", "pmid": "", "publication_date": "2018-07-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3553, "title": "Psychopharmacology of Psilocybin in Cancer Patients", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2018-07-19", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00465595", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Consciousness,Spirituality,Healthy Volunteers,Cancer Patients", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00465595", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00465595", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00465595", "source_url": "https://clinicaltrials.gov/study/NCT00465595", "doi": "", "pmid": "", "publication_date": "2018-07-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2396, "title": "Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.", "authors": "Blei F, Baldeweg F, Fricke J, Hoffmeister D", "journal": "Chemistry (Weinheim an der Bergstrasse, Germany)", "publication_date": "2018-07-17", "publication_year": 2018, "doi": "10.1002/chem.201801047", "pubmed_id": "29750381", "openalex_id": "https://openalex.org/W2802656036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29750381/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,In Vitro Study", "study_type": "In Vitro Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29750381", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29750381/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29750381", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29750381/", "doi": "10.1002/chem.201801047", "pmid": "29750381", "publication_date": "2018-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2405, "title": "Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.", "authors": "Lyons T, Carhart-Harris RL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2018-07-01", "publication_year": 2018, "doi": "10.1177/0269881117748902", "pubmed_id": "29338538", "openalex_id": "https://openalex.org/W2784860341", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29338538/", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29338538", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29338538/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29338538", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29338538/", "doi": "10.1177/0269881117748902", "pmid": "29338538", "publication_date": "2018-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2407, "title": "Out of the box: A psychedelic model to study the creative mind.", "authors": "Kuypers KPC", "journal": "Medical hypotheses", "publication_date": "2018-06-01", "publication_year": 2018, "doi": "10.1016/j.mehy.2018.03.010", "pubmed_id": "29685188", "openalex_id": "https://openalex.org/W2790867612", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29685188/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Aging,Creativity,Healthy Volunteers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29685188", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29685188/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29685188", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29685188/", "doi": "10.1016/j.mehy.2018.03.010", "pmid": "29685188", "publication_date": "2018-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2411, "title": "Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?", "authors": "Whelan A, Johnson MI", "journal": "Pain management", "publication_date": "2018-05-01", "publication_year": 2018, "doi": "10.2217/pmt-2017-0068", "pubmed_id": "29722608", "openalex_id": "https://openalex.org/W2794118706", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29722608/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29722608", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29722608/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29722608", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29722608/", "doi": "10.2217/pmt-2017-0068", "pmid": "29722608", "publication_date": "2018-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2417, "title": "Taking Psychedelics Seriously.", "authors": "Byock I", "journal": "Journal of palliative medicine", "publication_date": "2018-04-01", "publication_year": 2018, "doi": "10.1089/jpm.2017.0684", "pubmed_id": "29356590", "openalex_id": "https://openalex.org/W2784340661", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29356590/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Emotional Processing,Spirituality,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29356590", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29356590/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29356590", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29356590/", "doi": "10.1089/jpm.2017.0684", "pmid": "29356590", "publication_date": "2018-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2416, "title": "Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.", "authors": "Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL", "journal": "Journal of affective disorders", "publication_date": "2018-04-01", "publication_year": 2018, "doi": "10.1016/j.jad.2018.01.006", "pubmed_id": "29407543", "openalex_id": "https://openalex.org/W2790056169", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29407543/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29407543", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29407543/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29407543", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29407543/", "doi": "10.1016/j.jad.2018.01.006", "pmid": "29407543", "publication_date": "2018-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5164, "title": "Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway", "authors": "Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi", "journal": "DOAJ (DOAJ: Directory of Open Access Journals)", "publication_date": "2018-03-01", "publication_year": 2018, "doi": "10.22127/rjp.2018.58486", "pubmed_id": null, "openalex_id": "https://openalex.org/W2791918973", "source_url": "https://doaj.org/article/6982e7d479cc425db4622ec49357f976", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,Drug Interactions", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "DOI:10.22127/rjp.2018.58486", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doaj.org/article/6982e7d479cc425db4622ec49357f976", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22127/rjp.2018.58486", "source_url": "https://doaj.org/article/6982e7d479cc425db4622ec49357f976", "doi": "10.22127/rjp.2018.58486", "pmid": "", "publication_date": "2018-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2424, "title": "Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.", "authors": "Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2018-02-02", "publication_year": 2018, "doi": "10.1016/j.pnpbp.2017.09.012", "pubmed_id": "28947181", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947181/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28947181", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28947181/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28947181", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947181/", "doi": "10.1016/j.pnpbp.2017.09.012", "pmid": "28947181", "publication_date": "2018-02-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2429, "title": "Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.", "authors": "Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4754-y", "pubmed_id": "29085980", "openalex_id": "https://openalex.org/W2767171514", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29085980/", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Treatment-Resistant Depression,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29085980", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29085980/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29085980", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29085980/", "doi": "10.1007/s00213-017-4754-y", "pmid": "29085980", "publication_date": "2018-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2427, "title": "Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.", "authors": "Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4771-x", "pubmed_id": "29119217", "openalex_id": "https://openalex.org/W2767530231", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29119217/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29119217", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29119217/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29119217", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29119217/", "doi": "10.1007/s00213-017-4771-x", "pmid": "29119217", "publication_date": "2018-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2425, "title": "The hidden therapist: evidence for a central role of music in psychedelic therapy.", "authors": "Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4820-5", "pubmed_id": "29396616", "openalex_id": "https://openalex.org/W2784069100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29396616/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Mystical Experience,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29396616", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29396616/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29396616", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29396616/", "doi": "10.1007/s00213-017-4820-5", "pmid": "29396616", "publication_date": "2018-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5167, "title": "Can psychedelic drug help with depression?", "authors": "Jessica Hamzelou", "journal": "The New Scientist", "publication_date": "2018-01-31", "publication_year": 2018, "doi": "10.1016/s0262-4079(18)30332-4", "pubmed_id": null, "openalex_id": "https://openalex.org/W2793677349", "source_url": "https://doi.org/10.1016/s0262-4079(18)30332-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 06:52:02", "bibtex": null, "source_record_id": "DOI:10.1016/s0262-4079(18)30332-4", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0262-4079(18)30332-4", "source_url": "https://doi.org/10.1016/s0262-4079(18)30332-4", "doi": "10.1016/s0262-4079(18)30332-4", "pmid": "", "publication_date": "2018-01-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2442, "title": "Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.", "authors": "Barrett FS, Griffiths RR", "journal": "Current topics in behavioral neurosciences", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1007/7854_2017_474", "pubmed_id": "28401522", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28401522/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Default Mode Network,Mystical Experience,Review Article,Healthy Volunteers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28401522", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28401522/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28401522", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28401522/", "doi": "10.1007/7854_2017_474", "pmid": "28401522", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2441, "title": "Therapeutic Applications of Classic Hallucinogens.", "authors": "Bogenschutz MP, Ross S", "journal": "Current topics in behavioral neurosciences", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1007/7854_2016_464", "pubmed_id": "28512684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28512684/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Observational Study,In Vitro Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28512684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28512684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28512684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28512684/", "doi": "10.1007/7854_2016_464", "pmid": "28512684", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2440, "title": "The Effects of Hallucinogens on Gene Expression.", "authors": "Martin DA, Nichols CD", "journal": "Current topics in behavioral neurosciences", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1007/7854_2017_479", "pubmed_id": "28677095", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28677095/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Mystical Experience,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28677095", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28677095/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28677095", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28677095/", "doi": "10.1007/7854_2017_479", "pmid": "28677095", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2436, "title": "Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.", "authors": "Sherwood AM, Prisinzano TE", "journal": "Expert review of clinical pharmacology", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1080/17512433.2018.1415755", "pubmed_id": "29224406", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/29224406/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29224406", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29224406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29224406/", "doi": "10.1080/17512433.2018.1415755", "pmid": "29224406", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2435, "title": "Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.", "authors": "Canal CE", "journal": "Handbook of experimental pharmacology", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1007/164_2018_107", "pubmed_id": "29532180", "openalex_id": "https://openalex.org/W2789541163", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29532180/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29532180", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29532180/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29532180", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29532180/", "doi": "10.1007/164_2018_107", "pmid": "29532180", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2433, "title": "d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.", "authors": "De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G", "journal": "Progress in brain research", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1016/bs.pbr.2018.07.008", "pubmed_id": "30471683", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30471683/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:30471683", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30471683/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30471683", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30471683/", "doi": "10.1016/bs.pbr.2018.07.008", "pmid": "30471683", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2413, "title": "Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.", "authors": "Malone TC, Mennenga SE, Guss J, Podrebarac SK, Owens LT, Bossis AP, Belser AB, Agin-Liebes G, Bogenschutz MP, Ross S", "journal": "Frontiers in pharmacology", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.3389/fphar.2018.00256", "pubmed_id": "29666578", "openalex_id": "https://openalex.org/W2796179442", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29666578/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Cancer Patients,Healthcare Workers", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29666578", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29666578/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29666578", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29666578/", "doi": "10.3389/fphar.2018.00256", "pmid": "29666578", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2398, "title": "Psilocybin and Mental Health-Don't Lose Control.", "authors": "Barnby JM, Mehta MA", "journal": "Frontiers in psychiatry", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.3389/fpsyt.2018.00293", "pubmed_id": "30018574", "openalex_id": "https://openalex.org/W2807830955", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30018574/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30018574", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30018574/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30018574", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30018574/", "doi": "10.3389/fpsyt.2018.00293", "pmid": "30018574", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2385, "title": "More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.", "authors": "Lyons T, Carhart-Harris RL", "journal": "Frontiers in psychology", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.3389/fpsyg.2018.01721", "pubmed_id": "30369890", "openalex_id": "https://openalex.org/W2889504249", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30369890/", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30369890", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30369890/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30369890", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30369890/", "doi": "10.3389/fpsyg.2018.01721", "pmid": "30369890", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2365, "title": "Rapid-Acting Antidepressants.", "authors": "Witkin JM, Knutson DE, Rodriguez GJ, Shi S", "journal": "Current pharmaceutical design", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.2174/1381612824666180730104707", "pubmed_id": "30058481", "openalex_id": "https://openalex.org/W2890893449", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30058481/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Animal Study", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:30058481", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30058481/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30058481", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30058481/", "doi": "10.2174/1381612824666180730104707", "pmid": "30058481", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5179, "title": "Mikrodosering av lysergsyradietylamid och psilocybin och dess effekter på psykisk hälsa", "authors": "Anisha Lela Larsson", "journal": "KTH Publication Database DiVA (KTH Royal Institute of Technology)", "publication_date": "2017-12-31", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3101603169", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "substance_tags": "psilocybin", "topic_tags": "Depression,Animal Study", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476", "doi": "", "pmid": "", "publication_date": "2017-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3631, "title": "Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression", "authors": "University of Helsinki", "journal": "ClinicalTrials.gov", "publication_date": "2017-12-21", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03380442", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03380442", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03380442", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03380442", "source_url": "https://clinicaltrials.gov/study/NCT03380442", "doi": "", "pmid": "", "publication_date": "2017-12-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5181, "title": "„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku", "authors": "Joanna Stefaniuk", "journal": "CeON Repository (Centre for Evaluation in Education and Science)", "publication_date": "2017-12-01", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2771603125", "source_url": "https://depot.ceon.pl/handle/123456789/13483", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "https://depot.ceon.pl/handle/123456789/13483", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://depot.ceon.pl/handle/123456789/13483", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://depot.ceon.pl/handle/123456789/13483", "source_url": "https://depot.ceon.pl/handle/123456789/13483", "doi": "", "pmid": "", "publication_date": "2017-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2446, "title": "Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.", "authors": "Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR", "journal": "Clinical pharmacokinetics", "publication_date": "2017-12-01", "publication_year": 2017, "doi": "10.1007/s40262-017-0540-6", "pubmed_id": "28353056", "openalex_id": "https://openalex.org/W2600624779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28353056/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28353056", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28353056/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28353056", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28353056/", "doi": "10.1007/s40262-017-0540-6", "pmid": "28353056", "publication_date": "2017-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5185, "title": "Can Psilocybin Treat Severe Depression", "authors": "Barbara Geller", "journal": "Journal watch", "publication_date": "2017-11-03", "publication_year": 2017, "doi": "10.1056/nejm-jw.na45292", "pubmed_id": null, "openalex_id": "https://openalex.org/W2766340631", "source_url": "https://www.jwatch.org/na45292/2017/11/03/can-psilocybin-treat-severe-depression", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "DOI:10.1056/nejm-jw.na45292", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://www.jwatch.org/na45292/2017/11/03/can-psilocybin-treat-severe-depression", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1056/nejm-jw.na45292", "source_url": "https://www.jwatch.org/na45292/2017/11/03/can-psilocybin-treat-severe-depression", "doi": "10.1056/nejm-jw.na45292", "pmid": "", "publication_date": "2017-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2449, "title": "Psychedelic Drugs in Biomedicine.", "authors": "Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV", "journal": "Trends in pharmacological sciences", "publication_date": "2017-11-01", "publication_year": 2017, "doi": "10.1016/j.tips.2017.08.003", "pubmed_id": "28947075", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947075/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28947075", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28947075/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28947075", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947075/", "doi": "10.1016/j.tips.2017.08.003", "pmid": "28947075", "publication_date": "2017-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2452, "title": "Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.", "authors": "Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ", "journal": "Scientific reports", "publication_date": "2017-10-13", "publication_year": 2017, "doi": "10.1038/s41598-017-13282-7", "pubmed_id": "29030624", "openalex_id": "https://openalex.org/W2762746674", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29030624/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29030624", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29030624/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29030624", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29030624/", "doi": "10.1038/s41598-017-13282-7", "pmid": "29030624", "publication_date": "2017-10-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2456, "title": "The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.", "authors": "Carhart-Harris RL, Goodwin GM", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2017-10-01", "publication_year": 2017, "doi": "10.1038/npp.2017.84", "pubmed_id": "28443617", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28443617/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28443617", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28443617/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28443617", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28443617/", "doi": "10.1038/npp.2017.84", "pmid": "28443617", "publication_date": "2017-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5189, "title": "Google Trends Analyses and Case Report: A Persistently Dilated Pupil in Psychedelics’ User", "authors": "Ahmed Al-Imam", "journal": "Global Journal of Health Science", "publication_date": "2017-09-18", "publication_year": 2017, "doi": "10.5539/gjhs.v9n11p168", "pubmed_id": null, "openalex_id": "https://openalex.org/W2754605292", "source_url": "https://doi.org/10.5539/gjhs.v9n11p168", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Case Report,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "DOI:10.5539/gjhs.v9n11p168", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5539/gjhs.v9n11p168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5539/gjhs.v9n11p168", "source_url": "https://doi.org/10.5539/gjhs.v9n11p168", "doi": "10.5539/gjhs.v9n11p168", "pmid": "", "publication_date": "2017-09-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5191, "title": "‘Magic mushroom’ enzyme mystery solved", "authors": "STEVE RITTER", "journal": "C&EN Global Enterprise", "publication_date": "2017-08-20", "publication_year": 2017, "doi": "10.1021/cen-09533-notw1", "pubmed_id": null, "openalex_id": "https://openalex.org/W2746206207", "source_url": "https://doi.org/10.1021/cen-09533-notw1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1021/cen-09533-notw1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/cen-09533-notw1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/cen-09533-notw1", "source_url": "https://doi.org/10.1021/cen-09533-notw1", "doi": "10.1021/cen-09533-notw1", "pmid": "", "publication_date": "2017-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2468, "title": "An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.", "authors": "Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2017-07-01", "publication_year": 2017, "doi": "10.1177/0269881116684335", "pubmed_id": "28095732", "openalex_id": "https://openalex.org/W2573408014", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28095732/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Emotional Processing,Spirituality,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28095732", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28095732/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28095732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28095732/", "doi": "10.1177/0269881116684335", "pmid": "28095732", "publication_date": "2017-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2467, "title": "Potential Therapeutic Effects of Psilocybin.", "authors": "Johnson MW, Griffiths RR", "journal": "Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics", "publication_date": "2017-07-01", "publication_year": 2017, "doi": "10.1007/s13311-017-0542-y", "pubmed_id": "28585222", "openalex_id": "https://openalex.org/W2622982732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28585222/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28585222", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28585222/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28585222", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28585222/", "doi": "10.1007/s13311-017-0542-y", "pmid": "28585222", "publication_date": "2017-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2466, "title": "[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].", "authors": "Majić T, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J", "journal": "Fortschritte der Neurologie-Psychiatrie", "publication_date": "2017-07-01", "publication_year": 2017, "doi": "10.1055/s-0043-103085", "pubmed_id": "28768346", "openalex_id": "https://openalex.org/W2739569800", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28768346/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28768346", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28768346/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28768346", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28768346/", "doi": "10.1055/s-0043-103085", "pmid": "28768346", "publication_date": "2017-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5202, "title": "Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression", "authors": "Rosalind Watts, Camilla Day, Jacob Krzanowski, David Nutt, Robin Carhart-Harris", "journal": "Journal of Humanistic Psychology", "publication_date": "2017-06-19", "publication_year": 2017, "doi": "10.1177/0022167817709585", "pubmed_id": null, "openalex_id": "https://openalex.org/W2644260506", "source_url": "https://doi.org/10.1177/0022167817709585", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Treatment-Resistant Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "DOI:10.1177/0022167817709585", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0022167817709585", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/0022167817709585", "source_url": "https://doi.org/10.1177/0022167817709585", "doi": "10.1177/0022167817709585", "pmid": "", "publication_date": "2017-06-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2470, "title": "Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia.", "authors": "Strauss N", "journal": "The Medical journal of Australia", "publication_date": "2017-06-19", "publication_year": 2017, "doi": "10.5694/mja17.00081", "pubmed_id": "28918722", "openalex_id": "https://openalex.org/W2625663774", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28918722/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28918722", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28918722", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28918722/", "doi": "10.5694/mja17.00081", "pmid": "28918722", "publication_date": "2017-06-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5203, "title": "Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress", "authors": "Thomas Cody Swift, Alexander Belser, Gabrielle Agin-Liebes, Neşe Devenot, Sara Terrana, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross", "journal": "Journal of Humanistic Psychology", "publication_date": "2017-06-14", "publication_year": 2017, "doi": "10.1177/0022167817715966", "pubmed_id": null, "openalex_id": "https://openalex.org/W2626493232", "source_url": "https://doi.org/10.1177/0022167817715966", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Emotional Processing,Spirituality,Randomized Controlled Trial,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "DOI:10.1177/0022167817715966", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0022167817715966", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/0022167817715966", "source_url": "https://doi.org/10.1177/0022167817715966", "doi": "10.1177/0022167817715966", "pmid": "", "publication_date": "2017-06-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5832, "title": "Should addiction researchers be interested in psychedelic science?", "authors": "Stephen Bright, M.L. Williams, David Caldicott", "journal": "Drug and Alcohol Review", "publication_date": "2017-04-10", "publication_year": 2017, "doi": "10.1111/dar.12544", "pubmed_id": "28397321", "openalex_id": "https://openalex.org/W2606394595", "source_url": "https://doi.org/10.1111/dar.12544", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Observational Study,Veterans,Safety,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:52", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "PMID:28397321", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/dar.12544", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:28397321", "source_url": "https://doi.org/10.1111/dar.12544", "doi": "10.1111/dar.12544", "pmid": "28397321", "publication_date": "2017-04-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5208, "title": "Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma models", "authors": "Thomas W. Flanagan, Melaine N. Sebastian, Charles D. Nichols", "journal": "The FASEB Journal", "publication_date": "2017-04-01", "publication_year": 2017, "doi": "10.1096/fasebj.31.1_supplement.820.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W2970574043", "source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "DOI:10.1096/fasebj.31.1_supplement.820.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1096/fasebj.31.1_supplement.820.4", "source_url": "https://doi.org/10.1096/fasebj.31.1_supplement.820.4", "doi": "10.1096/fasebj.31.1_supplement.820.4", "pmid": "", "publication_date": "2017-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2473, "title": "Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.", "authors": "Dos Santos RG, Bouso JC, Hallak JEC", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2017-04-01", "publication_year": 2017, "doi": "10.1177/2045125316689030", "pubmed_id": "28540034", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28540034/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Case Report", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28540034", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28540034/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28540034", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28540034/", "doi": "10.1177/2045125316689030", "pmid": "28540034", "publication_date": "2017-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2474, "title": "The fibrinolytic system: A new target for treatment of depression with psychedelics.", "authors": "Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S", "journal": "Medical hypotheses", "publication_date": "2017-03-01", "publication_year": 2017, "doi": "10.1016/j.mehy.2017.01.013", "pubmed_id": "28236848", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28236848/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Receptor Pharmacology,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28236848", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28236848/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28236848", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28236848/", "doi": "10.1016/j.mehy.2017.01.013", "pmid": "28236848", "publication_date": "2017-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2478, "title": "Psilocybin for treating substance use disorders?", "authors": "de Veen BT, Schellekens AF, Verheij MM, Homberg JR", "journal": "Expert review of neurotherapeutics", "publication_date": "2017-02-01", "publication_year": 2017, "doi": "10.1080/14737175.2016.1220834", "pubmed_id": "27684102", "openalex_id": "https://openalex.org/W2499216663", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27684102/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:27684102", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27684102/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27684102", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27684102/", "doi": "10.1080/14737175.2016.1220834", "pmid": "27684102", "publication_date": "2017-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2477, "title": "Psychedelics as Medicines: An Emerging New Paradigm.", "authors": "Nichols DE, Johnson MW, Nichols CD", "journal": "Clinical pharmacology and therapeutics", "publication_date": "2017-02-01", "publication_year": 2017, "doi": "10.1002/cpt.557", "pubmed_id": "28019026", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28019026/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28019026", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28019026/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28019026", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28019026/", "doi": "10.1002/cpt.557", "pmid": "28019026", "publication_date": "2017-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5217, "title": "Maddening Therapies: How Hallucinogens Morphed into Novel Treatments", "authors": "Henry A. Nasrallah", "journal": "Current psychiatry", "publication_date": "2017-01-01", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2992985834", "source_url": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Brain Imaging,Pharmacology,Aging,Wellbeing,Creativity,Review Article,Treatment-Resistant Depression,Immune Function", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "source_url": "https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into", "doi": "", "pmid": "", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5215, "title": "Narrative therapy-assisted psilocybin use for treatment of depression", "authors": "Carlyn Delavan", "journal": "Seattle Pacific University Research Conference", "publication_date": "2017-01-01", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2797914777", "source_url": "https://digitalcommons.spu.edu/spfc_research_conference/spfc_conf_2017/spfc_conf_2017_events/43/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://digitalcommons.spu.edu/spfc_research_conference/spfc_conf_2017/spfc_conf_2017_events/43/", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.spu.edu/spfc_research_conference/spfc_conf_2017/spfc_conf_2017_events/43/", "source_url": "https://digitalcommons.spu.edu/spfc_research_conference/spfc_conf_2017/spfc_conf_2017_events/43/", "doi": "", "pmid": "", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2481, "title": "Role of psilocybin in the treatment of depression.", "authors": "Mahapatra A, Gupta R", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.1177/2045125316676092", "pubmed_id": "28101325", "openalex_id": "https://openalex.org/W2542493272", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28101325/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28101325", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28101325/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28101325", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28101325/", "doi": "10.1177/2045125316676092", "pmid": "28101325", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2479, "title": "Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand.", "authors": "Al-Imam A", "journal": "Case reports in neurological medicine", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.1155/2017/2503762", "pubmed_id": "28948056", "openalex_id": "https://openalex.org/W2748929572", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28948056/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Case Report", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28948056", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28948056/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28948056", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28948056/", "doi": "10.1155/2017/2503762", "pmid": "28948056", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2450, "title": "Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.", "authors": "Thomas K, Malcolm B, Lastra D", "journal": "Journal of psychoactive drugs", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.1080/02791072.2017.1320734", "pubmed_id": "28481178", "openalex_id": "https://openalex.org/W2612228298", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28481178/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Default Mode Network,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28481178", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28481178/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28481178", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28481178/", "doi": "10.1080/02791072.2017.1320734", "pmid": "28481178", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2447, "title": "The \"Endless Trip\" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.", "authors": "Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F", "journal": "Frontiers in psychiatry", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.3389/fpsyt.2017.00240", "pubmed_id": "29209235", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/29209235/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29209235", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29209235/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29209235", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29209235/", "doi": "10.3389/fpsyt.2017.00240", "pmid": "29209235", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2431, "title": "Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.", "authors": "Roseman L, Nutt DJ, Carhart-Harris RL", "journal": "Frontiers in pharmacology", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.3389/fphar.2017.00974", "pubmed_id": "29387009", "openalex_id": "https://openalex.org/W2792444257", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29387009/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29387009", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29387009/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29387009", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29387009/", "doi": "10.3389/fphar.2017.00974", "pmid": "29387009", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2419, "title": "Clinical potential of psilocybin as a treatment for mental health conditions.", "authors": "Daniel J, Haberman M", "journal": "The mental health clinician", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.9740/mhc.2017.01.024", "pubmed_id": "29955494", "openalex_id": "https://openalex.org/W2567379065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29955494/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Receptor Pharmacology,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29955494", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29955494/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29955494", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29955494/", "doi": "10.9740/mhc.2017.01.024", "pmid": "29955494", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5221, "title": "Lysergsyradietylamid (LSD) och psilocybin vid depression och ångestsjukdom: En litteraturstudie om effekter och biverkningar av LSD- och psilocybin-assisterad psykoterapi", "authors": "Natalie Engström", "journal": "KTH Publication Database DiVA (KTH Royal Institute of Technology)", "publication_date": "2016-12-31", "publication_year": 2016, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3047601216", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681", "doi": "", "pmid": "", "publication_date": "2016-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2498, "title": "The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.", "authors": "Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116678781", "pubmed_id": "27856683", "openalex_id": "https://openalex.org/W2549202270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856683/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Wellbeing,Spirituality,Case Report,Observational Study,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27856683", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27856683/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27856683", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856683/", "doi": "10.1177/0269881116678781", "pmid": "27856683", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2497, "title": "Psychedelics in the treatment of unipolar mood disorders: a systematic review.", "authors": "Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116679368", "pubmed_id": "27856684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856684/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27856684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27856684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27856684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856684/", "doi": "10.1177/0269881116679368", "pmid": "27856684", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2496, "title": "Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.", "authors": "Nutt D", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116675754", "pubmed_id": "27909163", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909163/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27909163", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27909163", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909163/", "doi": "10.1177/0269881116675754", "pmid": "27909163", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2495, "title": "Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.", "authors": "Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116675512", "pubmed_id": "27909164", "openalex_id": "https://openalex.org/W2559739670", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909164/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Randomized Controlled Trial,Cancer Patients", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27909164", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27909164/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27909164", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909164/", "doi": "10.1177/0269881116675512", "pmid": "27909164", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2494, "title": "Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.", "authors": "Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116675513", "pubmed_id": "27909165", "openalex_id": "https://openalex.org/W2558412547", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909165/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Cancer Patients,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27909165", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27909165/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27909165", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909165/", "doi": "10.1177/0269881116675513", "pmid": "27909165", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2490, "title": "Psilocybin for depression and anxiety associated with life-threatening illnesses.", "authors": "McCorvy JD, Olsen RH, Roth BL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116675771", "pubmed_id": "27909171", "openalex_id": "https://openalex.org/W2559733313", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909171/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27909171", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27909171", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909171/", "doi": "10.1177/0269881116675771", "pmid": "27909171", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2486, "title": "Return of the psychedelics: Psilocybin for treatment resistant depression.", "authors": "Patra S", "journal": "Asian journal of psychiatry", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1016/j.ajp.2016.08.010", "pubmed_id": "27931907", "openalex_id": "https://openalex.org/W2512668841", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27931907/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27931907", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27931907/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27931907", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27931907/", "doi": "10.1016/j.ajp.2016.08.010", "pmid": "27931907", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2502, "title": "Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models.", "authors": "Kyzar EJ, Kalueff AV", "journal": "Zebrafish", "publication_date": "2016-10-01", "publication_year": 2016, "doi": "10.1089/zeb.2016.1251", "pubmed_id": "27002655", "openalex_id": "https://openalex.org/W2309813531", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27002655/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Animal Study", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27002655", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27002655/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27002655", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27002655/", "doi": "10.1089/zeb.2016.1251", "pmid": "27002655", "publication_date": "2016-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5231, "title": "Psilocybin as an alternative medicine for patients suffering from depression", "authors": "Karolina Dydak, Mariola Śliwińska-Mossoń, Halina Milnerowicz", "journal": "Psychiatria i Psychologia Kliniczna", "publication_date": "2016-09-30", "publication_year": 2016, "doi": "10.15557/pipk.2016.0023", "pubmed_id": null, "openalex_id": "https://openalex.org/W2572466674", "source_url": "https://doi.org/10.15557/pipk.2016.0023", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "DOI:10.15557/pipk.2016.0023", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.15557/pipk.2016.0023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.15557/pipk.2016.0023", "source_url": "https://doi.org/10.15557/pipk.2016.0023", "doi": "10.15557/pipk.2016.0023", "pmid": "", "publication_date": "2016-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2511, "title": "Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.", "authors": "Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ", "journal": "The lancet. Psychiatry", "publication_date": "2016-07-01", "publication_year": 2016, "doi": "10.1016/s2215-0366(16)30065-7", "pubmed_id": "27210031", "openalex_id": "https://openalex.org/W2396675581", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27210031/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27210031", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27210031/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27210031", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27210031/", "doi": "10.1016/s2215-0366(16)30065-7", "pmid": "27210031", "publication_date": "2016-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2510, "title": "Altered states: psilocybin for treatment-resistant depression.", "authors": "Cowen P", "journal": "The lancet. Psychiatry", "publication_date": "2016-07-01", "publication_year": 2016, "doi": "10.1016/s2215-0366(16)30087-6", "pubmed_id": "27210032", "openalex_id": "https://openalex.org/W2398800790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27210032/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27210032", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27210032/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27210032", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27210032/", "doi": "10.1016/s2215-0366(16)30087-6", "pmid": "27210032", "publication_date": "2016-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2508, "title": "Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.", "authors": "Howland RH", "journal": "Journal of psychosocial nursing and mental health services", "publication_date": "2016-07-01", "publication_year": 2016, "doi": "10.3928/02793695-20160616-09", "pubmed_id": "27362381", "openalex_id": "https://openalex.org/W2470545286", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27362381/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27362381", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27362381/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27362381", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27362381/", "doi": "10.3928/02793695-20160616-09", "pmid": "27362381", "publication_date": "2016-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2513, "title": "Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.", "authors": "Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2016-06-01", "publication_year": 2016, "doi": "10.1177/2045125316638008", "pubmed_id": "27354908", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/27354908/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27354908", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27354908/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27354908", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27354908/", "doi": "10.1177/2045125316638008", "pmid": "27354908", "publication_date": "2016-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5243, "title": "A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects", "authors": "Joseph A. Zamaria", "journal": "NeuroQuantology", "publication_date": "2016-05-24", "publication_year": 2016, "doi": "10.14704/nq.2016.14.2.943", "pubmed_id": null, "openalex_id": "https://openalex.org/W77478258", "source_url": "https://doi.org/10.14704/nq.2016.14.2.943", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Consciousness,Emotional Processing,Spirituality", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "DOI:10.14704/nq.2016.14.2.943", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.14704/nq.2016.14.2.943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.14704/nq.2016.14.2.943", "source_url": "https://doi.org/10.14704/nq.2016.14.2.943", "doi": "10.14704/nq.2016.14.2.943", "pmid": "", "publication_date": "2016-05-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2519, "title": "Psychedelics.", "authors": "Nichols DE", "journal": "Pharmacological reviews", "publication_date": "2016-04-01", "publication_year": 2016, "doi": "10.1124/pr.115.011478", "pubmed_id": "26841800", "openalex_id": "https://openalex.org/W4386471172", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26841800/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Receptor Pharmacology,Default Mode Network,Aging,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:26841800", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/26841800/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:26841800", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26841800/", "doi": "10.1124/pr.115.011478", "pmid": "26841800", "publication_date": "2016-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5248, "title": "The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)", "authors": "Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis", "journal": "European Psychiatry", "publication_date": "2016-02-29", "publication_year": 2016, "doi": "10.1016/j.eurpsy.2016.01.1060", "pubmed_id": null, "openalex_id": "https://openalex.org/W2376514477", "source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Review Article,Case Report,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1016/j.eurpsy.2016.01.1060", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.eurpsy.2016.01.1060", "source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "doi": "10.1016/j.eurpsy.2016.01.1060", "pmid": "", "publication_date": "2016-02-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2525, "title": "The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.", "authors": "Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX", "journal": "NeuroImage. Clinical", "publication_date": "2016-01-01", "publication_year": 2016, "doi": "10.1016/j.nicl.2015.08.009", "pubmed_id": "26909323", "openalex_id": "https://openalex.org/W1191653087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26909323/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Receptor Pharmacology,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:26909323", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/26909323/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:26909323", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26909323/", "doi": "10.1016/j.nicl.2015.08.009", "pmid": "26909323", "publication_date": "2016-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2524, "title": "Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.", "authors": "Tófoli LF, de Araujo DB", "journal": "International review of neurobiology", "publication_date": "2016-01-01", "publication_year": 2016, "doi": "10.1016/bs.irn.2016.06.005", "pubmed_id": "27503452", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/27503452/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Aging,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27503452", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27503452/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27503452", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27503452/", "doi": "10.1016/bs.irn.2016.06.005", "pmid": "27503452", "publication_date": "2016-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2530, "title": "Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.", "authors": "Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX", "journal": "Biological psychiatry", "publication_date": "2015-10-15", "publication_year": 2015, "doi": "10.1016/j.biopsych.2014.04.010", "pubmed_id": "24882567", "openalex_id": "https://openalex.org/W2093203605", "source_url": "https://pubmed.ncbi.nlm.nih.gov/24882567/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Receptor Pharmacology,Aging,Emotional Processing,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:24882567", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/24882567/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:24882567", "source_url": "https://pubmed.ncbi.nlm.nih.gov/24882567/", "doi": "10.1016/j.biopsych.2014.04.010", "pmid": "24882567", "publication_date": "2015-10-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5263, "title": "P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers", "authors": "Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider", "journal": "European Neuropsychopharmacology", "publication_date": "2015-09-01", "publication_year": 2015, "doi": "10.1016/s0924-977x(15)30364-3", "pubmed_id": null, "openalex_id": "https://openalex.org/W2513457040", "source_url": "https://doi.org/10.1016/s0924-977x(15)30364-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Receptor Pharmacology,Healthy Volunteers", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/s0924-977x(15)30364-3", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0924-977x(15)30364-3", "source_url": "https://doi.org/10.1016/s0924-977x(15)30364-3", "doi": "10.1016/s0924-977x(15)30364-3", "pmid": "", "publication_date": "2015-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5268, "title": "5HT2a Receptors - a New Target for Depression?", "authors": "D.J. Nutt", "journal": "European Psychiatry", "publication_date": "2015-03-01", "publication_year": 2015, "doi": "10.1016/s0924-9338(15)30027-4", "pubmed_id": null, "openalex_id": "https://openalex.org/W562065783", "source_url": "https://doi.org/10.1016/s0924-9338(15)30027-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Default Mode Network", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/s0924-9338(15)30027-4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/s0924-9338(15)30027-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0924-9338(15)30027-4", "source_url": "https://doi.org/10.1016/s0924-9338(15)30027-4", "doi": "10.1016/s0924-9338(15)30027-4", "pmid": "", "publication_date": "2015-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5267, "title": "The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making", "authors": "Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider", "journal": "European Psychiatry", "publication_date": "2015-03-01", "publication_year": 2015, "doi": "10.1016/s0924-9338(15)30017-1", "pubmed_id": null, "openalex_id": "https://openalex.org/W563138297", "source_url": "https://doi.org/10.1016/s0924-9338(15)30017-1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Receptor Pharmacology,Emotional Processing,Healthy Volunteers,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/s0924-9338(15)30017-1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/s0924-9338(15)30017-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0924-9338(15)30017-1", "source_url": "https://doi.org/10.1016/s0924-9338(15)30017-1", "doi": "10.1016/s0924-9338(15)30017-1", "pmid": "", "publication_date": "2015-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2542, "title": "Psychedelics not linked to mental health problems or suicidal behavior: a population study.", "authors": "Johansen PØ, Krebs TS", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2015-03-01", "publication_year": 2015, "doi": "10.1177/0269881114568039", "pubmed_id": "25744618", "openalex_id": "https://openalex.org/W2097999899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25744618/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25744618", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25744618/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25744618", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25744618/", "doi": "10.1177/0269881114568039", "pmid": "25744618", "publication_date": "2015-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2558, "title": "Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.", "authors": "Baumeister D, Barnes G, Giaroli G, Tracy D", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2014-08-01", "publication_year": 2014, "doi": "10.1177/2045125314527985", "pubmed_id": "25083275", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Spirituality,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25083275", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25083275", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "doi": "10.1177/2045125314527985", "pmid": "25083275", "publication_date": "2014-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2567, "title": "The Heffter Research Institute: past and hopeful future.", "authors": "Nichols DE", "journal": "Journal of psychoactive drugs", "publication_date": "2014-01-01", "publication_year": 2014, "doi": "10.1080/02791072.2014.873688", "pubmed_id": "24830182", "openalex_id": "https://openalex.org/W1982006269", "source_url": "https://pubmed.ncbi.nlm.nih.gov/24830182/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:24830182", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/24830182/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:24830182", "source_url": "https://pubmed.ncbi.nlm.nih.gov/24830182/", "doi": "10.1080/02791072.2014.873688", "pmid": "24830182", "publication_date": "2014-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2578, "title": "Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.", "authors": "Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2013-09-01", "publication_year": 2013, "doi": "10.1177/0269881113494107", "pubmed_id": "23784738", "openalex_id": "https://openalex.org/W1982429022", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23784738/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23784738", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23784738/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23784738", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23784738/", "doi": "10.1177/0269881113494107", "pmid": "23784738", "publication_date": "2013-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2591, "title": "Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.", "authors": "Young SN", "journal": "Journal of psychiatry & neuroscience: JPN", "publication_date": "2013-03-01", "publication_year": 2013, "doi": "10.1503/jpn.120128", "pubmed_id": "23171696", "openalex_id": "https://openalex.org/W23171696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23171696/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Animal Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23171696", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23171696/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23171696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23171696/", "doi": "10.1503/jpn.120128", "pmid": "23171696", "publication_date": "2013-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5313, "title": "Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations", "authors": "Michael Kometer, André Schmidt, Lutz Jäncke, Franz X. Vollenweider", "journal": "Open MIND", "publication_date": "2013-01-01", "publication_year": 2013, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W6929930661", "source_url": "https://openalex.org/W6929930661", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Genomics", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:54", "bibtex": null, "source_record_id": "https://openalex.org/W6929930661", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://openalex.org/W6929930661", "source_url": "https://openalex.org/W6929930661", "doi": "", "pmid": "", "publication_date": "2013-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2579, "title": "Psychedelics and mental health: a population study.", "authors": "Krebs TS, Johansen PØ", "journal": "PloS one", "publication_date": "2013-01-01", "publication_year": 2013, "doi": "10.1371/journal.pone.0063972", "pubmed_id": "23976938", "openalex_id": "https://openalex.org/W2014761647", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23976938/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23976938", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23976938/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23976938", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23976938/", "doi": "10.1371/journal.pone.0063972", "pmid": "23976938", "publication_date": "2013-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2597, "title": "Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.", "authors": "Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX", "journal": "Biological psychiatry", "publication_date": "2012-12-01", "publication_year": 2012, "doi": "10.1016/j.biopsych.2012.04.005", "pubmed_id": "22578254", "openalex_id": "https://openalex.org/W1974074998", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22578254/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:22578254", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/22578254/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:22578254", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22578254/", "doi": "10.1016/j.biopsych.2012.04.005", "pmid": "22578254", "publication_date": "2012-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5836, "title": "Opening Doors of Perception: Psychedelic Drugs and End-of-Life Care", "authors": "Norra MacReady", "journal": "JNCI Journal of the National Cancer Institute", "publication_date": "2012-10-25", "publication_year": 2012, "doi": "10.1093/jnci/djs468", "pubmed_id": "23104218", "openalex_id": "https://openalex.org/W2073079459", "source_url": "https://doi.org/10.1093/jnci/djs468", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Consciousness,Aging,Spirituality,Mystical Experience,Review Article,Healthy Volunteers,Adolescents,Cancer Patients,Healthcare Workers", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:54", "last_checked": "2026-08-09 08:25:54", "bibtex": null, "source_record_id": "PMID:23104218", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/jnci/djs468", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:23104218", "source_url": "https://doi.org/10.1093/jnci/djs468", "doi": "10.1093/jnci/djs468", "pmid": "23104218", "publication_date": "2012-10-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2605, "title": "Neuroimaging: a scanner, colourfully.", "authors": "Roiser JP, Rees G", "journal": "Current biology: CB", "publication_date": "2012-04-10", "publication_year": 2012, "doi": "10.1016/j.cub.2012.02.033", "pubmed_id": "22497939", "openalex_id": "https://openalex.org/W2082661311", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22497939/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Emotional Processing", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:22497939", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/22497939/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:22497939", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22497939/", "doi": "10.1016/j.cub.2012.02.033", "pmid": "22497939", "publication_date": "2012-04-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2627, "title": "Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.", "authors": "Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR", "journal": "Archives of general psychiatry", "publication_date": "2011-01-01", "publication_year": 2011, "doi": "10.1001/archgenpsychiatry.2010.116", "pubmed_id": "20819978", "openalex_id": "https://openalex.org/W2161555895", "source_url": "https://pubmed.ncbi.nlm.nih.gov/20819978/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:20819978", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/20819978/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:20819978", "source_url": "https://pubmed.ncbi.nlm.nih.gov/20819978/", "doi": "10.1001/archgenpsychiatry.2010.116", "pmid": "20819978", "publication_date": "2011-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2649, "title": "Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.", "authors": "Adams JD", "journal": "Current medicinal chemistry", "publication_date": "2009-01-01", "publication_year": 2009, "doi": "10.2174/092986709789057626", "pubmed_id": "19799545", "openalex_id": "https://openalex.org/W2002362539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/19799545/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Receptor Pharmacology,Review Article,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:29", "bibtex": null, "source_record_id": "PMID:19799545", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/19799545/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:19799545", "source_url": "https://pubmed.ncbi.nlm.nih.gov/19799545/", "doi": "10.2174/092986709789057626", "pmid": "19799545", "publication_date": "2009-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5381, "title": "Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis", "authors": "Briony J. Catlow", "journal": "Digital Commons - University of South Florida (University of South Florida)", "publication_date": "2007-12-31", "publication_year": 2007, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W1522661265", "source_url": "https://digitalcommons.usf.edu/etd/166", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "https://digitalcommons.usf.edu/etd/166", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.usf.edu/etd/166", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.usf.edu/etd/166", "source_url": "https://digitalcommons.usf.edu/etd/166", "doi": "", "pmid": "", "publication_date": "2007-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5407, "title": "Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis", "authors": "Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren", "journal": "Pharmacopsychiatry", "publication_date": "2005-09-01", "publication_year": 2005, "doi": "10.1055/s-2005-918695", "pubmed_id": null, "openalex_id": "https://openalex.org/W2331400020", "source_url": "https://doi.org/10.1055/s-2005-918695", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Healthy Volunteers", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-08-09 08:25:55", "bibtex": null, "source_record_id": "DOI:10.1055/s-2005-918695", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/s-2005-918695", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/s-2005-918695", "source_url": "https://doi.org/10.1055/s-2005-918695", "doi": "10.1055/s-2005-918695", "pmid": "", "publication_date": "2005-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5838, "title": "Can psychedelics have a role in psychiatry once again?", "authors": "Ben Sessa", "journal": "The British Journal of Psychiatry", "publication_date": "2005-06-01", "publication_year": 2005, "doi": "10.1192/bjp.186.6.457", "pubmed_id": "15928353", "openalex_id": "https://openalex.org/W2134763275", "source_url": "https://doi.org/10.1192/bjp.186.6.457", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:55", "last_checked": "2026-08-09 08:25:55", "bibtex": null, "source_record_id": "PMID:15928353", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjp.186.6.457", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:15928353", "source_url": "https://doi.org/10.1192/bjp.186.6.457", "doi": "10.1192/bjp.186.6.457", "pmid": "15928353", "publication_date": "2005-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5421, "title": "Designer Hallucinogens", "authors": "Leon Gussow", "journal": "Emergency Medicine News", "publication_date": "2003-12-01", "publication_year": 2003, "doi": "10.1097/00132981-200312000-00015", "pubmed_id": null, "openalex_id": "https://openalex.org/W2319772829", "source_url": "https://doi.org/10.1097/00132981-200312000-00015", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-08-09 08:25:56", "bibtex": null, "source_record_id": "DOI:10.1097/00132981-200312000-00015", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/00132981-200312000-00015", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/00132981-200312000-00015", "source_url": "https://doi.org/10.1097/00132981-200312000-00015", "doi": "10.1097/00132981-200312000-00015", "pmid": "", "publication_date": "2003-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5422, "title": "P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis", "authors": "Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider", "journal": "European Neuropsychopharmacology", "publication_date": "2003-10-01", "publication_year": 2003, "doi": "10.1016/s0924-977x(03)92355-8", "pubmed_id": null, "openalex_id": "https://openalex.org/W2051778190", "source_url": "https://doi.org/10.1016/s0924-977x(03)92355-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-08-09 08:25:56", "bibtex": null, "source_record_id": "DOI:10.1016/s0924-977x(03)92355-8", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0924-977x(03)92355-8", "source_url": "https://doi.org/10.1016/s0924-977x(03)92355-8", "doi": "10.1016/s0924-977x(03)92355-8", "pmid": "", "publication_date": "2003-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2815, "title": "Chloroquine psychosis: a chemical psychosis?", "authors": "Mohan D, Mohandas E, Rajat R", "journal": "Journal of the National Medical Association", "publication_date": "1981-11-01", "publication_year": 1981, "doi": null, "pubmed_id": "7310924", "openalex_id": "https://openalex.org/W48775267", "source_url": "https://pubmed.ncbi.nlm.nih.gov/7310924/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-08-09 08:34:29", "bibtex": null, "source_record_id": "PMID:7310924", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/7310924/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:7310924", "source_url": "https://pubmed.ncbi.nlm.nih.gov/7310924/", "doi": "", "pmid": "7310924", "publication_date": "1981-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2819, "title": "Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.", "authors": "Trulson ME, Heym J, Jacobs BL", "journal": "Brain research", "publication_date": "1981-06-29", "publication_year": 1981, "doi": "10.1016/0006-8993(81)90507-2", "pubmed_id": "6114779", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/6114779/", "substance_tags": "psilocin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-08-09 08:28:30", "bibtex": null, "source_record_id": "PMID:6114779", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/6114779/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:6114779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/6114779/", "doi": "10.1016/0006-8993(81)90507-2", "pmid": "6114779", "publication_date": "1981-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5554, "title": "Psilocybin-induced Autonomic, Perceptual, and Behavioral Change", "authors": "R Fischer, Diana Warshay", "journal": "Pharmacopsychiatry", "publication_date": "1968-11-01", "publication_year": 1968, "doi": "10.1055/s-0028-1094227", "pubmed_id": null, "openalex_id": "https://openalex.org/W2047529423", "source_url": "https://doi.org/10.1055/s-0028-1094227", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Personality Change", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:09", "last_checked": "2026-08-09 08:25:58", "bibtex": null, "source_record_id": "DOI:10.1055/s-0028-1094227", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/s-0028-1094227", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/s-0028-1094227", "source_url": "https://doi.org/10.1055/s-0028-1094227", "doi": "10.1055/s-0028-1094227", "pmid": "", "publication_date": "1968-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5579, "title": "The effects of psychotomimetic drugs on primary suggestibility.", "authors": "Sjoberg BM, Hollister LE.", "journal": "Psychopharmacologia", "publication_date": "1965-10-30", "publication_year": 1965, "doi": "10.1007/bf00407857", "pubmed_id": "5885648", "openalex_id": null, "source_url": "https://doi.org/10.1007/bf00407857", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-04 06:52:09", "last_checked": "2026-08-09 08:37:19", "bibtex": null, "source_record_id": "PMID:5885648", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:5885648", "source_url": "https://doi.org/10.1007/bf00407857", "doi": "10.1007/bf00407857", "pmid": "5885648", "publication_date": "1965-10-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2914, "title": "[CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].", "authors": "REDA GC, VELLA G, CANCRINI L, D AGOSTINO E", "journal": "Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali", "publication_date": "1964-03-31", "publication_year": 1964, "doi": null, "pubmed_id": "14144273", "openalex_id": "https://openalex.org/W2419461447", "source_url": "https://pubmed.ncbi.nlm.nih.gov/14144273/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Consciousness,Personality Change,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-08-09 08:34:30", "bibtex": null, "source_record_id": "PMID:14144273", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:14144273", "source_url": "https://pubmed.ncbi.nlm.nih.gov/14144273/", "doi": "", "pmid": "14144273", "publication_date": "1964-03-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2953, "title": "[Clinical experiences with psilocybin (CY39 Sandoz)].", "authors": "SERCL M, KOVARIK J, JAROS O", "journal": "Psychiatria et neurologia", "publication_date": "1961-01-01", "publication_year": 1961, "doi": null, "pubmed_id": "13910754", "openalex_id": "https://openalex.org/W2438505389", "source_url": "https://pubmed.ncbi.nlm.nih.gov/13910754/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:15", "last_checked": "2026-08-09 08:34:30", "bibtex": null, "source_record_id": "PMID:13910754", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:13910754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/13910754/", "doi": "", "pmid": "13910754", "publication_date": "1961-01-01", "importer_version": "2.1.3", "text_redistributed": false } } ] }